data_1hqi_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hqi _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 44' ' ' LYS . 20.0 m . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -130.05 155.65 45.8 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.218 -0.926 . . . . 0.0 110.336 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.605 ' HB ' ' HA2' ' A' ' 74' ' ' GLY . 1.1 m -116.66 -150.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.566 -0.709 . . . . 0.0 109.361 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.586 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.0 OUTLIER 172.78 139.82 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.106 -0.996 . . . . 0.0 109.625 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.528 ' CG1' ' HB ' ' A' ' 40' ' ' ILE . 46.4 pt -136.61 139.41 45.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 39' ' ' ARG . . . -134.2 164.78 26.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.551 -1.343 . . . . 0.0 110.65 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.623 ' CZ ' ' CD1' ' A' ' 71' ' ' ILE . 0.5 OUTLIER -158.78 151.55 22.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.509 ' HG2' ' CB ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -131.81 92.97 3.22 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.05 -1.031 . . . . 0.0 108.51 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -87.04 -132.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.405 -0.809 . . . . 0.0 109.762 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.46 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 5.0 t-20 -86.42 -111.88 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.837 -1.164 . . . . 0.0 109.385 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -132.63 -24.52 1.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.927 -1.108 . . . . 0.0 109.775 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.6 t-20 -102.96 -54.35 2.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.025 -1.047 . . . . 0.0 109.817 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 18' ' ' VAL . . . -44.27 -31.17 0.94 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.809 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HD3' ' O ' ' A' ' 12' ' ' ASN . 55.9 mtm180 -64.79 -63.58 1.08 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.613 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 1.1 m-85 -47.5 -36.57 10.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -0.958 . . . . 0.0 109.455 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 15' ' ' ALA . 41.2 t -54.67 -58.64 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.93 . . . . 0.0 109.031 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.3 t -56.73 -22.78 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.207 -0.933 . . . . 0.0 108.865 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.473 ' O ' HG13 ' A' ' 23' ' ' ILE . 13.3 tt0 -69.46 -38.36 77.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.437 -0.789 . . . . 0.0 109.217 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.36 68.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.246 -0.909 . . . . 0.0 108.891 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.3 mm -70.31 -55.58 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 20' ' ' GLU . 1.0 OUTLIER -58.98 -35.54 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.055 -1.028 . . . . 0.0 109.668 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -69.63 -35.97 75.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.108 -0.995 . . . . 0.0 108.693 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 24' ' ' GLN . 0.3 OUTLIER -46.18 -42.8 14.56 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -79.8 136.54 54.81 Favored Pre-proline 0 N--CA 1.486 1.356 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -84.28 46.23 1.91 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.795 1.418 . . . . 0.0 109.979 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -149.04 -39.57 0.15 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.18 -0.95 . . . . 0.0 109.629 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -44.81 140.18 2.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 109.746 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.22 177.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.0 t -141.45 154.58 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.23 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -140.29 -71.73 0.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.636 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.486 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -95.27 176.66 6.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.969 . . . . 0.0 109.595 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.553 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -152.13 -64.55 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.285 -0.885 . . . . 0.0 109.538 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 4.2 Cg_exo -61.17 -75.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.636 1.335 . . . . 0.0 110.417 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.486 ' HB1' ' CE1' ' A' ' 33' ' ' HIS . . . -46.52 -93.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.509 ' CB ' ' HG2' ' A' ' 10' ' ' GLN . 2.0 ptm -115.46 -167.23 1.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.687 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 0.9 OUTLIER -128.43 101.96 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.356 -0.84 . . . . 0.0 109.114 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.543 ' HG3' ' NH1' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -87.31 169.26 12.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.746 -179.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.528 ' HB ' ' CG1' ' A' ' 7' ' ' ILE . 45.3 mt -142.69 164.92 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.725 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -143.85 147.27 33.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.209 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.56 ' CB ' ' CG2' ' A' ' 5' ' ' VAL . . . -127.51 -171.81 2.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 8.3 mt-10 -140.11 64.91 1.43 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.878 -1.139 . . . . 0.0 110.372 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 8.5 tttt 175.25 -140.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.952 -1.093 . . . . 0.0 110.263 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.567 ' CB ' ' HB3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -126.51 166.69 16.79 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.301 -0.874 . . . . 0.0 110.182 -178.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.507 ' O ' HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -129.03 157.72 40.93 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HG2' ' CG2' ' A' ' 85' ' ' VAL . 8.2 mt-10 -150.96 140.01 21.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.077 -1.014 . . . . 0.0 109.99 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.549 HD12 ' CE2' ' A' ' 84' ' ' PHE . 1.3 mp -138.94 150.44 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 0.0 109.159 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -97.3 176.42 5.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.122 -0.986 . . . . 0.0 109.969 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -67.08 -24.39 65.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 109.332 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.497 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 34.9 mm-40 -49.53 -40.89 39.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.028 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.474 ' OG1' ' CG2' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -65.56 -46.44 79.46 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.162 -0.961 . . . . 0.0 108.755 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.6 t -56.08 -22.98 14.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -75.58 -38.21 59.29 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -66.69 -53.02 38.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 108.956 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -56.12 -33.39 65.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.288 -0.883 . . . . 0.0 109.139 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.18 -55.83 29.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.246 -0.909 . . . . 0.0 109.095 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.32 -7.49 63.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.44 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -117.01 10.22 13.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -1.108 . . . . 0.0 109.402 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -69.3 -6.89 32.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.707 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -91.42 19.75 5.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.021 . . . . 0.0 109.336 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.427 ' OD1' ' CB ' ' A' ' 65' ' ' GLU . 26.8 t70 -111.84 10.2 20.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.541 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -49.54 -46.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 109.871 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -51.61 -45.87 63.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 109.406 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.427 ' CB ' ' OD1' ' A' ' 62' ' ' ASP . 2.7 tt0 -68.29 -27.86 66.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.195 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 69' ' ' ASP . 1.1 mtm -74.78 -17.88 60.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.301 -0.874 . . . . 0.0 109.224 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 -57.49 5.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.557 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.9 t -46.96 -64.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.524 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 2.0 p30 -82.87 154.79 24.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.521 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 21.1 t -99.53 165.75 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.168 -0.958 . . . . 0.0 109.568 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.623 ' CD1' ' CZ ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -146.11 151.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 0.0 109.648 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.542 ' CG2' ' OH ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -165.4 151.86 10.01 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -154.61 152.0 10.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.898 -1.126 . . . . 0.0 111.185 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.605 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 46.84 -85.12 0.01 OUTLIER Glycine 0 C--N 1.299 -1.492 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.926 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 73' ' ' ILE . . . 171.37 -47.81 0.19 Allowed Glycine 0 C--N 1.284 -2.329 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.521 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 16.2 t30 -120.34 -141.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.973 -1.31 . . . . 0.0 108.959 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.469 HG21 ' CE1' ' A' ' 84' ' ' PHE . 3.0 p 178.94 98.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.988 -1.07 . . . . 0.0 110.151 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.42 129.9 46.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 108.865 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -125.6 139.98 53.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.58 -96.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -104.04 -60.97 1.5 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.042 -1.036 . . . . 0.0 109.373 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -127.88 -30.8 2.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.341 -0.849 . . . . 0.0 109.01 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.496 ' CG ' ' N ' ' A' ' 84' ' ' PHE . 34.4 ttp180 -68.59 168.21 13.48 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.359 -0.838 . . . . 0.0 109.146 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.549 ' CE2' HD12 ' A' ' 48' ' ' ILE . 0.9 OUTLIER -141.84 127.11 18.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 108.907 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.513 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 3.7 p -138.64 150.72 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.22 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.537 ' CD1' ' HA3' ' A' ' 74' ' ' GLY . 1.7 tm? -157.19 135.75 11.42 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.567 ' HB3' ' CB ' ' A' ' 45' ' ' ARG . 2.0 mp0 . . . . . 0 C--N 1.303 -1.445 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 44' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.632 ' N ' ' CD1' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.17 154.92 42.32 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.032 -1.043 . . . . 0.0 110.47 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.523 HG21 ' CB ' ' A' ' 42' ' ' ALA . 3.4 m -115.1 -171.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.458 0.647 . . . . 0.0 109.313 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.567 ' O ' ' N ' ' A' ' 74' ' ' GLY . 4.9 t80 -159.08 137.98 11.11 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.526 HG21 ' HA ' ' A' ' 73' ' ' ILE . 3.2 pt -158.11 142.14 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.499 ' HB3' ' HA ' ' A' ' 39' ' ' ARG . . . -146.89 150.41 35.18 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.776 -1.203 . . . . 0.0 110.109 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CZ ' ' CG2' ' A' ' 71' ' ' ILE . 8.8 m-85 -134.57 172.27 13.16 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.523 ' NE2' ' C ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -147.33 80.99 1.52 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.258 178.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.518 ' CA ' ' HB3' ' A' ' 69' ' ' ASP . 5.5 t0 -106.75 -178.91 3.79 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.1 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.157 -0.964 . . . . 0.0 109.049 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.56 14.12 0.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.034 -1.041 . . . . 0.0 109.938 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -102.46 -56.5 2.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.317 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.41 -54.51 39.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.756 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.446 ' HD2' HG22 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -51.12 -39.2 55.68 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 109.611 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.432 ' N ' ' HG3' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -59.44 -47.5 85.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.229 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.401 ' O ' HD13 ' A' ' 22' ' ' ILE . 73.1 t -53.81 -53.84 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.287 -0.883 . . . . 0.0 109.241 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.454 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 53.3 t -62.37 -21.82 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.216 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -43.84 73.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.777 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.11 67.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.0 109.324 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 14.8 mt -67.14 -42.26 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.276 -0.89 . . . . 0.0 109.172 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.525 HG21 ' CB ' ' A' ' 29' ' ' ALA . 41.2 mt -60.87 -54.63 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.33 -0.856 . . . . 0.0 109.298 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 25' ' ' ASP . 18.6 mt-30 -57.79 -31.33 66.45 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.157 -0.964 . . . . 0.0 108.56 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 24' ' ' GLN . 9.0 t70 -46.12 -47.51 17.38 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -84.58 135.27 40.97 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -83.65 45.19 1.75 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.761 1.4 . . . . 0.0 110.155 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.6 t60 -151.7 -49.06 0.11 Allowed 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.165 -0.959 . . . . 0.0 109.759 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.525 ' CB ' HG21 ' A' ' 23' ' ' ILE . . . -41.85 141.43 0.83 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.4 -0.813 . . . . 0.0 109.704 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -100.85 -169.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.185 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.539 ' CG2' ' N ' ' A' ' 32' ' ' GLN . 2.0 p -169.01 166.46 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 0.0 109.536 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.539 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 2.8 mm-40 -144.84 77.24 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.513 ' CD2' ' O ' ' A' ' 33' ' ' HIS . 0.3 OUTLIER -48.49 103.36 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 109.547 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.557 ' CD2' ' HD2' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -104.84 -178.56 0.63 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.557 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 3.8 Cg_exo -67.6 -74.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.939 1.494 . . . . 0.0 110.116 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.39 3.39 11.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.758 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.3 mtt -112.28 157.54 20.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.128 -0.982 . . . . 0.0 109.388 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.515 ' CG1' ' O ' ' A' ' 9' ' ' PHE . 12.1 pt -134.51 92.02 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.651 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.499 ' HA ' ' HB3' ' A' ' 8' ' ' ALA . 2.1 ttp180 -85.55 162.23 18.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 110.086 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.484 ' HB ' ' CG1' ' A' ' 7' ' ' ILE . 4.1 mp -150.97 162.01 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 0.0 109.499 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.436 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -161.96 157.1 23.22 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.027 -1.046 . . . . 0.0 110.251 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.523 ' CB ' HG21 ' A' ' 5' ' ' VAL . . . -129.34 177.75 6.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.388 -0.82 . . . . 0.0 109.068 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 2.8 pt-20 -158.74 68.74 0.46 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.915 -1.116 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.4 OUTLIER 169.82 -152.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.816 -1.178 . . . . 0.0 110.82 178.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.543 ' C ' ' CD2' ' A' ' 46' ' ' LEU . 20.1 mtp180 -125.43 135.14 52.05 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.606 ' CD1' ' CD1' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -127.32 162.53 26.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.45 -0.781 . . . . 0.0 109.168 -178.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.532 ' CB ' HG21 ' A' ' 85' ' ' VAL . 1.2 pt-20 -176.19 158.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.984 -1.073 . . . . 0.0 110.668 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.526 ' CG2' ' CB ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -152.27 155.84 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.599 ' HA ' ' CB ' ' A' ' 83' ' ' ARG . 30.0 ttp180 -100.12 -112.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 110.112 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.407 ' N ' ' HD2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -61.63 -5.29 1.78 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.982 -1.074 . . . . 0.0 110.519 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.526 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 1.0 OUTLIER -54.61 -14.7 1.41 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.708 -1.245 . . . . 0.0 109.363 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 84' ' ' PHE . 1.9 m -58.26 -39.33 78.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.69 -1.256 . . . . 0.0 109.47 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.91 -32.45 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 1.3 tt0 -67.63 -40.56 84.63 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' CG ' ' HA ' ' A' ' 60' ' ' ALA . 1.1 tt0 -49.85 -63.29 1.16 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.541 ' HA ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -48.55 -31.44 6.53 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.634 -0.666 . . . . 0.0 109.387 179.006 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.495 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.5 tp -52.27 -59.03 4.88 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.68 ' O ' ' CB ' ' A' ' 59' ' ' ARG . . . -53.63 -24.52 25.19 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 106.861 -2.496 . . . . 0.0 106.861 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.68 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 1.6 ttm-85 110.68 35.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.786 1.234 . . . . 0.0 108.557 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 62.92 96.42 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.597 ' CZ2' HG23 ' A' ' 63' ' ' VAL . 24.6 t-105 -20.11 82.74 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 123.26 1.505 . . . . 0.0 109.35 -174.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 60' ' ' ALA . 19.0 t70 -109.2 71.1 0.76 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.415 -1.721 . . . . 0.0 109.738 -176.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.597 HG23 ' CZ2' ' A' ' 61' ' ' TRP . 2.1 t -86.91 6.51 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.865 . . . . 0.0 109.799 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.538 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.3 mp0 -41.63 -34.01 0.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.614 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.54 -50.93 67.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.003 -1.061 . . . . 0.0 108.979 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -75.68 -2.64 30.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.46 -0.775 . . . . 0.0 110.02 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 64' ' ' GLN . 3.7 pp -38.5 -26.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.503 -0.748 . . . . 0.0 110.961 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.506 ' N ' ' O ' ' A' ' 66' ' ' MET . 9.4 m -39.89 -45.42 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.151 -0.968 . . . . 0.0 110.156 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.518 ' HB3' ' CA ' ' A' ' 11' ' ' ASP . 15.8 p30 -65.29 149.45 49.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.67 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 10' ' ' GLN . 21.8 t -62.53 169.77 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.634 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 11.4 mt -143.56 157.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.056 -1.028 . . . . 0.0 110.643 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.495 ' OG1' ' HB1' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -159.31 142.38 14.34 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.526 ' HA ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -143.78 163.33 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.084 -1.01 . . . . 0.0 110.194 -179.087 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -174.25 71.95 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.454 ' O ' HD22 ' A' ' 86' ' ' LEU . . . 136.02 108.13 0.91 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.575 ' HA ' ' CD2' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -157.78 139.42 13.86 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.183 -1.187 . . . . 0.0 110.908 -178.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.546 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 1.8 t -152.37 30.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 5.2 p-10 -47.84 -38.95 17.12 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.898 0.856 . . . . 0.0 111.233 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.407 ' N ' ' CG ' ' A' ' 78' ' ' ASP . 1.5 mm-40 -110.79 103.06 11.54 Favored 'General case' 0 C--N 1.266 -3.023 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.93 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.53 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 58.1 t0 -115.2 -68.46 0.92 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.035 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -108.21 -96.6 0.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -0.93 . . . . 0.0 109.365 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -131.03 0.22 4.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.036 -1.04 . . . . 0.0 109.221 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.599 ' CB ' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -102.6 -107.09 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.796 . . . . 0.0 109.42 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 78' ' ' ASP . 12.9 t80 -174.74 118.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.831 -1.168 . . . . 0.0 108.718 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 10.7 p -131.83 174.92 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.867 -1.146 . . . . 0.0 110.588 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.606 ' CD1' ' CD1' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -177.84 130.56 0.15 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.559 ' N ' HD23 ' A' ' 86' ' ' LEU . 2.2 mt-10 . . . . . 0 C--N 1.302 -1.463 0 O-C-N 120.902 -1.124 . . . . 0.0 111.624 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 44' ' ' LYS . 15.8 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.072 0.463 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -122.44 168.41 12.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.049 -1.032 . . . . 0.0 109.707 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.528 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -132.85 -178.35 2.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.346 -0.846 . . . . 0.0 109.954 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 74' ' ' GLY . 1.3 t80 -149.53 142.37 24.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 6' ' ' TYR . 1.8 pp -160.84 158.51 2.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 72' ' ' THR . . . -159.35 145.69 16.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.658 -1.276 . . . . 0.0 109.691 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 2.6 p90 -145.26 -171.2 3.61 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 109.539 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.579 ' N ' ' HB ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -148.97 98.98 2.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -0.76 . . . . 0.0 109.108 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.445 ' OD1' ' OD2' ' A' ' 69' ' ' ASP . 35.4 t70 -108.57 136.76 47.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.629 -0.67 . . . . 0.0 109.525 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -71.67 -31.49 66.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 109.561 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.43 ' CB ' ' OD2' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -57.52 106.02 0.3 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.087 -1.008 . . . . 0.0 108.575 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.61 -11.43 7.21 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.82 -31.53 49.58 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.034 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.45 ' CG ' ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -67.29 -45.45 76.52 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.486 -0.759 . . . . 0.0 109.067 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.4 -44.53 72.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.206 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -54.95 -60.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.237 -0.915 . . . . 0.0 108.828 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.1 t -52.95 -23.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 108.864 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -54.39 19.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.191 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.89 -35.45 61.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.271 -0.893 . . . . 0.0 109.304 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.8 mt -64.52 -45.34 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 109.191 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' A' ' 29' ' ' ALA . 95.9 mt -51.43 -48.06 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.879 . . . . 0.0 109.14 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.2 72.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.21 -0.931 . . . . 0.0 108.573 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.12 -32.69 16.56 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -80.07 137.59 53.26 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -84.47 44.9 1.59 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.818 1.431 . . . . 0.0 109.822 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -151.06 -53.97 0.14 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.305 -0.872 . . . . 0.0 109.201 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.516 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . . . -63.49 139.59 58.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.356 -0.84 . . . . 0.0 109.075 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.527 ' CG1' ' HG3' ' A' ' 41' ' ' GLU . 11.7 p -101.21 158.95 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.193 -0.942 . . . . 0.0 109.609 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.78 148.7 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.408 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -144.29 43.73 1.42 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.225 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 32' ' ' GLN . 12.5 p80 -44.32 140.31 2.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.892 . . . . 0.0 109.35 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.468 ' CG ' ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -103.73 178.26 1.22 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.504 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 34' ' ' HIS . 2.7 Cg_endo -76.53 -28.01 7.13 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.066 1.561 . . . . 0.0 110.331 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.89 -30.62 3.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.592 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.484 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -117.16 -168.99 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.569 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 9' ' ' PHE . 11.3 pt -140.03 115.65 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.346 -0.847 . . . . 0.0 108.831 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.482 ' O ' ' CD1' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -111.89 142.76 43.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.447 -178.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 39' ' ' ARG . 28.0 mm -145.91 152.42 14.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.583 -0.698 . . . . 0.0 109.213 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.527 ' HG3' ' CG1' ' A' ' 30' ' ' VAL . 2.9 pt-20 -129.29 176.59 7.82 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.113 -0.992 . . . . 0.0 108.893 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.528 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -132.66 -179.43 5.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.079 -1.013 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 17.9 mt-10 -140.48 58.87 1.56 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.373 -0.83 . . . . 0.0 109.261 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 3' ' ' SER . 1.6 mmtp -153.0 -166.28 2.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.908 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.551 ' HA ' ' CG ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -141.26 -171.2 3.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.641 ' CB ' ' CD1' ' A' ' 86' ' ' LEU . 15.2 mt -159.03 157.33 30.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 110.741 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 1.4 tt0 -160.94 139.75 10.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.179 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.533 HG23 ' CB ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -154.69 141.63 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.128 -0.983 . . . . 0.0 109.912 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.586 ' HA ' ' CG ' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -101.58 -101.38 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.811 179.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -6.38 27.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.018 -1.052 . . . . 0.0 109.294 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.533 ' CB ' HG23 ' A' ' 48' ' ' ILE . 3.2 mt-10 -56.41 -16.12 5.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.422 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -59.14 -42.48 90.76 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.87 -1.144 . . . . 0.0 109.259 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 52' ' ' THR . 59.0 t -48.38 -33.48 4.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.979 -1.076 . . . . 0.0 108.158 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -68.39 -44.93 74.03 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -45.08 46.42 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -53.86 -44.13 70.12 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.595 ' C ' ' CD1' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -51.44 -72.52 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.363 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.494 ' N ' HD11 ' A' ' 57' ' ' LEU . . . -39.32 -28.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.506 ' CB ' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -53.07 -58.97 5.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -1.201 . . . . 0.0 109.008 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 59' ' ' ARG . . . -42.85 -32.92 0.68 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -90.86 50.21 1.77 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.56 78.7 2.57 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.942 0.877 . . . . 0.0 109.396 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' GLU . 8.2 t -72.58 7.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.918 -0.489 . . . . 0.0 110.622 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 63' ' ' VAL . 2.7 mp0 -39.52 -27.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.141 -0.974 . . . . 0.0 109.91 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 63' ' ' VAL . 11.7 mt-10 -57.48 -56.23 24.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.008 . . . . 0.0 108.902 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.465 ' HB2' HG13 ' A' ' 63' ' ' VAL . 1.6 mmm -67.39 -8.34 32.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 0.0 109.403 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' ASP . 5.9 tp -76.6 7.85 4.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.443 -0.786 . . . . 0.0 110.433 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 67' ' ' LEU . 58.2 t -40.41 -25.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.995 -1.066 . . . . 0.0 110.489 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' LEU . 7.2 m-20 -58.18 143.55 43.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.007 -1.058 . . . . 0.0 109.019 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.579 ' HB ' ' N ' ' A' ' 10' ' ' GLN . 57.3 t -43.82 159.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.144 -0.972 . . . . 0.0 109.126 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.577 ' N ' ' CD1' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -141.54 141.56 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.579 -0.7 . . . . 0.0 109.787 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -154.73 147.63 24.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.564 179.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.513 HD11 HG22 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -133.17 174.8 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.344 -0.847 . . . . 0.0 109.443 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 174.94 64.44 0.05 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.18 -95.3 0.49 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.26 153.58 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 0.0 109.473 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.54 102.8 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.127 -0.983 . . . . 0.0 109.869 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.528 ' OD1' ' CG1' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -107.7 112.95 25.9 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.006 178.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.58 131.46 54.83 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.473 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -104.04 -107.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -108.41 -56.34 2.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.93 -1.106 . . . . 0.0 109.495 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -127.28 -33.7 2.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.35 -0.844 . . . . 0.0 108.96 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.586 ' CG ' ' HA ' ' A' ' 49' ' ' ARG . 1.7 mpt_? -66.48 -178.06 0.64 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.548 -0.72 . . . . 0.0 109.397 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.471 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.3 t80 -161.5 130.16 4.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 109.661 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -132.64 157.31 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.989 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.641 ' CD1' ' CB ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -165.49 -150.41 0.13 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.315 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.551 ' CG ' ' HA ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER . . . . . 0 C--N 1.29 -1.986 0 O-C-N 121.092 -1.005 . . . . 0.0 109.373 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.15 0.5 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -122.33 161.56 23.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.222 -0.924 . . . . 0.0 109.212 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.543 ' CG2' ' CB ' ' A' ' 42' ' ' ALA . 3.1 m -125.52 -171.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.271 -0.893 . . . . 0.0 110.272 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.586 ' O ' ' N ' ' A' ' 74' ' ' GLY . 10.5 t80 -163.43 137.75 6.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.536 -0.727 . . . . 0.0 109.134 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' A' ' 39' ' ' ARG . 7.7 pt -148.76 139.67 17.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.938 ' HA ' ' CB ' ' A' ' 39' ' ' ARG . . . -144.36 137.52 27.18 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 117.752 -1.579 . . . . 0.0 111.98 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.608 ' CD2' ' HG2' ' A' ' 39' ' ' ARG . 2.0 p90 -128.8 178.15 6.56 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.084 -1.046 . . . . 0.0 109.106 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.594 ' N ' HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -127.03 94.04 3.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.478 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 5.1 p-10 -108.12 143.16 37.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 110.214 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -78.48 -5.06 51.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.446 -0.784 . . . . 0.0 109.157 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' O ' ' OD2' ' A' ' 11' ' ' ASP . 32.9 t0 -80.78 103.46 10.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.24 -0.913 . . . . 0.0 108.819 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.29 -9.16 21.91 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.32 -0.862 . . . . 0.0 108.895 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.06 -39.27 71.78 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.24 -0.913 . . . . 0.0 108.931 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.43 -44.95 80.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.429 -0.794 . . . . 0.0 109.009 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.58 ' CD2' HG23 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -55.11 -45.55 75.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.0 108.999 179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.18 -61.07 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -0.878 . . . . 0.0 108.81 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -53.05 -23.26 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.274 -0.892 . . . . 0.0 108.613 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -54.95 17.83 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.6 -37.41 17.99 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 25' ' ' ASP . 36.8 mt -61.26 -45.09 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.529 HG22 ' CB ' ' A' ' 29' ' ' ALA . 22.4 mm -50.45 -57.04 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 109.024 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -59.5 -28.52 67.12 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.195 -0.94 . . . . 0.0 108.489 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -50.4 -39.44 47.06 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -79.69 141.77 56.34 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -84.48 44.84 1.58 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.777 1.409 . . . . 0.0 109.904 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -150.65 -48.28 0.12 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.529 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -71.1 139.26 50.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.385 -0.822 . . . . 0.0 109.657 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.411 HG11 ' N ' ' A' ' 31' ' ' VAL . 7.6 t -101.98 152.04 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 109.502 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.411 ' N ' HG11 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -129.07 169.14 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.21 -0.932 . . . . 0.0 109.367 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -147.73 111.46 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.406 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -82.14 127.77 33.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -123.93 148.2 56.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.29 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.453 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 2.2 Cg_endo -87.23 43.77 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.895 1.471 . . . . 0.0 110.206 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 35' ' ' PRO . . . 166.43 -29.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.477 ' C ' ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -104.8 171.6 7.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.579 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.58 HG23 ' CD2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -156.04 124.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.448 -0.783 . . . . 0.0 109.199 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.938 ' CB ' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER 171.59 -151.88 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.993 -1.067 . . . . 0.0 110.949 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.515 ' CG1' ' C ' ' A' ' 39' ' ' ARG . 2.5 mt -160.79 -170.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.587 -1.321 . . . . 0.0 110.306 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -134.83 -173.35 3.28 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.543 ' CB ' ' CG2' ' A' ' 5' ' ' VAL . . . -138.74 -171.34 3.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.973 -1.08 . . . . 0.0 110.007 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 18.6 mt-10 -141.36 33.01 1.68 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.404 -0.81 . . . . 0.0 109.741 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -168.34 -144.65 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.891 -1.131 . . . . 0.0 110.332 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.564 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -145.3 -154.09 0.52 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.64 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -155.5 148.32 24.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.059 -1.026 . . . . 0.0 110.061 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.473 ' C ' ' CG1' ' A' ' 48' ' ' ILE . 4.3 tm-20 -137.81 139.56 40.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.064 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.473 ' CG1' ' C ' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -159.4 154.79 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.11 -0.994 . . . . 0.0 109.967 -179.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.459 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -82.82 -166.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.382 -0.823 . . . . 0.0 110.092 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.515 ' HG3' ' NH1' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -73.38 -27.01 61.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.928 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -49.19 -30.42 6.87 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.027 -1.046 . . . . 0.0 108.921 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.587 ' HB ' ' CD2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -65.74 -45.28 83.22 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.894 -1.129 . . . . 0.0 108.478 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.585 ' CG2' ' CD1' ' A' ' 84' ' ' PHE . 40.6 t -47.88 -29.56 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 3.3 tt0 -71.85 -45.09 62.57 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -55.97 -51.7 66.77 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.397 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.67 -38.64 72.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 109.643 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.21 -52.3 65.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.208 -0.932 . . . . 0.0 109.244 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.12 -14.55 61.64 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -112.52 20.87 16.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -1.082 . . . . 0.0 109.713 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.58 -7.43 43.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.665 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.612 ' CD1' ' O ' ' A' ' 61' ' ' TRP . 65.3 t-105 -92.31 22.89 4.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.932 . . . . 0.0 109.481 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -110.79 5.95 21.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.022 -1.049 . . . . 0.0 109.988 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.01 -33.84 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 109.644 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -53.48 -37.15 62.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.227 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.77 -31.52 68.34 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.348 -0.845 . . . . 0.0 109.236 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mtm -67.78 -12.84 61.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 tt -68.61 -50.57 50.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.095 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.86 -43.57 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 10' ' ' GLN . 1.4 p-10 -94.14 162.64 13.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.148 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.594 HG11 ' N ' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -81.5 175.39 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.207 -0.933 . . . . 0.0 109.124 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.35 137.5 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.309 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -144.3 154.86 43.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.482 ' HA ' HG21 ' A' ' 7' ' ' ILE . 1.9 pp -145.27 174.68 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.774 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -177.76 58.17 0.09 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 87' ' ' GLU . . . 120.12 61.42 0.25 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.552 ' CB ' ' HB3' ' A' ' 87' ' ' GLU . 2.3 p-10 -175.85 138.11 0.36 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.418 -1.048 . . . . 0.0 108.642 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.601 ' O ' ' O ' ' A' ' 85' ' ' VAL . 7.6 p 177.19 79.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 O-C-N 121.291 -0.88 . . . . 0.0 109.32 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.592 ' HB3' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -49.06 -15.86 0.12 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.754 -0.591 . . . . 0.0 111.679 -178.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' O ' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -111.66 100.82 9.27 Favored 'General case' 0 C--N 1.281 -2.401 0 O-C-N 121.153 -0.967 . . . . 0.0 109.21 179.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.8 -79.97 0.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.787 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.59 -90.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.922 . . . . 0.0 109.925 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -118.67 -29.5 5.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.824 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -88.84 -158.19 0.48 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 109.016 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -126.84 120.5 29.4 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.094 -1.004 . . . . 0.0 109.633 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.601 ' O ' ' O ' ' A' ' 77' ' ' VAL . 2.5 p -144.7 140.05 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.18 -0.95 . . . . 0.0 109.545 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.622 ' HG ' ' CB ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -151.53 -155.39 0.62 Allowed 'General case' 0 C--N 1.284 -2.252 0 O-C-N 120.885 -1.134 . . . . 0.0 108.124 177.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.64 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.283 -2.318 0 CA-C-O 122.115 0.959 . . . . 0.0 110.725 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 44' ' ' LYS . 20.8 p . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -143.22 164.86 29.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.965 -1.084 . . . . 0.0 110.485 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.486 ' HB ' ' HA3' ' A' ' 75' ' ' GLY . 10.5 m -130.79 167.37 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.515 0.674 . . . . 0.0 109.858 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.568 ' O ' ' N ' ' A' ' 74' ' ' GLY . 0.8 OUTLIER -145.06 135.78 24.5 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.53 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 1.9 pt -160.5 137.77 2.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.877 -1.139 . . . . 0.0 110.368 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.632 ' O ' ' CD1' ' A' ' 9' ' ' PHE . . . -120.79 167.72 12.2 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CD1' ' O ' ' A' ' 8' ' ' ALA . 12.0 m-85 -163.18 155.13 17.87 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.536 -1.353 . . . . 0.0 109.793 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.509 ' N ' HG12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -121.05 94.86 4.48 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.033 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.473 ' HB3' ' OD1' ' A' ' 69' ' ' ASP . 1.4 p30 -108.83 137.53 46.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.585 -0.697 . . . . 0.0 109.749 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -13.76 59.48 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.245 -0.91 . . . . 0.0 109.174 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.8 105.83 4.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.441 ' OD1' ' CB ' ' A' ' 17' ' ' TYR . 18.1 t30 -60.71 -12.83 11.65 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.28 -42.03 66.15 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.256 -0.903 . . . . 0.0 108.784 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -38.78 74.34 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.441 ' CB ' ' OD1' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -58.64 -43.16 89.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.477 -0.764 . . . . 0.0 108.966 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.49 -52.87 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 108.81 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 23' ' ' ILE . 48.1 t -62.39 -24.06 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.375 -0.828 . . . . 0.0 109.025 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.423 ' CG ' ' OE1' ' A' ' 24' ' ' GLN . 1.7 tt0 -76.08 -27.14 57.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.267 -0.896 . . . . 0.0 109.049 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.39 -44.48 64.88 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -63.82 -46.94 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.522 ' CG2' ' HB2' ' A' ' 29' ' ' ALA . 60.1 mt -54.25 -49.1 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.423 ' OE1' ' CG ' ' A' ' 20' ' ' GLU . 17.9 mt-30 -61.7 -32.64 72.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.146 -0.972 . . . . 0.0 108.457 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -47.06 -36.82 8.54 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -79.84 133.69 58.12 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.36 46.24 1.91 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.805 1.424 . . . . 0.0 109.98 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -149.92 -45.44 0.13 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.126 -0.984 . . . . 0.0 109.713 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.522 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . . . -59.92 144.21 49.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.487 ' C ' ' CG2' ' A' ' 31' ' ' VAL . 5.7 t -101.11 139.67 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.521 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.487 ' CG2' ' C ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -168.88 166.54 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 109.14 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 33' ' ' HIS . 2.5 mm-40 -149.43 -94.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.338 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 4.9 t60 55.72 110.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 109.88 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.547 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -154.16 -62.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.616 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.3 Cg_endo -67.21 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.652 1.343 . . . . 0.0 109.772 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.64 -53.75 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.399 -0.813 . . . . 0.0 109.243 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.469 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -72.08 157.33 37.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 109.153 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -122.83 165.22 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.017 -1.052 . . . . 0.0 109.34 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.492 ' NH1' ' HG2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -132.21 156.87 45.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.966 . . . . 0.0 109.986 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 8.7 mt -152.83 172.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.401 -0.812 . . . . 0.0 109.053 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 5.9 tt0 171.36 145.21 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.501 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -144.12 -162.8 1.54 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.085 -1.01 . . . . 0.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -140.67 82.92 1.87 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 3' ' ' SER . 31.2 mmtt -129.64 -165.13 1.48 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.048 -1.032 . . . . 0.0 110.856 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.541 ' CA ' ' HG3' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -165.24 165.34 19.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.56 ' CB ' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -164.55 150.61 10.56 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.897 -1.127 . . . . 0.0 110.478 178.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.442 ' HA ' HG21 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -142.99 139.67 30.72 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 52' ' ' THR . 2.3 pt -139.71 163.64 24.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.064 -1.022 . . . . 0.0 110.305 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.468 ' HA ' ' HG3' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -95.46 -147.43 0.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.476 -0.765 . . . . 0.0 109.336 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' NH1' ' CG ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -87.67 -40.59 14.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.081 -1.012 . . . . 0.0 109.726 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 69.1 tt0 -54.67 -31.21 57.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 109.06 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.536 ' CB ' ' HB ' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -61.92 -40.16 94.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.036 -1.04 . . . . 0.0 108.536 179.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 52' ' ' THR . 21.2 t -46.25 -32.93 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 3.8 tt0 -71.24 -46.01 61.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 52' ' ' THR . 40.0 mm-40 -52.82 -55.12 25.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.364 -0.835 . . . . 0.0 109.529 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -55.51 -34.92 65.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.257 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.476 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.8 tp -56.43 -54.8 41.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.149 -0.969 . . . . 0.0 109.284 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.65 -9.64 65.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.44 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -112.75 5.61 17.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -1.076 . . . . 0.0 109.396 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -79.29 -19.15 51.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -89.89 23.64 2.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.196 -0.94 . . . . 0.0 109.286 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.64 39.48 2.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.401 -0.812 . . . . 0.0 109.017 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.95 -3.94 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.708 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.419 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 13.1 mp0 -50.2 -25.24 3.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 0.0 109.465 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -66.31 -44.53 83.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.147 -0.971 . . . . 0.0 109.426 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.1 mtp -59.27 -16.11 19.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 0.0 109.523 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 11.2 tp -78.1 -52.25 9.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.703 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 10' ' ' GLN . 2.0 t -66.56 -55.19 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.626 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -98.76 85.22 3.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.636 ' O ' HG12 ' A' ' 71' ' ' ILE . 7.1 p -103.29 141.77 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.247 -0.908 . . . . 0.0 112.513 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 70' ' ' VAL . 2.1 mm 178.41 -85.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.565 ' N ' HG23 ' A' ' 71' ' ' ILE . 2.2 m -133.44 176.33 8.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.921 -1.112 . . . . 0.0 111.621 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.508 ' CG1' ' C ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -160.87 162.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -179.65 34.99 0.07 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 5' ' ' VAL . . . -162.58 85.31 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -129.2 -135.33 0.22 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.586 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.58 ' CG2' ' CD1' ' A' ' 84' ' ' PHE . 7.1 p -118.22 126.6 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -0.999 . . . . 0.0 109.724 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.98 148.0 28.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.513 -0.742 . . . . 0.0 109.943 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -103.3 133.52 48.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 108.961 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -106.15 -93.94 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 110.102 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -105.39 -75.72 0.62 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.899 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.53 -31.41 4.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 108.761 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.468 ' HG3' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -81.04 -171.74 3.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.58 ' CD1' ' CG2' ' A' ' 77' ' ' VAL . 0.2 OUTLIER -134.87 158.96 42.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.09 -1.006 . . . . 0.0 109.269 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.513 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 2.4 p -143.7 169.56 10.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.242 -0.911 . . . . 0.0 109.438 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.56 HD13 ' CB ' ' A' ' 46' ' ' LEU . 1.3 pp -176.84 -167.39 0.18 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.541 ' HG3' ' CA ' ' A' ' 45' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.298 -1.652 0 O-C-N 120.894 -1.129 . . . . 0.0 110.645 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -137.02 156.43 48.44 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.087 -1.008 . . . . 0.0 110.512 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -113.73 -176.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.642 ' CD2' HG22 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -147.05 139.15 24.52 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.737 ' HA ' HG21 ' A' ' 73' ' ' ILE . 1.3 pt -143.63 135.32 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.296 -0.878 . . . . 0.0 108.801 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.578 ' N ' ' HA ' ' A' ' 72' ' ' THR . . . -145.3 147.1 31.97 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.384 -1.326 . . . . 0.0 110.522 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.602 ' CE1' ' HB ' ' A' ' 38' ' ' ILE . 16.7 p90 -135.96 175.98 9.1 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -141.08 80.14 1.73 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.095 -1.003 . . . . 0.0 108.748 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.443 ' CB ' ' NH1' ' A' ' 16' ' ' ARG . 4.0 t70 -110.18 178.84 4.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.336 -0.853 . . . . 0.0 110.0 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -121.91 16.26 10.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 109.397 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -85.96 103.89 15.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.214 -0.929 . . . . 0.0 108.985 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -67.23 -7.76 26.43 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.251 -0.906 . . . . 0.0 108.873 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.77 -56.01 9.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.32 -0.863 . . . . 0.0 109.016 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.446 ' HG2' ' N ' ' A' ' 17' ' ' TYR . 6.2 ptm180 -59.37 -28.71 67.12 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.446 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 26.4 t80 -60.3 -49.94 75.59 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.4 t -54.38 -56.08 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HA ' HD11 ' A' ' 22' ' ' ILE . 95.6 t -49.59 -30.93 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.29 -46.17 77.9 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.99 -41.08 46.19 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.302 -0.874 . . . . 0.0 108.667 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' A' ' 19' ' ' VAL . 4.3 mp -65.55 -43.05 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.469 -0.769 . . . . 0.0 108.976 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 7.0 mt -52.89 -43.98 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 108.844 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.49 ' HG2' ' CG2' ' A' ' 31' ' ' VAL . 1.9 mt-30 -67.26 -32.08 72.85 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -24.88 6.54 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -83.05 135.37 44.95 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -84.6 47.12 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.761 1.4 . . . . 0.0 109.843 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -146.87 -40.07 0.2 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.338 -0.851 . . . . 0.0 109.084 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.411 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . . . -73.91 139.9 45.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.442 -0.786 . . . . 0.0 109.538 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 41' ' ' GLU . 16.0 t -71.24 -120.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.181 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.49 ' CG2' ' HG2' ' A' ' 24' ' ' GLN . 1.1 p -174.23 -165.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.729 -1.232 . . . . 0.0 109.935 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.512 ' NE2' HG21 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -114.19 -167.73 1.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.551 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -89.45 -99.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 109.928 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.536 ' HB3' ' HD3' ' A' ' 35' ' ' PRO . 46.7 t-80 -166.17 -58.69 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 110.587 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 34' ' ' HIS . 3.5 Cg_exo -49.53 -179.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 117.442 -1.239 . . . . 0.0 110.822 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.459 ' O ' HD12 ' A' ' 38' ' ' ILE . . . -52.21 -22.57 4.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.005 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.505 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 3.1 mmt -65.37 156.4 32.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.926 -1.109 . . . . 0.0 109.242 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.602 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -127.82 129.17 69.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.291 -0.881 . . . . 0.0 108.63 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 8' ' ' ALA . 2.2 ttt180 -126.52 164.62 20.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.06 -1.025 . . . . 0.0 110.053 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' A' ' 41' ' ' GLU . 2.7 mp -156.51 169.22 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.37 -0.831 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.552 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.9 OUTLIER -155.91 152.79 28.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.682 -1.261 . . . . 0.0 110.26 -179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 4' ' ' LEU . . . -129.93 -177.26 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 91.0 mt-10 -140.04 74.97 1.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.126 -0.984 . . . . 0.0 110.186 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 175.11 -141.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.972 -1.08 . . . . 0.0 110.208 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.567 ' CG ' ' HB3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -126.1 167.83 14.83 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.228 -0.92 . . . . 0.0 109.931 -179.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -130.88 152.91 49.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.384 -0.823 . . . . 0.0 109.665 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.35 154.7 46.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.2 mt -150.55 141.02 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.141 -0.975 . . . . 0.0 109.71 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.6 ptt180 -100.92 -171.93 2.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 109.567 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.54 ' NH1' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -75.76 -32.85 60.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.184 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 4.4 mt-10 -50.37 -41.59 52.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.865 . . . . 0.0 109.297 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -69.26 -47.67 64.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 108.88 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.6 -26.73 2.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 1.4 tt0 -74.84 -43.59 53.74 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -55.73 -50.32 70.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 108.731 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -59.79 -33.46 71.74 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.372 -0.83 . . . . 0.0 109.016 179.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.5 tp -57.73 -51.76 68.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 108.905 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.05 -14.82 66.48 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -113.02 15.23 19.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.964 . . . . 0.0 109.306 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -67.18 -19.42 65.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -0.838 . . . . 0.0 109.426 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -89.42 35.59 0.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.309 -0.869 . . . . 0.0 109.381 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 65' ' ' GLU . 34.9 t70 -104.97 5.87 33.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.8 t -52.21 -40.65 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.932 . . . . 0.0 109.539 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -52.46 -40.93 62.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.143 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.47 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -73.03 -28.39 62.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.049 179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -12.03 61.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.278 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.47 -56.97 4.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.297 -0.877 . . . . 0.0 109.945 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.53 ' CG1' ' OD2' ' A' ' 69' ' ' ASP . 2.3 p -90.52 -46.47 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.119 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -103.02 146.69 27.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.983 -1.073 . . . . 0.0 109.967 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.534 ' HB ' ' HA ' ' A' ' 9' ' ' PHE . 7.0 t -100.56 -176.07 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.551 ' O ' ' CG2' ' A' ' 72' ' ' THR . 0.6 OUTLIER -136.02 -37.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.276 -1.515 . . . . 0.0 112.165 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.589 ' CG2' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER 170.75 -148.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.682 -1.261 . . . . 0.0 108.7 -178.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.737 HG21 ' HA ' ' A' ' 7' ' ' ILE . 1.4 tp 176.95 -129.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 167.98 -108.27 0.3 Allowed Glycine 0 N--CA 1.485 1.965 0 O-C-N 120.04 -1.662 . . . . 0.0 109.945 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.53 -65.62 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.49 ' C ' HD22 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -124.42 -147.21 0.37 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -1.179 . . . . 0.0 108.662 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.627 ' CG2' ' CZ ' ' A' ' 84' ' ' PHE . 7.2 p 178.9 93.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.091 -1.006 . . . . 0.0 109.994 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.6 134.88 49.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.148 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -118.43 156.31 29.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 109.493 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -109.82 -94.93 0.41 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.556 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -106.03 -70.76 0.77 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.178 -0.951 . . . . 0.0 109.281 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.1 -6.37 7.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.313 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.94 -169.68 2.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -0.86 . . . . 0.0 109.406 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -155.51 122.07 5.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.941 . . . . 0.0 109.369 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.85 139.2 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.17 -0.956 . . . . 0.0 110.003 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.558 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -149.38 136.76 20.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.567 ' HB3' ' CG ' ' A' ' 45' ' ' ARG . 2.4 mp0 . . . . . 0 C--N 1.302 -1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.699 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.688 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 1.0 OUTLIER -126.98 158.14 37.68 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.994 -1.066 . . . . 0.0 110.283 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 0.7 OUTLIER -119.49 170.96 8.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.543 0.687 . . . . 0.0 110.232 -178.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 74' ' ' GLY . 10.2 t80 -140.49 141.33 35.39 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 6' ' ' TYR . 1.5 pp -159.18 152.84 5.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.483 ' HB1' ' OG1' ' A' ' 72' ' ' THR . . . -146.37 -173.4 4.18 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.599 -1.24 . . . . 0.0 110.59 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.771 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.84 171.23 14.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 122.633 1.206 . . . . 0.0 111.866 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.565 ' N ' ' HA ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER 176.35 105.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.32 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.596 ' CA ' HG22 ' A' ' 70' ' ' VAL . 3.3 t0 -109.87 -156.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.641 0.734 . . . . 0.0 110.078 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -128.45 -63.43 0.99 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -118.59 -15.06 9.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.441 -0.787 . . . . 0.0 108.904 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -82.51 7.59 14.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.399 -0.813 . . . . 0.0 109.017 179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 18' ' ' VAL . . . -42.4 -32.92 0.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.401 -0.812 . . . . 0.0 109.166 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -51.43 -56.74 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 109.012 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -61.74 -32.1 72.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.229 -0.92 . . . . 0.0 109.281 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 15' ' ' ALA . 55.8 t -57.01 -41.43 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.831 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.71 -30.96 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.63 -49.85 73.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.501 -0.749 . . . . 0.0 109.45 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -62.91 -40.17 96.78 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.119 -0.988 . . . . 0.0 108.97 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.537 ' CD1' HG13 ' A' ' 38' ' ' ILE . 5.6 mm -50.1 -42.92 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.026 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.487 ' O ' ' CD ' ' A' ' 27' ' ' PRO . 40.1 mm -69.29 -33.56 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.15 -0.969 . . . . 0.0 109.024 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -90.88 4.94 50.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.438 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -117.18 -11.64 10.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.528 ' OD1' ' CG1' ' A' ' 31' ' ' VAL . 1.1 m-80 -87.91 -68.79 0.12 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.519 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 26' ' ' ASN . 3.6 Cg_exo -41.28 -28.08 0.46 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.69 1.363 . . . . 0.0 110.195 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -97.78 -39.03 9.24 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.322 -0.861 . . . . 0.0 109.199 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 25' ' ' ASP . . . -102.94 -158.08 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.125 -0.985 . . . . 0.0 109.685 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.485 ' C ' ' CG2' ' A' ' 31' ' ' VAL . 3.2 t -96.3 -127.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.528 ' CG1' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -161.72 141.76 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.648 -1.283 . . . . 0.0 109.726 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -174.21 95.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 109.46 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.516 ' CE1' ' HB ' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -115.05 157.17 23.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.501 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.533 ' CD2' ' HD2' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -117.45 -167.22 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.523 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.533 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 2.3 Cg_endo -90.56 15.19 1.88 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.96 1.505 . . . . 0.0 110.338 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.68 -76.39 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.195 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -84.21 167.34 16.77 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.588 ' CG2' ' CB ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -97.95 163.44 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.843 -1.161 . . . . 0.0 108.922 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.535 ' O ' ' CG1' ' A' ' 40' ' ' ILE . 8.9 mtp180 -139.48 162.47 34.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.879 -1.138 . . . . 0.0 109.5 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.535 ' CG1' ' O ' ' A' ' 39' ' ' ARG . 33.0 mt -158.64 164.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 110.003 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -159.17 166.67 30.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.381 -0.825 . . . . 0.0 109.006 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.462 ' HB2' ' HE2' ' A' ' 44' ' ' LYS . . . -159.83 -165.23 1.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.937 -1.102 . . . . 0.0 110.545 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.688 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -139.2 97.28 3.26 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 3' ' ' SER . 30.8 mttm -142.43 -164.54 1.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.972 -1.08 . . . . 0.0 110.925 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.499 ' O ' ' CD2' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -167.79 171.32 10.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 109.154 -179.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.579 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -160.82 142.19 11.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.026 -1.046 . . . . 0.0 109.723 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.502 ' C ' ' CD1' ' A' ' 48' ' ' ILE . 1.1 tt0 -138.86 138.81 37.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.996 . . . . 0.0 109.434 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.502 ' CD1' ' C ' ' A' ' 47' ' ' GLU . 4.1 mp -151.2 162.8 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.257 -0.902 . . . . 0.0 110.294 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.43 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -98.36 -153.42 0.43 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.409 ' NH1' ' CG ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -69.98 -12.68 61.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.598 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 3.4 tt0 -64.84 -9.8 23.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.193 -0.942 . . . . 0.0 109.603 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.561 ' HB ' ' CD2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -59.99 -40.34 88.83 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.866 -1.146 . . . . 0.0 109.02 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 52' ' ' THR . 94.5 t -46.37 -34.24 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -70.27 -45.75 65.76 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 52' ' ' THR . 3.0 mm-40 -47.7 -46.1 29.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -38.75 88.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.357 -0.84 . . . . 0.0 108.812 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.2 tp -55.17 -55.22 33.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.364 -0.835 . . . . 0.0 109.15 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.41 -9.4 68.37 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -90.95 -9.53 45.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -1.123 . . . . 0.0 109.517 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.72 -25.35 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.453 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -88.29 40.26 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.389 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -111.28 74.63 0.88 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.397 -0.814 . . . . 0.0 109.137 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.16 2.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -0.86 . . . . 0.0 109.994 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -49.01 -22.63 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.055 -1.028 . . . . 0.0 109.315 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.522 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 7.0 pt-20 -56.4 -48.67 76.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -17.08 64.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.194 -0.941 . . . . 0.0 109.423 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.522 ' O ' ' CG1' ' A' ' 71' ' ' ILE . 4.9 tp -98.67 11.98 36.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 109.399 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 65' ' ' GLU . 40.5 t -39.34 -24.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.414 -0.804 . . . . 0.0 110.867 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 71' ' ' ILE . 67.4 m-20 -58.2 -100.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.713 -1.242 . . . . 0.0 109.807 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.771 ' O ' ' CG ' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -42.08 -13.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.175 -2.819 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.461 -178.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 69' ' ' ASP . 1.7 pt -123.42 131.91 72.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 120.453 1.478 . . . . 0.0 110.253 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.483 ' OG1' ' HB1' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -130.74 150.02 52.12 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.417 ' HA ' HG21 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -133.47 174.53 13.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.229 -0.919 . . . . 0.0 110.403 -178.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 178.89 38.74 0.07 OUTLIER Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.459 ' HA3' ' HB ' ' A' ' 5' ' ' VAL . . . -152.37 82.94 0.17 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -176.03 138.47 0.35 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.674 ' O ' ' O ' ' A' ' 85' ' ' VAL . 13.8 p -171.34 52.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.101 -0.999 . . . . 0.0 109.228 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -49.92 -9.54 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -110.52 94.83 5.21 Favored 'General case' 0 C--N 1.28 -2.422 0 O-C-N 120.6 -1.313 . . . . 0.0 109.729 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.435 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -107.11 -82.11 0.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 108.951 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.01 -82.72 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 108.996 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -128.18 -30.88 2.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.364 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -80.11 -157.88 0.16 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.561 ' CD2' ' HB ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -126.1 112.9 16.38 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.749 -1.22 . . . . 0.0 108.752 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.674 ' O ' ' O ' ' A' ' 77' ' ' VAL . 4.1 p -129.51 138.78 53.41 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.655 0 C-N-CA 118.922 -1.111 . . . . 0.0 109.763 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.579 ' O ' ' CB ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -143.0 -176.27 4.84 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 120.837 -1.164 . . . . 0.0 108.309 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.566 ' C ' ' HB2' ' A' ' 46' ' ' LEU . 1.9 tt0 . . . . . 0 C--N 1.286 -2.185 0 CA-C-O 121.947 0.88 . . . . 0.0 110.61 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 44' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -142.26 160.93 39.27 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.759 -1.213 . . . . 0.0 112.235 -178.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.625 ' CG1' ' N ' ' A' ' 6' ' ' TYR . 1.2 t -113.52 -176.65 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.691 ' O ' ' N ' ' A' ' 74' ' ' GLY . 0.4 OUTLIER -159.19 144.77 16.16 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.623 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 4.5 pt -160.31 137.11 2.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 120.529 -1.357 . . . . 0.0 107.919 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.711 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -132.36 146.41 51.95 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.186 -1.806 . . . . 0.0 109.606 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.646 ' CZ ' ' CG1' ' A' ' 38' ' ' ILE . 14.0 p90 -140.9 170.34 15.93 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.488 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.659 ' HG3' ' CA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -119.61 143.33 47.73 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.052 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -108.73 154.07 22.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.745 -1.222 . . . . 0.0 109.957 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -89.63 -37.97 14.26 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.377 -0.827 . . . . 0.0 109.424 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 12' ' ' ASN . 16.6 t0 168.84 -34.88 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -102.97 -30.31 10.87 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.65 -20.37 3.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.0 109.141 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -64.98 -56.14 14.91 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.832 . . . . 0.0 109.132 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.73 -39.32 73.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.238 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.1 t -56.49 -49.04 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 108.605 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.553 HG23 ' CZ ' ' A' ' 9' ' ' PHE . 60.9 t -67.45 -19.13 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.454 -0.779 . . . . 0.0 109.137 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.501 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 45.6 tt0 -76.28 -36.7 58.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.385 -0.822 . . . . 0.0 109.784 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.61 -36.23 65.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.8 mt -71.67 -48.91 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 19' ' ' VAL . 2.2 pp -57.81 -38.96 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.217 -0.927 . . . . 0.0 108.934 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -62.89 -43.05 99.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.343 -0.848 . . . . 0.0 109.035 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 24' ' ' GLN . 3.0 t0 -44.43 -36.3 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.56 88.15 23.39 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 2.4 Cg_endo -65.89 81.31 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 124.31 1.69 . . . . 0.0 110.308 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 5.5 t-80 179.33 -43.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -40.86 140.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.725 -0.61 . . . . 0.0 110.002 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 31' ' ' VAL . 3.7 p -97.42 165.77 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 0.0 109.441 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.521 ' CG2' ' N ' ' A' ' 32' ' ' GLN . 1.4 p -155.49 163.44 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.521 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -174.55 141.78 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 0.0 109.849 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.531 ' HB3' ' CG2' ' A' ' 38' ' ' ILE . 1.3 p-80 -143.66 160.34 40.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.27 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.562 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -157.62 -61.57 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.106 -0.996 . . . . 0.0 109.881 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.5 Cg_endo -66.92 -54.27 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.725 1.382 . . . . 0.0 110.002 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -177.63 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.315 -0.866 . . . . 0.0 108.971 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 1.2 ptm -69.02 158.62 34.42 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.646 ' CG1' ' CZ ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -110.31 120.59 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.891 -1.13 . . . . 0.0 109.857 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.53 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -81.85 177.78 8.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.34 -0.85 . . . . 0.0 110.219 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.499 ' HB ' ' CG1' ' A' ' 7' ' ' ILE . 3.1 mt -152.72 -174.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.273 -0.892 . . . . 0.0 109.673 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -171.09 158.55 5.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.795 -1.191 . . . . 0.0 111.04 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.451 ' O ' ' CB ' ' A' ' 4' ' ' LEU . . . -129.84 -175.31 3.56 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 10.2 pt-20 -151.25 70.67 0.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.147 -0.97 . . . . 0.0 110.033 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER 173.4 -143.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.856 -1.152 . . . . 0.0 109.321 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.6 ' HA ' ' HB3' ' A' ' 87' ' ' GLU . 4.9 mpt_? -126.01 154.99 42.15 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.04 -1.037 . . . . 0.0 109.375 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -144.92 135.76 24.68 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.173 -0.955 . . . . 0.0 109.833 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.642 ' HA ' HG11 ' A' ' 85' ' ' VAL . 2.3 pm0 -151.05 135.55 17.03 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.576 ' CG2' ' CG2' ' A' ' 53' ' ' VAL . 2.5 mt -137.8 152.4 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 0.0 109.117 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.527 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -50.49 147.58 4.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 108.949 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.436 ' CG ' ' NH1' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -89.27 -60.55 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.017 . . . . 0.0 109.716 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 16.5 tt0 -54.35 -44.66 72.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.751 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -50.81 50.06 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.017 -1.052 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.576 ' CG2' ' CG2' ' A' ' 48' ' ' ILE . 19.4 t -55.34 -21.48 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -74.99 -40.08 60.88 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.29 -56.27 9.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.267 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.436 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -55.3 -29.43 58.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 109.3 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 61' ' ' TRP . 7.6 tp -64.33 -56.11 16.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -0.842 . . . . 0.0 109.732 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.51 8.15 69.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.487 ' HG2' ' N ' ' A' ' 60' ' ' ALA . 22.7 ttt180 -98.8 -84.59 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -1.17 . . . . 0.0 109.973 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.487 ' N ' ' HG2' ' A' ' 59' ' ' ARG . . . -96.03 -22.6 17.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.585 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.504 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 8.6 t90 -90.18 25.78 2.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.313 -0.867 . . . . 0.0 109.177 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.2 44.31 1.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.264 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 65' ' ' GLU . 3.9 t -98.93 9.4 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.415 -0.803 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.467 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 16.7 mm-40 -39.9 -28.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.522 -0.736 . . . . 0.0 109.944 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 63' ' ' VAL . 16.1 tt0 -58.06 -55.26 37.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.136 -0.977 . . . . 0.0 109.404 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -9.57 58.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 67' ' ' LEU . 11.8 tp -53.74 -16.35 1.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.432 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 67' ' ' LEU . 17.2 t -40.2 -42.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -0.954 . . . . 0.0 109.715 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.659 ' CA ' ' HG3' ' A' ' 10' ' ' GLN . 10.1 m-20 -81.52 -74.75 0.32 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.181 -0.949 . . . . 0.0 109.818 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.625 ' O ' ' O ' ' A' ' 69' ' ' ASP . 1.3 t -43.56 -170.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 122.152 -0.343 . . . . 0.0 110.98 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.711 HG21 ' O ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER 161.46 -167.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.634 ' O ' HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -175.39 -158.87 0.07 Allowed 'General case' 0 C--O 1.193 -1.903 0 O-C-N 119.348 -2.095 . . . . 0.0 108.143 179.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 72' ' ' THR . 48.6 mm -168.39 -127.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.691 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 161.84 -71.81 0.21 Allowed Glycine 0 N--CA 1.486 1.996 0 O-C-N 120.427 -1.421 . . . . 0.0 110.591 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.16 -37.93 1.59 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.445 ' N ' HD12 ' A' ' 86' ' ' LEU . 2.4 t-20 -176.48 -149.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.974 . . . . 0.0 109.205 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.582 HG21 ' CE1' ' A' ' 84' ' ' PHE . 9.1 p -151.33 100.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.016 . . . . 0.0 109.415 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.439 ' HB2' ' CD ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -114.47 150.58 34.57 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.942 -1.098 . . . . 0.0 110.325 -179.006 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.565 ' HB3' ' CD1' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -118.12 164.64 14.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.588 -0.695 . . . . 0.0 109.229 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.513 ' OD1' ' HB2' ' A' ' 47' ' ' GLU . 3.6 p-10 -114.42 -115.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.035 -1.04 . . . . 0.0 109.646 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -98.36 -41.12 7.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.828 -1.17 . . . . 0.0 109.753 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -130.91 -58.78 1.01 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.03 -1.044 . . . . 0.0 108.606 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.1 mpp_? -57.2 -173.22 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.582 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.2 t80 173.41 120.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.051 -1.031 . . . . 0.0 111.816 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' ' 47' ' ' GLU . 8.1 p -160.39 -115.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.607 ' O ' ' CB ' ' A' ' 46' ' ' LEU . 22.0 tp -131.85 144.62 51.03 Favored 'General case' 0 C--N 1.282 -2.352 0 O-C-N 120.19 -1.569 . . . . 0.0 112.368 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.6 ' HB3' ' HA ' ' A' ' 45' ' ' ARG . 16.8 mt-10 . . . . . 0 C--N 1.301 -1.538 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -128.2 -167.03 1.7 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -0.98 . . . . 0.0 109.797 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.466 HG11 ' HA2' ' A' ' 75' ' ' GLY . 11.3 t -152.28 161.31 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.594 ' O ' ' N ' ' A' ' 74' ' ' GLY . 6.6 t80 -153.16 136.0 15.38 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -162.68 137.68 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.921 -1.112 . . . . 0.0 109.786 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.613 ' CB ' ' CG2' ' A' ' 71' ' ' ILE . . . -126.6 173.89 9.11 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 69' ' ' ASP . 2.6 m-85 -168.56 155.56 7.48 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.496 -1.378 . . . . 0.0 109.366 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.509 ' HA ' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -120.91 93.82 4.15 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.475 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 1.1 m-20 -74.38 -166.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.38 -0.825 . . . . 0.0 109.831 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.7 -114.59 0.12 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.09 -1.006 . . . . 0.0 108.911 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -119.08 -31.97 4.57 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.843 -1.161 . . . . 0.0 108.579 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -103.07 -34.87 8.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.473 -0.767 . . . . 0.0 109.331 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.45 ' HB2' ' OD1' ' A' ' 11' ' ' ASP . . . -59.86 -38.53 82.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.556 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.454 ' CG ' ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -63.07 -36.22 82.86 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.315 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -37.65 83.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.075 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.86 -53.04 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 109.191 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.443 ' HA ' HD11 ' A' ' 22' ' ' ILE . 55.9 t -64.37 -23.65 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.409 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.35 -35.28 73.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 109.747 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -77.53 -33.08 54.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.773 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.507 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 8.3 mt -71.89 -37.62 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.181 -0.949 . . . . 0.0 109.058 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.421 HD12 HD12 ' A' ' 40' ' ' ILE . 51.3 mt -67.24 -53.02 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.894 . . . . 0.0 109.335 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -63.48 -29.25 70.55 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -47.13 -43.94 21.16 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 22' ' ' ILE . 2.9 m-80 -87.01 126.96 61.28 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.7 Cg_endo -84.02 49.34 2.78 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.817 1.43 . . . . 0.0 110.254 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.8 t-160 -154.76 -48.47 0.09 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.19 -0.944 . . . . 0.0 109.917 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -41.11 141.08 0.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.475 -0.766 . . . . 0.0 109.873 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.411 ' C ' ' CG2' ' A' ' 31' ' ' VAL . 2.6 t -98.0 162.32 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.523 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.411 ' CG2' ' C ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -155.11 156.85 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.036 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -170.09 83.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.568 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -119.41 167.42 11.94 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.176 -0.953 . . . . 0.0 109.644 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.566 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -164.26 -48.09 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.833 . . . . 0.0 109.132 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 2.0 Cg_endo -81.98 -167.02 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.752 1.396 . . . . 0.0 109.737 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.77 -5.1 41.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.248 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.505 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 1.9 mtm -97.04 151.42 19.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.509 HG13 ' HA ' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -111.09 161.08 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.141 -0.975 . . . . 0.0 109.328 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.505 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -149.7 155.46 40.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 109.792 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.466 ' HB ' ' CD1' ' A' ' 7' ' ' ILE . 13.2 mt -156.25 175.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.821 . . . . 0.0 109.045 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 11.2 tt0 178.76 144.42 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.009 . . . . 0.0 109.367 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.445 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -129.19 -160.13 1.01 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.797 . . . . 0.0 109.642 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 17.0 pt-20 -164.01 69.23 0.19 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.452 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -159.46 -164.35 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 110.009 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.483 ' HA ' ' CG ' ' A' ' 87' ' ' GLU . 9.2 ptm180 -133.33 -166.42 1.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.506 -0.747 . . . . 0.0 109.014 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.553 ' CD1' ' O ' ' A' ' 87' ' ' GLU . 4.1 mt -163.42 156.04 18.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.036 -1.04 . . . . 0.0 110.193 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.471 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -146.32 139.74 25.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.573 ' N ' ' CD1' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -148.2 158.41 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 109.933 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.507 ' HA ' ' CG ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -100.62 -151.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -4.08 23.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.387 -0.821 . . . . 0.0 109.661 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 13.4 pt-20 -71.77 -23.8 61.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.784 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.44 ' OG1' ' CG2' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -64.08 -49.11 73.55 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.983 -1.073 . . . . 0.0 109.56 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.2 t -51.52 -25.82 5.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.066 -1.021 . . . . 0.0 108.889 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 10.0 mt-10 -75.38 -39.89 58.62 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.278 -0.889 . . . . 0.0 109.429 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 15.3 mm-40 -65.52 -46.59 79.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.344 -0.848 . . . . 0.0 109.376 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -43.61 80.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.533 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.09 -54.93 41.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.9 . . . . 0.0 109.556 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.31 -2.1 58.56 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 12.9 ttt180 -119.17 10.12 11.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -1.195 . . . . 0.0 109.701 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.19 -27.4 68.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.12 -0.988 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -89.35 29.04 1.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 109.706 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 66' ' ' MET . 0.7 OUTLIER -110.93 5.42 20.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.611 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.3 t -72.75 -49.44 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.593 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -49.9 -47.98 51.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -71.65 -25.1 61.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -81.37 -12.34 59.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.507 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.38 -22.16 26.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 10' ' ' GLN . 14.0 t -59.25 -33.91 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.523 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.633 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.6 86.84 3.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 109.185 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.564 ' O ' ' CB ' ' A' ' 71' ' ' ILE . 2.4 p -101.93 140.57 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.312 -0.867 . . . . 0.0 111.309 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.613 ' CG2' ' CB ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER 167.69 -53.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.038 -1.039 . . . . 0.0 111.912 175.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.543 ' N ' HG21 ' A' ' 71' ' ' ILE . 1.7 m -165.98 171.54 12.46 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.057 -1.652 . . . . 0.0 112.761 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.494 ' CG1' ' C ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -163.67 165.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 174.94 51.23 0.05 OUTLIER Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.514 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.466 ' HA2' HG11 ' A' ' 5' ' ' VAL . . . -104.67 -100.32 2.62 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.548 ' O ' ' CD2' ' A' ' 86' ' ' LEU . 1.9 t30 -175.33 -174.0 0.69 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.4 -1.059 . . . . 0.0 108.931 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.513 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 12.4 p 177.97 67.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 108.806 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.499 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -98.95 141.58 31.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 0.0 110.394 -178.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 80' ' ' ASP . 1.3 tt0 -127.21 145.24 50.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.775 . . . . 0.0 108.932 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . 0.402 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 41.7 t0 -107.24 -109.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.069 -1.02 . . . . 0.0 109.485 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -104.39 -77.14 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.817 -1.177 . . . . 0.0 109.242 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -109.94 -9.43 14.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.252 -0.905 . . . . 0.0 109.075 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.507 ' CG ' ' HA ' ' A' ' 49' ' ' ARG . 3.0 ttt180 -91.92 -160.62 0.75 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.374 -0.829 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 48' ' ' ILE . 2.1 t80 -169.38 148.89 3.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.072 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.499 ' CG1' ' HB2' ' A' ' 78' ' ' ASP . 2.5 p -133.73 179.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.053 -1.03 . . . . 0.0 109.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER 178.26 -169.34 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.553 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 3.9 mt-10 . . . . . 0 C--N 1.302 -1.488 0 O-C-N 120.941 -1.099 . . . . 0.0 109.796 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.8 p . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -122.48 -176.82 3.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.059 -1.025 . . . . 0.0 109.222 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.586 ' CG2' ' N ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -156.97 165.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.891 -1.131 . . . . 0.0 110.703 -179.157 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.586 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -135.41 147.53 49.04 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.935 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 1.4 pp -158.21 139.45 4.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.54 ' CB ' ' OG1' ' A' ' 72' ' ' THR . . . -124.72 -179.16 4.4 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.108 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.713 ' CD1' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -141.79 -178.7 5.79 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.195 177.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.699 ' N ' ' HA ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 177.97 97.93 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.305 -177.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.526 ' CA ' HG22 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -107.7 167.92 9.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.968 . . . . 0.0 109.856 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -124.57 -64.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.881 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -101.6 -32.64 10.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 109.57 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.411 ' HB2' ' OD2' ' A' ' 11' ' ' ASP . 25.9 m-80 -87.64 10.61 17.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.129 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 11' ' ' ASP . . . -58.8 -16.6 17.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.215 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.537 ' NH1' ' HG2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -61.97 -62.13 2.0 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 109.214 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 49.3 m-85 -62.95 -33.37 75.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 0.0 108.872 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.508 ' O ' ' CD1' ' A' ' 22' ' ' ILE . 60.1 t -59.34 -32.97 49.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 15' ' ' ALA . 61.3 t -77.45 -25.5 15.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 6.9 tp10 -65.27 -53.94 36.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -67.65 -44.31 78.19 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.206 -0.934 . . . . 0.0 108.556 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.51 HD11 ' N ' ' A' ' 22' ' ' ILE . 1.5 mp -54.04 -31.03 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.537 ' O ' ' CD ' ' A' ' 27' ' ' PRO . 17.9 mt -70.38 -42.16 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 108.844 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.3 4.92 49.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -118.67 -11.88 9.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.301 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.515 ' N ' ' HD2' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -85.57 -65.88 0.2 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 110.377 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.537 ' CD ' ' O ' ' A' ' 23' ' ' ILE . 2.5 Cg_endo -41.0 -27.95 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.66 1.348 . . . . 0.0 110.051 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 26' ' ' ASN . 2.6 t-160 -98.64 -33.45 10.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.667 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 25' ' ' ASP . . . -102.33 176.89 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -0.99 . . . . 0.0 110.265 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.453 ' O ' HG22 ' A' ' 40' ' ' ILE . 1.9 t -101.2 162.88 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.034 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 32' ' ' GLN . 2.1 p -169.66 166.88 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 109.813 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.547 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 2.5 pt20 -172.18 65.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 109.566 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.492 ' CB ' ' HA ' ' A' ' 38' ' ' ILE . 26.0 p80 -101.12 179.14 4.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.569 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -156.67 -62.62 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.589 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.569 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -67.84 -167.78 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.684 1.36 . . . . 0.0 109.911 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.19 -15.41 33.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 108.957 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.564 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 66.9 mtp -81.84 135.32 35.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.327 -0.858 . . . . 0.0 109.619 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.595 ' CG1' ' HB3' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -113.77 82.54 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.16 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.537 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.39 167.3 21.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 111.25 -178.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 30' ' ' VAL . 89.5 mt -149.99 155.25 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.414 ' N ' HG21 ' A' ' 40' ' ' ILE . 3.4 tt0 -131.15 147.14 52.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 109.662 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' A' ' 43' ' ' GLU . . . -143.88 -171.61 3.58 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.372 -0.83 . . . . 0.0 108.877 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 44.8 mt-10 -159.28 99.55 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -162.2 -145.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.768 -1.208 . . . . 0.0 111.078 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -162.43 159.65 25.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -0.869 . . . . 0.0 109.502 -178.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 1.4 mt -126.18 -173.79 2.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.056 -1.027 . . . . 0.0 108.298 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 4.3 pt-20 -178.95 141.99 0.19 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.256 -0.902 . . . . 0.0 109.421 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.408 ' CG1' ' C ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -160.43 -161.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.15 -0.969 . . . . 0.0 109.585 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -100.21 -169.08 1.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.859 . . . . 0.0 109.152 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -88.5 -46.3 9.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.162 -0.961 . . . . 0.0 109.026 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 30.7 tt0 -49.49 -32.15 11.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.362 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 53' ' ' VAL . 1.3 m -70.88 -50.28 36.86 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.207 -0.933 . . . . 0.0 109.039 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.542 HG23 ' CG ' ' A' ' 84' ' ' PHE . 97.4 t -48.1 -27.64 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 21.7 tp10 -74.54 -44.41 51.21 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -54.23 -47.11 72.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.349 -0.844 . . . . 0.0 108.853 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -60.47 -36.96 79.52 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.8 tp -57.99 -55.75 30.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 109.364 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.6 -11.29 59.69 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -114.82 7.25 15.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -1.139 . . . . 0.0 109.625 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -70.01 -29.97 67.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.26 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -90.34 38.45 0.94 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.868 . . . . 0.0 109.384 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -103.07 -86.06 0.44 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.299 -0.876 . . . . 0.0 109.571 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -97.92 0.99 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.599 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 1.2 mp0 -51.9 -27.57 13.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 109.574 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -64.18 -43.07 96.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.173 -0.954 . . . . 0.0 109.017 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.492 ' HB3' ' CD1' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -64.62 -9.96 23.19 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 71' ' ' ILE . 3.3 tt -53.29 -18.05 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 109.833 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.8 t -82.28 -35.43 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.009 -1.057 . . . . 0.0 109.775 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 39.9 m-20 -98.93 -118.26 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.952 . . . . 0.0 111.383 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.713 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -49.71 -3.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.179 -2.634 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -176.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 66' ' ' MET . 0.0 OUTLIER -132.31 142.92 41.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 121.658 2.026 . . . . 0.0 112.5 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.54 ' OG1' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -155.52 149.07 25.08 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 1.4 pp -139.06 -174.66 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.094 -1.003 . . . . 0.0 109.61 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 167.48 44.28 0.03 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 5' ' ' VAL . . . -94.05 -104.92 1.82 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 75' ' ' GLY . 0.7 OUTLIER -176.58 166.72 2.69 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.476 -1.014 . . . . 0.0 109.577 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.452 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 7.2 p -133.41 92.34 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.548 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -104.69 137.33 42.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 109.97 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.98 133.84 55.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.865 . . . . 0.0 109.457 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.6 -96.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 109.501 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.86 -61.14 1.58 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.253 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -126.37 -39.0 2.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.4 -173.77 0.16 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.542 ' CG ' HG23 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -141.05 166.42 24.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.228 -0.92 . . . . 0.0 109.051 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.574 ' CG2' ' O ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -154.62 162.75 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.533 -179.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.567 ' HG ' ' CB ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -172.75 -123.76 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 109.335 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 2.0 pt-20 . . . . . 0 C--N 1.297 -1.695 0 O-C-N 121.372 -0.83 . . . . 0.0 110.991 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.604 ' CB ' ' CB ' ' A' ' 44' ' ' LYS . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.622 ' HA ' ' CA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -156.59 160.61 39.59 Favored 'General case' 0 C--N 1.31 -1.152 0 O-C-N 120.918 -1.114 . . . . 0.0 111.213 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.574 ' HB ' ' CB ' ' A' ' 42' ' ' ALA . 48.8 t -114.71 171.36 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.611 ' O ' ' N ' ' A' ' 74' ' ' GLY . 50.3 t80 -147.73 138.59 23.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.743 -1.223 . . . . 0.0 109.259 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 6' ' ' TYR . 2.8 pt -160.68 159.31 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.58 ' O ' ' CD1' ' A' ' 9' ' ' PHE . . . -165.83 164.63 18.65 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.339 -1.476 . . . . 0.0 110.591 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.636 ' CE2' ' CG2' ' A' ' 71' ' ' ILE . 5.3 m-85 -149.18 163.15 38.44 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.571 ' NE2' ' C ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -125.76 81.65 2.0 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 14.9 p30 -106.41 167.13 10.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 0.0 110.37 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.32 5.86 40.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.529 -0.732 . . . . 0.0 109.505 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -79.66 103.93 9.9 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.111 -0.993 . . . . 0.0 108.972 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.8 t-20 -66.17 -8.82 26.47 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 108.715 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.89 -40.66 85.11 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.36 -36.5 84.2 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -46.67 81.67 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.345 -0.847 . . . . 0.0 108.937 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.12 -57.41 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.228 -0.92 . . . . 0.0 108.594 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.59 -21.68 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.379 -0.826 . . . . 0.0 108.801 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.543 ' OE2' ' CD2' ' A' ' 33' ' ' HIS . 6.8 tt0 -75.09 -37.6 61.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.517 -0.739 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.78 -28.02 63.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.056 -1.027 . . . . 0.0 109.231 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.4 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 32.1 mm -76.85 -41.13 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.231 -0.918 . . . . 0.0 109.086 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 24' ' ' GLN . 1.3 tt -60.45 -46.29 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 108.655 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.517 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -67.65 -32.15 72.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -49.18 -30.04 6.34 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.515 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -79.66 136.37 55.49 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -84.0 45.15 1.7 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.826 1.435 . . . . 0.0 110.108 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -149.6 -47.71 0.14 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.181 -0.949 . . . . 0.0 109.636 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.03 55.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.573 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.532 ' CG1' ' HG3' ' A' ' 41' ' ' GLU . 4.8 p -100.31 140.41 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.37 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 0.4 OUTLIER -151.34 166.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 0.0 109.449 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -165.16 82.37 0.36 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.543 ' CD2' ' OE2' ' A' ' 20' ' ' GLU . 2.2 p80 -117.36 142.61 46.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -0.896 . . . . 0.0 109.286 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.549 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -160.93 -58.58 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.183 -0.948 . . . . 0.0 109.54 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.9 Cg_endo -68.62 -155.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.715 1.376 . . . . 0.0 109.862 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.98 -4.03 58.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 109.425 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.484 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 2.9 ttm -89.57 168.54 12.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.656 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -138.48 115.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 40' ' ' ILE . 3.6 ptp180 -129.62 168.66 16.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.662 -1.274 . . . . 0.0 111.433 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.507 HG21 ' N ' ' A' ' 41' ' ' GLU . 2.7 mp -158.98 157.43 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.539 ' CB ' ' O ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -131.58 -177.4 4.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.944 -1.098 . . . . 0.0 109.71 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.574 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . . . -129.2 -149.02 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 109.113 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.622 ' CA ' ' HA ' ' A' ' 4' ' ' LEU . 1.2 mm-40 -135.6 26.94 3.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.824 -1.173 . . . . 0.0 111.699 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.604 ' CB ' ' CB ' ' A' ' 3' ' ' SER . 0.5 OUTLIER 83.07 -39.49 0.09 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.887 0.851 . . . . 0.0 111.629 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.493 ' CG ' ' HD3' ' A' ' 44' ' ' LYS . 6.3 mtm180 -127.81 113.23 15.68 Favored 'General case' 0 C--N 1.263 -3.177 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.087 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -141.18 144.52 34.84 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.503 ' CB ' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -154.54 139.65 17.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 109.598 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.545 HD12 ' CD2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -142.96 143.74 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -0.815 . . . . 0.0 109.132 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 -101.25 -98.35 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.002 . . . . 0.0 110.288 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -15.27 4.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.68 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 33.8 tp10 -49.43 -24.86 2.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.725 -1.234 . . . . 0.0 108.986 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 55' ' ' GLU . 1.6 m -66.4 -46.16 77.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.085 -1.009 . . . . 0.0 108.929 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 52' ' ' THR . 78.2 t -47.26 -30.27 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -70.43 -46.81 63.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 52' ' ' THR . 7.2 mt-10 -51.09 -63.62 1.07 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' ARG . 1.0 OUTLIER -44.05 -33.98 1.62 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.502 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.7 tp -51.06 -62.74 1.43 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.667 ' O ' ' CB ' ' A' ' 59' ' ' ARG . . . -52.79 -24.79 20.47 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.667 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 8.9 tpt180 110.59 39.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.869 1.267 . . . . 0.0 108.576 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 61.4 96.36 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 102.672 -3.085 . . . . 0.0 102.672 -176.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.586 ' C ' ' O ' ' A' ' 60' ' ' ALA . 29.3 t90 -18.41 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 123.219 1.485 . . . . 0.0 109.845 -174.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 60' ' ' ALA . 23.7 t70 -102.19 53.21 0.8 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.96 -177.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 63' ' ' VAL . 40.5 t -88.47 9.42 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.479 -0.763 . . . . 0.0 110.037 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 63' ' ' VAL . 61.3 mm-40 -39.88 -31.74 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 109.693 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -64.46 -53.42 48.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 108.889 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.04 -1.28 25.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.406 -0.809 . . . . 0.0 109.54 179.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 69' ' ' ASP . 12.0 tp -38.53 -23.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.657 -0.652 . . . . 0.0 111.367 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' MET . 2.4 m -39.0 -28.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.033 -1.042 . . . . 0.0 109.953 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 21.6 p30 -59.08 165.12 2.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.43 -0.794 . . . . 0.0 109.587 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.578 ' O ' ' CD2' ' A' ' 9' ' ' PHE . 45.7 t -79.45 167.09 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.194 -0.941 . . . . 0.0 109.015 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.636 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 1.5 pp -132.53 148.76 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.086 -1.009 . . . . 0.0 110.204 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.53 ' HB ' ' N ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -151.89 140.46 20.7 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.215 -0.928 . . . . 0.0 109.406 178.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.514 ' CD1' ' O ' ' A' ' 72' ' ' THR . 5.4 mm -137.33 153.82 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.448 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -166.33 32.27 0.22 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.477 ' HA3' ' CG1' ' A' ' 5' ' ' VAL . . . -146.24 -95.31 0.17 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.516 ' C ' ' CD2' ' A' ' 86' ' ' LEU . 5.4 t30 -172.8 -151.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -1.167 . . . . 0.0 109.519 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.463 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 7.6 p 179.18 89.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.369 -0.832 . . . . 0.0 109.273 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.78 129.93 55.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.114 -0.991 . . . . 0.0 109.811 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.68 146.71 50.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.498 -0.751 . . . . 0.0 109.14 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.64 -101.14 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.071 -1.018 . . . . 0.0 109.422 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.2 -53.95 2.57 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.966 -1.084 . . . . 0.0 109.322 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -130.86 -43.55 1.09 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 82' ' ' ASP . 10.1 mpt_? -54.53 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.661 -0.649 . . . . 0.0 109.346 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.545 ' CD2' HD12 ' A' ' 48' ' ' ILE . 14.5 t80 -161.17 143.12 12.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 109.027 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.503 HG22 ' CB ' ' A' ' 47' ' ' GLU . 9.3 p -150.73 144.27 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.987 -1.071 . . . . 0.0 110.606 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.7 tm? -143.72 133.99 24.49 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 5.5 mp0 . . . . . 0 C--N 1.306 -1.295 0 O-C-N 121.316 -0.865 . . . . 0.0 108.755 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.56 ' HB2' ' CB ' ' A' ' 44' ' ' LYS . 49.0 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.686 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 1.2 pp -148.35 152.1 36.47 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.384 -0.822 . . . . 0.0 109.884 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.555 ' CG2' ' HB2' ' A' ' 42' ' ' ALA . 3.7 t -113.63 176.62 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.608 -0.683 . . . . 0.0 109.197 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' A' ' 74' ' ' GLY . 8.9 t80 -143.18 138.46 29.74 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.001 -1.062 . . . . 0.0 108.276 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.517 HG21 ' HA ' ' A' ' 73' ' ' ILE . 3.6 pt -156.89 156.07 4.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 108.475 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' THR . . . -163.99 141.25 6.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.78 -1.2 . . . . 0.0 109.902 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.64 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -139.54 -167.47 2.27 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.079 -1.013 . . . . 0.0 109.02 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.636 ' N ' HG11 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -156.27 93.51 1.42 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.5 OUTLIER -109.6 -170.97 1.75 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -71.72 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.034 . . . . 0.0 109.235 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 16' ' ' ARG . 1.5 p30 -145.0 7.17 1.19 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.867 -1.146 . . . . 0.0 110.088 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -102.52 -57.13 2.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.045 -1.034 . . . . 0.0 109.494 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.2 92.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.816 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.511 ' NH1' ' HG3' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -66.46 -36.72 83.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.133 -0.979 . . . . 0.0 109.301 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 11.1 t80 -62.73 -44.13 97.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 0.0 109.148 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.14 -53.11 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.238 -0.913 . . . . 0.0 109.17 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.57 -24.01 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -0.934 . . . . 0.0 109.281 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -66.64 -48.87 68.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.289 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.63 91.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.371 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.81 -46.89 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.412 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.425 HG22 ' HB2' ' A' ' 29' ' ' ALA . 29.1 mt -52.83 -52.45 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 108.813 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 25' ' ' ASP . 1.4 mp0 -58.68 -31.06 67.86 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.208 -0.932 . . . . 0.0 108.631 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 24' ' ' GLN . 1.1 t70 -46.15 -42.0 13.28 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.589 -1.264 . . . . 0.0 107.589 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -96.63 131.49 28.09 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.92 47.57 2.31 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.703 1.37 . . . . 0.0 110.085 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 29' ' ' ALA . 30.0 t-80 -154.52 -50.83 0.09 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.25 -0.906 . . . . 0.0 109.977 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -41.36 140.42 0.87 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.796 . . . . 0.0 109.991 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.517 HG11 ' N ' ' A' ' 31' ' ' VAL . 1.6 p -78.66 -169.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.317 -0.864 . . . . 0.0 108.715 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.517 ' N ' HG11 ' A' ' 30' ' ' VAL . 15.6 m -122.88 -155.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.996 -1.065 . . . . 0.0 109.477 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.553 ' HB3' ' N ' ' A' ' 39' ' ' ARG . 2.3 mp0 -112.75 -151.74 0.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.073 -1.017 . . . . 0.0 109.604 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.34 -96.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.873 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.565 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -163.89 -69.55 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.009 -1.057 . . . . 0.0 109.569 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 34' ' ' HIS . 5.7 Cg_exo -49.27 -178.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.904 1.476 . . . . 0.0 110.47 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 10' ' ' GLN . . . -43.09 -36.07 1.52 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.384 -0.823 . . . . 0.0 109.896 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.474 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 66.2 mtm -63.91 144.18 57.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.002 -1.061 . . . . 0.0 109.13 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.579 HD12 ' CD2' ' A' ' 9' ' ' PHE . 6.3 pt -146.28 109.3 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.553 ' N ' ' HB3' ' A' ' 32' ' ' GLN . 1.6 mtt-85 -90.74 174.45 7.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 0.0 109.523 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 39' ' ' ARG . 11.4 mt -161.98 166.96 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.449 -0.782 . . . . 0.0 109.391 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.51 ' N ' HG23 ' A' ' 40' ' ' ILE . 5.7 tp10 -142.79 170.4 15.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 0.0 109.005 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.555 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . -140.84 -168.81 2.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.724 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.686 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 1.6 pm0 -143.37 85.16 1.84 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.511 -0.743 . . . . 0.0 109.758 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.56 ' CB ' ' HB2' ' A' ' 3' ' ' SER . 0.0 OUTLIER 83.4 -179.68 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -178.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.66 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 3.8 mmt180 179.5 -165.58 0.06 Allowed 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.435 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 4.8 mt 164.48 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.543 ' CB ' ' HA ' ' A' ' 85' ' ' VAL . 2.0 mt-10 162.59 -167.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.828 -1.17 . . . . 0.0 109.394 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -177.31 -151.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.972 . . . . 0.0 109.634 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.562 ' N ' ' CG2' ' A' ' 48' ' ' ILE . 11.0 ttp180 -91.73 -37.05 13.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.949 -1.095 . . . . 0.0 110.131 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -32.46 70.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.918 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 20.8 mm-40 -58.05 -27.64 63.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.134 -0.979 . . . . 0.0 109.665 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m -64.84 -41.39 95.76 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.003 -1.06 . . . . 0.0 109.434 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.6 t -53.52 -29.66 17.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -70.69 -40.5 72.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 17.8 mt-10 -57.49 -62.91 1.45 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.436 ' HA ' ' H ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -44.0 -36.75 2.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.98 . . . . 0.0 109.057 179.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.463 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 9.9 tp -57.65 -50.02 74.53 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -78.59 15.79 9.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 176.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HB3' ' O ' ' A' ' 58' ' ' GLY . 2.8 ttt180 68.34 49.64 0.79 Allowed 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 121.415 0.626 . . . . 0.0 110.056 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 57.31 93.21 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TRP . . . . . 0.598 ' C ' ' O ' ' A' ' 60' ' ' ALA . 57.4 t90 -16.3 81.09 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.434 1.588 . . . . 0.0 109.319 -174.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 60' ' ' ALA . 20.8 t70 -102.44 66.82 0.99 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.138 -1.846 . . . . 0.0 110.012 -176.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.504 ' CG2' ' NE1' ' A' ' 61' ' ' TRP . 19.5 t -89.56 6.63 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 109.558 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.515 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 5.4 mp0 -42.58 -31.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 109.454 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.48 -49.66 65.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.119 -0.988 . . . . 0.0 109.236 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.5 ' O ' ' N ' ' A' ' 68' ' ' VAL . 1.4 mtt -72.95 -5.35 37.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.919 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.541 ' N ' HD21 ' A' ' 67' ' ' LEU . 1.5 pt? -39.21 -26.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.467 -0.771 . . . . 0.0 110.788 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 69' ' ' ASP . 5.8 p -40.52 -49.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.554 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 0.6 OUTLIER -72.64 146.17 46.78 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.636 HG11 ' N ' ' A' ' 10' ' ' GLN . 6.9 p -76.15 173.79 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.841 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ILE . . . . . 0.462 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 9.1 mt -153.17 157.0 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.228 -0.92 . . . . 0.0 109.835 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -149.56 152.07 34.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.491 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.517 ' HA ' HG21 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -137.47 159.31 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -159.81 66.73 0.27 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.441 -1.362 . . . . 0.0 110.794 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.94 -105.89 1.31 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.534 ' C ' ' CD2' ' A' ' 86' ' ' LEU . 2.9 t-20 -165.12 -144.57 0.07 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -1.188 . . . . 0.0 108.435 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.582 ' N ' HD22 ' A' ' 86' ' ' LEU . 7.4 p -170.28 98.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.881 -1.137 . . . . 0.0 110.587 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -114.38 127.46 55.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.439 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -128.05 149.99 50.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 109.61 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -109.82 -103.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 109.364 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -104.23 -54.14 2.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.951 -1.093 . . . . 0.0 108.909 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ARG . 79.8 m-20 -130.67 -39.75 1.25 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ARG . . . . . 0.54 ' CG ' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -51.65 -175.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.602 0.715 . . . . 0.0 109.728 179.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -160.23 111.07 1.88 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.586 ' CG2' ' CD2' ' A' ' 46' ' ' LEU . 4.0 p -124.37 143.6 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.061 -1.024 . . . . 0.0 109.251 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.599 ' O ' ' CA ' ' A' ' 46' ' ' LEU . 2.2 tm? -151.22 129.45 11.95 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.885 -1.526 . . . . 0.0 110.571 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . 0.652 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.31 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.478 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -162.22 -54.21 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.315 -0.866 . . . . 0.0 109.271 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.563 ' HA ' ' CE3' ' A' ' 88' ' ' TRP . 20.0 m -44.35 110.15 0.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.554 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -130.05 155.65 45.8 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.218 -0.926 . . . . 0.0 110.336 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.605 ' HB ' ' HA2' ' A' ' 74' ' ' GLY . 1.1 m -116.66 -150.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.566 -0.709 . . . . 0.0 109.361 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.586 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.0 OUTLIER 172.78 139.82 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.106 -0.996 . . . . 0.0 109.625 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.528 ' CG1' ' HB ' ' A' ' 40' ' ' ILE . 46.4 pt -136.61 139.41 45.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.525 ' CB ' ' HA ' ' A' ' 39' ' ' ARG . . . -134.2 164.78 26.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.551 -1.343 . . . . 0.0 110.65 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.623 ' CZ ' ' CD1' ' A' ' 71' ' ' ILE . 0.5 OUTLIER -158.78 151.55 22.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.509 ' HG2' ' CB ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -131.81 92.97 3.22 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.05 -1.031 . . . . 0.0 108.51 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -87.04 -132.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.405 -0.809 . . . . 0.0 109.762 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.46 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 5.0 t-20 -86.42 -111.88 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.837 -1.164 . . . . 0.0 109.385 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -132.63 -24.52 1.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.927 -1.108 . . . . 0.0 109.775 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 15' ' ' ALA . 1.6 t-20 -102.96 -54.35 2.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.025 -1.047 . . . . 0.0 109.817 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.458 ' HA ' HG22 ' A' ' 18' ' ' VAL . . . -44.27 -31.17 0.94 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.809 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HD3' ' O ' ' A' ' 12' ' ' ASN . 55.9 mtm180 -64.79 -63.58 1.08 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.613 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.448 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 1.1 m-85 -47.5 -36.57 10.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -0.958 . . . . 0.0 109.455 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 15' ' ' ALA . 41.2 t -54.67 -58.64 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.93 . . . . 0.0 109.031 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.3 t -56.73 -22.78 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.207 -0.933 . . . . 0.0 108.865 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.473 ' O ' HG13 ' A' ' 23' ' ' ILE . 13.3 tt0 -69.46 -38.36 77.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.437 -0.789 . . . . 0.0 109.217 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.36 68.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.246 -0.909 . . . . 0.0 108.891 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.3 mm -70.31 -55.58 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.473 HG13 ' O ' ' A' ' 20' ' ' GLU . 1.0 OUTLIER -58.98 -35.54 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.055 -1.028 . . . . 0.0 109.668 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -69.63 -35.97 75.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.108 -0.995 . . . . 0.0 108.693 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 24' ' ' GLN . 0.3 OUTLIER -46.18 -42.8 14.56 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -79.8 136.54 54.81 Favored Pre-proline 0 N--CA 1.486 1.356 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -84.28 46.23 1.91 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.795 1.418 . . . . 0.0 109.979 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -149.04 -39.57 0.15 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.18 -0.95 . . . . 0.0 109.629 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -44.81 140.18 2.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 109.746 -179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.6 t -101.22 177.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 2.0 t -141.45 154.58 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.23 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -140.29 -71.73 0.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.636 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.486 ' CE1' ' HB1' ' A' ' 36' ' ' ALA . 0.2 OUTLIER -95.27 176.66 6.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.969 . . . . 0.0 109.595 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.553 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -152.13 -64.55 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.285 -0.885 . . . . 0.0 109.538 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 4.2 Cg_exo -61.17 -75.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.636 1.335 . . . . 0.0 110.417 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.486 ' HB1' ' CE1' ' A' ' 33' ' ' HIS . . . -46.52 -93.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.509 ' CB ' ' HG2' ' A' ' 10' ' ' GLN . 2.0 ptm -115.46 -167.23 1.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.687 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 0.9 OUTLIER -128.43 101.96 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.356 -0.84 . . . . 0.0 109.114 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.543 ' HG3' ' NH1' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -87.31 169.26 12.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.746 -179.265 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.528 ' HB ' ' CG1' ' A' ' 7' ' ' ILE . 45.3 mt -142.69 164.92 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.725 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -143.85 147.27 33.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.209 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.56 ' CB ' ' CG2' ' A' ' 5' ' ' VAL . . . -127.51 -171.81 2.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.649 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 8.3 mt-10 -140.11 64.91 1.43 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.878 -1.139 . . . . 0.0 110.372 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 8.5 tttt 175.25 -140.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.952 -1.093 . . . . 0.0 110.263 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.567 ' CB ' ' HB3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -126.51 166.69 16.79 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.301 -0.874 . . . . 0.0 110.182 -178.901 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.507 ' O ' HG21 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -129.03 157.72 40.93 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.497 ' HG2' ' CG2' ' A' ' 85' ' ' VAL . 8.2 mt-10 -150.96 140.01 21.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.077 -1.014 . . . . 0.0 109.99 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.549 HD12 ' CE2' ' A' ' 84' ' ' PHE . 1.3 mp -138.94 150.44 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 0.0 109.159 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -97.3 176.42 5.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.122 -0.986 . . . . 0.0 109.969 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -67.08 -24.39 65.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 109.332 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.497 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 34.9 mm-40 -49.53 -40.89 39.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.028 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.474 ' OG1' ' CG2' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -65.56 -46.44 79.46 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.162 -0.961 . . . . 0.0 108.755 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.6 t -56.08 -22.98 14.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -75.58 -38.21 59.29 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -66.69 -53.02 38.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 108.956 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -56.12 -33.39 65.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.288 -0.883 . . . . 0.0 109.139 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.18 -55.83 29.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.246 -0.909 . . . . 0.0 109.095 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.32 -7.49 63.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.44 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -117.01 10.22 13.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -1.108 . . . . 0.0 109.402 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -69.3 -6.89 32.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.707 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -91.42 19.75 5.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.021 . . . . 0.0 109.336 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.427 ' OD1' ' CB ' ' A' ' 65' ' ' GLU . 26.8 t70 -111.84 10.2 20.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.541 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -49.54 -46.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 109.871 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -51.61 -45.87 63.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 109.406 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.427 ' CB ' ' OD1' ' A' ' 62' ' ' ASP . 2.7 tt0 -68.29 -27.86 66.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.195 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 69' ' ' ASP . 1.1 mtm -74.78 -17.88 60.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.301 -0.874 . . . . 0.0 109.224 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.83 -57.49 5.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.557 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.9 t -46.96 -64.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.524 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.507 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 2.0 p30 -82.87 154.79 24.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.521 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 21.1 t -99.53 165.75 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.168 -0.958 . . . . 0.0 109.568 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.623 ' CD1' ' CZ ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -146.11 151.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 0.0 109.648 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.542 ' CG2' ' OH ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -165.4 151.86 10.01 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.264 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.524 ' O ' ' N ' ' A' ' 75' ' ' GLY . 0.0 OUTLIER -154.61 152.0 10.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.898 -1.126 . . . . 0.0 111.185 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.605 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 46.84 -85.12 0.01 OUTLIER Glycine 0 C--N 1.299 -1.492 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.926 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 73' ' ' ILE . . . 171.37 -47.81 0.19 Allowed Glycine 0 C--N 1.284 -2.329 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.521 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 16.2 t30 -120.34 -141.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.973 -1.31 . . . . 0.0 108.959 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.469 HG21 ' CE1' ' A' ' 84' ' ' PHE . 3.0 p 178.94 98.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.988 -1.07 . . . . 0.0 110.151 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.42 129.9 46.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 108.865 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -125.6 139.98 53.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.58 -96.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -104.04 -60.97 1.5 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.042 -1.036 . . . . 0.0 109.373 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -127.88 -30.8 2.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.341 -0.849 . . . . 0.0 109.01 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.496 ' CG ' ' N ' ' A' ' 84' ' ' PHE . 34.4 ttp180 -68.59 168.21 13.48 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.359 -0.838 . . . . 0.0 109.146 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.549 ' CE2' HD12 ' A' ' 48' ' ' ILE . 0.9 OUTLIER -141.84 127.11 18.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 108.907 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.513 ' N ' ' CD1' ' A' ' 84' ' ' PHE . 3.7 p -138.64 150.72 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.22 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.537 ' CD1' ' HA3' ' A' ' 74' ' ' GLY . 1.7 tm? -157.19 135.75 11.42 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.567 ' HB3' ' CB ' ' A' ' 45' ' ' ARG . 2.0 mp0 -121.47 -151.84 0.49 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 2.4 t90 -50.77 -78.37 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 76' ' ' ASN . 11.8 mmtt 58.93 112.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.403 ' OD1' ' C ' ' A' ' 90' ' ' ASN . 8.8 t-20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.474 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 3' ' ' SER . 54.0 m -137.08 -80.01 0.38 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.353 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.53 ' O ' ' N ' ' A' ' 44' ' ' LYS . 0.8 OUTLIER 72.05 93.19 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.7 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.632 ' N ' ' CD1' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.17 154.92 42.32 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.032 -1.043 . . . . 0.0 110.47 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.552 HG11 ' HA ' ' A' ' 88' ' ' TRP . 3.4 m -115.1 -171.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.458 0.647 . . . . 0.0 109.313 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.567 ' O ' ' N ' ' A' ' 74' ' ' GLY . 4.9 t80 -159.08 137.98 11.11 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.526 HG21 ' HA ' ' A' ' 73' ' ' ILE . 3.2 pt -158.11 142.14 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.499 ' HB3' ' HA ' ' A' ' 39' ' ' ARG . . . -146.89 150.41 35.18 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.776 -1.203 . . . . 0.0 110.109 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CZ ' ' CG2' ' A' ' 71' ' ' ILE . 8.8 m-85 -134.57 172.27 13.16 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.523 ' NE2' ' C ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -147.33 80.99 1.52 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.258 178.886 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.518 ' CA ' ' HB3' ' A' ' 69' ' ' ASP . 5.5 t0 -106.75 -178.91 3.79 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.1 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.157 -0.964 . . . . 0.0 109.049 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.56 14.12 0.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.034 -1.041 . . . . 0.0 109.938 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -102.46 -56.5 2.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.317 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.41 -54.51 39.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.756 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.446 ' HD2' HG22 ' A' ' 38' ' ' ILE . 0.3 OUTLIER -51.12 -39.2 55.68 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 109.611 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.432 ' N ' ' HG3' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -59.44 -47.5 85.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.229 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.401 ' O ' HD13 ' A' ' 22' ' ' ILE . 73.1 t -53.81 -53.84 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.287 -0.883 . . . . 0.0 109.241 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.454 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 53.3 t -62.37 -21.82 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.216 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -43.84 73.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.777 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.11 67.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.0 109.324 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.454 ' CD1' ' HA ' ' A' ' 19' ' ' VAL . 14.8 mt -67.14 -42.26 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.276 -0.89 . . . . 0.0 109.172 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.525 HG21 ' CB ' ' A' ' 29' ' ' ALA . 41.2 mt -60.87 -54.63 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.33 -0.856 . . . . 0.0 109.298 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 25' ' ' ASP . 18.6 mt-30 -57.79 -31.33 66.45 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.157 -0.964 . . . . 0.0 108.56 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 24' ' ' GLN . 9.0 t70 -46.12 -47.51 17.38 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -84.58 135.27 40.97 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -83.65 45.19 1.75 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.761 1.4 . . . . 0.0 110.155 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.6 t60 -151.7 -49.06 0.11 Allowed 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.165 -0.959 . . . . 0.0 109.759 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.525 ' CB ' HG21 ' A' ' 23' ' ' ILE . . . -41.85 141.43 0.83 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.4 -0.813 . . . . 0.0 109.704 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -100.85 -169.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.185 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.539 ' CG2' ' N ' ' A' ' 32' ' ' GLN . 2.0 p -169.01 166.46 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 0.0 109.536 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.539 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 2.8 mm-40 -144.84 77.24 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.513 ' CD2' ' O ' ' A' ' 33' ' ' HIS . 0.3 OUTLIER -48.49 103.36 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 109.547 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.557 ' CD2' ' HD2' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -104.84 -178.56 0.63 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.557 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 3.8 Cg_exo -67.6 -74.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.939 1.494 . . . . 0.0 110.116 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.39 3.39 11.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.758 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.3 mtt -112.28 157.54 20.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.128 -0.982 . . . . 0.0 109.388 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.515 ' CG1' ' O ' ' A' ' 9' ' ' PHE . 12.1 pt -134.51 92.02 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.651 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.499 ' HA ' ' HB3' ' A' ' 8' ' ' ALA . 2.1 ttp180 -85.55 162.23 18.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 110.086 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.484 ' HB ' ' CG1' ' A' ' 7' ' ' ILE . 4.1 mp -150.97 162.01 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 0.0 109.499 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.436 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.0 OUTLIER -161.96 157.1 23.22 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.027 -1.046 . . . . 0.0 110.251 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.523 ' CB ' HG21 ' A' ' 5' ' ' VAL . . . -129.34 177.75 6.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.388 -0.82 . . . . 0.0 109.068 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.581 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 2.8 pt-20 -158.74 68.74 0.46 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.915 -1.116 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.4 OUTLIER 169.82 -152.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.816 -1.178 . . . . 0.0 110.82 178.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.543 ' C ' ' CD2' ' A' ' 46' ' ' LEU . 20.1 mtp180 -125.43 135.14 52.05 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.606 ' CD1' ' CD1' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -127.32 162.53 26.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.45 -0.781 . . . . 0.0 109.168 -178.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.532 ' CB ' HG21 ' A' ' 85' ' ' VAL . 1.2 pt-20 -176.19 158.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.984 -1.073 . . . . 0.0 110.668 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.526 ' CG2' ' CB ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -152.27 155.84 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.599 ' HA ' ' CB ' ' A' ' 83' ' ' ARG . 30.0 ttp180 -100.12 -112.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 110.112 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.407 ' N ' ' HD2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -61.63 -5.29 1.78 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.982 -1.074 . . . . 0.0 110.519 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.526 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 1.0 OUTLIER -54.61 -14.7 1.41 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.708 -1.245 . . . . 0.0 109.363 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 84' ' ' PHE . 1.9 m -58.26 -39.33 78.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.69 -1.256 . . . . 0.0 109.47 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.91 -32.45 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 1.3 tt0 -67.63 -40.56 84.63 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' CG ' ' HA ' ' A' ' 60' ' ' ALA . 1.1 tt0 -49.85 -63.29 1.16 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.541 ' HA ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -48.55 -31.44 6.53 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.634 -0.666 . . . . 0.0 109.387 179.006 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.495 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.5 tp -52.27 -59.03 4.88 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.68 ' O ' ' CB ' ' A' ' 59' ' ' ARG . . . -53.63 -24.52 25.19 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 106.861 -2.496 . . . . 0.0 106.861 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.68 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 1.6 ttm-85 110.68 35.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.786 1.234 . . . . 0.0 108.557 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 62.92 96.42 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.597 ' CZ2' HG23 ' A' ' 63' ' ' VAL . 24.6 t-105 -20.11 82.74 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 123.26 1.505 . . . . 0.0 109.35 -174.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 60' ' ' ALA . 19.0 t70 -109.2 71.1 0.76 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.415 -1.721 . . . . 0.0 109.738 -176.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.597 HG23 ' CZ2' ' A' ' 61' ' ' TRP . 2.1 t -86.91 6.51 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.865 . . . . 0.0 109.799 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.538 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.3 mp0 -41.63 -34.01 0.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.614 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.54 -50.93 67.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.003 -1.061 . . . . 0.0 108.979 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.506 ' O ' ' N ' ' A' ' 68' ' ' VAL . 0.8 OUTLIER -75.68 -2.64 30.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.46 -0.775 . . . . 0.0 110.02 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.538 ' CD2' ' O ' ' A' ' 64' ' ' GLN . 3.7 pp -38.5 -26.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.503 -0.748 . . . . 0.0 110.961 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.506 ' N ' ' O ' ' A' ' 66' ' ' MET . 9.4 m -39.89 -45.42 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.151 -0.968 . . . . 0.0 110.156 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.518 ' HB3' ' CA ' ' A' ' 11' ' ' ASP . 15.8 p30 -65.29 149.45 49.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.67 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.499 ' HB ' ' HB2' ' A' ' 10' ' ' GLN . 21.8 t -62.53 169.77 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.634 ' CG2' ' CZ ' ' A' ' 9' ' ' PHE . 11.4 mt -143.56 157.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.056 -1.028 . . . . 0.0 110.643 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.495 ' OG1' ' HB1' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -159.31 142.38 14.34 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.526 ' HA ' HG21 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -143.78 163.33 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.084 -1.01 . . . . 0.0 110.194 -179.087 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -174.25 71.95 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.454 ' O ' HD22 ' A' ' 86' ' ' LEU . . . 136.02 108.13 0.91 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.575 ' HA ' ' CD2' ' A' ' 86' ' ' LEU . 0.7 OUTLIER -157.78 139.42 13.86 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.183 -1.187 . . . . 0.0 110.908 -178.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.546 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 1.8 t -152.37 30.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.583 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 5.2 p-10 -47.84 -38.95 17.12 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.898 0.856 . . . . 0.0 111.233 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.407 ' N ' ' CG ' ' A' ' 78' ' ' ASP . 1.5 mm-40 -110.79 103.06 11.54 Favored 'General case' 0 C--N 1.266 -3.023 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.93 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.53 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 58.1 t0 -115.2 -68.46 0.92 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.035 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -108.21 -96.6 0.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -0.93 . . . . 0.0 109.365 179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -131.03 0.22 4.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.036 -1.04 . . . . 0.0 109.221 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.599 ' CB ' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -102.6 -107.09 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.796 . . . . 0.0 109.42 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.57 ' CE2' ' HB2' ' A' ' 78' ' ' ASP . 12.9 t80 -174.74 118.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.831 -1.168 . . . . 0.0 108.718 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.583 ' O ' ' HA ' ' A' ' 78' ' ' ASP . 10.7 p -131.83 174.92 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.867 -1.146 . . . . 0.0 110.588 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.606 ' CD1' ' CD1' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -177.84 130.56 0.15 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.559 ' N ' HD23 ' A' ' 86' ' ' LEU . 2.2 mt-10 -128.23 -151.56 0.48 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.902 -1.124 . . . . 0.0 111.624 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.559 ' HB2' ' N ' ' A' ' 4' ' ' LEU . 1.4 p-90 -54.52 -157.55 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.858 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 88' ' ' TRP . 0.1 OUTLIER -59.26 -155.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.088 -1.008 . . . . 0.0 109.086 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.467 179.847 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.193 0.521 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.04 64.18 1.31 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.125 -0.984 . . . . 0.0 109.329 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 44' ' ' LYS . 15.8 m -130.55 33.88 4.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.867 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -122.44 168.41 12.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.049 -1.032 . . . . 0.0 109.707 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.528 ' CG2' ' HB1' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -132.85 -178.35 2.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.346 -0.846 . . . . 0.0 109.954 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 74' ' ' GLY . 1.3 t80 -149.53 142.37 24.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 6' ' ' TYR . 1.8 pp -160.84 158.51 2.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.541 ' O ' ' N ' ' A' ' 72' ' ' THR . . . -159.35 145.69 16.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.658 -1.276 . . . . 0.0 109.691 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.643 ' CE2' ' CD1' ' A' ' 38' ' ' ILE . 2.6 p90 -145.26 -171.2 3.61 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 109.539 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.579 ' N ' ' HB ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -148.97 98.98 2.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -0.76 . . . . 0.0 109.108 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.445 ' OD1' ' OD2' ' A' ' 69' ' ' ASP . 35.4 t70 -108.57 136.76 47.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.629 -0.67 . . . . 0.0 109.525 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -71.67 -31.49 66.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 109.561 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' CB ' ' OD2' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -57.52 106.02 0.3 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.087 -1.008 . . . . 0.0 108.575 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.61 -11.43 7.21 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.82 -31.53 49.58 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.034 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.45 ' CG ' ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -67.29 -45.45 76.52 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.486 -0.759 . . . . 0.0 109.067 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.4 -44.53 72.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.206 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -54.95 -60.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.237 -0.915 . . . . 0.0 108.828 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 85.1 t -52.95 -23.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 108.864 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -54.39 19.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.191 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.89 -35.45 61.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.271 -0.893 . . . . 0.0 109.304 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.8 mt -64.52 -45.34 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 109.191 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.516 ' CG2' ' HB2' ' A' ' 29' ' ' ALA . 95.9 mt -51.43 -48.06 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.879 . . . . 0.0 109.14 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.2 72.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.21 -0.931 . . . . 0.0 108.573 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.12 -32.69 16.56 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -80.07 137.59 53.26 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -84.47 44.9 1.59 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.818 1.431 . . . . 0.0 109.822 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -151.06 -53.97 0.14 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.305 -0.872 . . . . 0.0 109.201 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.516 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . . . -63.49 139.59 58.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.356 -0.84 . . . . 0.0 109.075 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.527 ' CG1' ' HG3' ' A' ' 41' ' ' GLU . 11.7 p -101.21 158.95 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.193 -0.942 . . . . 0.0 109.609 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 1.9 t -138.78 148.7 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.408 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -144.29 43.73 1.42 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.225 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 32' ' ' GLN . 12.5 p80 -44.32 140.31 2.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.892 . . . . 0.0 109.35 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.468 ' CG ' ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -103.73 178.26 1.22 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.504 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.468 ' HD2' ' CG ' ' A' ' 34' ' ' HIS . 2.7 Cg_endo -76.53 -28.01 7.13 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.066 1.561 . . . . 0.0 110.331 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.89 -30.62 3.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.592 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.484 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -117.16 -168.99 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.569 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 9' ' ' PHE . 11.3 pt -140.03 115.65 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.346 -0.847 . . . . 0.0 108.831 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.482 ' O ' ' CD1' ' A' ' 40' ' ' ILE . 0.1 OUTLIER -111.89 142.76 43.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.447 -178.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.482 ' CD1' ' O ' ' A' ' 39' ' ' ARG . 28.0 mm -145.91 152.42 14.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.583 -0.698 . . . . 0.0 109.213 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.527 ' HG3' ' CG1' ' A' ' 30' ' ' VAL . 2.9 pt-20 -129.29 176.59 7.82 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.113 -0.992 . . . . 0.0 108.893 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.528 ' HB1' ' CG2' ' A' ' 5' ' ' VAL . . . -132.66 -179.43 5.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.079 -1.013 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 17.9 mt-10 -140.48 58.87 1.56 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.373 -0.83 . . . . 0.0 109.261 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CB ' ' HB2' ' A' ' 88' ' ' TRP . 1.6 mmtp -153.0 -166.28 2.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.908 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.551 ' HA ' ' CG ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -141.26 -171.2 3.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.641 ' CB ' ' CD1' ' A' ' 86' ' ' LEU . 15.2 mt -159.03 157.33 30.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 110.741 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.546 ' HA ' ' CG2' ' A' ' 85' ' ' VAL . 1.4 tt0 -160.94 139.75 10.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.179 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.533 HG23 ' CB ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -154.69 141.63 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.128 -0.983 . . . . 0.0 109.912 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.586 ' HA ' ' CG ' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -101.58 -101.38 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.811 179.465 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -6.38 27.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.018 -1.052 . . . . 0.0 109.294 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.533 ' CB ' HG23 ' A' ' 48' ' ' ILE . 3.2 mt-10 -56.41 -16.12 5.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.422 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -59.14 -42.48 90.76 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.87 -1.144 . . . . 0.0 109.259 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 52' ' ' THR . 59.0 t -48.38 -33.48 4.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.979 -1.076 . . . . 0.0 108.158 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.49 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -68.39 -44.93 74.03 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.873 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -45.08 46.42 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -53.86 -44.13 70.12 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.595 ' C ' ' CD1' ' A' ' 57' ' ' LEU . 0.9 OUTLIER -51.44 -72.52 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.363 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.494 ' N ' HD11 ' A' ' 57' ' ' LEU . . . -39.32 -28.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.506 ' CB ' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -53.07 -58.97 5.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -1.201 . . . . 0.0 109.008 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 59' ' ' ARG . . . -42.85 -32.92 0.68 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -90.86 50.21 1.77 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.56 78.7 2.57 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.942 0.877 . . . . 0.0 109.396 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 65' ' ' GLU . 8.2 t -72.58 7.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.918 -0.489 . . . . 0.0 110.622 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 63' ' ' VAL . 2.7 mp0 -39.52 -27.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.141 -0.974 . . . . 0.0 109.91 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 63' ' ' VAL . 11.7 mt-10 -57.48 -56.23 24.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.008 . . . . 0.0 108.902 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.465 ' HB2' HG13 ' A' ' 63' ' ' VAL . 1.6 mmm -67.39 -8.34 32.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 0.0 109.403 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.501 ' O ' ' N ' ' A' ' 69' ' ' ASP . 5.9 tp -76.6 7.85 4.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.443 -0.786 . . . . 0.0 110.433 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 67' ' ' LEU . 58.2 t -40.41 -25.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.995 -1.066 . . . . 0.0 110.489 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' LEU . 7.2 m-20 -58.18 143.55 43.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.007 -1.058 . . . . 0.0 109.019 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.579 ' HB ' ' N ' ' A' ' 10' ' ' GLN . 57.3 t -43.82 159.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.144 -0.972 . . . . 0.0 109.126 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.577 ' N ' ' CD1' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -141.54 141.56 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.579 -0.7 . . . . 0.0 109.787 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.541 ' N ' ' O ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -154.73 147.63 24.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.564 179.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.513 HD11 HG22 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -133.17 174.8 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.344 -0.847 . . . . 0.0 109.443 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 174.94 64.44 0.05 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.18 -95.3 0.49 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.26 153.58 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 0.0 109.473 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.54 102.8 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.127 -0.983 . . . . 0.0 109.869 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.528 ' OD1' ' CG1' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -107.7 112.95 25.9 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.006 178.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.58 131.46 54.83 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.473 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -104.04 -107.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -108.41 -56.34 2.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.93 -1.106 . . . . 0.0 109.495 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -127.28 -33.7 2.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.35 -0.844 . . . . 0.0 108.96 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.586 ' CG ' ' HA ' ' A' ' 49' ' ' ARG . 1.7 mpt_? -66.48 -178.06 0.64 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.548 -0.72 . . . . 0.0 109.397 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.471 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.3 t80 -161.5 130.16 4.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 109.661 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.546 ' CG2' ' HA ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -132.64 157.31 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.989 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.641 ' CD1' ' CB ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -165.49 -150.41 0.13 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.315 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.551 ' CG ' ' HA ' ' A' ' 45' ' ' ARG . 0.2 OUTLIER -121.42 -171.06 2.14 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.092 -1.005 . . . . 0.0 109.373 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.566 ' HA ' ' HG ' ' A' ' 46' ' ' LEU . 0.1 OUTLIER -78.39 118.66 20.78 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.239 -0.913 . . . . 0.0 109.466 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 -53.26 0.87 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.845 . . . . 0.0 109.448 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.558 -179.935 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 t -74.81 136.48 41.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.246 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -133.12 90.31 2.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.843 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -122.33 161.56 23.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.222 -0.924 . . . . 0.0 109.212 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.543 ' CG2' ' CB ' ' A' ' 42' ' ' ALA . 3.1 m -125.52 -171.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.271 -0.893 . . . . 0.0 110.272 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.586 ' O ' ' N ' ' A' ' 74' ' ' GLY . 10.5 t80 -163.43 137.75 6.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.536 -0.727 . . . . 0.0 109.134 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.5 ' O ' ' HB3' ' A' ' 39' ' ' ARG . 7.7 pt -148.76 139.67 17.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.938 ' HA ' ' CB ' ' A' ' 39' ' ' ARG . . . -144.36 137.52 27.18 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 117.752 -1.579 . . . . 0.0 111.98 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.608 ' CD2' ' HG2' ' A' ' 39' ' ' ARG . 2.0 p90 -128.8 178.15 6.56 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.084 -1.046 . . . . 0.0 109.106 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.594 ' N ' HG11 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -127.03 94.04 3.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.478 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 5.1 p-10 -108.12 143.16 37.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 110.214 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -78.48 -5.06 51.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.446 -0.784 . . . . 0.0 109.157 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' O ' ' OD2' ' A' ' 11' ' ' ASP . 32.9 t0 -80.78 103.46 10.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.24 -0.913 . . . . 0.0 108.819 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.29 -9.16 21.91 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.32 -0.862 . . . . 0.0 108.895 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.06 -39.27 71.78 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.24 -0.913 . . . . 0.0 108.931 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.43 -44.95 80.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.429 -0.794 . . . . 0.0 109.009 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.58 ' CD2' HG23 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -55.11 -45.55 75.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.0 108.999 179.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.18 -61.07 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -0.878 . . . . 0.0 108.81 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -53.05 -23.26 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.274 -0.892 . . . . 0.0 108.613 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -54.95 17.83 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.6 -37.41 17.99 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 25' ' ' ASP . 36.8 mt -61.26 -45.09 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.529 HG22 ' CB ' ' A' ' 29' ' ' ALA . 22.4 mm -50.45 -57.04 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 109.024 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -59.5 -28.52 67.12 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.195 -0.94 . . . . 0.0 108.489 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -50.4 -39.44 47.06 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -79.69 141.77 56.34 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -84.48 44.84 1.58 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.777 1.409 . . . . 0.0 109.904 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -150.65 -48.28 0.12 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.529 ' CB ' HG22 ' A' ' 23' ' ' ILE . . . -71.1 139.26 50.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.385 -0.822 . . . . 0.0 109.657 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.411 HG11 ' N ' ' A' ' 31' ' ' VAL . 7.6 t -101.98 152.04 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 109.502 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.411 ' N ' HG11 ' A' ' 30' ' ' VAL . 0.1 OUTLIER -129.07 169.14 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.21 -0.932 . . . . 0.0 109.367 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -147.73 111.46 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.406 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -82.14 127.77 33.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -123.93 148.2 56.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.29 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.453 ' O ' ' CB ' ' A' ' 36' ' ' ALA . 2.2 Cg_endo -87.23 43.77 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.895 1.471 . . . . 0.0 110.206 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.453 ' CB ' ' O ' ' A' ' 35' ' ' PRO . . . 166.43 -29.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.477 ' C ' ' CD1' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -104.8 171.6 7.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.579 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.58 HG23 ' CD2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -156.04 124.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.448 -0.783 . . . . 0.0 109.199 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.938 ' CB ' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER 171.59 -151.88 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.993 -1.067 . . . . 0.0 110.949 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.515 ' CG1' ' C ' ' A' ' 39' ' ' ARG . 2.5 mt -160.79 -170.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.587 -1.321 . . . . 0.0 110.306 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 0.6 OUTLIER -134.83 -173.35 3.28 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.491 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.543 ' CB ' ' CG2' ' A' ' 5' ' ' VAL . . . -138.74 -171.34 3.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.973 -1.08 . . . . 0.0 110.007 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 18.6 mt-10 -141.36 33.01 1.68 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.404 -0.81 . . . . 0.0 109.741 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 88' ' ' TRP . 1.3 tttp -168.34 -144.65 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.891 -1.131 . . . . 0.0 110.332 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.585 ' O ' ' CA ' ' A' ' 88' ' ' TRP . 0.1 OUTLIER -145.3 -154.09 0.52 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.64 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -155.5 148.32 24.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.059 -1.026 . . . . 0.0 110.061 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.473 ' C ' ' CG1' ' A' ' 48' ' ' ILE . 4.3 tm-20 -137.81 139.56 40.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.064 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.473 ' CG1' ' C ' ' A' ' 47' ' ' GLU . 0.1 OUTLIER -159.4 154.79 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.11 -0.994 . . . . 0.0 109.967 -179.534 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.459 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -82.82 -166.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.382 -0.823 . . . . 0.0 110.092 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.515 ' HG3' ' NH1' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -73.38 -27.01 61.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.928 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -49.19 -30.42 6.87 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.027 -1.046 . . . . 0.0 108.921 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.587 ' HB ' ' CD2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -65.74 -45.28 83.22 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.894 -1.129 . . . . 0.0 108.478 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.585 ' CG2' ' CD1' ' A' ' 84' ' ' PHE . 40.6 t -47.88 -29.56 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 3.3 tt0 -71.85 -45.09 62.57 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -55.97 -51.7 66.77 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.397 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.67 -38.64 72.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 109.643 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.21 -52.3 65.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.208 -0.932 . . . . 0.0 109.244 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.12 -14.55 61.64 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -112.52 20.87 16.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -1.082 . . . . 0.0 109.713 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.58 -7.43 43.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.665 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.612 ' CD1' ' O ' ' A' ' 61' ' ' TRP . 65.3 t-105 -92.31 22.89 4.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.932 . . . . 0.0 109.481 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -110.79 5.95 21.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.022 -1.049 . . . . 0.0 109.988 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.01 -33.84 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 109.644 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -53.48 -37.15 62.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.227 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.77 -31.52 68.34 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.348 -0.845 . . . . 0.0 109.236 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mtm -67.78 -12.84 61.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 tt -68.61 -50.57 50.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.095 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.86 -43.57 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 10' ' ' GLN . 1.4 p-10 -94.14 162.64 13.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.148 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.594 HG11 ' N ' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -81.5 175.39 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.207 -0.933 . . . . 0.0 109.124 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.35 137.5 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.309 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -144.3 154.86 43.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.482 ' HA ' HG21 ' A' ' 7' ' ' ILE . 1.9 pp -145.27 174.68 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.774 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -177.76 58.17 0.09 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.5 ' O ' ' CB ' ' A' ' 87' ' ' GLU . . . 120.12 61.42 0.25 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.552 ' CB ' ' HB3' ' A' ' 87' ' ' GLU . 2.3 p-10 -175.85 138.11 0.36 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.418 -1.048 . . . . 0.0 108.642 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.601 ' O ' ' O ' ' A' ' 85' ' ' VAL . 7.6 p 177.19 79.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 O-C-N 121.291 -0.88 . . . . 0.0 109.32 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.592 ' HB3' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -49.06 -15.86 0.12 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.754 -0.591 . . . . 0.0 111.679 -178.709 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' O ' HG21 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -111.66 100.82 9.27 Favored 'General case' 0 C--N 1.281 -2.401 0 O-C-N 121.153 -0.967 . . . . 0.0 109.21 179.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.8 -79.97 0.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.787 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.59 -90.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.922 . . . . 0.0 109.925 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -118.67 -29.5 5.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.824 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -88.84 -158.19 0.48 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 109.016 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.592 ' CE2' ' HB3' ' A' ' 78' ' ' ASP . 0.1 OUTLIER -126.84 120.5 29.4 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.094 -1.004 . . . . 0.0 109.633 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.601 ' O ' ' O ' ' A' ' 77' ' ' VAL . 2.5 p -144.7 140.05 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.18 -0.95 . . . . 0.0 109.545 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.622 ' HG ' ' CB ' ' A' ' 46' ' ' LEU . 0.5 OUTLIER -151.53 -155.39 0.62 Allowed 'General case' 0 C--N 1.284 -2.252 0 O-C-N 120.885 -1.134 . . . . 0.0 108.124 177.754 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.64 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 0.6 OUTLIER -89.14 173.4 8.45 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-O 122.115 0.959 . . . . 0.0 110.725 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.585 ' CA ' ' O ' ' A' ' 45' ' ' ARG . 4.8 t90 -77.9 122.07 24.99 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.784 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.78 19.94 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.925 -1.035 . . . . 0.0 109.503 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -172.28 59.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.231 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 44' ' ' LYS . 20.8 p -123.41 9.33 9.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.839 . . . . 0.0 109.798 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -143.22 164.86 29.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.965 -1.084 . . . . 0.0 110.485 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.486 ' HB ' ' HA3' ' A' ' 75' ' ' GLY . 10.5 m -130.79 167.37 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.515 0.674 . . . . 0.0 109.858 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.568 ' O ' ' N ' ' A' ' 74' ' ' GLY . 0.8 OUTLIER -145.06 135.78 24.5 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.53 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 1.9 pt -160.5 137.77 2.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.877 -1.139 . . . . 0.0 110.368 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.632 ' O ' ' CD1' ' A' ' 9' ' ' PHE . . . -120.79 167.72 12.2 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CD1' ' O ' ' A' ' 8' ' ' ALA . 12.0 m-85 -163.18 155.13 17.87 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.536 -1.353 . . . . 0.0 109.793 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.509 ' N ' HG12 ' A' ' 71' ' ' ILE . 0.0 OUTLIER -121.05 94.86 4.48 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.033 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.473 ' HB3' ' OD1' ' A' ' 69' ' ' ASP . 1.4 p30 -108.83 137.53 46.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.585 -0.697 . . . . 0.0 109.749 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -13.76 59.48 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.245 -0.91 . . . . 0.0 109.174 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.8 105.83 4.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.441 ' OD1' ' CB ' ' A' ' 17' ' ' TYR . 18.1 t30 -60.71 -12.83 11.65 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.28 -42.03 66.15 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.256 -0.903 . . . . 0.0 108.784 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -38.78 74.34 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.441 ' CB ' ' OD1' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -58.64 -43.16 89.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.477 -0.764 . . . . 0.0 108.966 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.49 -52.87 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 108.81 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 23' ' ' ILE . 48.1 t -62.39 -24.06 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.375 -0.828 . . . . 0.0 109.025 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.423 ' CG ' ' OE1' ' A' ' 24' ' ' GLN . 1.7 tt0 -76.08 -27.14 57.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.267 -0.896 . . . . 0.0 109.049 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.39 -44.48 64.88 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -63.82 -46.94 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.522 ' CG2' ' HB2' ' A' ' 29' ' ' ALA . 60.1 mt -54.25 -49.1 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.423 ' OE1' ' CG ' ' A' ' 20' ' ' GLU . 17.9 mt-30 -61.7 -32.64 72.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.146 -0.972 . . . . 0.0 108.457 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -47.06 -36.82 8.54 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -79.84 133.69 58.12 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.36 46.24 1.91 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.805 1.424 . . . . 0.0 109.98 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -149.92 -45.44 0.13 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.126 -0.984 . . . . 0.0 109.713 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.522 ' HB2' ' CG2' ' A' ' 23' ' ' ILE . . . -59.92 144.21 49.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.487 ' C ' ' CG2' ' A' ' 31' ' ' VAL . 5.7 t -101.11 139.67 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.521 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.487 ' CG2' ' C ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -168.88 166.54 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 109.14 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 33' ' ' HIS . 2.5 mm-40 -149.43 -94.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.338 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.48 ' HB2' ' HB ' ' A' ' 38' ' ' ILE . 4.9 t60 55.72 110.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 109.88 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.547 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -154.16 -62.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.616 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.3 Cg_endo -67.21 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.652 1.343 . . . . 0.0 109.772 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.64 -53.75 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.399 -0.813 . . . . 0.0 109.243 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.469 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -72.08 157.33 37.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 109.153 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -122.83 165.22 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.017 -1.052 . . . . 0.0 109.34 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.492 ' NH1' ' HG2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -132.21 156.87 45.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.966 . . . . 0.0 109.986 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.497 ' O ' ' HB2' ' A' ' 41' ' ' GLU . 8.7 mt -152.83 172.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.401 -0.812 . . . . 0.0 109.053 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' A' ' 42' ' ' ALA . 5.9 tt0 171.36 145.21 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.501 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -144.12 -162.8 1.54 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.085 -1.01 . . . . 0.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.557 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -140.67 82.92 1.87 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HB3' ' CB ' ' A' ' 88' ' ' TRP . 31.2 mmtt -129.64 -165.13 1.48 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.048 -1.032 . . . . 0.0 110.856 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.541 ' CA ' ' HG3' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -165.24 165.34 19.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.56 ' CB ' HD13 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -164.55 150.61 10.56 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.897 -1.127 . . . . 0.0 110.478 178.895 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.442 ' HA ' HG21 ' A' ' 85' ' ' VAL . 0.6 OUTLIER -142.99 139.67 30.72 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 52' ' ' THR . 2.3 pt -139.71 163.64 24.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.064 -1.022 . . . . 0.0 110.305 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.468 ' HA ' ' HG3' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -95.46 -147.43 0.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.476 -0.765 . . . . 0.0 109.336 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' NH1' ' CG ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -87.67 -40.59 14.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.081 -1.012 . . . . 0.0 109.726 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 69.1 tt0 -54.67 -31.21 57.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 109.06 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.536 ' CB ' ' HB ' ' A' ' 48' ' ' ILE . 0.6 OUTLIER -61.92 -40.16 94.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.036 -1.04 . . . . 0.0 108.536 179.409 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 52' ' ' THR . 21.2 t -46.25 -32.93 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.476 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 3.8 tt0 -71.24 -46.01 61.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 52' ' ' THR . 40.0 mm-40 -52.82 -55.12 25.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.364 -0.835 . . . . 0.0 109.529 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -55.51 -34.92 65.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.257 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.476 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.8 tp -56.43 -54.8 41.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.149 -0.969 . . . . 0.0 109.284 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.65 -9.64 65.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.44 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -112.75 5.61 17.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -1.076 . . . . 0.0 109.396 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -79.29 -19.15 51.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -89.89 23.64 2.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.196 -0.94 . . . . 0.0 109.286 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.64 39.48 2.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.401 -0.812 . . . . 0.0 109.017 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -91.95 -3.94 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.708 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.419 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 13.1 mp0 -50.2 -25.24 3.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 0.0 109.465 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -66.31 -44.53 83.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.147 -0.971 . . . . 0.0 109.426 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 5.1 mtp -59.27 -16.11 19.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 0.0 109.523 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.419 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 11.2 tp -78.1 -52.25 9.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.703 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.42 ' O ' ' O ' ' A' ' 10' ' ' GLN . 2.0 t -66.56 -55.19 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.626 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -98.76 85.22 3.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.636 ' O ' HG12 ' A' ' 71' ' ' ILE . 7.1 p -103.29 141.77 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.247 -0.908 . . . . 0.0 112.513 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.636 HG12 ' O ' ' A' ' 70' ' ' VAL . 2.1 mm 178.41 -85.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.565 ' N ' HG23 ' A' ' 71' ' ' ILE . 2.2 m -133.44 176.33 8.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.921 -1.112 . . . . 0.0 111.621 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.508 ' CG1' ' C ' ' A' ' 72' ' ' THR . 0.6 OUTLIER -160.87 162.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -179.65 34.99 0.07 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.486 ' HA3' ' HB ' ' A' ' 5' ' ' VAL . . . -162.58 85.31 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -129.2 -135.33 0.22 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.586 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.58 ' CG2' ' CD1' ' A' ' 84' ' ' PHE . 7.1 p -118.22 126.6 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -0.999 . . . . 0.0 109.724 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -105.98 148.0 28.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.513 -0.742 . . . . 0.0 109.943 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -103.3 133.52 48.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 108.961 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -106.15 -93.94 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 110.102 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -105.39 -75.72 0.62 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.899 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.53 -31.41 4.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 108.761 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.468 ' HG3' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -81.04 -171.74 3.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.58 ' CD1' ' CG2' ' A' ' 77' ' ' VAL . 0.2 OUTLIER -134.87 158.96 42.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.09 -1.006 . . . . 0.0 109.269 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.513 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 2.4 p -143.7 169.56 10.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.242 -0.911 . . . . 0.0 109.438 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.56 HD13 ' CB ' ' A' ' 46' ' ' LEU . 1.3 pp -176.84 -167.39 0.18 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.541 ' HG3' ' CA ' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -119.91 173.07 7.28 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.894 -1.129 . . . . 0.0 110.645 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.513 ' CB ' ' HB3' ' A' ' 44' ' ' LYS . 1.5 t90 -70.65 128.47 36.18 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.666 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -107.37 159.49 16.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.953 . . . . 0.0 109.669 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.1 t30 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.392 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -90.7 -35.38 14.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 109.377 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.597 ' HA ' ' CE3' ' A' ' 88' ' ' TRP . 0.1 OUTLIER -173.85 93.29 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.424 -0.798 . . . . 0.0 108.962 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -137.02 156.43 48.44 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.087 -1.008 . . . . 0.0 110.512 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -113.73 -176.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.642 ' CD2' HG22 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -147.05 139.15 24.52 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.089 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.737 ' HA ' HG21 ' A' ' 73' ' ' ILE . 1.3 pt -143.63 135.32 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.296 -0.878 . . . . 0.0 108.801 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.578 ' N ' ' HA ' ' A' ' 72' ' ' THR . . . -145.3 147.1 31.97 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.384 -1.326 . . . . 0.0 110.522 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.602 ' CE1' ' HB ' ' A' ' 38' ' ' ILE . 16.7 p90 -135.96 175.98 9.1 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.586 ' O ' ' HA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -141.08 80.14 1.73 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.095 -1.003 . . . . 0.0 108.748 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.443 ' CB ' ' NH1' ' A' ' 16' ' ' ARG . 4.0 t70 -110.18 178.84 4.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.336 -0.853 . . . . 0.0 110.0 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -121.91 16.26 10.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 109.397 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -85.96 103.89 15.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.214 -0.929 . . . . 0.0 108.985 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -67.23 -7.76 26.43 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.251 -0.906 . . . . 0.0 108.873 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.77 -56.01 9.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.32 -0.863 . . . . 0.0 109.016 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.446 ' HG2' ' N ' ' A' ' 17' ' ' TYR . 6.2 ptm180 -59.37 -28.71 67.12 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 26.4 t80 -60.3 -49.94 75.59 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.4 t -54.38 -56.08 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.461 ' HA ' HD11 ' A' ' 22' ' ' ILE . 95.6 t -49.59 -30.93 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.29 -46.17 77.9 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.99 -41.08 46.19 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.302 -0.874 . . . . 0.0 108.667 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.461 HD11 ' HA ' ' A' ' 19' ' ' VAL . 4.3 mp -65.55 -43.05 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.469 -0.769 . . . . 0.0 108.976 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 7.0 mt -52.89 -43.98 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 108.844 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.49 ' HG2' ' CG2' ' A' ' 31' ' ' VAL . 1.9 mt-30 -67.26 -32.08 72.85 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -24.88 6.54 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -83.05 135.37 44.95 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -84.6 47.12 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.761 1.4 . . . . 0.0 109.843 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -146.87 -40.07 0.2 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.338 -0.851 . . . . 0.0 109.084 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.411 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . . . -73.91 139.9 45.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.442 -0.786 . . . . 0.0 109.538 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 41' ' ' GLU . 16.0 t -71.24 -120.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.181 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.49 ' CG2' ' HG2' ' A' ' 24' ' ' GLN . 1.1 p -174.23 -165.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.729 -1.232 . . . . 0.0 109.935 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.512 ' NE2' HG21 ' A' ' 38' ' ' ILE . 0.9 OUTLIER -114.19 -167.73 1.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.551 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -89.45 -99.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 109.928 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.536 ' HB3' ' HD3' ' A' ' 35' ' ' PRO . 46.7 t-80 -166.17 -58.69 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 110.587 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 34' ' ' HIS . 3.5 Cg_exo -49.53 -179.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 117.442 -1.239 . . . . 0.0 110.822 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.459 ' O ' HD12 ' A' ' 38' ' ' ILE . . . -52.21 -22.57 4.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.005 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.505 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 3.1 mmt -65.37 156.4 32.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.926 -1.109 . . . . 0.0 109.242 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.602 ' HB ' ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -127.82 129.17 69.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.291 -0.881 . . . . 0.0 108.63 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.55 ' HA ' ' HB3' ' A' ' 8' ' ' ALA . 2.2 ttt180 -126.52 164.62 20.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.06 -1.025 . . . . 0.0 110.053 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.552 ' CG2' ' N ' ' A' ' 41' ' ' GLU . 2.7 mp -156.51 169.22 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.37 -0.831 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.552 ' N ' ' CG2' ' A' ' 40' ' ' ILE . 0.9 OUTLIER -155.91 152.79 28.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.682 -1.261 . . . . 0.0 110.26 -179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.533 ' O ' ' CB ' ' A' ' 4' ' ' LEU . . . -129.93 -177.26 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.611 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 91.0 mt-10 -140.04 74.97 1.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.126 -0.984 . . . . 0.0 110.186 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 175.11 -141.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.972 -1.08 . . . . 0.0 110.208 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.567 ' CG ' ' HB3' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -126.1 167.83 14.83 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.228 -0.92 . . . . 0.0 109.931 -179.093 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 86' ' ' LEU . 0.3 OUTLIER -130.88 152.91 49.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.384 -0.823 . . . . 0.0 109.665 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.35 154.7 46.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.2 mt -150.55 141.02 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.141 -0.975 . . . . 0.0 109.71 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.454 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.6 ptt180 -100.92 -171.93 2.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 109.567 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.54 ' NH1' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -75.76 -32.85 60.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.184 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 4.4 mt-10 -50.37 -41.59 52.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.865 . . . . 0.0 109.297 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -69.26 -47.67 64.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 108.88 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.6 -26.73 2.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 1.4 tt0 -74.84 -43.59 53.74 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -55.73 -50.32 70.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 108.731 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -59.79 -33.46 71.74 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.372 -0.83 . . . . 0.0 109.016 179.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.465 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.5 tp -57.73 -51.76 68.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 108.905 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.05 -14.82 66.48 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -113.02 15.23 19.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.964 . . . . 0.0 109.306 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -67.18 -19.42 65.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -0.838 . . . . 0.0 109.426 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -89.42 35.59 0.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.309 -0.869 . . . . 0.0 109.381 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.459 ' OD1' ' HB2' ' A' ' 65' ' ' GLU . 34.9 t70 -104.97 5.87 33.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.8 t -52.21 -40.65 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.932 . . . . 0.0 109.539 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -52.46 -40.93 62.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.143 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.47 ' O ' ' OD1' ' A' ' 69' ' ' ASP . 0.4 OUTLIER -73.03 -28.39 62.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.049 179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -12.03 61.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.278 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -74.47 -56.97 4.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.297 -0.877 . . . . 0.0 109.945 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.53 ' CG1' ' OD2' ' A' ' 69' ' ' ASP . 2.3 p -90.52 -46.47 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.119 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -103.02 146.69 27.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.983 -1.073 . . . . 0.0 109.967 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.534 ' HB ' ' HA ' ' A' ' 9' ' ' PHE . 7.0 t -100.56 -176.07 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.551 ' O ' ' CG2' ' A' ' 72' ' ' THR . 0.6 OUTLIER -136.02 -37.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.276 -1.515 . . . . 0.0 112.165 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.589 ' CG2' ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER 170.75 -148.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.682 -1.261 . . . . 0.0 108.7 -178.503 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.737 HG21 ' HA ' ' A' ' 7' ' ' ILE . 1.4 tp 176.95 -129.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.617 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 167.98 -108.27 0.3 Allowed Glycine 0 N--CA 1.485 1.965 0 O-C-N 120.04 -1.662 . . . . 0.0 109.945 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.53 -65.62 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.49 ' C ' HD22 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -124.42 -147.21 0.37 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -1.179 . . . . 0.0 108.662 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.627 ' CG2' ' CZ ' ' A' ' 84' ' ' PHE . 7.2 p 178.9 93.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.091 -1.006 . . . . 0.0 109.994 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.6 134.88 49.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.148 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -118.43 156.31 29.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 109.493 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -109.82 -94.93 0.41 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.556 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -106.03 -70.76 0.77 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.178 -0.951 . . . . 0.0 109.281 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.1 -6.37 7.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.313 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -90.94 -169.68 2.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -0.86 . . . . 0.0 109.406 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -155.51 122.07 5.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.941 . . . . 0.0 109.369 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.85 139.2 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.17 -0.956 . . . . 0.0 110.003 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.558 HD23 ' N ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -149.38 136.76 20.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.567 ' HB3' ' CG ' ' A' ' 45' ' ' ARG . 2.4 mp0 -121.14 -148.39 0.41 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.699 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.597 ' CE3' ' HA ' ' A' ' 3' ' ' SER . 2.7 t90 -47.09 -91.1 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.58 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -141.77 -37.87 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 109.831 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.448 ' N ' ' CD ' ' A' ' 89' ' ' LYS . 22.5 t30 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.446 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.82 48.94 9.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.28 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -120.84 -2.36 9.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.691 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.688 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 1.0 OUTLIER -126.98 158.14 37.68 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.994 -1.066 . . . . 0.0 110.283 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 41' ' ' GLU . 0.7 OUTLIER -119.49 170.96 8.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.543 0.687 . . . . 0.0 110.232 -178.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 74' ' ' GLY . 10.2 t80 -140.49 141.33 35.39 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.496 ' CG2' ' O ' ' A' ' 6' ' ' TYR . 1.5 pp -159.18 152.84 5.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.483 ' HB1' ' OG1' ' A' ' 72' ' ' THR . . . -146.37 -173.4 4.18 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.599 -1.24 . . . . 0.0 110.59 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.771 ' CG ' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.84 171.23 14.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 122.633 1.206 . . . . 0.0 111.866 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.565 ' N ' ' HA ' ' A' ' 70' ' ' VAL . 0.5 OUTLIER 176.35 105.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.32 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.596 ' CA ' HG22 ' A' ' 70' ' ' VAL . 3.3 t0 -109.87 -156.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.641 0.734 . . . . 0.0 110.078 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -128.45 -63.43 0.99 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -118.59 -15.06 9.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.441 -0.787 . . . . 0.0 108.904 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.439 ' O ' ' C ' ' A' ' 15' ' ' ALA . 0.6 OUTLIER -82.51 7.59 14.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.399 -0.813 . . . . 0.0 109.017 179.361 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 18' ' ' VAL . . . -42.4 -32.92 0.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.401 -0.812 . . . . 0.0 109.166 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -51.43 -56.74 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 109.012 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -61.74 -32.1 72.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.229 -0.92 . . . . 0.0 109.281 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 15' ' ' ALA . 55.8 t -57.01 -41.43 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.831 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.71 -30.96 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.63 -49.85 73.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.501 -0.749 . . . . 0.0 109.45 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -62.91 -40.17 96.78 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.119 -0.988 . . . . 0.0 108.97 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.537 ' CD1' HG13 ' A' ' 38' ' ' ILE . 5.6 mm -50.1 -42.92 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.026 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.487 ' O ' ' CD ' ' A' ' 27' ' ' PRO . 40.1 mm -69.29 -33.56 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.15 -0.969 . . . . 0.0 109.024 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -90.88 4.94 50.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.438 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -117.18 -11.64 10.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.528 ' OD1' ' CG1' ' A' ' 31' ' ' VAL . 1.1 m-80 -87.91 -68.79 0.12 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.519 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.517 ' HD3' ' HB2' ' A' ' 26' ' ' ASN . 3.6 Cg_exo -41.28 -28.08 0.46 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.69 1.363 . . . . 0.0 110.195 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -97.78 -39.03 9.24 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.322 -0.861 . . . . 0.0 109.199 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 25' ' ' ASP . . . -102.94 -158.08 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.125 -0.985 . . . . 0.0 109.685 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.485 ' C ' ' CG2' ' A' ' 31' ' ' VAL . 3.2 t -96.3 -127.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.528 ' CG1' ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -161.72 141.76 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.648 -1.283 . . . . 0.0 109.726 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.472 ' O ' ' O ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -174.21 95.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 109.46 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.516 ' CE1' ' HB ' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -115.05 157.17 23.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.501 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.533 ' CD2' ' HD2' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -117.45 -167.22 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.523 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.533 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 2.3 Cg_endo -90.56 15.19 1.88 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.96 1.505 . . . . 0.0 110.338 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.68 -76.39 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.195 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.411 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -84.21 167.34 16.77 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.588 ' CG2' ' CB ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -97.95 163.44 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.843 -1.161 . . . . 0.0 108.922 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.535 ' O ' ' CG1' ' A' ' 40' ' ' ILE . 8.9 mtp180 -139.48 162.47 34.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.879 -1.138 . . . . 0.0 109.5 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.535 ' CG1' ' O ' ' A' ' 39' ' ' ARG . 33.0 mt -158.64 164.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 110.003 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -159.17 166.67 30.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.381 -0.825 . . . . 0.0 109.006 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.462 ' HB2' ' HE2' ' A' ' 44' ' ' LYS . . . -159.83 -165.23 1.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.937 -1.102 . . . . 0.0 110.545 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.688 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -139.2 97.28 3.26 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.532 ' CD ' ' HB3' ' A' ' 88' ' ' TRP . 30.8 mttm -142.43 -164.54 1.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.972 -1.08 . . . . 0.0 110.925 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.499 ' O ' ' CD2' ' A' ' 46' ' ' LEU . 0.7 OUTLIER -167.79 171.32 10.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 109.154 -179.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.579 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 0.2 OUTLIER -160.82 142.19 11.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.026 -1.046 . . . . 0.0 109.723 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.502 ' C ' ' CD1' ' A' ' 48' ' ' ILE . 1.1 tt0 -138.86 138.81 37.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.996 . . . . 0.0 109.434 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.502 ' CD1' ' C ' ' A' ' 47' ' ' GLU . 4.1 mp -151.2 162.8 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.257 -0.902 . . . . 0.0 110.294 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.43 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -98.36 -153.42 0.43 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.409 ' NH1' ' CG ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -69.98 -12.68 61.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.598 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 3.4 tt0 -64.84 -9.8 23.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.193 -0.942 . . . . 0.0 109.603 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.561 ' HB ' ' CD2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -59.99 -40.34 88.83 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.866 -1.146 . . . . 0.0 109.02 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 52' ' ' THR . 94.5 t -46.37 -34.24 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -70.27 -45.75 65.76 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 52' ' ' THR . 3.0 mm-40 -47.7 -46.1 29.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -38.75 88.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.357 -0.84 . . . . 0.0 108.812 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.446 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.2 tp -55.17 -55.22 33.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.364 -0.835 . . . . 0.0 109.15 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.41 -9.4 68.37 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.451 ' HD2' ' OD1' ' A' ' 90' ' ' ASN . 1.1 ttp180 -90.95 -9.53 45.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -1.123 . . . . 0.0 109.517 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.72 -25.35 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.453 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -88.29 40.26 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.389 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -111.28 74.63 0.88 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.397 -0.814 . . . . 0.0 109.137 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.16 2.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -0.86 . . . . 0.0 109.994 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -49.01 -22.63 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.055 -1.028 . . . . 0.0 109.315 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.522 ' O ' ' CG2' ' A' ' 68' ' ' VAL . 7.0 pt-20 -56.4 -48.67 76.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -17.08 64.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.194 -0.941 . . . . 0.0 109.423 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.522 ' O ' ' CG1' ' A' ' 71' ' ' ILE . 4.9 tp -98.67 11.98 36.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 109.399 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 65' ' ' GLU . 40.5 t -39.34 -24.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.414 -0.804 . . . . 0.0 110.867 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 71' ' ' ILE . 67.4 m-20 -58.2 -100.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.713 -1.242 . . . . 0.0 109.807 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.771 ' O ' ' CG ' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -42.08 -13.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.175 -2.819 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.461 -178.166 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.558 ' N ' ' O ' ' A' ' 69' ' ' ASP . 1.7 pt -123.42 131.91 72.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 120.453 1.478 . . . . 0.0 110.253 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.483 ' OG1' ' HB1' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -130.74 150.02 52.12 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.417 ' HA ' HG21 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -133.47 174.53 13.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.229 -0.919 . . . . 0.0 110.403 -178.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 178.89 38.74 0.07 OUTLIER Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.459 ' HA3' ' HB ' ' A' ' 5' ' ' VAL . . . -152.37 82.94 0.17 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -176.03 138.47 0.35 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.674 ' O ' ' O ' ' A' ' 85' ' ' VAL . 13.8 p -171.34 52.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.101 -0.999 . . . . 0.0 109.228 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.546 ' O ' ' HA ' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -49.92 -9.54 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.265 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -110.52 94.83 5.21 Favored 'General case' 0 C--N 1.28 -2.422 0 O-C-N 120.6 -1.313 . . . . 0.0 109.729 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.435 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 0.3 OUTLIER -107.11 -82.11 0.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 108.951 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.01 -82.72 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 108.996 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -128.18 -30.88 2.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.364 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -80.11 -157.88 0.16 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.561 ' CD2' ' HB ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -126.1 112.9 16.38 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.749 -1.22 . . . . 0.0 108.752 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.674 ' O ' ' O ' ' A' ' 77' ' ' VAL . 4.1 p -129.51 138.78 53.41 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.655 0 C-N-CA 118.922 -1.111 . . . . 0.0 109.763 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.579 ' O ' ' CB ' ' A' ' 46' ' ' LEU . 0.9 OUTLIER -143.0 -176.27 4.84 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 120.837 -1.164 . . . . 0.0 108.309 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.566 ' C ' ' HB2' ' A' ' 46' ' ' LEU . 1.9 tt0 -101.1 171.8 7.4 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.947 0.88 . . . . 0.0 110.61 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.532 ' HB3' ' CD ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -73.07 81.21 1.24 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.786 -178.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER 175.2 139.82 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 0.0 109.312 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.451 ' OD1' ' HD2' ' A' ' 59' ' ' ARG . 15.2 t30 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.114 -0.991 . . . . 0.0 109.584 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' O ' ' HB2' ' A' ' 2' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 1' ' ' MET . 9.0 t -179.57 122.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.894 . . . . 0.0 109.363 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.622 ' HA ' ' CG ' ' A' ' 88' ' ' TRP . 1.0 OUTLIER 67.66 101.01 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.271 -179.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -142.26 160.93 39.27 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.759 -1.213 . . . . 0.0 112.235 -178.837 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.625 ' CG1' ' N ' ' A' ' 6' ' ' TYR . 1.2 t -113.52 -176.65 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.691 ' O ' ' N ' ' A' ' 74' ' ' GLY . 0.4 OUTLIER -159.19 144.77 16.16 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.623 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 4.5 pt -160.31 137.11 2.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 120.529 -1.357 . . . . 0.0 107.919 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.711 ' O ' HG21 ' A' ' 71' ' ' ILE . . . -132.36 146.41 51.95 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.186 -1.806 . . . . 0.0 109.606 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.646 ' CZ ' ' CG1' ' A' ' 38' ' ' ILE . 14.0 p90 -140.9 170.34 15.93 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.488 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.659 ' HG3' ' CA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -119.61 143.33 47.73 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.052 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -108.73 154.07 22.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.745 -1.222 . . . . 0.0 109.957 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.484 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -89.63 -37.97 14.26 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.377 -0.827 . . . . 0.0 109.424 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 12' ' ' ASN . 16.6 t0 168.84 -34.88 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -102.97 -30.31 10.87 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.65 -20.37 3.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.0 109.141 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -64.98 -56.14 14.91 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.832 . . . . 0.0 109.132 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.73 -39.32 73.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.238 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.1 t -56.49 -49.04 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 108.605 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.553 HG23 ' CZ ' ' A' ' 9' ' ' PHE . 60.9 t -67.45 -19.13 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.454 -0.779 . . . . 0.0 109.137 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.501 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 45.6 tt0 -76.28 -36.7 58.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.385 -0.822 . . . . 0.0 109.784 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.61 -36.23 65.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.8 mt -71.67 -48.91 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 19' ' ' VAL . 2.2 pp -57.81 -38.96 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.217 -0.927 . . . . 0.0 108.934 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -62.89 -43.05 99.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.343 -0.848 . . . . 0.0 109.035 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 24' ' ' GLN . 3.0 t0 -44.43 -36.3 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.56 88.15 23.39 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 2.4 Cg_endo -65.89 81.31 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 124.31 1.69 . . . . 0.0 110.308 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.474 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 5.5 t-80 179.33 -43.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -40.86 140.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.725 -0.61 . . . . 0.0 110.002 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.514 HG23 ' N ' ' A' ' 31' ' ' VAL . 3.7 p -97.42 165.77 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 0.0 109.441 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.521 ' CG2' ' N ' ' A' ' 32' ' ' GLN . 1.4 p -155.49 163.44 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.521 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -174.55 141.78 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 0.0 109.849 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.531 ' HB3' ' CG2' ' A' ' 38' ' ' ILE . 1.3 p-80 -143.66 160.34 40.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.27 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.562 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -157.62 -61.57 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.106 -0.996 . . . . 0.0 109.881 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.562 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.5 Cg_endo -66.92 -54.27 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.725 1.382 . . . . 0.0 110.002 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -177.63 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.315 -0.866 . . . . 0.0 108.971 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.466 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 1.2 ptm -69.02 158.62 34.42 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.646 ' CG1' ' CZ ' ' A' ' 9' ' ' PHE . 0.1 OUTLIER -110.31 120.59 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.891 -1.13 . . . . 0.0 109.857 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.53 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -81.85 177.78 8.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.34 -0.85 . . . . 0.0 110.219 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.499 ' HB ' ' CG1' ' A' ' 7' ' ' ILE . 3.1 mt -152.72 -174.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.273 -0.892 . . . . 0.0 109.673 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.562 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -171.09 158.55 5.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.795 -1.191 . . . . 0.0 111.04 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.451 ' O ' ' CB ' ' A' ' 4' ' ' LEU . . . -129.84 -175.31 3.56 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.62 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 10.2 pt-20 -151.25 70.67 0.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.147 -0.97 . . . . 0.0 110.033 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER 173.4 -143.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.856 -1.152 . . . . 0.0 109.321 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.6 ' HA ' ' HB3' ' A' ' 87' ' ' GLU . 4.9 mpt_? -126.01 154.99 42.15 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.04 -1.037 . . . . 0.0 109.375 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.607 ' CB ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -144.92 135.76 24.68 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.173 -0.955 . . . . 0.0 109.833 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.642 ' HA ' HG11 ' A' ' 85' ' ' VAL . 2.3 pm0 -151.05 135.55 17.03 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.576 ' CG2' ' CG2' ' A' ' 53' ' ' VAL . 2.5 mt -137.8 152.4 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 0.0 109.117 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.527 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -50.49 147.58 4.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 108.949 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.436 ' CG ' ' NH1' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -89.27 -60.55 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.017 . . . . 0.0 109.716 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.471 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 16.5 tt0 -54.35 -44.66 72.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.751 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -50.81 50.06 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.017 -1.052 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.576 ' CG2' ' CG2' ' A' ' 48' ' ' ILE . 19.4 t -55.34 -21.48 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -74.99 -40.08 60.88 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.29 -56.27 9.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.267 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.436 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -55.3 -29.43 58.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 109.3 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.504 ' HA ' ' HB3' ' A' ' 61' ' ' TRP . 7.6 tp -64.33 -56.11 16.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -0.842 . . . . 0.0 109.732 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.51 8.15 69.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.487 ' HG2' ' N ' ' A' ' 60' ' ' ALA . 22.7 ttt180 -98.8 -84.59 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -1.17 . . . . 0.0 109.973 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.487 ' N ' ' HG2' ' A' ' 59' ' ' ARG . . . -96.03 -22.6 17.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.585 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.504 ' HB3' ' HA ' ' A' ' 57' ' ' LEU . 8.6 t90 -90.18 25.78 2.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.313 -0.867 . . . . 0.0 109.177 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.2 44.31 1.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.264 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 65' ' ' GLU . 3.9 t -98.93 9.4 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.415 -0.803 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.467 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 16.7 mm-40 -39.9 -28.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.522 -0.736 . . . . 0.0 109.944 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 63' ' ' VAL . 16.1 tt0 -58.06 -55.26 37.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.136 -0.977 . . . . 0.0 109.404 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -9.57 58.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 67' ' ' LEU . 11.8 tp -53.74 -16.35 1.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.432 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.464 ' C ' ' O ' ' A' ' 67' ' ' LEU . 17.2 t -40.2 -42.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -0.954 . . . . 0.0 109.715 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.659 ' CA ' ' HG3' ' A' ' 10' ' ' GLN . 10.1 m-20 -81.52 -74.75 0.32 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.181 -0.949 . . . . 0.0 109.818 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.625 ' O ' ' O ' ' A' ' 69' ' ' ASP . 1.3 t -43.56 -170.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 122.152 -0.343 . . . . 0.0 110.98 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.711 HG21 ' O ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER 161.46 -167.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.634 ' O ' HG12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -175.39 -158.87 0.07 Allowed 'General case' 0 C--O 1.193 -1.903 0 O-C-N 119.348 -2.095 . . . . 0.0 108.143 179.371 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.634 HG12 ' O ' ' A' ' 72' ' ' THR . 48.6 mm -168.39 -127.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.691 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 161.84 -71.81 0.21 Allowed Glycine 0 N--CA 1.486 1.996 0 O-C-N 120.427 -1.421 . . . . 0.0 110.591 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.16 -37.93 1.59 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.445 ' N ' HD12 ' A' ' 86' ' ' LEU . 2.4 t-20 -176.48 -149.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.974 . . . . 0.0 109.205 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.582 HG21 ' CE1' ' A' ' 84' ' ' PHE . 9.1 p -151.33 100.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.016 . . . . 0.0 109.415 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.463 ' OD2' ' HD3' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -114.47 150.58 34.57 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.942 -1.098 . . . . 0.0 110.325 -179.006 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.565 ' HB3' ' CD1' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -118.12 164.64 14.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.588 -0.695 . . . . 0.0 109.229 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.513 ' OD1' ' HB2' ' A' ' 47' ' ' GLU . 3.6 p-10 -114.42 -115.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.035 -1.04 . . . . 0.0 109.646 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -98.36 -41.12 7.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.828 -1.17 . . . . 0.0 109.753 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -130.91 -58.78 1.01 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.03 -1.044 . . . . 0.0 108.606 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 84' ' ' PHE . 2.1 mpp_? -57.2 -173.22 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.582 ' CE1' HG21 ' A' ' 77' ' ' VAL . 2.2 t80 173.41 120.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.051 -1.031 . . . . 0.0 111.816 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.642 HG11 ' HA ' ' A' ' 47' ' ' GLU . 8.1 p -160.39 -115.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.607 ' O ' ' CB ' ' A' ' 46' ' ' LEU . 22.0 tp -131.85 144.62 51.03 Favored 'General case' 0 C--N 1.282 -2.352 0 O-C-N 120.19 -1.569 . . . . 0.0 112.368 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.6 ' HB3' ' HA ' ' A' ' 45' ' ' ARG . 16.8 mt-10 -120.72 -150.16 0.45 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.622 ' CG ' ' HA ' ' A' ' 3' ' ' SER . 7.0 t90 -64.19 -90.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.802 -1.186 . . . . 0.0 108.2 177.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.525 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 5.9 mptt 43.42 97.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.57 -0.706 . . . . 0.0 110.049 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.378 179.698 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.301 0.572 . . . . 0.0 109.489 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.62 -51.29 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.201 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.84 23.21 3.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 109.414 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -128.2 -167.03 1.7 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -0.98 . . . . 0.0 109.797 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 88' ' ' TRP . 11.3 t -152.28 161.31 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.594 ' O ' ' N ' ' A' ' 74' ' ' GLY . 6.6 t80 -153.16 136.0 15.38 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.549 ' CG2' ' O ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -162.68 137.68 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.921 -1.112 . . . . 0.0 109.786 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.613 ' CB ' ' CG2' ' A' ' 71' ' ' ILE . . . -126.6 173.89 9.11 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 69' ' ' ASP . 2.6 m-85 -168.56 155.56 7.48 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.496 -1.378 . . . . 0.0 109.366 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.509 ' HA ' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -120.91 93.82 4.15 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.475 ' O ' ' OE1' ' A' ' 10' ' ' GLN . 1.1 m-20 -74.38 -166.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.38 -0.825 . . . . 0.0 109.831 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.7 -114.59 0.12 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.09 -1.006 . . . . 0.0 108.911 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -119.08 -31.97 4.57 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.843 -1.161 . . . . 0.0 108.579 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -103.07 -34.87 8.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.473 -0.767 . . . . 0.0 109.331 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' HB2' ' OD1' ' A' ' 11' ' ' ASP . . . -59.86 -38.53 82.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.556 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.454 ' CG ' ' NH1' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -63.07 -36.22 82.86 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.315 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -37.65 83.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.075 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.86 -53.04 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 109.191 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.443 ' HA ' HD11 ' A' ' 22' ' ' ILE . 55.9 t -64.37 -23.65 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.409 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.35 -35.28 73.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 109.747 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.433 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -77.53 -33.08 54.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.773 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.507 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 8.3 mt -71.89 -37.62 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.181 -0.949 . . . . 0.0 109.058 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.421 HD12 HD12 ' A' ' 40' ' ' ILE . 51.3 mt -67.24 -53.02 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.894 . . . . 0.0 109.335 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -63.48 -29.25 70.55 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.358 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 21' ' ' ALA . 0.9 OUTLIER -47.13 -43.94 21.16 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 22' ' ' ILE . 2.9 m-80 -87.01 126.96 61.28 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.7 Cg_endo -84.02 49.34 2.78 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.817 1.43 . . . . 0.0 110.254 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.8 t-160 -154.76 -48.47 0.09 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.19 -0.944 . . . . 0.0 109.917 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -41.11 141.08 0.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.475 -0.766 . . . . 0.0 109.873 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.411 ' C ' ' CG2' ' A' ' 31' ' ' VAL . 2.6 t -98.0 162.32 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.523 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.411 ' CG2' ' C ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -155.11 156.85 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.036 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -170.09 83.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.568 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -119.41 167.42 11.94 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.176 -0.953 . . . . 0.0 109.644 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.566 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -164.26 -48.09 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.833 . . . . 0.0 109.132 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 2.0 Cg_endo -81.98 -167.02 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.752 1.396 . . . . 0.0 109.737 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.77 -5.1 41.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.248 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.505 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 1.9 mtm -97.04 151.42 19.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.509 HG13 ' HA ' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -111.09 161.08 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.141 -0.975 . . . . 0.0 109.328 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.505 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -149.7 155.46 40.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 109.792 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.466 ' HB ' ' CD1' ' A' ' 7' ' ' ILE . 13.2 mt -156.25 175.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.821 . . . . 0.0 109.045 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 5' ' ' VAL . 11.2 tt0 178.76 144.42 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.009 . . . . 0.0 109.367 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.609 ' CB ' ' CD2' ' A' ' 88' ' ' TRP . . . -129.19 -160.13 1.01 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.797 . . . . 0.0 109.642 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 17.0 pt-20 -164.01 69.23 0.19 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.452 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -159.46 -164.35 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 110.009 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.483 ' HA ' ' CG ' ' A' ' 87' ' ' GLU . 9.2 ptm180 -133.33 -166.42 1.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.506 -0.747 . . . . 0.0 109.014 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.553 ' CD1' ' O ' ' A' ' 87' ' ' GLU . 4.1 mt -163.42 156.04 18.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.036 -1.04 . . . . 0.0 110.193 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.471 ' O ' HG13 ' A' ' 48' ' ' ILE . 0.1 OUTLIER -146.32 139.74 25.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.573 ' N ' ' CD1' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -148.2 158.41 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 109.933 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.507 ' HA ' ' CG ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -100.62 -151.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -4.08 23.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.387 -0.821 . . . . 0.0 109.661 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 13.4 pt-20 -71.77 -23.8 61.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.784 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.44 ' OG1' ' CG2' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -64.08 -49.11 73.55 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.983 -1.073 . . . . 0.0 109.56 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.2 t -51.52 -25.82 5.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.066 -1.021 . . . . 0.0 108.889 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 10.0 mt-10 -75.38 -39.89 58.62 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.278 -0.889 . . . . 0.0 109.429 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.462 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 15.3 mm-40 -65.52 -46.59 79.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.344 -0.848 . . . . 0.0 109.376 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -43.61 80.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.533 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.09 -54.93 41.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.9 . . . . 0.0 109.556 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.31 -2.1 58.56 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 12.9 ttt180 -119.17 10.12 11.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -1.195 . . . . 0.0 109.701 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.19 -27.4 68.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.12 -0.988 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -89.35 29.04 1.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 109.706 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.449 ' O ' ' HB2' ' A' ' 66' ' ' MET . 0.7 OUTLIER -110.93 5.42 20.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.611 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.3 t -72.75 -49.44 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.593 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -49.9 -47.98 51.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -71.65 -25.1 61.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -81.37 -12.34 59.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.507 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.38 -22.16 26.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 10' ' ' GLN . 14.0 t -59.25 -33.91 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.523 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.633 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.6 86.84 3.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 109.185 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.564 ' O ' ' CB ' ' A' ' 71' ' ' ILE . 2.4 p -101.93 140.57 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.312 -0.867 . . . . 0.0 111.309 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.613 ' CG2' ' CB ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER 167.69 -53.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.038 -1.039 . . . . 0.0 111.912 175.797 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.543 ' N ' HG21 ' A' ' 71' ' ' ILE . 1.7 m -165.98 171.54 12.46 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.057 -1.652 . . . . 0.0 112.761 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.494 ' CG1' ' C ' ' A' ' 72' ' ' THR . 0.2 OUTLIER -163.67 165.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 174.94 51.23 0.05 OUTLIER Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.514 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.466 ' HA2' HG11 ' A' ' 5' ' ' VAL . . . -104.67 -100.32 2.62 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.548 ' O ' ' CD2' ' A' ' 86' ' ' LEU . 1.9 t30 -175.33 -174.0 0.69 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.4 -1.059 . . . . 0.0 108.931 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.513 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 12.4 p 177.97 67.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 108.806 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.499 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -98.95 141.58 31.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 0.0 110.394 -178.806 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HG2' ' N ' ' A' ' 80' ' ' ASP . 1.3 tt0 -127.21 145.24 50.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.775 . . . . 0.0 108.932 179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.402 ' N ' ' HG2' ' A' ' 79' ' ' GLU . 41.7 t0 -107.24 -109.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.069 -1.02 . . . . 0.0 109.485 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -104.39 -77.14 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.817 -1.177 . . . . 0.0 109.242 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -109.94 -9.43 14.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.252 -0.905 . . . . 0.0 109.075 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.507 ' CG ' ' HA ' ' A' ' 49' ' ' ARG . 3.0 ttt180 -91.92 -160.62 0.75 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.374 -0.829 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 48' ' ' ILE . 2.1 t80 -169.38 148.89 3.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.072 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.499 ' CG1' ' HB2' ' A' ' 78' ' ' ASP . 2.5 p -133.73 179.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.053 -1.03 . . . . 0.0 109.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER 178.26 -169.34 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.553 ' O ' ' CD1' ' A' ' 46' ' ' LEU . 3.9 mt-10 -121.71 -164.81 1.18 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.941 -1.099 . . . . 0.0 109.796 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.609 ' CD2' ' CB ' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -42.49 154.1 0.07 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.504 ' O ' ' CE2' ' A' ' 88' ' ' TRP . 0.5 OUTLIER -107.41 148.77 28.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.381 -0.824 . . . . 0.0 109.385 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.8 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.507 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m 56.22 20.31 4.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.528 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.8 p -102.94 12.36 36.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.882 . . . . 0.0 109.677 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -122.48 -176.82 3.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.059 -1.025 . . . . 0.0 109.222 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.586 ' CG2' ' N ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -156.97 165.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.891 -1.131 . . . . 0.0 110.703 -179.157 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.586 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -135.41 147.53 49.04 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.935 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 73' ' ' ILE . 1.4 pp -158.21 139.45 4.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.54 ' CB ' ' OG1' ' A' ' 72' ' ' THR . . . -124.72 -179.16 4.4 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.108 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.713 ' CD1' ' O ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -141.79 -178.7 5.79 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.195 177.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.699 ' N ' ' HA ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 177.97 97.93 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.305 -177.628 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.526 ' CA ' HG22 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -107.7 167.92 9.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.968 . . . . 0.0 109.856 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -124.57 -64.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.881 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -101.6 -32.64 10.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 109.57 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.411 ' HB2' ' OD2' ' A' ' 11' ' ' ASP . 25.9 m-80 -87.64 10.61 17.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.129 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' A' ' 11' ' ' ASP . . . -58.8 -16.6 17.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.215 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.537 ' NH1' ' HG2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -61.97 -62.13 2.0 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 109.214 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.427 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 49.3 m-85 -62.95 -33.37 75.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 0.0 108.872 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.508 ' O ' ' CD1' ' A' ' 22' ' ' ILE . 60.1 t -59.34 -32.97 49.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.407 ' CG2' ' O ' ' A' ' 15' ' ' ALA . 61.3 t -77.45 -25.5 15.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 6.9 tp10 -65.27 -53.94 36.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -67.65 -44.31 78.19 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.206 -0.934 . . . . 0.0 108.556 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.51 HD11 ' N ' ' A' ' 22' ' ' ILE . 1.5 mp -54.04 -31.03 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.537 ' O ' ' CD ' ' A' ' 27' ' ' PRO . 17.9 mt -70.38 -42.16 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 108.844 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.3 4.92 49.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -118.67 -11.88 9.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.301 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.515 ' N ' ' HD2' ' A' ' 27' ' ' PRO . 1.0 OUTLIER -85.57 -65.88 0.2 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 110.377 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.537 ' CD ' ' O ' ' A' ' 23' ' ' ILE . 2.5 Cg_endo -41.0 -27.95 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.66 1.348 . . . . 0.0 110.051 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 26' ' ' ASN . 2.6 t-160 -98.64 -33.45 10.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.667 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 25' ' ' ASP . . . -102.33 176.89 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -0.99 . . . . 0.0 110.265 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.453 ' O ' HG22 ' A' ' 40' ' ' ILE . 1.9 t -101.2 162.88 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.034 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.547 ' CG2' ' N ' ' A' ' 32' ' ' GLN . 2.1 p -169.66 166.88 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 109.813 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.547 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 2.5 pt20 -172.18 65.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 109.566 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.492 ' CB ' ' HA ' ' A' ' 38' ' ' ILE . 26.0 p80 -101.12 179.14 4.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.569 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -156.67 -62.62 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.589 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.569 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -67.84 -167.78 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.684 1.36 . . . . 0.0 109.911 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.19 -15.41 33.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 108.957 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.564 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 66.9 mtp -81.84 135.32 35.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.327 -0.858 . . . . 0.0 109.619 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.595 ' CG1' ' HB3' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -113.77 82.54 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.16 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.537 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.39 167.3 21.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 111.25 -178.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.453 HG22 ' O ' ' A' ' 30' ' ' VAL . 89.5 mt -149.99 155.25 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.414 ' N ' HG21 ' A' ' 40' ' ' ILE . 3.4 tt0 -131.15 147.14 52.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 109.662 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' A' ' 43' ' ' GLU . . . -143.88 -171.61 3.58 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.372 -0.83 . . . . 0.0 108.877 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.625 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 44.8 mt-10 -159.28 99.55 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.542 ' HB3' ' CB ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -162.2 -145.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.768 -1.208 . . . . 0.0 111.078 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -162.43 159.65 25.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -0.869 . . . . 0.0 109.502 -178.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.608 ' HB2' ' O ' ' A' ' 87' ' ' GLU . 1.4 mt -126.18 -173.79 2.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.056 -1.027 . . . . 0.0 108.298 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 4.3 pt-20 -178.95 141.99 0.19 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.256 -0.902 . . . . 0.0 109.421 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.408 ' CG1' ' C ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -160.43 -161.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.15 -0.969 . . . . 0.0 109.585 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -100.21 -169.08 1.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.859 . . . . 0.0 109.152 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -88.5 -46.3 9.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.162 -0.961 . . . . 0.0 109.026 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 30.7 tt0 -49.49 -32.15 11.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.362 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 53' ' ' VAL . 1.3 m -70.88 -50.28 36.86 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.207 -0.933 . . . . 0.0 109.039 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.542 HG23 ' CG ' ' A' ' 84' ' ' PHE . 97.4 t -48.1 -27.64 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.459 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 21.7 tp10 -74.54 -44.41 51.21 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -54.23 -47.11 72.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.349 -0.844 . . . . 0.0 108.853 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -60.47 -36.96 79.52 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.427 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.8 tp -57.99 -55.75 30.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 109.364 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.6 -11.29 59.69 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -114.82 7.25 15.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -1.139 . . . . 0.0 109.625 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -70.01 -29.97 67.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.26 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -90.34 38.45 0.94 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.868 . . . . 0.0 109.384 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -103.07 -86.06 0.44 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.299 -0.876 . . . . 0.0 109.571 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 1.3 t -97.92 0.99 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.599 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.46 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 1.2 mp0 -51.9 -27.57 13.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 109.574 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -64.18 -43.07 96.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.173 -0.954 . . . . 0.0 109.017 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.492 ' HB3' ' CD1' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -64.62 -9.96 23.19 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.481 ' O ' ' O ' ' A' ' 71' ' ' ILE . 3.3 tt -53.29 -18.05 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 109.833 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.8 t -82.28 -35.43 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.009 -1.057 . . . . 0.0 109.775 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.563 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 39.9 m-20 -98.93 -118.26 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.952 . . . . 0.0 111.383 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.713 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -49.71 -3.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.179 -2.634 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -176.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 66' ' ' MET . 0.0 OUTLIER -132.31 142.92 41.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 121.658 2.026 . . . . 0.0 112.5 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.54 ' OG1' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -155.52 149.07 25.08 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.487 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 1.4 pp -139.06 -174.66 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.094 -1.003 . . . . 0.0 109.61 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 167.48 44.28 0.03 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.533 ' HA2' ' HA ' ' A' ' 5' ' ' VAL . . . -94.05 -104.92 1.82 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 75' ' ' GLY . 0.7 OUTLIER -176.58 166.72 2.69 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.476 -1.014 . . . . 0.0 109.577 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.452 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 7.2 p -133.41 92.34 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.548 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 0.0 OUTLIER -104.69 137.33 42.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 109.97 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.98 133.84 55.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.865 . . . . 0.0 109.457 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.6 -96.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 109.501 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.86 -61.14 1.58 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.253 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -126.37 -39.0 2.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.4 -173.77 0.16 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.542 ' CG ' HG23 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -141.05 166.42 24.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.228 -0.92 . . . . 0.0 109.051 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.574 ' CG2' ' O ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -154.62 162.75 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.533 -179.725 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.567 ' HG ' ' CB ' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -172.75 -123.76 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 109.335 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 46' ' ' LEU . 2.0 pt-20 -112.18 165.75 11.87 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.372 -0.83 . . . . 0.0 110.991 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.542 ' CB ' ' HB3' ' A' ' 44' ' ' LYS . 0.2 OUTLIER -104.59 134.34 47.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.047 -1.033 . . . . 0.0 109.469 177.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.33 103.89 9.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.311 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.1 t30 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.385 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 2' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 72.8 -160.69 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.604 ' CB ' ' CB ' ' A' ' 44' ' ' LYS . 0.3 OUTLIER -171.55 108.71 0.26 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.564 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.622 ' HA ' ' CA ' ' A' ' 43' ' ' GLU . 0.0 OUTLIER -156.59 160.61 39.59 Favored 'General case' 0 C--N 1.31 -1.152 0 O-C-N 120.918 -1.114 . . . . 0.0 111.213 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.574 ' HB ' ' CB ' ' A' ' 42' ' ' ALA . 48.8 t -114.71 171.36 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.611 ' O ' ' N ' ' A' ' 74' ' ' GLY . 50.3 t80 -147.73 138.59 23.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.743 -1.223 . . . . 0.0 109.259 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.528 ' CG2' ' O ' ' A' ' 6' ' ' TYR . 2.8 pt -160.68 159.31 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.58 ' O ' ' CD1' ' A' ' 9' ' ' PHE . . . -165.83 164.63 18.65 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.339 -1.476 . . . . 0.0 110.591 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.636 ' CE2' ' CG2' ' A' ' 71' ' ' ILE . 5.3 m-85 -149.18 163.15 38.44 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.571 ' NE2' ' C ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -125.76 81.65 2.0 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.487 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 14.9 p30 -106.41 167.13 10.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 0.0 110.37 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.32 5.86 40.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.529 -0.732 . . . . 0.0 109.505 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -79.66 103.93 9.9 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.111 -0.993 . . . . 0.0 108.972 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.8 t-20 -66.17 -8.82 26.47 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 108.715 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.89 -40.66 85.11 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.36 -36.5 84.2 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -46.67 81.67 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.345 -0.847 . . . . 0.0 108.937 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.12 -57.41 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.228 -0.92 . . . . 0.0 108.594 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.59 -21.68 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.379 -0.826 . . . . 0.0 108.801 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.543 ' OE2' ' CD2' ' A' ' 33' ' ' HIS . 6.8 tt0 -75.09 -37.6 61.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.517 -0.739 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.78 -28.02 63.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.056 -1.027 . . . . 0.0 109.231 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.4 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 32.1 mm -76.85 -41.13 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.231 -0.918 . . . . 0.0 109.086 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 24' ' ' GLN . 1.3 tt -60.45 -46.29 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 108.655 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.517 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -67.65 -32.15 72.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -49.18 -30.04 6.34 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.819 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.515 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -79.66 136.37 55.49 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -84.0 45.15 1.7 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.826 1.435 . . . . 0.0 110.108 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -149.6 -47.71 0.14 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.181 -0.949 . . . . 0.0 109.636 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.03 55.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.573 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.532 ' CG1' ' HG3' ' A' ' 41' ' ' GLU . 4.8 p -100.31 140.41 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.37 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.464 ' O ' ' HG3' ' A' ' 32' ' ' GLN . 0.4 OUTLIER -151.34 166.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 0.0 109.449 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -165.16 82.37 0.36 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.543 ' CD2' ' OE2' ' A' ' 20' ' ' GLU . 2.2 p80 -117.36 142.61 46.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -0.896 . . . . 0.0 109.286 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.549 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -160.93 -58.58 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.183 -0.948 . . . . 0.0 109.54 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.9 Cg_endo -68.62 -155.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.715 1.376 . . . . 0.0 109.862 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.98 -4.03 58.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 109.425 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.484 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 2.9 ttm -89.57 168.54 12.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.656 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -138.48 115.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.467 ' O ' HG13 ' A' ' 40' ' ' ILE . 3.6 ptp180 -129.62 168.66 16.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.662 -1.274 . . . . 0.0 111.433 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.507 HG21 ' N ' ' A' ' 41' ' ' GLU . 2.7 mp -158.98 157.43 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.539 ' CB ' ' O ' ' A' ' 5' ' ' VAL . 1.0 OUTLIER -131.58 -177.4 4.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.944 -1.098 . . . . 0.0 109.71 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.574 ' CB ' ' HB ' ' A' ' 5' ' ' VAL . . . -129.2 -149.02 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 109.113 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.622 ' CA ' ' HA ' ' A' ' 4' ' ' LEU . 1.2 mm-40 -135.6 26.94 3.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.824 -1.173 . . . . 0.0 111.699 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.604 ' CB ' ' CB ' ' A' ' 3' ' ' SER . 0.5 OUTLIER 83.07 -39.49 0.09 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.887 0.851 . . . . 0.0 111.629 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.493 ' CG ' ' HD3' ' A' ' 44' ' ' LYS . 6.3 mtm180 -127.81 113.23 15.68 Favored 'General case' 0 C--N 1.263 -3.177 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.087 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -141.18 144.52 34.84 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.503 ' CB ' HG22 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -154.54 139.65 17.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 109.598 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.545 HD12 ' CD2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -142.96 143.74 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -0.815 . . . . 0.0 109.132 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 -101.25 -98.35 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.002 . . . . 0.0 110.288 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -15.27 4.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.68 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 33.8 tp10 -49.43 -24.86 2.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.725 -1.234 . . . . 0.0 108.986 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.428 ' O ' ' N ' ' A' ' 55' ' ' GLU . 1.6 m -66.4 -46.16 77.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.085 -1.009 . . . . 0.0 108.929 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 52' ' ' THR . 78.2 t -47.26 -30.27 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -70.43 -46.81 63.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.424 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 52' ' ' THR . 7.2 mt-10 -51.09 -63.62 1.07 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' ARG . 1.0 OUTLIER -44.05 -33.98 1.62 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.502 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.7 tp -51.06 -62.74 1.43 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.667 ' O ' ' CB ' ' A' ' 59' ' ' ARG . . . -52.79 -24.79 20.47 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.667 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 8.9 tpt180 110.59 39.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.869 1.267 . . . . 0.0 108.576 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 61.4 96.36 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 102.672 -3.085 . . . . 0.0 102.672 -176.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.586 ' C ' ' O ' ' A' ' 60' ' ' ALA . 29.3 t90 -18.41 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 123.219 1.485 . . . . 0.0 109.845 -174.121 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 60' ' ' ALA . 23.7 t70 -102.19 53.21 0.8 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.96 -177.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.462 ' O ' HG13 ' A' ' 63' ' ' VAL . 40.5 t -88.47 9.42 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.479 -0.763 . . . . 0.0 110.037 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 63' ' ' VAL . 61.3 mm-40 -39.88 -31.74 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 109.693 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -64.46 -53.42 48.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 108.889 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.04 -1.28 25.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.406 -0.809 . . . . 0.0 109.54 179.255 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 69' ' ' ASP . 12.0 tp -38.53 -23.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.657 -0.652 . . . . 0.0 111.367 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' MET . 2.4 m -39.0 -28.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.033 -1.042 . . . . 0.0 109.953 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.557 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 21.6 p30 -59.08 165.12 2.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.43 -0.794 . . . . 0.0 109.587 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.578 ' O ' ' CD2' ' A' ' 9' ' ' PHE . 45.7 t -79.45 167.09 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.194 -0.941 . . . . 0.0 109.015 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.636 ' CG2' ' CE2' ' A' ' 9' ' ' PHE . 1.5 pp -132.53 148.76 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.086 -1.009 . . . . 0.0 110.204 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.53 ' HB ' ' N ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -151.89 140.46 20.7 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.215 -0.928 . . . . 0.0 109.406 178.835 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.514 ' CD1' ' O ' ' A' ' 72' ' ' THR . 5.4 mm -137.33 153.82 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.448 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -166.33 32.27 0.22 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.477 ' HA3' ' CG1' ' A' ' 5' ' ' VAL . . . -146.24 -95.31 0.17 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.522 ' ND2' ' HD3' ' A' ' 89' ' ' LYS . 5.4 t30 -172.8 -151.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -1.167 . . . . 0.0 109.519 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.463 ' O ' ' CG1' ' A' ' 77' ' ' VAL . 7.6 p 179.18 89.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.369 -0.832 . . . . 0.0 109.273 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.78 129.93 55.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.114 -0.991 . . . . 0.0 109.811 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.68 146.71 50.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.498 -0.751 . . . . 0.0 109.14 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.64 -101.14 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.071 -1.018 . . . . 0.0 109.422 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.2 -53.95 2.57 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.966 -1.084 . . . . 0.0 109.322 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.414 ' O ' ' O ' ' A' ' 83' ' ' ARG . 0.5 OUTLIER -130.86 -43.55 1.09 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 82' ' ' ASP . 10.1 mpt_? -54.53 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.661 -0.649 . . . . 0.0 109.346 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.545 ' CD2' HD12 ' A' ' 48' ' ' ILE . 14.5 t80 -161.17 143.12 12.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 109.027 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.503 HG22 ' CB ' ' A' ' 47' ' ' GLU . 9.3 p -150.73 144.27 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.987 -1.071 . . . . 0.0 110.606 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.554 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 2.7 tm? -143.72 133.99 24.49 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.505 ' HB3' ' O ' ' A' ' 44' ' ' LYS . 5.5 mp0 -125.2 -135.45 0.27 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.316 -0.865 . . . . 0.0 108.755 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.603 ' HB2' ' CG ' ' A' ' 44' ' ' LYS . 10.0 t90 -92.62 -95.6 0.14 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.181 -0.949 . . . . 0.0 109.4 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.522 ' HD3' ' ND2' ' A' ' 76' ' ' ASN . 0.1 OUTLIER 67.75 157.33 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.0 109.475 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 t30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.583 -179.967 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' O ' ' HB3' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.264 0.554 . . . . 0.0 109.547 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.456 ' HB3' ' O ' ' A' ' 1' ' ' MET . 4.1 p 178.01 -31.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.587 ' HA ' ' CE3' ' A' ' 88' ' ' TRP . 49.0 m -77.65 152.28 33.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.402 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.686 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 1.2 pp -148.35 152.1 36.47 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.384 -0.822 . . . . 0.0 109.884 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.555 ' CG2' ' HB2' ' A' ' 42' ' ' ALA . 3.7 t -113.63 176.62 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.608 -0.683 . . . . 0.0 109.197 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.565 ' O ' ' N ' ' A' ' 74' ' ' GLY . 8.9 t80 -143.18 138.46 29.74 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.001 -1.062 . . . . 0.0 108.276 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.517 HG21 ' HA ' ' A' ' 73' ' ' ILE . 3.6 pt -156.89 156.07 4.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 108.475 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' THR . . . -163.99 141.25 6.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.78 -1.2 . . . . 0.0 109.902 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.64 ' CD1' ' N ' ' A' ' 9' ' ' PHE . 0.2 OUTLIER -139.54 -167.47 2.27 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.079 -1.013 . . . . 0.0 109.02 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.636 ' N ' HG11 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -156.27 93.51 1.42 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.5 OUTLIER -109.6 -170.97 1.75 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -71.72 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.034 . . . . 0.0 109.235 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.4 ' HA ' ' HD3' ' A' ' 16' ' ' ARG . 1.5 p30 -145.0 7.17 1.19 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.867 -1.146 . . . . 0.0 110.088 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -102.52 -57.13 2.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.045 -1.034 . . . . 0.0 109.494 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.2 92.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.816 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.511 ' NH1' ' HG3' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -66.46 -36.72 83.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.133 -0.979 . . . . 0.0 109.301 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 11.1 t80 -62.73 -44.13 97.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 0.0 109.148 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.14 -53.11 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.238 -0.913 . . . . 0.0 109.17 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.57 -24.01 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -0.934 . . . . 0.0 109.281 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -66.64 -48.87 68.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.289 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.63 91.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.371 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.81 -46.89 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.412 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.425 HG22 ' HB2' ' A' ' 29' ' ' ALA . 29.1 mt -52.83 -52.45 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 108.813 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 25' ' ' ASP . 1.4 mp0 -58.68 -31.06 67.86 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.208 -0.932 . . . . 0.0 108.631 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 24' ' ' GLN . 1.1 t70 -46.15 -42.0 13.28 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.589 -1.264 . . . . 0.0 107.589 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -96.63 131.49 28.09 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.92 47.57 2.31 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.703 1.37 . . . . 0.0 110.085 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 29' ' ' ALA . 30.0 t-80 -154.52 -50.83 0.09 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.25 -0.906 . . . . 0.0 109.977 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -41.36 140.42 0.87 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.796 . . . . 0.0 109.991 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.517 HG11 ' N ' ' A' ' 31' ' ' VAL . 1.6 p -78.66 -169.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.317 -0.864 . . . . 0.0 108.715 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.517 ' N ' HG11 ' A' ' 30' ' ' VAL . 15.6 m -122.88 -155.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.996 -1.065 . . . . 0.0 109.477 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.553 ' HB3' ' N ' ' A' ' 39' ' ' ARG . 2.3 mp0 -112.75 -151.74 0.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.073 -1.017 . . . . 0.0 109.604 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.34 -96.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.873 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.565 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -163.89 -69.55 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.009 -1.057 . . . . 0.0 109.569 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 34' ' ' HIS . 5.7 Cg_exo -49.27 -178.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.904 1.476 . . . . 0.0 110.47 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.44 ' O ' ' HG2' ' A' ' 10' ' ' GLN . . . -43.09 -36.07 1.52 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.384 -0.823 . . . . 0.0 109.896 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.474 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 66.2 mtm -63.91 144.18 57.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.002 -1.061 . . . . 0.0 109.13 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.579 HD12 ' CD2' ' A' ' 9' ' ' PHE . 6.3 pt -146.28 109.3 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.553 ' N ' ' HB3' ' A' ' 32' ' ' GLN . 1.6 mtt-85 -90.74 174.45 7.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 0.0 109.523 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.546 ' CG1' ' O ' ' A' ' 39' ' ' ARG . 11.4 mt -161.98 166.96 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.449 -0.782 . . . . 0.0 109.391 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.51 ' N ' HG23 ' A' ' 40' ' ' ILE . 5.7 tp10 -142.79 170.4 15.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 0.0 109.005 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.555 ' HB2' ' CG2' ' A' ' 5' ' ' VAL . . . -140.84 -168.81 2.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.724 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.686 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 1.6 pm0 -143.37 85.16 1.84 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.511 -0.743 . . . . 0.0 109.758 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.56 ' CB ' ' HB2' ' A' ' 3' ' ' SER . 0.0 OUTLIER 83.4 -179.68 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -178.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.66 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 3.8 mmt180 179.5 -165.58 0.06 Allowed 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.435 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 4.8 mt 164.48 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.543 ' CB ' ' HA ' ' A' ' 85' ' ' VAL . 2.0 mt-10 162.59 -167.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.828 -1.17 . . . . 0.0 109.394 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.562 ' CG2' ' N ' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -177.31 -151.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.972 . . . . 0.0 109.634 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.562 ' N ' ' CG2' ' A' ' 48' ' ' ILE . 11.0 ttp180 -91.73 -37.05 13.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.949 -1.095 . . . . 0.0 110.131 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -32.46 70.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.918 -179.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.486 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 20.8 mm-40 -58.05 -27.64 63.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.134 -0.979 . . . . 0.0 109.665 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m -64.84 -41.39 95.76 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.003 -1.06 . . . . 0.0 109.434 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.6 t -53.52 -29.66 17.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -70.69 -40.5 72.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 17.8 mt-10 -57.49 -62.91 1.45 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.436 ' HA ' ' H ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -44.0 -36.75 2.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.98 . . . . 0.0 109.057 179.306 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.463 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 9.9 tp -57.65 -50.02 74.53 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.589 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -78.59 15.79 9.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 176.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.589 ' HB3' ' O ' ' A' ' 58' ' ' GLY . 2.8 ttt180 68.34 49.64 0.79 Allowed 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 121.415 0.626 . . . . 0.0 110.056 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 57.31 93.21 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TRP . . . . . 0.598 ' C ' ' O ' ' A' ' 60' ' ' ALA . 57.4 t90 -16.3 81.09 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.434 1.588 . . . . 0.0 109.319 -174.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 60' ' ' ALA . 20.8 t70 -102.44 66.82 0.99 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.138 -1.846 . . . . 0.0 110.012 -176.446 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.504 ' CG2' ' NE1' ' A' ' 61' ' ' TRP . 19.5 t -89.56 6.63 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 109.558 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.515 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 5.4 mp0 -42.58 -31.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 109.454 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.48 -49.66 65.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.119 -0.988 . . . . 0.0 109.236 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.5 ' O ' ' N ' ' A' ' 68' ' ' VAL . 1.4 mtt -72.95 -5.35 37.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.919 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.541 ' N ' HD21 ' A' ' 67' ' ' LEU . 1.5 pt? -39.21 -26.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.467 -0.771 . . . . 0.0 110.788 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 69' ' ' ASP . 5.8 p -40.52 -49.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.554 ' N ' ' CG1' ' A' ' 68' ' ' VAL . 0.6 OUTLIER -72.64 146.17 46.78 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.636 HG11 ' N ' ' A' ' 10' ' ' GLN . 6.9 p -76.15 173.79 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.841 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ILE . . . . . 0.462 ' HA ' ' HB3' ' A' ' 9' ' ' PHE . 9.1 mt -153.17 157.0 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.228 -0.92 . . . . 0.0 109.835 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -149.56 152.07 34.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.491 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.517 ' HA ' HG21 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -137.47 159.31 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -159.81 66.73 0.27 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.441 -1.362 . . . . 0.0 110.794 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.505 ' C ' ' O ' ' A' ' 88' ' ' TRP . . . -127.94 -105.89 1.31 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.534 ' C ' ' CD2' ' A' ' 86' ' ' LEU . 2.9 t-20 -165.12 -144.57 0.07 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -1.188 . . . . 0.0 108.435 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.582 ' N ' HD22 ' A' ' 86' ' ' LEU . 7.4 p -170.28 98.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.881 -1.137 . . . . 0.0 110.587 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -114.38 127.46 55.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.439 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -128.05 149.99 50.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 109.61 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -109.82 -103.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 109.364 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -104.23 -54.14 2.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.951 -1.093 . . . . 0.0 108.909 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ARG . 79.8 m-20 -130.67 -39.75 1.25 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.54 ' CG ' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -51.65 -175.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.602 0.715 . . . . 0.0 109.728 179.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -160.23 111.07 1.88 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.586 ' CG2' ' CD2' ' A' ' 46' ' ' LEU . 4.0 p -124.37 143.6 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.061 -1.024 . . . . 0.0 109.251 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.599 ' O ' ' CA ' ' A' ' 46' ' ' LEU . 2.2 tm? -151.22 129.45 11.95 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.885 -1.526 . . . . 0.0 110.571 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.652 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -118.18 -178.9 3.62 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.647 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 5.6 t90 -43.1 -88.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.457 -1.297 . . . . 0.0 108.244 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.558 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 1.3 tttt -167.11 36.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.022 -1.049 . . . . 0.0 109.523 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.7 t30 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.415 179.879 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 44' ' ' LYS . 20.0 m . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.69 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -130.05 155.65 45.8 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.218 -0.926 . . . . 0.0 110.336 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.13 HG11 HD21 ' A' ' 46' ' ' LEU . 1.1 m -116.66 -150.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.566 -0.709 . . . . 0.0 109.361 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.959 ' OH ' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER 172.78 139.82 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.106 -0.996 . . . . 0.0 109.625 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.817 HG22 ' HA ' ' A' ' 73' ' ' ILE . 46.4 pt -136.61 139.41 45.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.612 ' HB2' ' HD2' ' A' ' 39' ' ' ARG . . . -134.2 164.78 26.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.551 -1.343 . . . . 0.0 110.65 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 1.065 ' CZ ' HD13 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -158.78 151.55 22.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.526 ' HG2' ' CB ' ' A' ' 37' ' ' MET . 0.8 OUTLIER -131.81 92.97 3.22 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.05 -1.031 . . . . 0.0 108.51 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -87.04 -132.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.405 -0.809 . . . . 0.0 109.762 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.451 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 5.0 t-20 -86.42 -111.88 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.837 -1.164 . . . . 0.0 109.385 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -132.63 -24.52 1.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.927 -1.108 . . . . 0.0 109.775 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.416 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.6 t-20 -102.96 -54.35 2.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.025 -1.047 . . . . 0.0 109.817 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ASN . . . -44.27 -31.17 0.94 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.809 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 13' ' ' ASP . 55.9 mtm180 -64.79 -63.58 1.08 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.613 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 1.1 m-85 -47.5 -36.57 10.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -0.958 . . . . 0.0 109.455 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 14' ' ' ASN . 41.2 t -54.67 -58.64 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.93 . . . . 0.0 109.031 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.3 t -56.73 -22.78 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.207 -0.933 . . . . 0.0 108.865 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 23' ' ' ILE . 13.3 tt0 -69.46 -38.36 77.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.437 -0.789 . . . . 0.0 109.217 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.36 68.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.246 -0.909 . . . . 0.0 108.891 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.43 ' HA ' HD13 ' A' ' 22' ' ' ILE . 24.3 mm -70.31 -55.58 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 20' ' ' GLU . 1.0 OUTLIER -58.98 -35.54 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.055 -1.028 . . . . 0.0 109.668 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -69.63 -35.97 75.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.108 -0.995 . . . . 0.0 108.693 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 24' ' ' GLN . 0.3 OUTLIER -46.18 -42.8 14.56 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -79.8 136.54 54.81 Favored Pre-proline 0 N--CA 1.486 1.356 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -84.28 46.23 1.91 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.795 1.418 . . . . 0.0 109.979 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -149.04 -39.57 0.15 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.18 -0.95 . . . . 0.0 109.629 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 23' ' ' ILE . . . -44.81 140.18 2.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 109.746 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.663 HG12 ' H ' ' A' ' 31' ' ' VAL . 2.6 t -101.22 177.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.663 ' H ' HG12 ' A' ' 30' ' ' VAL . 2.0 t -141.45 154.58 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.23 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -140.29 -71.73 0.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.636 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -95.27 176.66 6.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.969 . . . . 0.0 109.595 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.565 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -152.13 -64.55 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.285 -0.885 . . . . 0.0 109.538 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 4.2 Cg_exo -61.17 -75.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.636 1.335 . . . . 0.0 110.417 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 35' ' ' PRO . . . -46.52 -93.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.526 ' CB ' ' HG2' ' A' ' 10' ' ' GLN . 2.0 ptm -115.46 -167.23 1.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.687 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 0.9 OUTLIER -128.43 101.96 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.356 -0.84 . . . . 0.0 109.114 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.612 ' HD2' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -87.31 169.26 12.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.746 -179.265 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.563 HG22 ' N ' ' A' ' 41' ' ' GLU . 45.3 mt -142.69 164.92 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.725 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -143.85 147.27 33.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.209 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.019 ' CB ' HG22 ' A' ' 5' ' ' VAL . . . -127.51 -171.81 2.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.69 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 8.3 mt-10 -140.11 64.91 1.43 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.878 -1.139 . . . . 0.0 110.372 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 8.5 tttt 175.25 -140.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.952 -1.093 . . . . 0.0 110.263 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.982 ' C ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -126.51 166.69 16.79 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.301 -0.874 . . . . 0.0 110.182 -178.901 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.13 HD21 HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -129.03 157.72 40.93 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HG2' HG23 ' A' ' 85' ' ' VAL . 8.2 mt-10 -150.96 140.01 21.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.077 -1.014 . . . . 0.0 109.99 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.658 HG22 ' OG1' ' A' ' 52' ' ' THR . 1.3 mp -138.94 150.44 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 0.0 109.159 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -97.3 176.42 5.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.122 -0.986 . . . . 0.0 109.969 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -67.08 -24.39 65.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 109.332 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 34.9 mm-40 -49.53 -40.89 39.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.028 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.658 ' OG1' HG22 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -65.56 -46.44 79.46 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.162 -0.961 . . . . 0.0 108.755 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.6 t -56.08 -22.98 14.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -75.58 -38.21 59.29 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -66.69 -53.02 38.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 108.956 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -56.12 -33.39 65.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.288 -0.883 . . . . 0.0 109.139 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.18 -55.83 29.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.246 -0.909 . . . . 0.0 109.095 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.32 -7.49 63.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.44 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -117.01 10.22 13.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -1.108 . . . . 0.0 109.402 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -69.3 -6.89 32.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.707 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -91.42 19.75 5.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.021 . . . . 0.0 109.336 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.435 ' OD1' ' HB3' ' A' ' 65' ' ' GLU . 26.8 t70 -111.84 10.2 20.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.541 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 63' ' ' VAL . 3.1 t -49.54 -46.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 109.871 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -51.61 -45.87 63.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 109.406 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HB3' ' OD1' ' A' ' 62' ' ' ASP . 2.7 tt0 -68.29 -27.86 66.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.195 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 69' ' ' ASP . 1.1 mtm -74.78 -17.88 60.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.301 -0.874 . . . . 0.0 109.224 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -69.83 -57.49 5.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.557 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.9 t -46.96 -64.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.524 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 2.0 p30 -82.87 154.79 24.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 71' ' ' ILE . 21.1 t -99.53 165.75 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.168 -0.958 . . . . 0.0 109.568 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.065 HD13 ' CZ ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -146.11 151.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 0.0 109.648 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.959 HG21 ' OH ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -165.4 151.86 10.01 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.264 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.817 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -154.61 152.0 10.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.898 -1.126 . . . . 0.0 111.185 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.661 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 46.84 -85.12 0.01 OUTLIER Glycine 0 C--N 1.299 -1.492 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.926 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 73' ' ' ILE . . . 171.37 -47.81 0.19 Allowed Glycine 0 C--N 1.284 -2.329 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.538 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 16.2 t30 -120.34 -141.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.973 -1.31 . . . . 0.0 108.959 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.85 HG23 ' CE1' ' A' ' 84' ' ' PHE . 3.0 p 178.94 98.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.988 -1.07 . . . . 0.0 110.151 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.42 129.9 46.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 108.865 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -125.6 139.98 53.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.58 -96.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -104.04 -60.97 1.5 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.042 -1.036 . . . . 0.0 109.373 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -127.88 -30.8 2.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.341 -0.849 . . . . 0.0 109.01 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.496 ' CG ' ' N ' ' A' ' 84' ' ' PHE . 34.4 ttp180 -68.59 168.21 13.48 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.359 -0.838 . . . . 0.0 109.146 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.85 ' CE1' HG23 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -141.84 127.11 18.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 108.907 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.531 HG23 ' HG2' ' A' ' 47' ' ' GLU . 3.7 p -138.64 150.72 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.22 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.811 HD22 ' N ' ' A' ' 87' ' ' GLU . 1.7 tm? -157.19 135.75 11.42 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.811 ' N ' HD22 ' A' ' 86' ' ' LEU . 2.0 mp0 . . . . . 0 C--N 1.303 -1.445 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.672 ' C ' HD13 ' A' ' 4' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.916 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.17 154.92 42.32 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.032 -1.043 . . . . 0.0 110.47 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.023 HG22 ' HB3' ' A' ' 42' ' ' ALA . 3.4 m -115.1 -171.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.458 0.647 . . . . 0.0 109.313 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.567 ' O ' ' N ' ' A' ' 74' ' ' GLY . 4.9 t80 -159.08 137.98 11.11 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.553 HG22 ' HA ' ' A' ' 73' ' ' ILE . 3.2 pt -158.11 142.14 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.694 ' HB3' ' OG1' ' A' ' 72' ' ' THR . . . -146.89 150.41 35.18 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.776 -1.203 . . . . 0.0 110.109 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 1.102 ' CZ ' HG23 ' A' ' 71' ' ' ILE . 8.8 m-85 -134.57 172.27 13.16 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.632 ' HB3' HG23 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -147.33 80.99 1.52 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.258 178.886 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.546 ' CA ' ' HB3' ' A' ' 69' ' ' ASP . 5.5 t0 -106.75 -178.91 3.79 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.1 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.157 -0.964 . . . . 0.0 109.049 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.56 14.12 0.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.034 -1.041 . . . . 0.0 109.938 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -102.46 -56.5 2.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.317 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.41 -54.51 39.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.756 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -51.12 -39.2 55.68 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 109.611 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' N ' ' HG3' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -59.44 -47.5 85.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.229 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.479 HG12 HD11 ' A' ' 22' ' ' ILE . 73.1 t -53.81 -53.84 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.287 -0.883 . . . . 0.0 109.241 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.972 ' HA ' HD12 ' A' ' 22' ' ' ILE . 53.3 t -62.37 -21.82 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.216 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -43.84 73.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.777 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.11 67.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.0 109.324 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.972 HD12 ' HA ' ' A' ' 19' ' ' VAL . 14.8 mt -67.14 -42.26 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.276 -0.89 . . . . 0.0 109.172 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.789 HG23 ' CB ' ' A' ' 29' ' ' ALA . 41.2 mt -60.87 -54.63 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.33 -0.856 . . . . 0.0 109.298 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 25' ' ' ASP . 18.6 mt-30 -57.79 -31.33 66.45 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.157 -0.964 . . . . 0.0 108.56 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 24' ' ' GLN . 9.0 t70 -46.12 -47.51 17.38 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -84.58 135.27 40.97 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -83.65 45.19 1.75 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.761 1.4 . . . . 0.0 110.155 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.6 t60 -151.7 -49.06 0.11 Allowed 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.165 -0.959 . . . . 0.0 109.759 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.789 ' CB ' HG23 ' A' ' 23' ' ' ILE . . . -41.85 141.43 0.83 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.4 -0.813 . . . . 0.0 109.704 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -100.85 -169.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.185 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG22 ' N ' ' A' ' 32' ' ' GLN . 2.0 p -169.01 166.46 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 0.0 109.536 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.592 ' N ' HG22 ' A' ' 31' ' ' VAL . 2.8 mm-40 -144.84 77.24 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -48.49 103.36 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 109.547 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.47 ' CG ' ' HD2' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -104.84 -178.56 0.63 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 34' ' ' HIS . 3.8 Cg_exo -67.6 -74.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.939 1.494 . . . . 0.0 110.116 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.39 3.39 11.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.758 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.3 mtt -112.28 157.54 20.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.128 -0.982 . . . . 0.0 109.388 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.515 ' CG1' ' O ' ' A' ' 9' ' ' PHE . 12.1 pt -134.51 92.02 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.651 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.645 ' C ' HD12 ' A' ' 40' ' ' ILE . 2.1 ttp180 -85.55 162.23 18.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 110.086 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.645 HD12 ' C ' ' A' ' 39' ' ' ARG . 4.1 mp -150.97 162.01 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 0.0 109.499 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.516 ' N ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -161.96 157.1 23.22 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.027 -1.046 . . . . 0.0 110.251 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.023 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -129.34 177.75 6.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.388 -0.82 . . . . 0.0 109.068 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 2.8 pt-20 -158.74 68.74 0.46 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.915 -1.116 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.4 OUTLIER 169.82 -152.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.816 -1.178 . . . . 0.0 110.82 178.744 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 1.045 ' C ' HD23 ' A' ' 46' ' ' LEU . 20.1 mtp180 -125.43 135.14 52.05 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.045 HD23 ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -127.32 162.53 26.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.45 -0.781 . . . . 0.0 109.168 -178.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.948 ' CB ' HG23 ' A' ' 85' ' ' VAL . 1.2 pt-20 -176.19 158.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.984 -1.073 . . . . 0.0 110.668 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.526 ' CG2' ' CB ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -152.27 155.84 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.627 ' HA ' ' CB ' ' A' ' 83' ' ' ARG . 30.0 ttp180 -100.12 -112.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 110.112 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -61.63 -5.29 1.78 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.982 -1.074 . . . . 0.0 110.519 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.526 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 1.0 OUTLIER -54.61 -14.7 1.41 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.708 -1.245 . . . . 0.0 109.363 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 1.9 m -58.26 -39.33 78.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.69 -1.256 . . . . 0.0 109.47 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.91 -32.45 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 1.3 tt0 -67.63 -40.56 84.63 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 60' ' ' ALA . 1.1 tt0 -49.85 -63.29 1.16 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.536 ' HA ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -48.55 -31.44 6.53 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.634 -0.666 . . . . 0.0 109.387 179.006 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.516 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.5 tp -52.27 -59.03 4.88 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.68 ' O ' ' CB ' ' A' ' 59' ' ' ARG . . . -53.63 -24.52 25.19 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 106.861 -2.496 . . . . 0.0 106.861 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.68 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 1.6 ttm-85 110.68 35.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.786 1.234 . . . . 0.0 108.557 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 62.92 96.42 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.772 ' CZ2' HG21 ' A' ' 63' ' ' VAL . 24.6 t-105 -20.11 82.74 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 123.26 1.505 . . . . 0.0 109.35 -174.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 60' ' ' ALA . 19.0 t70 -109.2 71.1 0.76 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.415 -1.721 . . . . 0.0 109.738 -176.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.772 HG21 ' CZ2' ' A' ' 61' ' ' TRP . 2.1 t -86.91 6.51 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.865 . . . . 0.0 109.799 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.887 ' O ' HD23 ' A' ' 67' ' ' LEU . 2.8 mp0 -41.63 -34.01 0.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.614 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.54 -50.93 67.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.003 -1.061 . . . . 0.0 108.979 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.575 ' HB2' HG12 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -75.68 -2.64 30.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.46 -0.775 . . . . 0.0 110.02 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 64' ' ' GLN . 3.7 pp -38.5 -26.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.503 -0.748 . . . . 0.0 110.961 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.608 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.4 m -39.89 -45.42 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.151 -0.968 . . . . 0.0 110.156 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.546 ' HB3' ' CA ' ' A' ' 11' ' ' ASP . 15.8 p30 -65.29 149.45 49.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.67 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.632 HG23 ' HB3' ' A' ' 10' ' ' GLN . 21.8 t -62.53 169.77 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.102 HG23 ' CZ ' ' A' ' 9' ' ' PHE . 11.4 mt -143.56 157.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.056 -1.028 . . . . 0.0 110.643 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.694 ' OG1' ' HB3' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -159.31 142.38 14.34 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.553 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -143.78 163.33 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.084 -1.01 . . . . 0.0 110.194 -179.087 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -174.25 71.95 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.02 108.13 0.91 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 1.008 ' HA ' HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -157.78 139.42 13.86 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.183 -1.187 . . . . 0.0 110.908 -178.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 85' ' ' VAL . 1.8 t -152.37 30.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.634 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 5.2 p-10 -47.84 -38.95 17.12 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.898 0.856 . . . . 0.0 111.233 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.407 ' N ' ' CG ' ' A' ' 78' ' ' ASP . 1.5 mm-40 -110.79 103.06 11.54 Favored 'General case' 0 C--N 1.266 -3.023 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.93 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.557 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 58.1 t0 -115.2 -68.46 0.92 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.035 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 24.0 m-20 -108.21 -96.6 0.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -0.93 . . . . 0.0 109.365 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -131.03 0.22 4.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.036 -1.04 . . . . 0.0 109.221 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.627 ' CB ' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -102.6 -107.09 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.796 . . . . 0.0 109.42 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 78' ' ' ASP . 12.9 t80 -174.74 118.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.831 -1.168 . . . . 0.0 108.718 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.948 HG23 ' CB ' ' A' ' 47' ' ' GLU . 10.7 p -131.83 174.92 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.867 -1.146 . . . . 0.0 110.588 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.008 HD23 ' HA ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER -177.84 130.56 0.15 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.992 ' N ' HD22 ' A' ' 86' ' ' LEU . 2.2 mt-10 . . . . . 0 C--N 1.302 -1.463 0 O-C-N 120.902 -1.124 . . . . 0.0 111.624 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 44' ' ' LYS . 15.8 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.072 0.463 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -122.44 168.41 12.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.049 -1.032 . . . . 0.0 109.707 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.772 HG22 ' HB3' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -132.85 -178.35 2.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.346 -0.846 . . . . 0.0 109.954 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 74' ' ' GLY . 1.3 t80 -149.53 142.37 24.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 6' ' ' TYR . 1.8 pp -160.84 158.51 2.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.555 ' N ' ' HB ' ' A' ' 72' ' ' THR . . . -159.35 145.69 16.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.658 -1.276 . . . . 0.0 109.691 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 1.005 ' CE2' HD11 ' A' ' 38' ' ' ILE . 2.6 p90 -145.26 -171.2 3.61 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 109.539 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.684 ' HB3' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -148.97 98.98 2.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -0.76 . . . . 0.0 109.108 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.445 ' OD1' ' OD2' ' A' ' 69' ' ' ASP . 35.4 t70 -108.57 136.76 47.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.629 -0.67 . . . . 0.0 109.525 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -71.67 -31.49 66.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 109.561 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.43 ' CB ' ' OD2' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -57.52 106.02 0.3 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.087 -1.008 . . . . 0.0 108.575 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.61 -11.43 7.21 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.82 -31.53 49.58 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.034 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.459 HH11 ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -67.29 -45.45 76.52 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.486 -0.759 . . . . 0.0 109.067 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.4 -44.53 72.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.206 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -54.95 -60.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.237 -0.915 . . . . 0.0 108.828 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.683 ' HA ' HD12 ' A' ' 22' ' ' ILE . 85.1 t -52.95 -23.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 108.864 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -54.39 19.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.191 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.89 -35.45 61.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.271 -0.893 . . . . 0.0 109.304 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 19' ' ' VAL . 57.8 mt -64.52 -45.34 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 109.191 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.512 HG23 ' CB ' ' A' ' 29' ' ' ALA . 95.9 mt -51.43 -48.06 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.879 . . . . 0.0 109.14 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.2 72.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.21 -0.931 . . . . 0.0 108.573 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.12 -32.69 16.56 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -80.07 137.59 53.26 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -84.47 44.9 1.59 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.818 1.431 . . . . 0.0 109.822 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -151.06 -53.97 0.14 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.305 -0.872 . . . . 0.0 109.201 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.512 ' CB ' HG23 ' A' ' 23' ' ' ILE . . . -63.49 139.59 58.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.356 -0.84 . . . . 0.0 109.075 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.546 ' CG1' ' HG3' ' A' ' 41' ' ' GLU . 11.7 p -101.21 158.95 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.193 -0.942 . . . . 0.0 109.609 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.444 ' N ' HG22 ' A' ' 30' ' ' VAL . 1.9 t -138.78 148.7 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.408 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -144.29 43.73 1.42 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.225 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 32' ' ' GLN . 12.5 p80 -44.32 140.31 2.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.892 . . . . 0.0 109.35 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.492 ' CG ' ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -103.73 178.26 1.22 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.504 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.492 ' HD2' ' CG ' ' A' ' 34' ' ' HIS . 2.7 Cg_endo -76.53 -28.01 7.13 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.066 1.561 . . . . 0.0 110.331 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.89 -30.62 3.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.592 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.518 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -117.16 -168.99 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.569 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.005 HD11 ' CE2' ' A' ' 9' ' ' PHE . 11.3 pt -140.03 115.65 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.346 -0.847 . . . . 0.0 108.831 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.773 ' O ' HD13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -111.89 142.76 43.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.447 -178.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.773 HD13 ' O ' ' A' ' 39' ' ' ARG . 28.0 mm -145.91 152.42 14.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.583 -0.698 . . . . 0.0 109.213 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.546 ' HG3' ' CG1' ' A' ' 30' ' ' VAL . 2.9 pt-20 -129.29 176.59 7.82 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.113 -0.992 . . . . 0.0 108.893 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.772 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -132.66 -179.43 5.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.079 -1.013 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 17.9 mt-10 -140.48 58.87 1.56 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.373 -0.83 . . . . 0.0 109.261 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 3' ' ' SER . 1.6 mmtp -153.0 -166.28 2.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.908 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.56 ' HA ' ' CG ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -141.26 -171.2 3.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.798 HD12 ' O ' ' A' ' 87' ' ' GLU . 15.2 mt -159.03 157.33 30.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 110.741 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.88 ' HA ' HG23 ' A' ' 85' ' ' VAL . 1.4 tt0 -160.94 139.75 10.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.179 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.793 HG22 ' CG ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -154.69 141.63 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.128 -0.983 . . . . 0.0 109.912 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.601 ' HA ' ' CG ' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -101.58 -101.38 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.811 179.465 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -6.38 27.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.018 -1.052 . . . . 0.0 109.294 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.793 ' CG ' HG22 ' A' ' 48' ' ' ILE . 3.2 mt-10 -56.41 -16.12 5.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.422 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -59.14 -42.48 90.76 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.87 -1.144 . . . . 0.0 109.259 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 52' ' ' THR . 59.0 t -48.38 -33.48 4.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.979 -1.076 . . . . 0.0 108.158 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -68.39 -44.93 74.03 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.873 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -45.08 46.42 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 59' ' ' ARG . 10.0 t-20 -53.86 -44.13 70.12 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.674 ' C ' HD13 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -51.44 -72.52 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.363 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 57' ' ' LEU . . . -39.32 -28.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.506 ' CB ' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -53.07 -58.97 5.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -1.201 . . . . 0.0 109.008 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 59' ' ' ARG . . . -42.85 -32.92 0.68 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -90.86 50.21 1.77 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.56 78.7 2.57 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.942 0.877 . . . . 0.0 109.396 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.505 HG12 ' HB2' ' A' ' 66' ' ' MET . 8.2 t -72.58 7.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.918 -0.489 . . . . 0.0 110.622 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 63' ' ' VAL . 2.7 mp0 -39.52 -27.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.141 -0.974 . . . . 0.0 109.91 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.657 ' O ' HG23 ' A' ' 68' ' ' VAL . 11.7 mt-10 -57.48 -56.23 24.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.008 . . . . 0.0 108.902 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.505 ' HB2' HG12 ' A' ' 63' ' ' VAL . 1.6 mmm -67.39 -8.34 32.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 0.0 109.403 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.87 HD21 HG21 ' A' ' 71' ' ' ILE . 5.9 tp -76.6 7.85 4.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.443 -0.786 . . . . 0.0 110.433 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 65' ' ' GLU . 58.2 t -40.41 -25.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.995 -1.066 . . . . 0.0 110.489 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' LEU . 7.2 m-20 -58.18 143.55 43.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.007 -1.058 . . . . 0.0 109.019 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.694 ' C ' HD13 ' A' ' 71' ' ' ILE . 57.3 t -43.82 159.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.144 -0.972 . . . . 0.0 109.126 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.87 HG21 HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -141.54 141.56 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.579 -0.7 . . . . 0.0 109.787 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.555 ' HB ' ' N ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -154.73 147.63 24.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.564 179.178 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.511 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -133.17 174.8 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.344 -0.847 . . . . 0.0 109.443 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 174.94 64.44 0.05 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.18 -95.3 0.49 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -176.26 153.58 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 0.0 109.473 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.54 102.8 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.127 -0.983 . . . . 0.0 109.869 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.619 ' OD1' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -107.7 112.95 25.9 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.006 178.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.58 131.46 54.83 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.473 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -104.04 -107.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -108.41 -56.34 2.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.93 -1.106 . . . . 0.0 109.495 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -127.28 -33.7 2.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.35 -0.844 . . . . 0.0 108.96 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.601 ' CG ' ' HA ' ' A' ' 49' ' ' ARG . 1.7 mpt_? -66.48 -178.06 0.64 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.548 -0.72 . . . . 0.0 109.397 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.478 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.3 t80 -161.5 130.16 4.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 109.661 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.88 HG23 ' HA ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -132.64 157.31 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.989 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.641 ' CD1' ' CB ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -165.49 -150.41 0.13 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.315 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.798 ' O ' HD12 ' A' ' 46' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.29 -1.986 0 O-C-N 121.092 -1.005 . . . . 0.0 109.373 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.15 0.5 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 4' ' ' LEU . 0.7 OUTLIER -122.33 161.56 23.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.222 -0.924 . . . . 0.0 109.212 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.019 HG22 ' HB3' ' A' ' 42' ' ' ALA . 3.1 m -125.52 -171.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.271 -0.893 . . . . 0.0 110.272 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.586 ' O ' ' N ' ' A' ' 74' ' ' GLY . 10.5 t80 -163.43 137.75 6.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.536 -0.727 . . . . 0.0 109.134 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.583 HG22 ' HA ' ' A' ' 73' ' ' ILE . 7.7 pt -148.76 139.67 17.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.965 ' HA ' ' CB ' ' A' ' 39' ' ' ARG . . . -144.36 137.52 27.18 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 117.752 -1.579 . . . . 0.0 111.98 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD2' ' HG2' ' A' ' 39' ' ' ARG . 2.0 p90 -128.8 178.15 6.56 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.084 -1.046 . . . . 0.0 109.106 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.844 ' N ' HG12 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -127.03 94.04 3.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 5.1 p-10 -108.12 143.16 37.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 110.214 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.48 -5.06 51.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.446 -0.784 . . . . 0.0 109.157 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' O ' ' OD2' ' A' ' 11' ' ' ASP . 32.9 t0 -80.78 103.46 10.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.24 -0.913 . . . . 0.0 108.819 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -65.29 -9.16 21.91 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.32 -0.862 . . . . 0.0 108.895 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.06 -39.27 71.78 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.24 -0.913 . . . . 0.0 108.931 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.43 -44.95 80.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.429 -0.794 . . . . 0.0 109.009 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CE2' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -55.11 -45.55 75.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.0 108.999 179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.18 -61.07 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -0.878 . . . . 0.0 108.81 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -53.05 -23.26 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.274 -0.892 . . . . 0.0 108.613 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -54.95 17.83 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.6 -37.41 17.99 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 25' ' ' ASP . 36.8 mt -61.26 -45.09 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.718 HG23 ' HB1' ' A' ' 29' ' ' ALA . 22.4 mm -50.45 -57.04 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 109.024 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.477 ' HB2' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -59.5 -28.52 67.12 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.195 -0.94 . . . . 0.0 108.489 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -50.4 -39.44 47.06 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -79.69 141.77 56.34 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -84.48 44.84 1.58 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.777 1.409 . . . . 0.0 109.904 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -150.65 -48.28 0.12 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.718 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -71.1 139.26 50.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.385 -0.822 . . . . 0.0 109.657 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 t -101.98 152.04 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 109.502 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -129.07 169.14 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.21 -0.932 . . . . 0.0 109.367 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -147.73 111.46 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.406 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -82.14 127.77 33.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -123.93 148.2 56.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.29 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.661 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 2.2 Cg_endo -87.23 43.77 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.895 1.471 . . . . 0.0 110.206 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 35' ' ' PRO . . . 166.43 -29.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.957 ' C ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -104.8 171.6 7.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.579 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.957 HD13 ' C ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -156.04 124.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.448 -0.783 . . . . 0.0 109.199 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.965 ' CB ' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER 171.59 -151.88 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.993 -1.067 . . . . 0.0 110.949 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.775 HG22 ' H ' ' A' ' 41' ' ' GLU . 2.5 mt -160.79 -170.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.587 -1.321 . . . . 0.0 110.306 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.775 ' H ' HG22 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -134.83 -173.35 3.28 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.491 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 1.019 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -138.74 -171.34 3.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.973 -1.08 . . . . 0.0 110.007 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 18.6 mt-10 -141.36 33.01 1.68 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.404 -0.81 . . . . 0.0 109.741 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -168.34 -144.65 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.891 -1.131 . . . . 0.0 110.332 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -145.3 -154.09 0.52 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.23 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.716 HD13 HD21 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -155.5 148.32 24.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.059 -1.026 . . . . 0.0 110.061 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.492 ' HA ' HG23 ' A' ' 85' ' ' VAL . 4.3 tm-20 -137.81 139.56 40.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.064 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.536 ' CD1' HG21 ' A' ' 52' ' ' THR . 0.1 OUTLIER -159.4 154.79 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.11 -0.994 . . . . 0.0 109.967 -179.534 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.459 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -82.82 -166.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.382 -0.823 . . . . 0.0 110.092 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.52 ' HG3' ' NH1' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -73.38 -27.01 61.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.928 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -49.19 -30.42 6.87 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.027 -1.046 . . . . 0.0 108.921 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.598 ' HB ' ' CD2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -65.74 -45.28 83.22 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.894 -1.129 . . . . 0.0 108.478 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.941 HG22 ' CD1' ' A' ' 84' ' ' PHE . 40.6 t -47.88 -29.56 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 3.3 tt0 -71.85 -45.09 62.57 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -55.97 -51.7 66.77 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.397 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.67 -38.64 72.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 109.643 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.21 -52.3 65.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.208 -0.932 . . . . 0.0 109.244 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.12 -14.55 61.64 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -112.52 20.87 16.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -1.082 . . . . 0.0 109.713 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.58 -7.43 43.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.665 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.612 ' CD1' ' O ' ' A' ' 61' ' ' TRP . 65.3 t-105 -92.31 22.89 4.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.932 . . . . 0.0 109.481 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -110.79 5.95 21.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.022 -1.049 . . . . 0.0 109.988 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.01 -33.84 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 109.644 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -53.48 -37.15 62.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.227 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.77 -31.52 68.34 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.348 -0.845 . . . . 0.0 109.236 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mtm -67.78 -12.84 61.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 tt -68.61 -50.57 50.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.095 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.86 -43.57 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 10' ' ' GLN . 1.4 p-10 -94.14 162.64 13.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.148 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.844 HG12 ' N ' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -81.5 175.39 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.207 -0.933 . . . . 0.0 109.124 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.403 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -147.35 137.5 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.309 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -144.3 154.86 43.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.583 ' HA ' HG22 ' A' ' 7' ' ' ILE . 1.9 pp -145.27 174.68 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.774 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -177.76 58.17 0.09 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 87' ' ' GLU . . . 120.12 61.42 0.25 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.574 ' CB ' ' HB3' ' A' ' 87' ' ' GLU . 2.3 p-10 -175.85 138.11 0.36 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.418 -1.048 . . . . 0.0 108.642 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.6 p 177.19 79.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 O-C-N 121.291 -0.88 . . . . 0.0 109.32 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.591 ' HB3' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -49.06 -15.86 0.12 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.754 -0.591 . . . . 0.0 111.679 -178.709 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -111.66 100.82 9.27 Favored 'General case' 0 C--N 1.281 -2.401 0 O-C-N 121.153 -0.967 . . . . 0.0 109.21 179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.8 -79.97 0.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.787 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.59 -90.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.922 . . . . 0.0 109.925 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -118.67 -29.5 5.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.824 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -88.84 -158.19 0.48 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 109.016 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.941 ' CD1' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -126.84 120.5 29.4 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.094 -1.004 . . . . 0.0 109.633 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.601 ' O ' ' O ' ' A' ' 77' ' ' VAL . 2.5 p -144.7 140.05 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.18 -0.95 . . . . 0.0 109.545 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.729 HD12 ' H ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -151.53 -155.39 0.62 Allowed 'General case' 0 C--N 1.284 -2.252 0 O-C-N 120.885 -1.134 . . . . 0.0 108.124 177.754 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.999 ' CD ' HG21 ' A' ' 5' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.283 -2.318 0 CA-C-O 122.115 0.959 . . . . 0.0 110.725 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 44' ' ' LYS . 20.8 p . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -143.22 164.86 29.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.965 -1.084 . . . . 0.0 110.485 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.524 ' HB ' ' HA3' ' A' ' 75' ' ' GLY . 10.5 m -130.79 167.37 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.515 0.674 . . . . 0.0 109.858 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.568 ' O ' ' N ' ' A' ' 74' ' ' GLY . 0.8 OUTLIER -145.06 135.78 24.5 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.53 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 1.9 pt -160.5 137.77 2.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.877 -1.139 . . . . 0.0 110.368 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.706 ' HB3' HG22 ' A' ' 71' ' ' ILE . . . -120.79 167.72 12.2 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CD1' ' O ' ' A' ' 8' ' ' ALA . 12.0 m-85 -163.18 155.13 17.87 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.536 -1.353 . . . . 0.0 109.793 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.53 ' H ' ' N ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -121.05 94.86 4.48 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.033 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB3' ' OD1' ' A' ' 69' ' ' ASP . 1.4 p30 -108.83 137.53 46.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.585 -0.697 . . . . 0.0 109.749 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -79.23 -13.76 59.48 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.245 -0.91 . . . . 0.0 109.174 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.8 105.83 4.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 17' ' ' TYR . 18.1 t30 -60.71 -12.83 11.65 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.28 -42.03 66.15 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.256 -0.903 . . . . 0.0 108.784 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -38.78 74.34 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.442 ' HB3' ' OD1' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -58.64 -43.16 89.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.477 -0.764 . . . . 0.0 108.966 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.49 -52.87 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 108.81 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 23' ' ' ILE . 48.1 t -62.39 -24.06 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.375 -0.828 . . . . 0.0 109.025 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.572 ' HA ' HD12 ' A' ' 23' ' ' ILE . 1.7 tt0 -76.08 -27.14 57.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.267 -0.896 . . . . 0.0 109.049 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.39 -44.48 64.88 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -63.82 -46.94 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 20' ' ' GLU . 60.1 mt -54.25 -49.1 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.423 ' OE1' ' CG ' ' A' ' 20' ' ' GLU . 17.9 mt-30 -61.7 -32.64 72.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.146 -0.972 . . . . 0.0 108.457 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -47.06 -36.82 8.54 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -79.84 133.69 58.12 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.36 46.24 1.91 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.805 1.424 . . . . 0.0 109.98 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -149.92 -45.44 0.13 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.126 -0.984 . . . . 0.0 109.713 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -59.92 144.21 49.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.613 ' C ' HG22 ' A' ' 31' ' ' VAL . 5.7 t -101.11 139.67 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.521 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.613 HG22 ' C ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -168.88 166.54 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 109.14 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 33' ' ' HIS . 2.5 mm-40 -149.43 -94.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.338 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.765 ' CE1' HG22 ' A' ' 38' ' ' ILE . 4.9 t60 55.72 110.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 109.88 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.559 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -154.16 -62.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.616 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.3 Cg_endo -67.21 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.652 1.343 . . . . 0.0 109.772 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.64 -53.75 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.399 -0.813 . . . . 0.0 109.243 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.486 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -72.08 157.33 37.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 109.153 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.765 HG22 ' CE1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -122.83 165.22 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.017 -1.052 . . . . 0.0 109.34 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.494 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -132.21 156.87 45.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.966 . . . . 0.0 109.986 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.555 HG22 ' H ' ' A' ' 41' ' ' GLU . 8.7 mt -152.83 172.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.401 -0.812 . . . . 0.0 109.053 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.555 ' H ' HG22 ' A' ' 40' ' ' ILE . 5.9 tt0 171.36 145.21 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.522 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -144.12 -162.8 1.54 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.085 -1.01 . . . . 0.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -140.67 82.92 1.87 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 3' ' ' SER . 31.2 mmtt -129.64 -165.13 1.48 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.048 -1.032 . . . . 0.0 110.856 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.546 ' CA ' ' HG3' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -165.24 165.34 19.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.645 HD13 ' H ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -164.55 150.61 10.56 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.897 -1.127 . . . . 0.0 110.478 178.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.645 ' H ' HD13 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -142.99 139.67 30.72 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.037 HG21 HG21 ' A' ' 52' ' ' THR . 2.3 pt -139.71 163.64 24.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.064 -1.022 . . . . 0.0 110.305 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.504 ' HA ' ' HG3' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -95.46 -147.43 0.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.476 -0.765 . . . . 0.0 109.336 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' NH1' ' CG ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -87.67 -40.59 14.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.081 -1.012 . . . . 0.0 109.726 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 69.1 tt0 -54.67 -31.21 57.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 109.06 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 1.037 HG21 HG21 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -61.92 -40.16 94.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.036 -1.04 . . . . 0.0 108.536 179.409 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.579 HG22 ' CD2' ' A' ' 84' ' ' PHE . 21.2 t -46.25 -32.93 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 3.8 tt0 -71.24 -46.01 61.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 52' ' ' THR . 40.0 mm-40 -52.82 -55.12 25.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.364 -0.835 . . . . 0.0 109.529 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -55.51 -34.92 65.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.257 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.8 tp -56.43 -54.8 41.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.149 -0.969 . . . . 0.0 109.284 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.65 -9.64 65.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.44 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -112.75 5.61 17.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -1.076 . . . . 0.0 109.396 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -79.29 -19.15 51.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -89.89 23.64 2.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.196 -0.94 . . . . 0.0 109.286 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.64 39.48 2.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.401 -0.812 . . . . 0.0 109.017 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' A' ' 66' ' ' MET . 2.1 t -91.95 -3.94 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.708 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.433 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 4.1 mp0 -50.2 -25.24 3.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 0.0 109.465 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -66.31 -44.53 83.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.147 -0.971 . . . . 0.0 109.426 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.45 ' CE ' HD11 ' A' ' 73' ' ' ILE . 5.1 mtp -59.27 -16.11 19.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 0.0 109.523 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 11.2 tp -78.1 -52.25 9.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.703 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 68' ' ' VAL . 2.0 t -66.56 -55.19 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.626 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -98.76 85.22 3.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.648 ' O ' HG12 ' A' ' 71' ' ' ILE . 7.1 p -103.29 141.77 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.247 -0.908 . . . . 0.0 112.513 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.706 HG22 ' HB3' ' A' ' 8' ' ' ALA . 2.1 mm 178.41 -85.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.699 HG22 ' H ' ' A' ' 73' ' ' ILE . 2.2 m -133.44 176.33 8.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.921 -1.112 . . . . 0.0 111.621 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.699 ' H ' HG22 ' A' ' 72' ' ' THR . 0.6 OUTLIER -160.87 162.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -179.65 34.99 0.07 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.524 ' HA3' ' HB ' ' A' ' 5' ' ' VAL . . . -162.58 85.31 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -129.2 -135.33 0.22 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.586 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 85' ' ' VAL . 7.1 p -118.22 126.6 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -0.999 . . . . 0.0 109.724 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.486 ' O ' HG12 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -105.98 148.0 28.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.513 -0.742 . . . . 0.0 109.943 -179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -103.3 133.52 48.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 108.961 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -106.15 -93.94 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 110.102 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -105.39 -75.72 0.62 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.899 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.53 -31.41 4.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 108.761 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.504 ' HG3' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -81.04 -171.74 3.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.699 ' CE1' HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -134.87 158.96 42.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.09 -1.006 . . . . 0.0 109.269 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 77' ' ' VAL . 2.4 p -143.7 169.56 10.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.242 -0.911 . . . . 0.0 109.438 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 77' ' ' VAL . 1.3 pp -176.84 -167.39 0.18 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.546 ' HG3' ' CA ' ' A' ' 45' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.298 -1.652 0 O-C-N 120.894 -1.129 . . . . 0.0 110.645 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 4' ' ' LEU . 0.4 OUTLIER -137.02 156.43 48.44 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.087 -1.008 . . . . 0.0 110.512 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.131 HG11 HD21 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -113.73 -176.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.956 ' CE2' HG21 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -147.05 139.15 24.52 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.089 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.991 ' HB ' HG22 ' A' ' 72' ' ' THR . 1.3 pt -143.63 135.32 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.296 -0.878 . . . . 0.0 108.801 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.652 ' HB2' ' HE1' ' A' ' 6' ' ' TYR . . . -145.3 147.1 31.97 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.384 -1.326 . . . . 0.0 110.522 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.607 ' CE2' HG13 ' A' ' 38' ' ' ILE . 16.7 p90 -135.96 175.98 9.1 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.677 ' HB2' HG23 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -141.08 80.14 1.73 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.095 -1.003 . . . . 0.0 108.748 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.443 ' CB ' ' NH1' ' A' ' 16' ' ' ARG . 4.0 t70 -110.18 178.84 4.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.336 -0.853 . . . . 0.0 110.0 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -121.91 16.26 10.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 109.397 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -85.96 103.89 15.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.214 -0.929 . . . . 0.0 108.985 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -67.23 -7.76 26.43 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.251 -0.906 . . . . 0.0 108.873 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.77 -56.01 9.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.32 -0.863 . . . . 0.0 109.016 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HG2' ' N ' ' A' ' 17' ' ' TYR . 6.2 ptm180 -59.37 -28.71 67.12 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.46 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 26.4 t80 -60.3 -49.94 75.59 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.523 ' O ' HD12 ' A' ' 22' ' ' ILE . 70.4 t -54.38 -56.08 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.663 ' HA ' HD13 ' A' ' 22' ' ' ILE . 95.6 t -49.59 -30.93 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.29 -46.17 77.9 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.99 -41.08 46.19 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.302 -0.874 . . . . 0.0 108.667 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.727 ' H ' HD12 ' A' ' 22' ' ' ILE . 4.3 mp -65.55 -43.05 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.469 -0.769 . . . . 0.0 108.976 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 7.0 mt -52.89 -43.98 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 108.844 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.906 ' HG2' HG23 ' A' ' 31' ' ' VAL . 6.1 mt-30 -67.26 -32.08 72.85 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -24.88 6.54 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -83.05 135.37 44.95 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -84.6 47.12 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.761 1.4 . . . . 0.0 109.843 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -146.87 -40.07 0.2 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.338 -0.851 . . . . 0.0 109.084 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.411 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . . . -73.91 139.9 45.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.442 -0.786 . . . . 0.0 109.538 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.674 HG21 ' HB3' ' A' ' 41' ' ' GLU . 16.0 t -71.24 -120.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.181 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.906 HG23 ' HG2' ' A' ' 24' ' ' GLN . 1.1 p -174.23 -165.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.729 -1.232 . . . . 0.0 109.935 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.711 ' H ' HG22 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -114.19 -167.73 1.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.551 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -89.45 -99.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 109.928 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.569 ' HB3' ' HD3' ' A' ' 35' ' ' PRO . 46.7 t-80 -166.17 -58.69 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 110.587 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 34' ' ' HIS . 3.5 Cg_exo -49.53 -179.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 117.442 -1.239 . . . . 0.0 110.822 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 38' ' ' ILE . . . -52.21 -22.57 4.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.005 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.524 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 3.1 mmt -65.37 156.4 32.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.926 -1.109 . . . . 0.0 109.242 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.607 HG13 ' CE2' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -127.82 129.17 69.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.291 -0.881 . . . . 0.0 108.63 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.74 ' C ' HD12 ' A' ' 40' ' ' ILE . 2.2 ttt180 -126.52 164.62 20.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.06 -1.025 . . . . 0.0 110.053 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 7' ' ' ILE . 2.7 mp -156.51 169.22 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.37 -0.831 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.674 ' HB3' HG21 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -155.91 152.79 28.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.682 -1.261 . . . . 0.0 110.26 -179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.839 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -129.93 -177.26 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 91.0 mt-10 -140.04 74.97 1.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.126 -0.984 . . . . 0.0 110.186 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 175.11 -141.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.972 -1.08 . . . . 0.0 110.208 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.957 ' C ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -126.1 167.83 14.83 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.228 -0.92 . . . . 0.0 109.931 -179.093 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 1.131 HD21 HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -130.88 152.91 49.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.384 -0.823 . . . . 0.0 109.665 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.35 154.7 46.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.2 mt -150.55 141.02 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.141 -0.975 . . . . 0.0 109.71 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.46 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.6 ptt180 -100.92 -171.93 2.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 109.567 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.53 ' NH1' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -75.76 -32.85 60.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.184 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 4.4 mt-10 -50.37 -41.59 52.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.865 . . . . 0.0 109.297 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -69.26 -47.67 64.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 108.88 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.6 -26.73 2.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 1.4 tt0 -74.84 -43.59 53.74 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -55.73 -50.32 70.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 108.731 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -59.79 -33.46 71.74 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.372 -0.83 . . . . 0.0 109.016 179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.5 tp -57.73 -51.76 68.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 108.905 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.05 -14.82 66.48 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -113.02 15.23 19.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.964 . . . . 0.0 109.306 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -67.18 -19.42 65.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -0.838 . . . . 0.0 109.426 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -89.42 35.59 0.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.309 -0.869 . . . . 0.0 109.381 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 65' ' ' GLU . 34.9 t70 -104.97 5.87 33.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.476 ' H ' HG23 ' A' ' 63' ' ' VAL . 2.8 t -52.21 -40.65 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.932 . . . . 0.0 109.539 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.46 -40.93 62.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.143 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 0.4 OUTLIER -73.03 -28.39 62.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.049 179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -12.03 61.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.278 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 67' ' ' LEU . 1.5 mm? -74.47 -56.97 4.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.297 -0.877 . . . . 0.0 109.945 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.53 ' CG1' ' OD2' ' A' ' 69' ' ' ASP . 2.3 p -90.52 -46.47 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.119 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -103.02 146.69 27.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.983 -1.073 . . . . 0.0 109.967 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.742 HG12 ' H ' ' A' ' 71' ' ' ILE . 7.0 t -100.56 -176.07 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.797 ' O ' HG23 ' A' ' 72' ' ' THR . 0.6 OUTLIER -136.02 -37.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.276 -1.515 . . . . 0.0 112.165 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.991 HG22 ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER 170.75 -148.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.682 -1.261 . . . . 0.0 108.7 -178.503 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.956 HG21 ' CE2' ' A' ' 6' ' ' TYR . 1.4 tp 176.95 -129.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.648 ' H ' HG23 ' A' ' 73' ' ' ILE . . . 167.98 -108.27 0.3 Allowed Glycine 0 N--CA 1.485 1.965 0 O-C-N 120.04 -1.662 . . . . 0.0 109.945 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.53 -65.62 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.639 ' H ' HD21 ' A' ' 86' ' ' LEU . 9.6 t-20 -124.42 -147.21 0.37 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -1.179 . . . . 0.0 108.662 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.2 p 178.9 93.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.091 -1.006 . . . . 0.0 109.994 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.6 134.88 49.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.148 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -118.43 156.31 29.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 109.493 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -109.82 -94.93 0.41 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.556 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -106.03 -70.76 0.77 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.178 -0.951 . . . . 0.0 109.281 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.1 -6.37 7.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.313 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -90.94 -169.68 2.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -0.86 . . . . 0.0 109.406 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -155.51 122.07 5.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.941 . . . . 0.0 109.369 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.85 139.2 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.17 -0.956 . . . . 0.0 110.003 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.976 HD22 ' N ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -149.38 136.76 20.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.976 ' N ' HD22 ' A' ' 86' ' ' LEU . 2.4 mp0 . . . . . 0 C--N 1.302 -1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.699 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 1.0 OUTLIER -126.98 158.14 37.68 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.994 -1.066 . . . . 0.0 110.283 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -119.49 170.96 8.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.543 0.687 . . . . 0.0 110.232 -178.503 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 74' ' ' GLY . 10.2 t80 -140.49 141.33 35.39 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.867 HD11 HD12 ' A' ' 40' ' ' ILE . 1.5 pp -159.18 152.84 5.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.671 ' HB1' ' O ' ' A' ' 38' ' ' ILE . . . -146.37 -173.4 4.18 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.599 -1.24 . . . . 0.0 110.59 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 1.095 ' CD2' HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.84 171.23 14.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 122.633 1.206 . . . . 0.0 111.866 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.716 ' C ' HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER 176.35 105.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.32 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.623 ' N ' HG23 ' A' ' 70' ' ' VAL . 3.3 t0 -109.87 -156.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.641 0.734 . . . . 0.0 110.078 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -128.45 -63.43 0.99 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -118.59 -15.06 9.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.441 -0.787 . . . . 0.0 108.904 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' HB3' ' OD2' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -82.51 7.59 14.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.399 -0.813 . . . . 0.0 109.017 179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 18' ' ' VAL . . . -42.4 -32.92 0.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.401 -0.812 . . . . 0.0 109.166 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -51.43 -56.74 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 109.012 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -61.74 -32.1 72.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.229 -0.92 . . . . 0.0 109.281 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 15' ' ' ALA . 55.8 t -57.01 -41.43 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.831 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.71 -30.96 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.63 -49.85 73.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.501 -0.749 . . . . 0.0 109.45 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -62.91 -40.17 96.78 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.119 -0.988 . . . . 0.0 108.97 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.004 HD11 HG13 ' A' ' 38' ' ' ILE . 5.6 mm -50.1 -42.92 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.026 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.487 ' O ' ' CD ' ' A' ' 27' ' ' PRO . 40.1 mm -69.29 -33.56 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.15 -0.969 . . . . 0.0 109.024 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -90.88 4.94 50.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.438 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.872 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -117.18 -11.64 10.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.875 ' OD1' HG13 ' A' ' 31' ' ' VAL . 1.1 m-80 -87.91 -68.79 0.12 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.519 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 26' ' ' ASN . 3.6 Cg_exo -41.28 -28.08 0.46 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.69 1.363 . . . . 0.0 110.195 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -97.78 -39.03 9.24 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.322 -0.861 . . . . 0.0 109.199 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' A' ' 25' ' ' ASP . . . -102.94 -158.08 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.125 -0.985 . . . . 0.0 109.685 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.519 ' O ' HG22 ' A' ' 31' ' ' VAL . 3.2 t -96.3 -127.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.875 HG13 ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -161.72 141.76 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.648 -1.283 . . . . 0.0 109.726 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -174.21 95.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 109.46 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.535 ' CE1' ' HB ' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -115.05 157.17 23.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.501 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.463 ' CG ' ' HD2' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -117.45 -167.22 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.523 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 34' ' ' HIS . 2.3 Cg_endo -90.56 15.19 1.88 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.96 1.505 . . . . 0.0 110.338 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.68 -76.39 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.195 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -84.21 167.34 16.77 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.004 HG13 HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.95 163.44 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.843 -1.161 . . . . 0.0 108.922 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.554 ' N ' HD13 ' A' ' 38' ' ' ILE . 8.9 mtp180 -139.48 162.47 34.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.879 -1.138 . . . . 0.0 109.5 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.867 HD12 HD11 ' A' ' 7' ' ' ILE . 33.0 mt -158.64 164.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 110.003 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.567 ' N ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -159.17 166.67 30.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.381 -0.825 . . . . 0.0 109.006 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.515 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -159.83 -165.23 1.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.937 -1.102 . . . . 0.0 110.545 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -139.2 97.28 3.26 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 3' ' ' SER . 30.8 mttm -142.43 -164.54 1.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.972 -1.08 . . . . 0.0 110.925 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.509 ' HA ' ' HG3' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -167.79 171.32 10.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 109.154 -179.3 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.964 HD12 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -160.82 142.19 11.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.026 -1.046 . . . . 0.0 109.723 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.817 ' C ' HD12 ' A' ' 48' ' ' ILE . 1.1 tt0 -138.86 138.81 37.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.996 . . . . 0.0 109.434 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 46' ' ' LEU . 4.1 mp -151.2 162.8 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.257 -0.902 . . . . 0.0 110.294 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.524 ' N ' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -98.36 -153.42 0.43 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.425 ' CG ' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -69.98 -12.68 61.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.598 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 3.4 tt0 -64.84 -9.8 23.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.193 -0.942 . . . . 0.0 109.603 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.743 HG21 ' OD2' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -59.99 -40.34 88.83 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.866 -1.146 . . . . 0.0 109.02 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 52' ' ' THR . 94.5 t -46.37 -34.24 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -70.27 -45.75 65.76 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.648 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 52' ' ' THR . 3.0 mm-40 -47.7 -46.1 29.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -38.75 88.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.357 -0.84 . . . . 0.0 108.812 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.2 tp -55.17 -55.22 33.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.364 -0.835 . . . . 0.0 109.15 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.41 -9.4 68.37 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -90.95 -9.53 45.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -1.123 . . . . 0.0 109.517 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.72 -25.35 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.453 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -88.29 40.26 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.389 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -111.28 74.63 0.88 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.397 -0.814 . . . . 0.0 109.137 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.16 2.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -0.86 . . . . 0.0 109.994 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.546 ' O ' HD11 ' A' ' 71' ' ' ILE . 2.3 mp0 -49.01 -22.63 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.055 -1.028 . . . . 0.0 109.315 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 1.016 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.0 pt-20 -56.4 -48.67 76.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -17.08 64.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.194 -0.941 . . . . 0.0 109.423 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.714 HD23 HG12 ' A' ' 71' ' ' ILE . 4.9 tp -98.67 11.98 36.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 109.399 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.016 HG23 ' O ' ' A' ' 65' ' ' GLU . 40.5 t -39.34 -24.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.414 -0.804 . . . . 0.0 110.867 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 71' ' ' ILE . 67.4 m-20 -58.2 -100.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.713 -1.242 . . . . 0.0 109.807 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.095 HG22 ' CD2' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -42.08 -13.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.175 -2.819 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.461 -178.166 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.714 HG12 HD23 ' A' ' 67' ' ' LEU . 1.7 pt -123.42 131.91 72.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 120.453 1.478 . . . . 0.0 110.253 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.659 ' OG1' ' HB3' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -130.74 150.02 52.12 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -133.47 174.53 13.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.229 -0.919 . . . . 0.0 110.403 -178.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 178.89 38.74 0.07 OUTLIER Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 5' ' ' VAL . . . -152.37 82.94 0.17 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' H ' ' A' ' 87' ' ' GLU . 27.6 p-10 -176.03 138.47 0.35 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.674 ' O ' ' O ' ' A' ' 85' ' ' VAL . 13.8 p -171.34 52.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.101 -0.999 . . . . 0.0 109.228 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.995 ' CG ' HD23 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -49.92 -9.54 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.265 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -110.52 94.83 5.21 Favored 'General case' 0 C--N 1.28 -2.422 0 O-C-N 120.6 -1.313 . . . . 0.0 109.729 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.685 ' HB2' HG12 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -107.11 -82.11 0.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 108.951 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.01 -82.72 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 108.996 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -128.18 -30.88 2.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.364 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -80.11 -157.88 0.16 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.575 ' CD2' ' HB ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -126.1 112.9 16.38 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.749 -1.22 . . . . 0.0 108.752 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.685 HG12 ' HB2' ' A' ' 80' ' ' ASP . 4.1 p -129.51 138.78 53.41 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.655 0 C-N-CA 118.922 -1.111 . . . . 0.0 109.763 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.995 HD23 ' CG ' ' A' ' 78' ' ' ASP . 0.9 OUTLIER -143.0 -176.27 4.84 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 120.837 -1.164 . . . . 0.0 108.309 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.588 ' C ' ' HB2' ' A' ' 46' ' ' LEU . 1.9 tt0 . . . . . 0 C--N 1.286 -2.185 0 CA-C-O 121.947 0.88 . . . . 0.0 110.61 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 44' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -142.26 160.93 39.27 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.759 -1.213 . . . . 0.0 112.235 -178.837 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.922 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 1.2 t -113.52 -176.65 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.734 ' CE2' HG21 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -159.19 144.77 16.16 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.939 ' HB ' HG22 ' A' ' 72' ' ' THR . 4.5 pt -160.31 137.11 2.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 120.529 -1.357 . . . . 0.0 107.919 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.728 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -132.36 146.41 51.95 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.186 -1.806 . . . . 0.0 109.606 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 1.007 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 14.0 p90 -140.9 170.34 15.93 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.488 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.696 ' HG3' ' CA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -119.61 143.33 47.73 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.052 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 2.7 p30 -108.73 154.07 22.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.745 -1.222 . . . . 0.0 109.957 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -89.63 -37.97 14.26 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.377 -0.827 . . . . 0.0 109.424 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 12' ' ' ASN . 16.6 t0 168.84 -34.88 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -102.97 -30.31 10.87 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 11' ' ' ASP . . . -52.65 -20.37 3.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.0 109.141 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -64.98 -56.14 14.91 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.832 . . . . 0.0 109.132 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.73 -39.32 73.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.238 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.1 t -56.49 -49.04 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 108.605 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 1.007 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 60.9 t -67.45 -19.13 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.454 -0.779 . . . . 0.0 109.137 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.509 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 45.6 tt0 -76.28 -36.7 58.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.385 -0.822 . . . . 0.0 109.784 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.61 -36.23 65.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.8 mt -71.67 -48.91 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.642 HD12 ' N ' ' A' ' 24' ' ' GLN . 2.2 pp -57.81 -38.96 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.217 -0.927 . . . . 0.0 108.934 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.642 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -62.89 -43.05 99.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.343 -0.848 . . . . 0.0 109.035 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 24' ' ' GLN . 3.0 t0 -44.43 -36.3 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.56 88.15 23.39 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 2.4 Cg_endo -65.89 81.31 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 124.31 1.69 . . . . 0.0 110.308 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 5.5 t-80 179.33 -43.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -40.86 140.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.725 -0.61 . . . . 0.0 110.002 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.604 HG22 ' N ' ' A' ' 31' ' ' VAL . 3.7 p -97.42 165.77 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 0.0 109.441 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.604 ' N ' HG22 ' A' ' 30' ' ' VAL . 1.4 p -155.49 163.44 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.521 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -174.55 141.78 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 0.0 109.849 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.931 ' HB3' HG22 ' A' ' 38' ' ' ILE . 1.3 p-80 -143.66 160.34 40.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.27 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.579 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -157.62 -61.57 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.106 -0.996 . . . . 0.0 109.881 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.5 Cg_endo -66.92 -54.27 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.725 1.382 . . . . 0.0 110.002 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -177.63 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.315 -0.866 . . . . 0.0 108.971 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 1.2 ptm -69.02 158.62 34.42 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.931 HG22 ' HB3' ' A' ' 33' ' ' HIS . 0.1 OUTLIER -110.31 120.59 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.891 -1.13 . . . . 0.0 109.857 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.535 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -81.85 177.78 8.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.34 -0.85 . . . . 0.0 110.219 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.698 HD12 HG13 ' A' ' 7' ' ' ILE . 3.1 mt -152.72 -174.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.273 -0.892 . . . . 0.0 109.673 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.67 ' H ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -171.09 158.55 5.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.795 -1.191 . . . . 0.0 111.04 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.922 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . . . -129.84 -175.31 3.56 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 10.2 pt-20 -151.25 70.67 0.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.147 -0.97 . . . . 0.0 110.033 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 173.4 -143.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.856 -1.152 . . . . 0.0 109.321 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.966 ' O ' HD23 ' A' ' 46' ' ' LEU . 4.9 mpt_? -126.01 154.99 42.15 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.04 -1.037 . . . . 0.0 109.375 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.966 HD23 ' O ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -144.92 135.76 24.68 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.173 -0.955 . . . . 0.0 109.833 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 1.088 ' CA ' HG12 ' A' ' 85' ' ' VAL . 2.3 pm0 -151.05 135.55 17.03 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.781 ' CD1' HG11 ' A' ' 85' ' ' VAL . 2.5 mt -137.8 152.4 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 0.0 109.117 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.527 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -50.49 147.58 4.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 108.949 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.453 ' CG ' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -89.27 -60.55 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.017 . . . . 0.0 109.716 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 16.5 tt0 -54.35 -44.66 72.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.751 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -50.81 50.06 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.017 -1.052 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.576 ' CG2' ' CG2' ' A' ' 48' ' ' ILE . 19.4 t -55.34 -21.48 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -74.99 -40.08 60.88 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.29 -56.27 9.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.267 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -55.3 -29.43 58.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 109.3 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.612 HD12 ' CE3' ' A' ' 61' ' ' TRP . 7.6 tp -64.33 -56.11 16.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -0.842 . . . . 0.0 109.732 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.51 8.15 69.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.488 ' HG2' ' N ' ' A' ' 60' ' ' ALA . 22.7 ttt180 -98.8 -84.59 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -1.17 . . . . 0.0 109.973 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.488 ' N ' ' HG2' ' A' ' 59' ' ' ARG . . . -96.03 -22.6 17.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.585 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.612 ' CE3' HD12 ' A' ' 57' ' ' LEU . 8.6 t90 -90.18 25.78 2.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.313 -0.867 . . . . 0.0 109.177 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.2 44.31 1.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.264 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 65' ' ' GLU . 3.9 t -98.93 9.4 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.415 -0.803 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.503 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 7.4 mm100 -39.9 -28.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.522 -0.736 . . . . 0.0 109.944 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 68' ' ' VAL . 16.1 tt0 -58.06 -55.26 37.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.136 -0.977 . . . . 0.0 109.404 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.433 ' HB2' HG12 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -72.32 -9.57 58.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 64' ' ' GLN . 11.8 tp -53.74 -16.35 1.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.432 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 65' ' ' GLU . 17.2 t -40.2 -42.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -0.954 . . . . 0.0 109.715 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.696 ' CA ' ' HG3' ' A' ' 10' ' ' GLN . 10.1 m-20 -81.52 -74.75 0.32 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.181 -0.949 . . . . 0.0 109.818 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 71' ' ' ILE . 1.3 t -43.56 -170.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 122.152 -0.343 . . . . 0.0 110.98 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.728 HG22 ' O ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER 161.46 -167.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.939 HG22 ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -175.39 -158.87 0.07 Allowed 'General case' 0 C--O 1.193 -1.903 0 O-C-N 119.348 -2.095 . . . . 0.0 108.143 179.371 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.747 HG22 ' H ' ' A' ' 74' ' ' GLY . 48.6 mm -168.39 -127.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.747 ' H ' HG22 ' A' ' 73' ' ' ILE . . . 161.84 -71.81 0.21 Allowed Glycine 0 N--CA 1.486 1.996 0 O-C-N 120.427 -1.421 . . . . 0.0 110.591 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.16 -37.93 1.59 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.813 ' C ' HD13 ' A' ' 86' ' ' LEU . 2.4 t-20 -176.48 -149.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.974 . . . . 0.0 109.205 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.779 ' O ' HG13 ' A' ' 77' ' ' VAL . 9.1 p -151.33 100.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.016 . . . . 0.0 109.415 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.459 ' HB2' ' CD ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -114.47 150.58 34.57 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.942 -1.098 . . . . 0.0 110.325 -179.006 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.577 ' HB3' ' CD1' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -118.12 164.64 14.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.588 -0.695 . . . . 0.0 109.229 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASP . . . . . 0.533 ' OD1' ' HB2' ' A' ' 47' ' ' GLU . 3.6 p-10 -114.42 -115.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.035 -1.04 . . . . 0.0 109.646 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -98.36 -41.12 7.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.828 -1.17 . . . . 0.0 109.753 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -130.91 -58.78 1.01 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.03 -1.044 . . . . 0.0 108.606 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 48' ' ' ILE . 2.1 mpp_? -57.2 -173.22 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.664 ' CE1' HG22 ' A' ' 77' ' ' VAL . 2.2 t80 173.41 120.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.051 -1.031 . . . . 0.0 111.816 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.088 HG12 ' CA ' ' A' ' 47' ' ' GLU . 8.1 p -160.39 -115.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.813 HD13 ' C ' ' A' ' 76' ' ' ASN . 22.0 tp -131.85 144.62 51.03 Favored 'General case' 0 C--N 1.282 -2.352 0 O-C-N 120.19 -1.569 . . . . 0.0 112.368 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.803 ' H ' HD12 ' A' ' 86' ' ' LEU . 16.8 mt-10 . . . . . 0 C--N 1.301 -1.538 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -128.2 -167.03 1.7 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -0.98 . . . . 0.0 109.797 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.835 HG13 ' HA2' ' A' ' 75' ' ' GLY . 11.3 t -152.28 161.31 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.594 ' O ' ' N ' ' A' ' 74' ' ' GLY . 6.6 t80 -153.16 136.0 15.38 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.67 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -162.68 137.68 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.921 -1.112 . . . . 0.0 109.786 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.635 ' C ' HG22 ' A' ' 71' ' ' ILE . . . -126.6 173.89 9.11 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 69' ' ' ASP . 2.6 m-85 -168.56 155.56 7.48 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.496 -1.378 . . . . 0.0 109.366 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.633 ' NE2' ' O ' ' A' ' 11' ' ' ASP . 0.4 OUTLIER -120.91 93.82 4.15 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.633 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 1.1 m-20 -74.38 -166.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.38 -0.825 . . . . 0.0 109.831 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.7 -114.59 0.12 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.09 -1.006 . . . . 0.0 108.911 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -119.08 -31.97 4.57 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.843 -1.161 . . . . 0.0 108.579 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -103.07 -34.87 8.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.473 -0.767 . . . . 0.0 109.331 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.53 82.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.556 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.463 HH11 ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -63.07 -36.22 82.86 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.315 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -37.65 83.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.075 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.86 -53.04 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 109.191 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.411 ' HA ' HD12 ' A' ' 22' ' ' ILE . 55.9 t -64.37 -23.65 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.409 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.35 -35.28 73.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 109.747 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -77.53 -33.08 54.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.773 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 19' ' ' VAL . 8.3 mt -71.89 -37.62 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.181 -0.949 . . . . 0.0 109.058 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.3 mt -67.24 -53.02 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.894 . . . . 0.0 109.335 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -63.48 -29.25 70.55 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.358 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -47.13 -43.94 21.16 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.01 126.96 61.28 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.7 Cg_endo -84.02 49.34 2.78 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.817 1.43 . . . . 0.0 110.254 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.8 t-160 -154.76 -48.47 0.09 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.19 -0.944 . . . . 0.0 109.917 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -41.11 141.08 0.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.475 -0.766 . . . . 0.0 109.873 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.411 ' C ' ' CG2' ' A' ' 31' ' ' VAL . 2.6 t -98.0 162.32 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.523 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.411 ' CG2' ' C ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -155.11 156.85 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.036 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -170.09 83.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.568 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -119.41 167.42 11.94 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.176 -0.953 . . . . 0.0 109.644 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.582 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -164.26 -48.09 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.833 . . . . 0.0 109.132 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 2.0 Cg_endo -81.98 -167.02 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.752 1.396 . . . . 0.0 109.737 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.77 -5.1 41.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.248 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.522 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 1.9 mtm -97.04 151.42 19.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -111.09 161.08 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.141 -0.975 . . . . 0.0 109.328 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.51 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -149.7 155.46 40.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 109.792 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.648 HG22 ' H ' ' A' ' 41' ' ' GLU . 13.2 mt -156.25 175.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.821 . . . . 0.0 109.045 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.648 ' H ' HG22 ' A' ' 40' ' ' ILE . 11.2 tt0 178.76 144.42 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.009 . . . . 0.0 109.367 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . . . -129.19 -160.13 1.01 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.797 . . . . 0.0 109.642 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 17.0 pt-20 -164.01 69.23 0.19 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.452 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -159.46 -164.35 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 110.009 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.494 ' HA ' ' CG ' ' A' ' 87' ' ' GLU . 9.2 ptm180 -133.33 -166.42 1.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.506 -0.747 . . . . 0.0 109.014 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 87' ' ' GLU . 4.1 mt -163.42 156.04 18.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.036 -1.04 . . . . 0.0 110.193 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.743 ' HG3' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -146.32 139.74 25.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.81 ' N ' HD12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -148.2 158.41 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 109.933 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.517 ' HA ' ' CG ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -100.62 -151.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -4.08 23.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.387 -0.821 . . . . 0.0 109.661 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 13.4 pt-20 -71.77 -23.8 61.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.784 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.44 ' OG1' ' CG2' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -64.08 -49.11 73.55 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.983 -1.073 . . . . 0.0 109.56 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.2 t -51.52 -25.82 5.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.066 -1.021 . . . . 0.0 108.889 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 10.0 mt-10 -75.38 -39.89 58.62 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.278 -0.889 . . . . 0.0 109.429 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 15.3 mm-40 -65.52 -46.59 79.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.344 -0.848 . . . . 0.0 109.376 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -43.61 80.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.533 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.09 -54.93 41.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.9 . . . . 0.0 109.556 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.31 -2.1 58.56 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 12.9 ttt180 -119.17 10.12 11.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -1.195 . . . . 0.0 109.701 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.19 -27.4 68.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.12 -0.988 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -89.35 29.04 1.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 109.706 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -110.93 5.42 20.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.611 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.3 t -72.75 -49.44 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.593 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -49.9 -47.98 51.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -71.65 -25.1 61.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -81.37 -12.34 59.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.507 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.38 -22.16 26.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 10' ' ' GLN . 14.0 t -59.25 -33.91 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.523 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.633 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.6 86.84 3.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 109.185 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.564 ' O ' ' CB ' ' A' ' 71' ' ' ILE . 2.4 p -101.93 140.57 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.312 -0.867 . . . . 0.0 111.309 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.635 HG22 ' C ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER 167.69 -53.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.038 -1.039 . . . . 0.0 111.912 175.797 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 73' ' ' ILE . 1.7 m -165.98 171.54 12.46 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.057 -1.652 . . . . 0.0 112.761 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.625 ' H ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -163.67 165.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 174.94 51.23 0.05 OUTLIER Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.514 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.835 ' HA2' HG13 ' A' ' 5' ' ' VAL . . . -104.67 -100.32 2.62 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.738 ' O ' HD21 ' A' ' 86' ' ' LEU . 1.9 t30 -175.33 -174.0 0.69 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.4 -1.059 . . . . 0.0 108.931 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.775 HG13 ' O ' ' A' ' 77' ' ' VAL . 12.4 p 177.97 67.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 108.806 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.505 ' O ' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -98.95 141.58 31.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 0.0 110.394 -178.806 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -127.21 145.24 50.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.775 . . . . 0.0 108.932 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -107.24 -109.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.069 -1.02 . . . . 0.0 109.485 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -104.39 -77.14 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.817 -1.177 . . . . 0.0 109.242 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -109.94 -9.43 14.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.252 -0.905 . . . . 0.0 109.075 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.517 ' CG ' ' HA ' ' A' ' 49' ' ' ARG . 3.0 ttt180 -91.92 -160.62 0.75 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.374 -0.829 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 48' ' ' ILE . 2.1 t80 -169.38 148.89 3.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.072 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.743 HG23 ' HG3' ' A' ' 47' ' ' GLU . 2.5 p -133.73 179.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.053 -1.03 . . . . 0.0 109.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.738 HD21 ' O ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER 178.26 -169.34 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 46' ' ' LEU . 3.9 mt-10 . . . . . 0 C--N 1.302 -1.488 0 O-C-N 120.941 -1.099 . . . . 0.0 109.796 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.8 p . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -122.48 -176.82 3.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.059 -1.025 . . . . 0.0 109.222 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.586 ' CG2' ' N ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -156.97 165.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.891 -1.131 . . . . 0.0 110.703 -179.157 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.586 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -135.41 147.53 49.04 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.935 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.566 ' C ' HD12 ' A' ' 7' ' ' ILE . 1.4 pp -158.21 139.45 4.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.881 ' HB3' ' OG1' ' A' ' 72' ' ' THR . . . -124.72 -179.16 4.4 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.108 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 1.012 ' CD2' HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -141.79 -178.7 5.79 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.195 177.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.774 ' N ' ' HA ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 177.97 97.93 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.305 -177.628 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.644 ' OD1' HG21 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -107.7 167.92 9.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.968 . . . . 0.0 109.856 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -124.57 -64.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.881 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -101.6 -32.64 10.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 109.57 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.403 ' HB2' ' OD2' ' A' ' 11' ' ' ASP . 25.9 m-80 -87.64 10.61 17.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.129 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.903 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -58.8 -16.6 17.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.215 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.523 ' NH1' ' HG2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -61.97 -62.13 2.0 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 109.214 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.432 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 49.3 m-85 -62.95 -33.37 75.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 0.0 108.872 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.936 ' O ' HD13 ' A' ' 22' ' ' ILE . 60.1 t -59.34 -32.97 49.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 15' ' ' ALA . 61.3 t -77.45 -25.5 15.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 6.9 tp10 -65.27 -53.94 36.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -67.65 -44.31 78.19 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.206 -0.934 . . . . 0.0 108.556 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.936 HD13 ' O ' ' A' ' 18' ' ' VAL . 1.5 mp -54.04 -31.03 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.537 ' O ' ' CD ' ' A' ' 27' ' ' PRO . 17.9 mt -70.38 -42.16 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 108.844 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.3 4.92 49.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.722 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -118.67 -11.88 9.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.301 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.576 ' ND2' HG11 ' A' ' 31' ' ' VAL . 3.4 m-20 -85.57 -65.88 0.2 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 110.377 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.537 ' CD ' ' O ' ' A' ' 23' ' ' ILE . 2.5 Cg_endo -41.0 -27.95 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.66 1.348 . . . . 0.0 110.051 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 26' ' ' ASN . 2.6 t-160 -98.64 -33.45 10.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.667 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 25' ' ' ASP . . . -102.33 176.89 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -0.99 . . . . 0.0 110.265 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 40' ' ' ILE . 1.9 t -101.2 162.88 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.034 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.6 HG22 ' N ' ' A' ' 32' ' ' GLN . 2.1 p -169.66 166.88 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 109.813 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.6 ' N ' HG22 ' A' ' 31' ' ' VAL . 2.5 pt20 -172.18 65.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 109.566 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.508 ' CB ' ' HA ' ' A' ' 38' ' ' ILE . 26.0 p80 -101.12 179.14 4.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.588 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -156.67 -62.62 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.589 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -67.84 -167.78 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.684 1.36 . . . . 0.0 109.911 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.19 -15.41 33.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 108.957 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.583 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 66.9 mtp -81.84 135.32 35.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.327 -0.858 . . . . 0.0 109.619 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.63 ' CG1' ' HB3' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -113.77 82.54 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.16 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.532 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.39 167.3 21.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 111.25 -178.389 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 30' ' ' VAL . 89.5 mt -149.99 155.25 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.408 ' N ' HG22 ' A' ' 40' ' ' ILE . 3.4 tt0 -131.15 147.14 52.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 109.662 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' A' ' 43' ' ' GLU . . . -143.88 -171.61 3.58 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.372 -0.83 . . . . 0.0 108.877 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 44.8 mt-10 -159.28 99.55 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -162.2 -145.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.768 -1.208 . . . . 0.0 111.078 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -162.43 159.65 25.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -0.869 . . . . 0.0 109.502 -178.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.754 ' CD1' HD11 ' A' ' 86' ' ' LEU . 1.4 mt -126.18 -173.79 2.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.056 -1.027 . . . . 0.0 108.298 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 4.3 pt-20 -178.95 141.99 0.19 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.256 -0.902 . . . . 0.0 109.421 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.408 ' CG1' ' C ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -160.43 -161.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.15 -0.969 . . . . 0.0 109.585 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -100.21 -169.08 1.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.859 . . . . 0.0 109.152 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -88.5 -46.3 9.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.162 -0.961 . . . . 0.0 109.026 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 30.7 tt0 -49.49 -32.15 11.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.362 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 53' ' ' VAL . 1.3 m -70.88 -50.28 36.86 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.207 -0.933 . . . . 0.0 109.039 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.739 HG21 ' CD1' ' A' ' 84' ' ' PHE . 97.4 t -48.1 -27.64 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 21.7 tp10 -74.54 -44.41 51.21 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -54.23 -47.11 72.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.349 -0.844 . . . . 0.0 108.853 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.8 t-20 -60.47 -36.96 79.52 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.8 tp -57.99 -55.75 30.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 109.364 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.6 -11.29 59.69 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -114.82 7.25 15.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -1.139 . . . . 0.0 109.625 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -70.01 -29.97 67.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.26 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -90.34 38.45 0.94 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.868 . . . . 0.0 109.384 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -103.07 -86.06 0.44 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.299 -0.876 . . . . 0.0 109.571 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' A' ' 66' ' ' MET . 1.3 t -97.92 0.99 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.599 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.486 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 1.2 mp0 -51.9 -27.57 13.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 109.574 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -64.18 -43.07 96.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.173 -0.954 . . . . 0.0 109.017 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.517 ' HB3' ' CD1' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -64.62 -9.96 23.19 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 3.3 tt -53.29 -18.05 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 109.833 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.8 t -82.28 -35.43 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.009 -1.057 . . . . 0.0 109.775 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 39.9 m-20 -98.93 -118.26 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.952 . . . . 0.0 111.383 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 1.012 HG22 ' CD2' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -49.71 -3.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.179 -2.634 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -176.586 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.64 HG23 ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -132.31 142.92 41.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 121.658 2.026 . . . . 0.0 112.5 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.881 ' OG1' ' HB3' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -155.52 149.07 25.08 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 1.4 pp -139.06 -174.66 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.094 -1.003 . . . . 0.0 109.61 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 167.48 44.28 0.03 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.594 ' O ' ' ND2' ' A' ' 76' ' ' ASN . . . -94.05 -104.92 1.82 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 75' ' ' GLY . 0.4 OUTLIER -176.58 166.72 2.69 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.476 -1.014 . . . . 0.0 109.577 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.2 p -133.41 92.34 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.709 ' OD1' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -104.69 137.33 42.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 109.97 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.98 133.84 55.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.865 . . . . 0.0 109.457 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.6 -96.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 109.501 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.86 -61.14 1.58 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.253 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -126.37 -39.0 2.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.4 -173.77 0.16 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.739 ' CD1' HG21 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -141.05 166.42 24.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.228 -0.92 . . . . 0.0 109.051 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.709 HG13 ' OD1' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -154.62 162.75 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.533 -179.725 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.754 HD11 ' CD1' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -172.75 -123.76 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 109.335 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 pt-20 . . . . . 0 C--N 1.297 -1.695 0 O-C-N 121.372 -0.83 . . . . 0.0 110.991 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.788 ' C ' HD13 ' A' ' 4' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.883 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -156.59 160.61 39.59 Favored 'General case' 0 C--N 1.31 -1.152 0 O-C-N 120.918 -1.114 . . . . 0.0 111.213 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.968 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 48.8 t -114.71 171.36 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.618 ' N ' HG12 ' A' ' 5' ' ' VAL . 50.3 t80 -147.73 138.59 23.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.743 -1.223 . . . . 0.0 109.259 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' A' ' 73' ' ' ILE . 2.8 pt -160.68 159.31 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 39' ' ' ARG . . . -165.83 164.63 18.65 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.339 -1.476 . . . . 0.0 110.591 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 1.185 ' CE2' HG22 ' A' ' 71' ' ' ILE . 5.3 m-85 -149.18 163.15 38.44 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.73 ' HB3' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -125.76 81.65 2.0 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.807 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.508 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 14.9 p30 -106.41 167.13 10.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 0.0 110.37 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.32 5.86 40.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.529 -0.732 . . . . 0.0 109.505 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -79.66 103.93 9.9 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.111 -0.993 . . . . 0.0 108.972 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.8 t-20 -66.17 -8.82 26.47 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 108.715 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.89 -40.66 85.11 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.42 ' NH2' HD13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -65.36 -36.5 84.2 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -46.67 81.67 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.345 -0.847 . . . . 0.0 108.937 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.12 -57.41 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.228 -0.92 . . . . 0.0 108.594 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.59 -21.68 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.379 -0.826 . . . . 0.0 108.801 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 23' ' ' ILE . 6.8 tt0 -75.09 -37.6 61.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.517 -0.739 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.78 -28.02 63.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.056 -1.027 . . . . 0.0 109.231 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.413 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 32.1 mm -76.85 -41.13 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.231 -0.918 . . . . 0.0 109.086 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 24' ' ' GLN . 1.3 tt -60.45 -46.29 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 108.655 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.517 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -67.65 -32.15 72.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.413 ' HB2' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -49.18 -30.04 6.34 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.66 136.37 55.49 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -84.0 45.15 1.7 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.826 1.435 . . . . 0.0 110.108 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -149.6 -47.71 0.14 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.181 -0.949 . . . . 0.0 109.636 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.03 55.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.573 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.717 HG13 ' HG3' ' A' ' 41' ' ' GLU . 4.8 p -100.31 140.41 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.37 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.498 HG21 HG23 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -151.34 166.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 0.0 109.449 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -165.16 82.37 0.36 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.491 ' CE1' ' HG2' ' A' ' 20' ' ' GLU . 2.3 p-80 -117.36 142.61 46.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -0.896 . . . . 0.0 109.286 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.566 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -160.93 -58.58 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.183 -0.948 . . . . 0.0 109.54 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.9 Cg_endo -68.62 -155.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.715 1.376 . . . . 0.0 109.862 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.98 -4.03 58.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 109.425 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.505 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 2.9 ttm -89.57 168.54 12.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.656 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -138.48 115.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.642 ' C ' HD12 ' A' ' 40' ' ' ILE . 3.6 ptp180 -129.62 168.66 16.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.662 -1.274 . . . . 0.0 111.433 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.642 HD12 ' C ' ' A' ' 39' ' ' ARG . 2.7 mp -158.98 157.43 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.717 ' HG3' HG13 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -131.58 -177.4 4.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.944 -1.098 . . . . 0.0 109.71 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.968 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . . . -129.2 -149.02 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 109.113 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.663 ' H ' HD21 ' A' ' 46' ' ' LEU . 1.2 mm-40 -135.6 26.94 3.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.824 -1.173 . . . . 0.0 111.699 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.612 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER 83.07 -39.49 0.09 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.887 0.851 . . . . 0.0 111.629 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.696 ' O ' HD23 ' A' ' 46' ' ' LEU . 6.3 mtm180 -127.81 113.23 15.68 Favored 'General case' 0 C--N 1.263 -3.177 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.087 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.696 HD23 ' O ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -141.18 144.52 34.84 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.696 ' HA ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -154.54 139.65 17.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 109.598 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -142.96 143.74 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -0.815 . . . . 0.0 109.132 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 -101.25 -98.35 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.002 . . . . 0.0 110.288 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -15.27 4.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.68 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HB3' ' HB ' ' A' ' 48' ' ' ILE . 33.8 tp10 -49.43 -24.86 2.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.725 -1.234 . . . . 0.0 108.986 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.663 HG21 ' O ' ' A' ' 82' ' ' ASP . 1.6 m -66.4 -46.16 77.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.085 -1.009 . . . . 0.0 108.929 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 52' ' ' THR . 78.2 t -47.26 -30.27 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -70.43 -46.81 63.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.424 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 52' ' ' THR . 7.2 mt-10 -51.09 -63.62 1.07 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' ARG . 1.0 OUTLIER -44.05 -33.98 1.62 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.526 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.7 tp -51.06 -62.74 1.43 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.667 ' O ' ' CB ' ' A' ' 59' ' ' ARG . . . -52.79 -24.79 20.47 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.667 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 8.9 tpt180 110.59 39.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.869 1.267 . . . . 0.0 108.576 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 61.4 96.36 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 102.672 -3.085 . . . . 0.0 102.672 -176.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.594 ' CD1' HG23 ' A' ' 63' ' ' VAL . 29.3 t90 -18.41 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 123.219 1.485 . . . . 0.0 109.845 -174.121 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 60' ' ' ALA . 23.7 t70 -102.19 53.21 0.8 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.96 -177.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 63' ' ' VAL . 40.5 t -88.47 9.42 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.479 -0.763 . . . . 0.0 110.037 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 63' ' ' VAL . 61.3 mm-40 -39.88 -31.74 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 109.693 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -64.46 -53.42 48.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 108.889 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.04 -1.28 25.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.406 -0.809 . . . . 0.0 109.54 179.255 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 69' ' ' ASP . 12.0 tp -38.53 -23.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.657 -0.652 . . . . 0.0 111.367 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' MET . 2.4 m -39.0 -28.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.033 -1.042 . . . . 0.0 109.953 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 21.6 p30 -59.08 165.12 2.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.43 -0.794 . . . . 0.0 109.587 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.73 HG23 ' HB3' ' A' ' 10' ' ' GLN . 45.7 t -79.45 167.09 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.194 -0.941 . . . . 0.0 109.015 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 1.185 HG22 ' CE2' ' A' ' 9' ' ' PHE . 1.5 pp -132.53 148.76 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.086 -1.009 . . . . 0.0 110.204 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 1.041 ' O ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -151.89 140.46 20.7 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.215 -0.928 . . . . 0.0 109.406 178.835 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.041 HD13 ' O ' ' A' ' 72' ' ' THR . 5.4 mm -137.33 153.82 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.448 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -166.33 32.27 0.22 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.576 ' CA ' HG13 ' A' ' 5' ' ' VAL . . . -146.24 -95.31 0.17 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.573 ' C ' HD21 ' A' ' 86' ' ' LEU . 5.4 t30 -172.8 -151.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -1.167 . . . . 0.0 109.519 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.731 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.6 p 179.18 89.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.369 -0.832 . . . . 0.0 109.273 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.483 ' OD2' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -110.78 129.93 55.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.114 -0.991 . . . . 0.0 109.811 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.68 146.71 50.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.498 -0.751 . . . . 0.0 109.14 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.64 -101.14 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.071 -1.018 . . . . 0.0 109.422 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.2 -53.95 2.57 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.966 -1.084 . . . . 0.0 109.322 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.663 ' O ' HG21 ' A' ' 52' ' ' THR . 0.5 OUTLIER -130.86 -43.55 1.09 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.513 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 82' ' ' ASP . 10.1 mpt_? -54.53 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.661 -0.649 . . . . 0.0 109.346 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.923 ' O ' HD12 ' A' ' 48' ' ' ILE . 14.5 t80 -161.17 143.12 12.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 109.027 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.696 HG23 ' HA ' ' A' ' 47' ' ' GLU . 9.3 p -150.73 144.27 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.987 -1.071 . . . . 0.0 110.606 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.69 HD12 HD12 ' A' ' 46' ' ' LEU . 2.7 tm? -143.72 133.99 24.49 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.614 ' O ' HG21 ' A' ' 5' ' ' VAL . 5.5 mp0 . . . . . 0 C--N 1.306 -1.295 0 O-C-N 121.316 -0.865 . . . . 0.0 108.755 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.581 ' HB2' ' CB ' ' A' ' 44' ' ' LYS . 49.0 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.866 ' O ' HD12 ' A' ' 4' ' ' LEU . 1.2 pp -148.35 152.1 36.47 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.384 -0.822 . . . . 0.0 109.884 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.821 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 3.7 t -113.63 176.62 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.608 -0.683 . . . . 0.0 109.197 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.625 ' H ' HG12 ' A' ' 5' ' ' VAL . 8.9 t80 -143.18 138.46 29.74 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.001 -1.062 . . . . 0.0 108.276 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 73' ' ' ILE . 3.6 pt -156.89 156.07 4.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 108.475 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' THR . . . -163.99 141.25 6.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.78 -1.2 . . . . 0.0 109.902 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.67 ' CD2' HD11 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -139.54 -167.47 2.27 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.079 -1.013 . . . . 0.0 109.02 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.665 ' HB2' HG12 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -156.27 93.51 1.42 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.5 OUTLIER -109.6 -170.97 1.75 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -71.72 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.034 . . . . 0.0 109.235 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -145.0 7.17 1.19 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.867 -1.146 . . . . 0.0 110.088 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -102.52 -57.13 2.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.045 -1.034 . . . . 0.0 109.494 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.2 92.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.816 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.512 ' NH1' ' HG3' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -66.46 -36.72 83.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.133 -0.979 . . . . 0.0 109.301 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 11.1 t80 -62.73 -44.13 97.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 0.0 109.148 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.14 -53.11 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.238 -0.913 . . . . 0.0 109.17 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.57 -24.01 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -0.934 . . . . 0.0 109.281 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -66.64 -48.87 68.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.289 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.63 91.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.371 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.81 -46.89 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.412 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.402 HG21 ' O ' ' A' ' 30' ' ' VAL . 29.1 mt -52.83 -52.45 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 108.813 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 25' ' ' ASP . 1.4 mp0 -58.68 -31.06 67.86 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.208 -0.932 . . . . 0.0 108.631 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 24' ' ' GLN . 1.1 t70 -46.15 -42.0 13.28 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.589 -1.264 . . . . 0.0 107.589 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -96.63 131.49 28.09 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.92 47.57 2.31 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.703 1.37 . . . . 0.0 110.085 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 29' ' ' ALA . 30.0 t-80 -154.52 -50.83 0.09 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.25 -0.906 . . . . 0.0 109.977 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -41.36 140.42 0.87 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.796 . . . . 0.0 109.991 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.708 HG22 ' H ' ' A' ' 31' ' ' VAL . 1.6 p -78.66 -169.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.317 -0.864 . . . . 0.0 108.715 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.708 ' H ' HG22 ' A' ' 30' ' ' VAL . 15.6 m -122.88 -155.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.996 -1.065 . . . . 0.0 109.477 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.559 ' HB3' ' CA ' ' A' ' 38' ' ' ILE . 2.3 mp0 -112.75 -151.74 0.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.073 -1.017 . . . . 0.0 109.604 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.34 -96.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.873 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.565 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -163.89 -69.55 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.009 -1.057 . . . . 0.0 109.569 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 34' ' ' HIS . 5.7 Cg_exo -49.27 -178.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.904 1.476 . . . . 0.0 110.47 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.451 ' HB1' ' CD ' ' A' ' 10' ' ' GLN . . . -43.09 -36.07 1.52 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.384 -0.823 . . . . 0.0 109.896 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.494 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 66.2 mtm -63.91 144.18 57.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.002 -1.061 . . . . 0.0 109.13 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.67 HD11 ' CD2' ' A' ' 9' ' ' PHE . 6.3 pt -146.28 109.3 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.554 ' N ' ' HB3' ' A' ' 32' ' ' GLN . 1.6 mtt-85 -90.74 174.45 7.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 0.0 109.523 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 41' ' ' GLU . 11.4 mt -161.98 166.96 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.449 -0.782 . . . . 0.0 109.391 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.615 ' HB2' HG11 ' A' ' 30' ' ' VAL . 5.7 tp10 -142.79 170.4 15.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 0.0 109.005 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.821 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . . . -140.84 -168.81 2.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.724 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.741 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 1.6 pm0 -143.37 85.16 1.84 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.511 -0.743 . . . . 0.0 109.758 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.581 ' CB ' ' HB2' ' A' ' 3' ' ' SER . 0.0 OUTLIER 83.4 -179.68 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -178.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.674 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 3.8 mmt180 179.5 -165.58 0.06 Allowed 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.435 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 4.8 mt 164.48 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.836 ' H ' HG23 ' A' ' 85' ' ' VAL . 2.0 mt-10 162.59 -167.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.828 -1.17 . . . . 0.0 109.394 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.825 HG23 ' N ' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -177.31 -151.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.972 . . . . 0.0 109.634 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.825 ' N ' HG23 ' A' ' 48' ' ' ILE . 11.0 ttp180 -91.73 -37.05 13.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.949 -1.095 . . . . 0.0 110.131 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.621 ' H ' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -59.7 -32.46 70.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.918 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 20.8 mm-40 -58.05 -27.64 63.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.134 -0.979 . . . . 0.0 109.665 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m -64.84 -41.39 95.76 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.003 -1.06 . . . . 0.0 109.434 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.6 t -53.52 -29.66 17.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -70.69 -40.5 72.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 17.8 mt-10 -57.49 -62.91 1.45 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.47 ' HA ' ' H ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -44.0 -36.75 2.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.98 . . . . 0.0 109.057 179.306 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 9.9 tp -57.65 -50.02 74.53 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -78.59 15.79 9.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 176.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.565 ' HB3' ' O ' ' A' ' 58' ' ' GLY . 2.8 ttt180 68.34 49.64 0.79 Allowed 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 121.415 0.626 . . . . 0.0 110.056 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 57.31 93.21 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TRP . . . . . 0.598 ' C ' ' O ' ' A' ' 60' ' ' ALA . 57.4 t90 -16.3 81.09 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.434 1.588 . . . . 0.0 109.319 -174.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 60' ' ' ALA . 20.8 t70 -102.44 66.82 0.99 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.138 -1.846 . . . . 0.0 110.012 -176.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 63' ' ' VAL . 19.5 t -89.56 6.63 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 109.558 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.946 ' O ' HD22 ' A' ' 67' ' ' LEU . 5.4 mp0 -42.58 -31.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 109.454 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.48 -49.66 65.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.119 -0.988 . . . . 0.0 109.236 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.5 ' O ' ' N ' ' A' ' 68' ' ' VAL . 1.4 mtt -72.95 -5.35 37.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.919 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.946 HD22 ' O ' ' A' ' 64' ' ' GLN . 1.5 pt? -39.21 -26.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.467 -0.771 . . . . 0.0 110.788 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 69' ' ' ASP . 5.8 p -40.52 -49.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.589 ' N ' HG13 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -72.64 146.17 46.78 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 10' ' ' GLN . 6.9 p -76.15 173.79 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.841 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ILE . . . . . 0.64 ' H ' HG22 ' A' ' 70' ' ' VAL . 9.1 mt -153.17 157.0 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.228 -0.92 . . . . 0.0 109.835 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -149.56 152.07 34.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.491 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.697 HD13 ' C ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -137.47 159.31 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -159.81 66.73 0.27 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.441 -1.362 . . . . 0.0 110.794 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.94 -105.89 1.31 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.609 ' C ' HD21 ' A' ' 86' ' ' LEU . 2.9 t-20 -165.12 -144.57 0.07 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -1.188 . . . . 0.0 108.435 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.4 p -170.28 98.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.881 -1.137 . . . . 0.0 110.587 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -114.38 127.46 55.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.439 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -128.05 149.99 50.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 109.61 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -109.82 -103.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 109.364 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -104.23 -54.14 2.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.951 -1.093 . . . . 0.0 108.909 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ARG . 79.8 m-20 -130.67 -39.75 1.25 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -51.65 -175.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.602 0.715 . . . . 0.0 109.728 179.457 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -160.23 111.07 1.88 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.836 HG23 ' H ' ' A' ' 47' ' ' GLU . 4.0 p -124.37 143.6 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.061 -1.024 . . . . 0.0 109.251 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.803 ' C ' HD13 ' A' ' 86' ' ' LEU . 2.2 tm? -151.22 129.45 11.95 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.885 -1.526 . . . . 0.0 110.571 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.665 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.31 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.487 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -162.22 -54.21 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.315 -0.866 . . . . 0.0 109.271 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.577 ' HA ' ' CE3' ' A' ' 88' ' ' TRP . 20.0 m -44.35 110.15 0.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.554 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.69 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -130.05 155.65 45.8 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.218 -0.926 . . . . 0.0 110.336 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.13 HG11 HD21 ' A' ' 46' ' ' LEU . 1.1 m -116.66 -150.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.566 -0.709 . . . . 0.0 109.361 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.959 ' OH ' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER 172.78 139.82 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.106 -0.996 . . . . 0.0 109.625 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.817 HG22 ' HA ' ' A' ' 73' ' ' ILE . 46.4 pt -136.61 139.41 45.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.612 ' HB2' ' HD2' ' A' ' 39' ' ' ARG . . . -134.2 164.78 26.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.551 -1.343 . . . . 0.0 110.65 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 1.065 ' CZ ' HD13 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -158.78 151.55 22.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.526 ' HG2' ' CB ' ' A' ' 37' ' ' MET . 0.8 OUTLIER -131.81 92.97 3.22 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.05 -1.031 . . . . 0.0 108.51 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -87.04 -132.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.405 -0.809 . . . . 0.0 109.762 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.451 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 5.0 t-20 -86.42 -111.88 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.837 -1.164 . . . . 0.0 109.385 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -132.63 -24.52 1.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.927 -1.108 . . . . 0.0 109.775 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.416 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.6 t-20 -102.96 -54.35 2.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.025 -1.047 . . . . 0.0 109.817 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ASN . . . -44.27 -31.17 0.94 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.809 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 13' ' ' ASP . 55.9 mtm180 -64.79 -63.58 1.08 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.613 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 1.1 m-85 -47.5 -36.57 10.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -0.958 . . . . 0.0 109.455 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 14' ' ' ASN . 41.2 t -54.67 -58.64 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.93 . . . . 0.0 109.031 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.3 t -56.73 -22.78 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.207 -0.933 . . . . 0.0 108.865 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 23' ' ' ILE . 13.3 tt0 -69.46 -38.36 77.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.437 -0.789 . . . . 0.0 109.217 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.36 68.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.246 -0.909 . . . . 0.0 108.891 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.43 ' HA ' HD13 ' A' ' 22' ' ' ILE . 24.3 mm -70.31 -55.58 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 20' ' ' GLU . 1.0 OUTLIER -58.98 -35.54 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.055 -1.028 . . . . 0.0 109.668 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -69.63 -35.97 75.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.108 -0.995 . . . . 0.0 108.693 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 24' ' ' GLN . 0.3 OUTLIER -46.18 -42.8 14.56 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -79.8 136.54 54.81 Favored Pre-proline 0 N--CA 1.486 1.356 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -84.28 46.23 1.91 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.795 1.418 . . . . 0.0 109.979 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -149.04 -39.57 0.15 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.18 -0.95 . . . . 0.0 109.629 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 23' ' ' ILE . . . -44.81 140.18 2.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 109.746 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.663 HG12 ' H ' ' A' ' 31' ' ' VAL . 2.6 t -101.22 177.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.663 ' H ' HG12 ' A' ' 30' ' ' VAL . 2.0 t -141.45 154.58 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.23 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -140.29 -71.73 0.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.636 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -95.27 176.66 6.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.969 . . . . 0.0 109.595 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.565 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -152.13 -64.55 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.285 -0.885 . . . . 0.0 109.538 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 4.2 Cg_exo -61.17 -75.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.636 1.335 . . . . 0.0 110.417 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 35' ' ' PRO . . . -46.52 -93.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.526 ' CB ' ' HG2' ' A' ' 10' ' ' GLN . 2.0 ptm -115.46 -167.23 1.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.687 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 0.9 OUTLIER -128.43 101.96 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.356 -0.84 . . . . 0.0 109.114 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.612 ' HD2' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -87.31 169.26 12.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.746 -179.265 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.563 HG22 ' N ' ' A' ' 41' ' ' GLU . 45.3 mt -142.69 164.92 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.725 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -143.85 147.27 33.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.209 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.019 ' CB ' HG22 ' A' ' 5' ' ' VAL . . . -127.51 -171.81 2.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.69 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 8.3 mt-10 -140.11 64.91 1.43 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.878 -1.139 . . . . 0.0 110.372 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 8.5 tttt 175.25 -140.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.952 -1.093 . . . . 0.0 110.263 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.982 ' C ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -126.51 166.69 16.79 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.301 -0.874 . . . . 0.0 110.182 -178.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.13 HD21 HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -129.03 157.72 40.93 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HG2' HG23 ' A' ' 85' ' ' VAL . 8.2 mt-10 -150.96 140.01 21.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.077 -1.014 . . . . 0.0 109.99 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.658 HG22 ' OG1' ' A' ' 52' ' ' THR . 1.3 mp -138.94 150.44 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 0.0 109.159 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -97.3 176.42 5.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.122 -0.986 . . . . 0.0 109.969 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -67.08 -24.39 65.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 109.332 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 34.9 mm-40 -49.53 -40.89 39.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.028 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.658 ' OG1' HG22 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -65.56 -46.44 79.46 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.162 -0.961 . . . . 0.0 108.755 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.6 t -56.08 -22.98 14.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -75.58 -38.21 59.29 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -66.69 -53.02 38.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 108.956 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -56.12 -33.39 65.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.288 -0.883 . . . . 0.0 109.139 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.18 -55.83 29.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.246 -0.909 . . . . 0.0 109.095 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.32 -7.49 63.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.44 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -117.01 10.22 13.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -1.108 . . . . 0.0 109.402 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -69.3 -6.89 32.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.707 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -91.42 19.75 5.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.021 . . . . 0.0 109.336 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.435 ' OD1' ' HB3' ' A' ' 65' ' ' GLU . 26.8 t70 -111.84 10.2 20.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.541 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 63' ' ' VAL . 3.1 t -49.54 -46.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 109.871 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -51.61 -45.87 63.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 109.406 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HB3' ' OD1' ' A' ' 62' ' ' ASP . 2.7 tt0 -68.29 -27.86 66.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.195 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 69' ' ' ASP . 1.1 mtm -74.78 -17.88 60.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.301 -0.874 . . . . 0.0 109.224 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -69.83 -57.49 5.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.557 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.9 t -46.96 -64.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.524 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 2.0 p30 -82.87 154.79 24.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 71' ' ' ILE . 21.1 t -99.53 165.75 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.168 -0.958 . . . . 0.0 109.568 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.065 HD13 ' CZ ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -146.11 151.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 0.0 109.648 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.959 HG21 ' OH ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -165.4 151.86 10.01 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.264 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.817 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -154.61 152.0 10.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.898 -1.126 . . . . 0.0 111.185 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.661 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 46.84 -85.12 0.01 OUTLIER Glycine 0 C--N 1.299 -1.492 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.926 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 73' ' ' ILE . . . 171.37 -47.81 0.19 Allowed Glycine 0 C--N 1.284 -2.329 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.538 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 16.2 t30 -120.34 -141.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.973 -1.31 . . . . 0.0 108.959 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.85 HG23 ' CE1' ' A' ' 84' ' ' PHE . 3.0 p 178.94 98.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.988 -1.07 . . . . 0.0 110.151 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.42 129.9 46.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 108.865 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -125.6 139.98 53.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.58 -96.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -104.04 -60.97 1.5 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.042 -1.036 . . . . 0.0 109.373 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -127.88 -30.8 2.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.341 -0.849 . . . . 0.0 109.01 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.496 ' CG ' ' N ' ' A' ' 84' ' ' PHE . 34.4 ttp180 -68.59 168.21 13.48 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.359 -0.838 . . . . 0.0 109.146 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.85 ' CE1' HG23 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -141.84 127.11 18.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 108.907 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.531 HG23 ' HG2' ' A' ' 47' ' ' GLU . 3.7 p -138.64 150.72 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.22 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.811 HD22 ' N ' ' A' ' 87' ' ' GLU . 1.7 tm? -157.19 135.75 11.42 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.811 ' N ' HD22 ' A' ' 86' ' ' LEU . 2.0 mp0 -121.47 -151.84 0.49 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 2.4 t90 -50.77 -78.37 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 76' ' ' ASN . 11.8 mmtt 58.93 112.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.403 ' OD1' ' C ' ' A' ' 90' ' ' ASN . 8.8 t-20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.474 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 3' ' ' SER . 54.0 m -137.08 -80.01 0.38 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.353 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.672 ' C ' HD13 ' A' ' 4' ' ' LEU . 0.8 OUTLIER 72.05 93.19 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.7 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.916 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.17 154.92 42.32 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.032 -1.043 . . . . 0.0 110.47 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.023 HG22 ' HB3' ' A' ' 42' ' ' ALA . 3.4 m -115.1 -171.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.458 0.647 . . . . 0.0 109.313 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.567 ' O ' ' N ' ' A' ' 74' ' ' GLY . 4.9 t80 -159.08 137.98 11.11 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.553 HG22 ' HA ' ' A' ' 73' ' ' ILE . 3.2 pt -158.11 142.14 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.694 ' HB3' ' OG1' ' A' ' 72' ' ' THR . . . -146.89 150.41 35.18 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.776 -1.203 . . . . 0.0 110.109 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 1.102 ' CZ ' HG23 ' A' ' 71' ' ' ILE . 8.8 m-85 -134.57 172.27 13.16 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.632 ' HB3' HG23 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -147.33 80.99 1.52 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.258 178.886 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.546 ' CA ' ' HB3' ' A' ' 69' ' ' ASP . 5.5 t0 -106.75 -178.91 3.79 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.1 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.157 -0.964 . . . . 0.0 109.049 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.56 14.12 0.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.034 -1.041 . . . . 0.0 109.938 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -102.46 -56.5 2.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.317 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.41 -54.51 39.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.756 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -51.12 -39.2 55.68 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 109.611 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' N ' ' HG3' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -59.44 -47.5 85.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.229 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.479 HG12 HD11 ' A' ' 22' ' ' ILE . 73.1 t -53.81 -53.84 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.287 -0.883 . . . . 0.0 109.241 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.972 ' HA ' HD12 ' A' ' 22' ' ' ILE . 53.3 t -62.37 -21.82 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.216 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -43.84 73.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.777 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.11 67.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.0 109.324 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.972 HD12 ' HA ' ' A' ' 19' ' ' VAL . 14.8 mt -67.14 -42.26 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.276 -0.89 . . . . 0.0 109.172 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.789 HG23 ' CB ' ' A' ' 29' ' ' ALA . 41.2 mt -60.87 -54.63 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.33 -0.856 . . . . 0.0 109.298 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 25' ' ' ASP . 18.6 mt-30 -57.79 -31.33 66.45 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.157 -0.964 . . . . 0.0 108.56 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 24' ' ' GLN . 9.0 t70 -46.12 -47.51 17.38 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -84.58 135.27 40.97 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -83.65 45.19 1.75 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.761 1.4 . . . . 0.0 110.155 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.6 t60 -151.7 -49.06 0.11 Allowed 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.165 -0.959 . . . . 0.0 109.759 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.789 ' CB ' HG23 ' A' ' 23' ' ' ILE . . . -41.85 141.43 0.83 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.4 -0.813 . . . . 0.0 109.704 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -100.85 -169.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.185 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG22 ' N ' ' A' ' 32' ' ' GLN . 2.0 p -169.01 166.46 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 0.0 109.536 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.592 ' N ' HG22 ' A' ' 31' ' ' VAL . 2.8 mm-40 -144.84 77.24 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -48.49 103.36 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 109.547 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.47 ' CG ' ' HD2' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -104.84 -178.56 0.63 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 34' ' ' HIS . 3.8 Cg_exo -67.6 -74.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.939 1.494 . . . . 0.0 110.116 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.39 3.39 11.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.758 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.3 mtt -112.28 157.54 20.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.128 -0.982 . . . . 0.0 109.388 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.515 ' CG1' ' O ' ' A' ' 9' ' ' PHE . 12.1 pt -134.51 92.02 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.651 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.645 ' C ' HD12 ' A' ' 40' ' ' ILE . 2.1 ttp180 -85.55 162.23 18.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 110.086 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.645 HD12 ' C ' ' A' ' 39' ' ' ARG . 4.1 mp -150.97 162.01 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 0.0 109.499 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.516 ' N ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -161.96 157.1 23.22 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.027 -1.046 . . . . 0.0 110.251 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.023 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -129.34 177.75 6.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.388 -0.82 . . . . 0.0 109.068 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 2.8 pt-20 -158.74 68.74 0.46 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.915 -1.116 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.4 OUTLIER 169.82 -152.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.816 -1.178 . . . . 0.0 110.82 178.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 1.045 ' C ' HD23 ' A' ' 46' ' ' LEU . 20.1 mtp180 -125.43 135.14 52.05 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.045 HD23 ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -127.32 162.53 26.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.45 -0.781 . . . . 0.0 109.168 -178.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.948 ' CB ' HG23 ' A' ' 85' ' ' VAL . 1.2 pt-20 -176.19 158.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.984 -1.073 . . . . 0.0 110.668 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.526 ' CG2' ' CB ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -152.27 155.84 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.627 ' HA ' ' CB ' ' A' ' 83' ' ' ARG . 30.0 ttp180 -100.12 -112.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 110.112 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -61.63 -5.29 1.78 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.982 -1.074 . . . . 0.0 110.519 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.526 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 1.0 OUTLIER -54.61 -14.7 1.41 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.708 -1.245 . . . . 0.0 109.363 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 1.9 m -58.26 -39.33 78.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.69 -1.256 . . . . 0.0 109.47 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.91 -32.45 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 1.3 tt0 -67.63 -40.56 84.63 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 60' ' ' ALA . 1.1 tt0 -49.85 -63.29 1.16 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.536 ' HA ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -48.55 -31.44 6.53 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.634 -0.666 . . . . 0.0 109.387 179.006 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.516 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.5 tp -52.27 -59.03 4.88 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.68 ' O ' ' CB ' ' A' ' 59' ' ' ARG . . . -53.63 -24.52 25.19 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 106.861 -2.496 . . . . 0.0 106.861 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.68 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 1.6 ttm-85 110.68 35.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.786 1.234 . . . . 0.0 108.557 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 62.92 96.42 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.772 ' CZ2' HG21 ' A' ' 63' ' ' VAL . 24.6 t-105 -20.11 82.74 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 123.26 1.505 . . . . 0.0 109.35 -174.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 60' ' ' ALA . 19.0 t70 -109.2 71.1 0.76 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.415 -1.721 . . . . 0.0 109.738 -176.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.772 HG21 ' CZ2' ' A' ' 61' ' ' TRP . 2.1 t -86.91 6.51 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.865 . . . . 0.0 109.799 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.887 ' O ' HD23 ' A' ' 67' ' ' LEU . 2.8 mp0 -41.63 -34.01 0.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.614 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.54 -50.93 67.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.003 -1.061 . . . . 0.0 108.979 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.575 ' HB2' HG12 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -75.68 -2.64 30.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.46 -0.775 . . . . 0.0 110.02 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 64' ' ' GLN . 3.7 pp -38.5 -26.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.503 -0.748 . . . . 0.0 110.961 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.608 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.4 m -39.89 -45.42 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.151 -0.968 . . . . 0.0 110.156 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.546 ' HB3' ' CA ' ' A' ' 11' ' ' ASP . 15.8 p30 -65.29 149.45 49.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.67 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.632 HG23 ' HB3' ' A' ' 10' ' ' GLN . 21.8 t -62.53 169.77 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.102 HG23 ' CZ ' ' A' ' 9' ' ' PHE . 11.4 mt -143.56 157.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.056 -1.028 . . . . 0.0 110.643 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.694 ' OG1' ' HB3' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -159.31 142.38 14.34 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.553 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -143.78 163.33 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.084 -1.01 . . . . 0.0 110.194 -179.087 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -174.25 71.95 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 89' ' ' LYS . . . 136.02 108.13 0.91 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 1.008 ' HA ' HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -157.78 139.42 13.86 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.183 -1.187 . . . . 0.0 110.908 -178.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 85' ' ' VAL . 1.8 t -152.37 30.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.634 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 5.2 p-10 -47.84 -38.95 17.12 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.898 0.856 . . . . 0.0 111.233 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.407 ' N ' ' CG ' ' A' ' 78' ' ' ASP . 1.5 mm-40 -110.79 103.06 11.54 Favored 'General case' 0 C--N 1.266 -3.023 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.93 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.557 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 58.1 t0 -115.2 -68.46 0.92 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.035 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 24.0 m-20 -108.21 -96.6 0.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -0.93 . . . . 0.0 109.365 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -131.03 0.22 4.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.036 -1.04 . . . . 0.0 109.221 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.627 ' CB ' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -102.6 -107.09 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.796 . . . . 0.0 109.42 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 78' ' ' ASP . 12.9 t80 -174.74 118.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.831 -1.168 . . . . 0.0 108.718 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.948 HG23 ' CB ' ' A' ' 47' ' ' GLU . 10.7 p -131.83 174.92 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.867 -1.146 . . . . 0.0 110.588 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.008 HD23 ' HA ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER -177.84 130.56 0.15 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.992 ' N ' HD22 ' A' ' 86' ' ' LEU . 2.2 mt-10 -128.23 -151.56 0.48 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.902 -1.124 . . . . 0.0 111.624 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.851 ' C ' HG12 ' A' ' 5' ' ' VAL . 1.4 p-90 -54.52 -157.55 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.858 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 88' ' ' TRP . 0.1 OUTLIER -59.26 -155.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.088 -1.008 . . . . 0.0 109.086 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.467 179.847 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.193 0.521 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.04 64.18 1.31 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.125 -0.984 . . . . 0.0 109.329 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 44' ' ' LYS . 15.8 m -130.55 33.88 4.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.867 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -122.44 168.41 12.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.049 -1.032 . . . . 0.0 109.707 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.772 HG22 ' HB3' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -132.85 -178.35 2.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.346 -0.846 . . . . 0.0 109.954 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 74' ' ' GLY . 1.3 t80 -149.53 142.37 24.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 6' ' ' TYR . 1.8 pp -160.84 158.51 2.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.555 ' N ' ' HB ' ' A' ' 72' ' ' THR . . . -159.35 145.69 16.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.658 -1.276 . . . . 0.0 109.691 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 1.005 ' CE2' HD11 ' A' ' 38' ' ' ILE . 2.6 p90 -145.26 -171.2 3.61 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 109.539 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.684 ' HB3' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -148.97 98.98 2.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -0.76 . . . . 0.0 109.108 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.445 ' OD1' ' OD2' ' A' ' 69' ' ' ASP . 35.4 t70 -108.57 136.76 47.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.629 -0.67 . . . . 0.0 109.525 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -71.67 -31.49 66.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 109.561 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' CB ' ' OD2' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -57.52 106.02 0.3 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.087 -1.008 . . . . 0.0 108.575 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.61 -11.43 7.21 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.82 -31.53 49.58 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.034 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.459 HH11 ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -67.29 -45.45 76.52 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.486 -0.759 . . . . 0.0 109.067 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.4 -44.53 72.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.206 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -54.95 -60.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.237 -0.915 . . . . 0.0 108.828 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.683 ' HA ' HD12 ' A' ' 22' ' ' ILE . 85.1 t -52.95 -23.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 108.864 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -54.39 19.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.191 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.89 -35.45 61.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.271 -0.893 . . . . 0.0 109.304 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 19' ' ' VAL . 57.8 mt -64.52 -45.34 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 109.191 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.512 HG23 ' CB ' ' A' ' 29' ' ' ALA . 95.9 mt -51.43 -48.06 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.879 . . . . 0.0 109.14 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.2 72.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.21 -0.931 . . . . 0.0 108.573 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.12 -32.69 16.56 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -80.07 137.59 53.26 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -84.47 44.9 1.59 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.818 1.431 . . . . 0.0 109.822 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -151.06 -53.97 0.14 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.305 -0.872 . . . . 0.0 109.201 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.512 ' CB ' HG23 ' A' ' 23' ' ' ILE . . . -63.49 139.59 58.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.356 -0.84 . . . . 0.0 109.075 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.546 ' CG1' ' HG3' ' A' ' 41' ' ' GLU . 11.7 p -101.21 158.95 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.193 -0.942 . . . . 0.0 109.609 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.444 ' N ' HG22 ' A' ' 30' ' ' VAL . 1.9 t -138.78 148.7 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.408 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -144.29 43.73 1.42 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.225 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 32' ' ' GLN . 12.5 p80 -44.32 140.31 2.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.892 . . . . 0.0 109.35 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.492 ' CG ' ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -103.73 178.26 1.22 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.504 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.492 ' HD2' ' CG ' ' A' ' 34' ' ' HIS . 2.7 Cg_endo -76.53 -28.01 7.13 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.066 1.561 . . . . 0.0 110.331 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.89 -30.62 3.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.592 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.518 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -117.16 -168.99 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.569 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.005 HD11 ' CE2' ' A' ' 9' ' ' PHE . 11.3 pt -140.03 115.65 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.346 -0.847 . . . . 0.0 108.831 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.773 ' O ' HD13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -111.89 142.76 43.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.447 -178.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.773 HD13 ' O ' ' A' ' 39' ' ' ARG . 28.0 mm -145.91 152.42 14.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.583 -0.698 . . . . 0.0 109.213 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.546 ' HG3' ' CG1' ' A' ' 30' ' ' VAL . 2.9 pt-20 -129.29 176.59 7.82 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.113 -0.992 . . . . 0.0 108.893 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.772 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -132.66 -179.43 5.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.079 -1.013 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 17.9 mt-10 -140.48 58.87 1.56 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.373 -0.83 . . . . 0.0 109.261 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.499 ' CB ' ' HB2' ' A' ' 88' ' ' TRP . 1.6 mmtp -153.0 -166.28 2.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.908 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.56 ' HA ' ' CG ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -141.26 -171.2 3.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.798 HD12 ' O ' ' A' ' 87' ' ' GLU . 15.2 mt -159.03 157.33 30.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 110.741 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.88 ' HA ' HG23 ' A' ' 85' ' ' VAL . 1.4 tt0 -160.94 139.75 10.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.179 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.793 HG22 ' CG ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -154.69 141.63 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.128 -0.983 . . . . 0.0 109.912 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.601 ' HA ' ' CG ' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -101.58 -101.38 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.811 179.465 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -6.38 27.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.018 -1.052 . . . . 0.0 109.294 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.793 ' CG ' HG22 ' A' ' 48' ' ' ILE . 3.2 mt-10 -56.41 -16.12 5.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.422 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -59.14 -42.48 90.76 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.87 -1.144 . . . . 0.0 109.259 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 52' ' ' THR . 59.0 t -48.38 -33.48 4.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.979 -1.076 . . . . 0.0 108.158 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -68.39 -44.93 74.03 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.873 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -45.08 46.42 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 59' ' ' ARG . 10.0 t-20 -53.86 -44.13 70.12 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.674 ' C ' HD13 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -51.44 -72.52 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.363 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 57' ' ' LEU . . . -39.32 -28.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.506 ' CB ' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -53.07 -58.97 5.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -1.201 . . . . 0.0 109.008 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 59' ' ' ARG . . . -42.85 -32.92 0.68 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -90.86 50.21 1.77 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.56 78.7 2.57 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.942 0.877 . . . . 0.0 109.396 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.505 HG12 ' HB2' ' A' ' 66' ' ' MET . 8.2 t -72.58 7.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.918 -0.489 . . . . 0.0 110.622 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 63' ' ' VAL . 2.7 mp0 -39.52 -27.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.141 -0.974 . . . . 0.0 109.91 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.657 ' O ' HG23 ' A' ' 68' ' ' VAL . 11.7 mt-10 -57.48 -56.23 24.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.008 . . . . 0.0 108.902 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.505 ' HB2' HG12 ' A' ' 63' ' ' VAL . 1.6 mmm -67.39 -8.34 32.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 0.0 109.403 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.87 HD21 HG21 ' A' ' 71' ' ' ILE . 5.9 tp -76.6 7.85 4.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.443 -0.786 . . . . 0.0 110.433 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 65' ' ' GLU . 58.2 t -40.41 -25.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.995 -1.066 . . . . 0.0 110.489 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' LEU . 7.2 m-20 -58.18 143.55 43.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.007 -1.058 . . . . 0.0 109.019 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.694 ' C ' HD13 ' A' ' 71' ' ' ILE . 57.3 t -43.82 159.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.144 -0.972 . . . . 0.0 109.126 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.87 HG21 HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -141.54 141.56 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.579 -0.7 . . . . 0.0 109.787 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.555 ' HB ' ' N ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -154.73 147.63 24.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.564 179.178 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.511 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -133.17 174.8 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.344 -0.847 . . . . 0.0 109.443 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 174.94 64.44 0.05 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.18 -95.3 0.49 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -176.26 153.58 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 0.0 109.473 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.54 102.8 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.127 -0.983 . . . . 0.0 109.869 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.619 ' OD1' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -107.7 112.95 25.9 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.006 178.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.58 131.46 54.83 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.473 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -104.04 -107.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -108.41 -56.34 2.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.93 -1.106 . . . . 0.0 109.495 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -127.28 -33.7 2.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.35 -0.844 . . . . 0.0 108.96 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.601 ' CG ' ' HA ' ' A' ' 49' ' ' ARG . 1.7 mpt_? -66.48 -178.06 0.64 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.548 -0.72 . . . . 0.0 109.397 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.478 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.3 t80 -161.5 130.16 4.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 109.661 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.88 HG23 ' HA ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -132.64 157.31 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.989 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.641 ' CD1' ' CB ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -165.49 -150.41 0.13 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.315 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.798 ' O ' HD12 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -121.42 -171.06 2.14 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.092 -1.005 . . . . 0.0 109.373 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.77 ' O ' HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -78.39 118.66 20.78 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.239 -0.913 . . . . 0.0 109.466 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 -53.26 0.87 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.845 . . . . 0.0 109.448 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.558 -179.935 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 t -74.81 136.48 41.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.246 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -133.12 90.31 2.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.843 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 4' ' ' LEU . 0.7 OUTLIER -122.33 161.56 23.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.222 -0.924 . . . . 0.0 109.212 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.019 HG22 ' HB3' ' A' ' 42' ' ' ALA . 3.1 m -125.52 -171.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.271 -0.893 . . . . 0.0 110.272 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.586 ' O ' ' N ' ' A' ' 74' ' ' GLY . 10.5 t80 -163.43 137.75 6.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.536 -0.727 . . . . 0.0 109.134 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.583 HG22 ' HA ' ' A' ' 73' ' ' ILE . 7.7 pt -148.76 139.67 17.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.965 ' HA ' ' CB ' ' A' ' 39' ' ' ARG . . . -144.36 137.52 27.18 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 117.752 -1.579 . . . . 0.0 111.98 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD2' ' HG2' ' A' ' 39' ' ' ARG . 2.0 p90 -128.8 178.15 6.56 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.084 -1.046 . . . . 0.0 109.106 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.844 ' N ' HG12 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -127.03 94.04 3.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 5.1 p-10 -108.12 143.16 37.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 110.214 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.48 -5.06 51.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.446 -0.784 . . . . 0.0 109.157 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' O ' ' OD2' ' A' ' 11' ' ' ASP . 32.9 t0 -80.78 103.46 10.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.24 -0.913 . . . . 0.0 108.819 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -65.29 -9.16 21.91 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.32 -0.862 . . . . 0.0 108.895 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.06 -39.27 71.78 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.24 -0.913 . . . . 0.0 108.931 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.43 -44.95 80.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.429 -0.794 . . . . 0.0 109.009 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CE2' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -55.11 -45.55 75.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.0 108.999 179.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.18 -61.07 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -0.878 . . . . 0.0 108.81 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -53.05 -23.26 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.274 -0.892 . . . . 0.0 108.613 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -54.95 17.83 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.6 -37.41 17.99 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 25' ' ' ASP . 36.8 mt -61.26 -45.09 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.718 HG23 ' HB1' ' A' ' 29' ' ' ALA . 22.4 mm -50.45 -57.04 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 109.024 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.477 ' HB2' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -59.5 -28.52 67.12 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.195 -0.94 . . . . 0.0 108.489 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -50.4 -39.44 47.06 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -79.69 141.77 56.34 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -84.48 44.84 1.58 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.777 1.409 . . . . 0.0 109.904 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -150.65 -48.28 0.12 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.718 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -71.1 139.26 50.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.385 -0.822 . . . . 0.0 109.657 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 t -101.98 152.04 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 109.502 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -129.07 169.14 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.21 -0.932 . . . . 0.0 109.367 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -147.73 111.46 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.406 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -82.14 127.77 33.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -123.93 148.2 56.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.29 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.661 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 2.2 Cg_endo -87.23 43.77 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.895 1.471 . . . . 0.0 110.206 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 35' ' ' PRO . . . 166.43 -29.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.957 ' C ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -104.8 171.6 7.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.579 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.957 HD13 ' C ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -156.04 124.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.448 -0.783 . . . . 0.0 109.199 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.965 ' CB ' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER 171.59 -151.88 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.993 -1.067 . . . . 0.0 110.949 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.775 HG22 ' H ' ' A' ' 41' ' ' GLU . 2.5 mt -160.79 -170.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.587 -1.321 . . . . 0.0 110.306 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.775 ' H ' HG22 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -134.83 -173.35 3.28 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.491 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 1.019 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -138.74 -171.34 3.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.973 -1.08 . . . . 0.0 110.007 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 18.6 mt-10 -141.36 33.01 1.68 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.404 -0.81 . . . . 0.0 109.741 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 88' ' ' TRP . 1.3 tttp -168.34 -144.65 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.891 -1.131 . . . . 0.0 110.332 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.585 ' O ' ' CA ' ' A' ' 88' ' ' TRP . 0.1 OUTLIER -145.3 -154.09 0.52 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.23 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.716 HD13 HD21 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -155.5 148.32 24.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.059 -1.026 . . . . 0.0 110.061 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.492 ' HA ' HG23 ' A' ' 85' ' ' VAL . 4.3 tm-20 -137.81 139.56 40.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.064 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.536 ' CD1' HG21 ' A' ' 52' ' ' THR . 0.1 OUTLIER -159.4 154.79 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.11 -0.994 . . . . 0.0 109.967 -179.534 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.459 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -82.82 -166.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.382 -0.823 . . . . 0.0 110.092 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.52 ' HG3' ' NH1' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -73.38 -27.01 61.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.928 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -49.19 -30.42 6.87 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.027 -1.046 . . . . 0.0 108.921 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.598 ' HB ' ' CD2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -65.74 -45.28 83.22 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.894 -1.129 . . . . 0.0 108.478 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.941 HG22 ' CD1' ' A' ' 84' ' ' PHE . 40.6 t -47.88 -29.56 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 3.3 tt0 -71.85 -45.09 62.57 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -55.97 -51.7 66.77 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.397 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.67 -38.64 72.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 109.643 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.21 -52.3 65.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.208 -0.932 . . . . 0.0 109.244 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.12 -14.55 61.64 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -112.52 20.87 16.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -1.082 . . . . 0.0 109.713 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.58 -7.43 43.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.665 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.612 ' CD1' ' O ' ' A' ' 61' ' ' TRP . 65.3 t-105 -92.31 22.89 4.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.932 . . . . 0.0 109.481 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -110.79 5.95 21.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.022 -1.049 . . . . 0.0 109.988 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.01 -33.84 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 109.644 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -53.48 -37.15 62.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.227 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.77 -31.52 68.34 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.348 -0.845 . . . . 0.0 109.236 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mtm -67.78 -12.84 61.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 tt -68.61 -50.57 50.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.095 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.86 -43.57 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 10' ' ' GLN . 1.4 p-10 -94.14 162.64 13.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.148 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.844 HG12 ' N ' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -81.5 175.39 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.207 -0.933 . . . . 0.0 109.124 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.403 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -147.35 137.5 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.309 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -144.3 154.86 43.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.583 ' HA ' HG22 ' A' ' 7' ' ' ILE . 1.9 pp -145.27 174.68 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.774 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -177.76 58.17 0.09 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 87' ' ' GLU . . . 120.12 61.42 0.25 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.574 ' CB ' ' HB3' ' A' ' 87' ' ' GLU . 2.3 p-10 -175.85 138.11 0.36 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.418 -1.048 . . . . 0.0 108.642 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.6 p 177.19 79.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 O-C-N 121.291 -0.88 . . . . 0.0 109.32 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.591 ' HB3' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -49.06 -15.86 0.12 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.754 -0.591 . . . . 0.0 111.679 -178.709 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -111.66 100.82 9.27 Favored 'General case' 0 C--N 1.281 -2.401 0 O-C-N 121.153 -0.967 . . . . 0.0 109.21 179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.8 -79.97 0.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.787 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.59 -90.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.922 . . . . 0.0 109.925 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -118.67 -29.5 5.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.824 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -88.84 -158.19 0.48 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 109.016 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.941 ' CD1' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -126.84 120.5 29.4 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.094 -1.004 . . . . 0.0 109.633 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.601 ' O ' ' O ' ' A' ' 77' ' ' VAL . 2.5 p -144.7 140.05 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.18 -0.95 . . . . 0.0 109.545 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.729 HD12 ' H ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -151.53 -155.39 0.62 Allowed 'General case' 0 C--N 1.284 -2.252 0 O-C-N 120.885 -1.134 . . . . 0.0 108.124 177.754 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.999 ' CD ' HG21 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -89.14 173.4 8.45 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-O 122.115 0.959 . . . . 0.0 110.725 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.591 ' HA ' ' HG ' ' A' ' 46' ' ' LEU . 4.8 t90 -77.9 122.07 24.99 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.784 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.78 19.94 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.428 ' OXT' ' ND2' ' A' ' 90' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.925 -1.035 . . . . 0.0 109.503 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -172.28 59.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.231 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 44' ' ' LYS . 20.8 p -123.41 9.33 9.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.839 . . . . 0.0 109.798 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -143.22 164.86 29.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.965 -1.084 . . . . 0.0 110.485 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.524 ' HB ' ' HA3' ' A' ' 75' ' ' GLY . 10.5 m -130.79 167.37 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.515 0.674 . . . . 0.0 109.858 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.568 ' O ' ' N ' ' A' ' 74' ' ' GLY . 0.8 OUTLIER -145.06 135.78 24.5 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.53 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 1.9 pt -160.5 137.77 2.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.877 -1.139 . . . . 0.0 110.368 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.706 ' HB3' HG22 ' A' ' 71' ' ' ILE . . . -120.79 167.72 12.2 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CD1' ' O ' ' A' ' 8' ' ' ALA . 12.0 m-85 -163.18 155.13 17.87 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.536 -1.353 . . . . 0.0 109.793 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.53 ' H ' ' N ' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -121.05 94.86 4.48 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.033 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB3' ' OD1' ' A' ' 69' ' ' ASP . 1.4 p30 -108.83 137.53 46.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.585 -0.697 . . . . 0.0 109.749 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -79.23 -13.76 59.48 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.245 -0.91 . . . . 0.0 109.174 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.8 105.83 4.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 17' ' ' TYR . 18.1 t30 -60.71 -12.83 11.65 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.28 -42.03 66.15 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.256 -0.903 . . . . 0.0 108.784 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -38.78 74.34 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.442 ' HB3' ' OD1' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -58.64 -43.16 89.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.477 -0.764 . . . . 0.0 108.966 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.49 -52.87 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 108.81 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 23' ' ' ILE . 48.1 t -62.39 -24.06 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.375 -0.828 . . . . 0.0 109.025 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.572 ' HA ' HD12 ' A' ' 23' ' ' ILE . 1.7 tt0 -76.08 -27.14 57.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.267 -0.896 . . . . 0.0 109.049 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.39 -44.48 64.88 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -63.82 -46.94 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 20' ' ' GLU . 60.1 mt -54.25 -49.1 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.423 ' OE1' ' CG ' ' A' ' 20' ' ' GLU . 17.9 mt-30 -61.7 -32.64 72.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.146 -0.972 . . . . 0.0 108.457 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -47.06 -36.82 8.54 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -79.84 133.69 58.12 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.36 46.24 1.91 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.805 1.424 . . . . 0.0 109.98 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -149.92 -45.44 0.13 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.126 -0.984 . . . . 0.0 109.713 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -59.92 144.21 49.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.613 ' C ' HG22 ' A' ' 31' ' ' VAL . 5.7 t -101.11 139.67 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.521 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.613 HG22 ' C ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -168.88 166.54 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 109.14 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 33' ' ' HIS . 2.5 mm-40 -149.43 -94.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.338 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.765 ' CE1' HG22 ' A' ' 38' ' ' ILE . 4.9 t60 55.72 110.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 109.88 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.559 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -154.16 -62.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.616 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.3 Cg_endo -67.21 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.652 1.343 . . . . 0.0 109.772 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.64 -53.75 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.399 -0.813 . . . . 0.0 109.243 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.486 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -72.08 157.33 37.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 109.153 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.765 HG22 ' CE1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -122.83 165.22 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.017 -1.052 . . . . 0.0 109.34 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.494 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -132.21 156.87 45.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.966 . . . . 0.0 109.986 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.555 HG22 ' H ' ' A' ' 41' ' ' GLU . 8.7 mt -152.83 172.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.401 -0.812 . . . . 0.0 109.053 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.555 ' H ' HG22 ' A' ' 40' ' ' ILE . 5.9 tt0 171.36 145.21 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.522 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -144.12 -162.8 1.54 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.085 -1.01 . . . . 0.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -140.67 82.92 1.87 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' ' CB ' ' A' ' 88' ' ' TRP . 31.2 mmtt -129.64 -165.13 1.48 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.048 -1.032 . . . . 0.0 110.856 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.546 ' CA ' ' HG3' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -165.24 165.34 19.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.645 HD13 ' H ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -164.55 150.61 10.56 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.897 -1.127 . . . . 0.0 110.478 178.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.645 ' H ' HD13 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -142.99 139.67 30.72 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.037 HG21 HG21 ' A' ' 52' ' ' THR . 2.3 pt -139.71 163.64 24.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.064 -1.022 . . . . 0.0 110.305 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.504 ' HA ' ' HG3' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -95.46 -147.43 0.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.476 -0.765 . . . . 0.0 109.336 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' NH1' ' CG ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -87.67 -40.59 14.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.081 -1.012 . . . . 0.0 109.726 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 69.1 tt0 -54.67 -31.21 57.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 109.06 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 1.037 HG21 HG21 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -61.92 -40.16 94.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.036 -1.04 . . . . 0.0 108.536 179.409 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.579 HG22 ' CD2' ' A' ' 84' ' ' PHE . 21.2 t -46.25 -32.93 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 3.8 tt0 -71.24 -46.01 61.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 52' ' ' THR . 40.0 mm-40 -52.82 -55.12 25.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.364 -0.835 . . . . 0.0 109.529 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -55.51 -34.92 65.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.257 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.8 tp -56.43 -54.8 41.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.149 -0.969 . . . . 0.0 109.284 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.65 -9.64 65.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.44 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -112.75 5.61 17.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -1.076 . . . . 0.0 109.396 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -79.29 -19.15 51.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -89.89 23.64 2.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.196 -0.94 . . . . 0.0 109.286 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.64 39.48 2.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.401 -0.812 . . . . 0.0 109.017 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' A' ' 66' ' ' MET . 2.1 t -91.95 -3.94 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.708 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.433 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 4.1 mp0 -50.2 -25.24 3.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 0.0 109.465 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -66.31 -44.53 83.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.147 -0.971 . . . . 0.0 109.426 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.45 ' CE ' HD11 ' A' ' 73' ' ' ILE . 5.1 mtp -59.27 -16.11 19.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 0.0 109.523 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 11.2 tp -78.1 -52.25 9.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.703 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 68' ' ' VAL . 2.0 t -66.56 -55.19 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.626 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -98.76 85.22 3.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.648 ' O ' HG12 ' A' ' 71' ' ' ILE . 7.1 p -103.29 141.77 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.247 -0.908 . . . . 0.0 112.513 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.706 HG22 ' HB3' ' A' ' 8' ' ' ALA . 2.1 mm 178.41 -85.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.699 HG22 ' H ' ' A' ' 73' ' ' ILE . 2.2 m -133.44 176.33 8.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.921 -1.112 . . . . 0.0 111.621 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.699 ' H ' HG22 ' A' ' 72' ' ' THR . 0.6 OUTLIER -160.87 162.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -179.65 34.99 0.07 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.524 ' HA3' ' HB ' ' A' ' 5' ' ' VAL . . . -162.58 85.31 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -129.2 -135.33 0.22 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.586 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 85' ' ' VAL . 7.1 p -118.22 126.6 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -0.999 . . . . 0.0 109.724 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.486 ' O ' HG12 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -105.98 148.0 28.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.513 -0.742 . . . . 0.0 109.943 -179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -103.3 133.52 48.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 108.961 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -106.15 -93.94 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 110.102 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -105.39 -75.72 0.62 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.899 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.53 -31.41 4.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 108.761 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.504 ' HG3' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -81.04 -171.74 3.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.699 ' CE1' HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -134.87 158.96 42.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.09 -1.006 . . . . 0.0 109.269 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 77' ' ' VAL . 2.4 p -143.7 169.56 10.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.242 -0.911 . . . . 0.0 109.438 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 77' ' ' VAL . 1.3 pp -176.84 -167.39 0.18 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.546 ' HG3' ' CA ' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -119.91 173.07 7.28 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.894 -1.129 . . . . 0.0 110.645 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.54 ' CB ' ' HB3' ' A' ' 44' ' ' LYS . 1.5 t90 -70.65 128.47 36.18 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.666 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -107.37 159.49 16.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.953 . . . . 0.0 109.669 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.1 t30 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.392 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -90.7 -35.38 14.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 109.377 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.609 ' HA ' ' CE3' ' A' ' 88' ' ' TRP . 0.1 OUTLIER -173.85 93.29 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.424 -0.798 . . . . 0.0 108.962 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 4' ' ' LEU . 0.4 OUTLIER -137.02 156.43 48.44 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.087 -1.008 . . . . 0.0 110.512 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.131 HG11 HD21 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -113.73 -176.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.956 ' CE2' HG21 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -147.05 139.15 24.52 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.089 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.991 ' HB ' HG22 ' A' ' 72' ' ' THR . 1.3 pt -143.63 135.32 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.296 -0.878 . . . . 0.0 108.801 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.652 ' HB2' ' HE1' ' A' ' 6' ' ' TYR . . . -145.3 147.1 31.97 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.384 -1.326 . . . . 0.0 110.522 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.607 ' CE2' HG13 ' A' ' 38' ' ' ILE . 16.7 p90 -135.96 175.98 9.1 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.677 ' HB2' HG23 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -141.08 80.14 1.73 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.095 -1.003 . . . . 0.0 108.748 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.443 ' CB ' ' NH1' ' A' ' 16' ' ' ARG . 4.0 t70 -110.18 178.84 4.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.336 -0.853 . . . . 0.0 110.0 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -121.91 16.26 10.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 109.397 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -85.96 103.89 15.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.214 -0.929 . . . . 0.0 108.985 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -67.23 -7.76 26.43 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.251 -0.906 . . . . 0.0 108.873 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.77 -56.01 9.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.32 -0.863 . . . . 0.0 109.016 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HG2' ' N ' ' A' ' 17' ' ' TYR . 6.2 ptm180 -59.37 -28.71 67.12 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.46 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 26.4 t80 -60.3 -49.94 75.59 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.523 ' O ' HD12 ' A' ' 22' ' ' ILE . 70.4 t -54.38 -56.08 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.663 ' HA ' HD13 ' A' ' 22' ' ' ILE . 95.6 t -49.59 -30.93 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.29 -46.17 77.9 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.99 -41.08 46.19 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.302 -0.874 . . . . 0.0 108.667 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.727 ' H ' HD12 ' A' ' 22' ' ' ILE . 4.3 mp -65.55 -43.05 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.469 -0.769 . . . . 0.0 108.976 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 7.0 mt -52.89 -43.98 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 108.844 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.906 ' HG2' HG23 ' A' ' 31' ' ' VAL . 6.1 mt-30 -67.26 -32.08 72.85 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -24.88 6.54 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -83.05 135.37 44.95 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -84.6 47.12 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.761 1.4 . . . . 0.0 109.843 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -146.87 -40.07 0.2 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.338 -0.851 . . . . 0.0 109.084 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.411 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . . . -73.91 139.9 45.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.442 -0.786 . . . . 0.0 109.538 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.674 HG21 ' HB3' ' A' ' 41' ' ' GLU . 16.0 t -71.24 -120.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.181 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.906 HG23 ' HG2' ' A' ' 24' ' ' GLN . 1.1 p -174.23 -165.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.729 -1.232 . . . . 0.0 109.935 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.711 ' H ' HG22 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -114.19 -167.73 1.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.551 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -89.45 -99.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 109.928 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.569 ' HB3' ' HD3' ' A' ' 35' ' ' PRO . 46.7 t-80 -166.17 -58.69 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 110.587 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 34' ' ' HIS . 3.5 Cg_exo -49.53 -179.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 117.442 -1.239 . . . . 0.0 110.822 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 38' ' ' ILE . . . -52.21 -22.57 4.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.005 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.524 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 3.1 mmt -65.37 156.4 32.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.926 -1.109 . . . . 0.0 109.242 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.607 HG13 ' CE2' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -127.82 129.17 69.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.291 -0.881 . . . . 0.0 108.63 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.74 ' C ' HD12 ' A' ' 40' ' ' ILE . 2.2 ttt180 -126.52 164.62 20.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.06 -1.025 . . . . 0.0 110.053 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 7' ' ' ILE . 2.7 mp -156.51 169.22 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.37 -0.831 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.674 ' HB3' HG21 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -155.91 152.79 28.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.682 -1.261 . . . . 0.0 110.26 -179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.839 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -129.93 -177.26 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 91.0 mt-10 -140.04 74.97 1.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.126 -0.984 . . . . 0.0 110.186 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 175.11 -141.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.972 -1.08 . . . . 0.0 110.208 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.957 ' C ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -126.1 167.83 14.83 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.228 -0.92 . . . . 0.0 109.931 -179.093 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 1.131 HD21 HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -130.88 152.91 49.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.384 -0.823 . . . . 0.0 109.665 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.35 154.7 46.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.2 mt -150.55 141.02 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.141 -0.975 . . . . 0.0 109.71 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.46 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.6 ptt180 -100.92 -171.93 2.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 109.567 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.53 ' NH1' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -75.76 -32.85 60.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.184 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 4.4 mt-10 -50.37 -41.59 52.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.865 . . . . 0.0 109.297 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -69.26 -47.67 64.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 108.88 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.6 -26.73 2.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 1.4 tt0 -74.84 -43.59 53.74 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -55.73 -50.32 70.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 108.731 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -59.79 -33.46 71.74 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.372 -0.83 . . . . 0.0 109.016 179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.5 tp -57.73 -51.76 68.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 108.905 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.05 -14.82 66.48 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -113.02 15.23 19.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.964 . . . . 0.0 109.306 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -67.18 -19.42 65.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -0.838 . . . . 0.0 109.426 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -89.42 35.59 0.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.309 -0.869 . . . . 0.0 109.381 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 65' ' ' GLU . 34.9 t70 -104.97 5.87 33.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.476 ' H ' HG23 ' A' ' 63' ' ' VAL . 2.8 t -52.21 -40.65 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.932 . . . . 0.0 109.539 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -52.46 -40.93 62.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.143 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 0.4 OUTLIER -73.03 -28.39 62.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.049 179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -12.03 61.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.278 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 67' ' ' LEU . 1.5 mm? -74.47 -56.97 4.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.297 -0.877 . . . . 0.0 109.945 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.53 ' CG1' ' OD2' ' A' ' 69' ' ' ASP . 2.3 p -90.52 -46.47 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.119 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -103.02 146.69 27.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.983 -1.073 . . . . 0.0 109.967 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.742 HG12 ' H ' ' A' ' 71' ' ' ILE . 7.0 t -100.56 -176.07 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.797 ' O ' HG23 ' A' ' 72' ' ' THR . 0.6 OUTLIER -136.02 -37.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.276 -1.515 . . . . 0.0 112.165 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.991 HG22 ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER 170.75 -148.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.682 -1.261 . . . . 0.0 108.7 -178.503 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.956 HG21 ' CE2' ' A' ' 6' ' ' TYR . 1.4 tp 176.95 -129.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.648 ' H ' HG23 ' A' ' 73' ' ' ILE . . . 167.98 -108.27 0.3 Allowed Glycine 0 N--CA 1.485 1.965 0 O-C-N 120.04 -1.662 . . . . 0.0 109.945 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.53 -65.62 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.639 ' H ' HD21 ' A' ' 86' ' ' LEU . 9.6 t-20 -124.42 -147.21 0.37 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -1.179 . . . . 0.0 108.662 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.2 p 178.9 93.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.091 -1.006 . . . . 0.0 109.994 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.6 134.88 49.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.148 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -118.43 156.31 29.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 109.493 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -109.82 -94.93 0.41 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.556 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -106.03 -70.76 0.77 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.178 -0.951 . . . . 0.0 109.281 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.1 -6.37 7.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.313 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -90.94 -169.68 2.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -0.86 . . . . 0.0 109.406 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -155.51 122.07 5.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.941 . . . . 0.0 109.369 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.85 139.2 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.17 -0.956 . . . . 0.0 110.003 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.976 HD22 ' N ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -149.38 136.76 20.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.976 ' N ' HD22 ' A' ' 86' ' ' LEU . 2.4 mp0 -121.14 -148.39 0.41 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.699 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.609 ' CE3' ' HA ' ' A' ' 3' ' ' SER . 2.7 t90 -47.09 -91.1 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.58 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -141.77 -37.87 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 109.831 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.448 ' N ' ' CD ' ' A' ' 89' ' ' LYS . 22.5 t30 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.446 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.82 48.94 9.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.28 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -120.84 -2.36 9.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.691 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 1.0 OUTLIER -126.98 158.14 37.68 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.994 -1.066 . . . . 0.0 110.283 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -119.49 170.96 8.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.543 0.687 . . . . 0.0 110.232 -178.503 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 74' ' ' GLY . 10.2 t80 -140.49 141.33 35.39 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.867 HD11 HD12 ' A' ' 40' ' ' ILE . 1.5 pp -159.18 152.84 5.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.671 ' HB1' ' O ' ' A' ' 38' ' ' ILE . . . -146.37 -173.4 4.18 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.599 -1.24 . . . . 0.0 110.59 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 1.095 ' CD2' HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.84 171.23 14.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 122.633 1.206 . . . . 0.0 111.866 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.716 ' C ' HG23 ' A' ' 70' ' ' VAL . 0.2 OUTLIER 176.35 105.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.32 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.623 ' N ' HG23 ' A' ' 70' ' ' VAL . 3.3 t0 -109.87 -156.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.641 0.734 . . . . 0.0 110.078 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -128.45 -63.43 0.99 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -118.59 -15.06 9.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.441 -0.787 . . . . 0.0 108.904 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.459 ' HB3' ' OD2' ' A' ' 11' ' ' ASP . 0.7 OUTLIER -82.51 7.59 14.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.399 -0.813 . . . . 0.0 109.017 179.361 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 18' ' ' VAL . . . -42.4 -32.92 0.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.401 -0.812 . . . . 0.0 109.166 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -51.43 -56.74 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 109.012 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -61.74 -32.1 72.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.229 -0.92 . . . . 0.0 109.281 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 15' ' ' ALA . 55.8 t -57.01 -41.43 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.831 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.71 -30.96 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.63 -49.85 73.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.501 -0.749 . . . . 0.0 109.45 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -62.91 -40.17 96.78 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.119 -0.988 . . . . 0.0 108.97 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.004 HD11 HG13 ' A' ' 38' ' ' ILE . 5.6 mm -50.1 -42.92 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.026 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.487 ' O ' ' CD ' ' A' ' 27' ' ' PRO . 40.1 mm -69.29 -33.56 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.15 -0.969 . . . . 0.0 109.024 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -90.88 4.94 50.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.438 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.872 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -117.18 -11.64 10.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.875 ' OD1' HG13 ' A' ' 31' ' ' VAL . 1.1 m-80 -87.91 -68.79 0.12 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.519 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 26' ' ' ASN . 3.6 Cg_exo -41.28 -28.08 0.46 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.69 1.363 . . . . 0.0 110.195 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -97.78 -39.03 9.24 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.322 -0.861 . . . . 0.0 109.199 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' A' ' 25' ' ' ASP . . . -102.94 -158.08 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.125 -0.985 . . . . 0.0 109.685 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.519 ' O ' HG22 ' A' ' 31' ' ' VAL . 3.2 t -96.3 -127.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.875 HG13 ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -161.72 141.76 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.648 -1.283 . . . . 0.0 109.726 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -174.21 95.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 109.46 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.535 ' CE1' ' HB ' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -115.05 157.17 23.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.501 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.463 ' CG ' ' HD2' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -117.45 -167.22 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.523 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.463 ' HD2' ' CG ' ' A' ' 34' ' ' HIS . 2.3 Cg_endo -90.56 15.19 1.88 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.96 1.505 . . . . 0.0 110.338 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.68 -76.39 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.195 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -84.21 167.34 16.77 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.004 HG13 HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.95 163.44 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.843 -1.161 . . . . 0.0 108.922 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.554 ' N ' HD13 ' A' ' 38' ' ' ILE . 8.9 mtp180 -139.48 162.47 34.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.879 -1.138 . . . . 0.0 109.5 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.867 HD12 HD11 ' A' ' 7' ' ' ILE . 33.0 mt -158.64 164.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 110.003 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.567 ' N ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -159.17 166.67 30.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.381 -0.825 . . . . 0.0 109.006 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.515 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -159.83 -165.23 1.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.937 -1.102 . . . . 0.0 110.545 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -139.2 97.28 3.26 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' CD ' ' HB3' ' A' ' 88' ' ' TRP . 30.8 mttm -142.43 -164.54 1.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.972 -1.08 . . . . 0.0 110.925 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' HA ' ' HG3' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -167.79 171.32 10.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 109.154 -179.3 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.964 HD12 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -160.82 142.19 11.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.026 -1.046 . . . . 0.0 109.723 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.817 ' C ' HD12 ' A' ' 48' ' ' ILE . 1.1 tt0 -138.86 138.81 37.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.996 . . . . 0.0 109.434 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 46' ' ' LEU . 4.1 mp -151.2 162.8 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.257 -0.902 . . . . 0.0 110.294 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.524 ' N ' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -98.36 -153.42 0.43 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.425 ' CG ' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -69.98 -12.68 61.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.598 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 3.4 tt0 -64.84 -9.8 23.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.193 -0.942 . . . . 0.0 109.603 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.743 HG21 ' OD2' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -59.99 -40.34 88.83 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.866 -1.146 . . . . 0.0 109.02 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 52' ' ' THR . 94.5 t -46.37 -34.24 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -70.27 -45.75 65.76 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.648 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 52' ' ' THR . 3.0 mm-40 -47.7 -46.1 29.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -38.75 88.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.357 -0.84 . . . . 0.0 108.812 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.2 tp -55.17 -55.22 33.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.364 -0.835 . . . . 0.0 109.15 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.41 -9.4 68.37 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HD2' ' OD1' ' A' ' 90' ' ' ASN . 1.1 ttp180 -90.95 -9.53 45.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -1.123 . . . . 0.0 109.517 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.72 -25.35 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.453 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -88.29 40.26 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.389 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -111.28 74.63 0.88 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.397 -0.814 . . . . 0.0 109.137 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.16 2.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -0.86 . . . . 0.0 109.994 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.546 ' O ' HD11 ' A' ' 71' ' ' ILE . 2.3 mp0 -49.01 -22.63 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.055 -1.028 . . . . 0.0 109.315 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 1.016 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.0 pt-20 -56.4 -48.67 76.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -17.08 64.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.194 -0.941 . . . . 0.0 109.423 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.714 HD23 HG12 ' A' ' 71' ' ' ILE . 4.9 tp -98.67 11.98 36.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 109.399 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.016 HG23 ' O ' ' A' ' 65' ' ' GLU . 40.5 t -39.34 -24.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.414 -0.804 . . . . 0.0 110.867 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 71' ' ' ILE . 67.4 m-20 -58.2 -100.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.713 -1.242 . . . . 0.0 109.807 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.095 HG22 ' CD2' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -42.08 -13.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.175 -2.819 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.461 -178.166 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.714 HG12 HD23 ' A' ' 67' ' ' LEU . 1.7 pt -123.42 131.91 72.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 120.453 1.478 . . . . 0.0 110.253 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.659 ' OG1' ' HB3' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -130.74 150.02 52.12 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -133.47 174.53 13.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.229 -0.919 . . . . 0.0 110.403 -178.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 178.89 38.74 0.07 OUTLIER Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 5' ' ' VAL . . . -152.37 82.94 0.17 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' H ' ' A' ' 87' ' ' GLU . 27.6 p-10 -176.03 138.47 0.35 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.674 ' O ' ' O ' ' A' ' 85' ' ' VAL . 13.8 p -171.34 52.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.101 -0.999 . . . . 0.0 109.228 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.995 ' CG ' HD23 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -49.92 -9.54 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.265 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -110.52 94.83 5.21 Favored 'General case' 0 C--N 1.28 -2.422 0 O-C-N 120.6 -1.313 . . . . 0.0 109.729 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.685 ' HB2' HG12 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -107.11 -82.11 0.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 108.951 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.01 -82.72 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 108.996 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -128.18 -30.88 2.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.364 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -80.11 -157.88 0.16 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.575 ' CD2' ' HB ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -126.1 112.9 16.38 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.749 -1.22 . . . . 0.0 108.752 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.685 HG12 ' HB2' ' A' ' 80' ' ' ASP . 4.1 p -129.51 138.78 53.41 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.655 0 C-N-CA 118.922 -1.111 . . . . 0.0 109.763 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.995 HD23 ' CG ' ' A' ' 78' ' ' ASP . 0.9 OUTLIER -143.0 -176.27 4.84 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 120.837 -1.164 . . . . 0.0 108.309 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.588 ' C ' ' HB2' ' A' ' 46' ' ' LEU . 1.9 tt0 -101.1 171.8 7.4 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.947 0.88 . . . . 0.0 110.61 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.547 ' HB3' ' CD ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -73.07 81.21 1.24 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.786 -178.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER 175.2 139.82 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 0.0 109.312 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.453 ' OD1' ' HD2' ' A' ' 59' ' ' ARG . 15.2 t30 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.114 -0.991 . . . . 0.0 109.584 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' HB2' ' A' ' 2' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 1' ' ' MET . 9.0 t -179.57 122.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.894 . . . . 0.0 109.363 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.639 ' HA ' ' CG ' ' A' ' 88' ' ' TRP . 1.0 OUTLIER 67.66 101.01 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.271 -179.746 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -142.26 160.93 39.27 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.759 -1.213 . . . . 0.0 112.235 -178.837 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.922 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 1.2 t -113.52 -176.65 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.734 ' CE2' HG21 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -159.19 144.77 16.16 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.939 ' HB ' HG22 ' A' ' 72' ' ' THR . 4.5 pt -160.31 137.11 2.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 120.529 -1.357 . . . . 0.0 107.919 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.728 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -132.36 146.41 51.95 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.186 -1.806 . . . . 0.0 109.606 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 1.007 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 14.0 p90 -140.9 170.34 15.93 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.488 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.696 ' HG3' ' CA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -119.61 143.33 47.73 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.052 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 2.7 p30 -108.73 154.07 22.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.745 -1.222 . . . . 0.0 109.957 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -89.63 -37.97 14.26 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.377 -0.827 . . . . 0.0 109.424 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 12' ' ' ASN . 16.6 t0 168.84 -34.88 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -102.97 -30.31 10.87 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 11' ' ' ASP . . . -52.65 -20.37 3.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.0 109.141 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -64.98 -56.14 14.91 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.832 . . . . 0.0 109.132 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.73 -39.32 73.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.238 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.1 t -56.49 -49.04 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 108.605 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 1.007 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 60.9 t -67.45 -19.13 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.454 -0.779 . . . . 0.0 109.137 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.509 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 45.6 tt0 -76.28 -36.7 58.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.385 -0.822 . . . . 0.0 109.784 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.61 -36.23 65.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.8 mt -71.67 -48.91 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.642 HD12 ' N ' ' A' ' 24' ' ' GLN . 2.2 pp -57.81 -38.96 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.217 -0.927 . . . . 0.0 108.934 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.642 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -62.89 -43.05 99.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.343 -0.848 . . . . 0.0 109.035 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 24' ' ' GLN . 3.0 t0 -44.43 -36.3 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.56 88.15 23.39 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 2.4 Cg_endo -65.89 81.31 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 124.31 1.69 . . . . 0.0 110.308 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 5.5 t-80 179.33 -43.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -40.86 140.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.725 -0.61 . . . . 0.0 110.002 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.604 HG22 ' N ' ' A' ' 31' ' ' VAL . 3.7 p -97.42 165.77 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 0.0 109.441 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.604 ' N ' HG22 ' A' ' 30' ' ' VAL . 1.4 p -155.49 163.44 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.521 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -174.55 141.78 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 0.0 109.849 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.931 ' HB3' HG22 ' A' ' 38' ' ' ILE . 1.3 p-80 -143.66 160.34 40.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.27 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.579 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -157.62 -61.57 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.106 -0.996 . . . . 0.0 109.881 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.5 Cg_endo -66.92 -54.27 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.725 1.382 . . . . 0.0 110.002 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -177.63 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.315 -0.866 . . . . 0.0 108.971 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 1.2 ptm -69.02 158.62 34.42 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.931 HG22 ' HB3' ' A' ' 33' ' ' HIS . 0.1 OUTLIER -110.31 120.59 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.891 -1.13 . . . . 0.0 109.857 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.535 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -81.85 177.78 8.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.34 -0.85 . . . . 0.0 110.219 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.698 HD12 HG13 ' A' ' 7' ' ' ILE . 3.1 mt -152.72 -174.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.273 -0.892 . . . . 0.0 109.673 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.67 ' H ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -171.09 158.55 5.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.795 -1.191 . . . . 0.0 111.04 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.922 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . . . -129.84 -175.31 3.56 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 10.2 pt-20 -151.25 70.67 0.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.147 -0.97 . . . . 0.0 110.033 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 173.4 -143.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.856 -1.152 . . . . 0.0 109.321 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.966 ' O ' HD23 ' A' ' 46' ' ' LEU . 4.9 mpt_? -126.01 154.99 42.15 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.04 -1.037 . . . . 0.0 109.375 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.966 HD23 ' O ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -144.92 135.76 24.68 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.173 -0.955 . . . . 0.0 109.833 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 1.088 ' CA ' HG12 ' A' ' 85' ' ' VAL . 2.3 pm0 -151.05 135.55 17.03 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.781 ' CD1' HG11 ' A' ' 85' ' ' VAL . 2.5 mt -137.8 152.4 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 0.0 109.117 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.527 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -50.49 147.58 4.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 108.949 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.453 ' CG ' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -89.27 -60.55 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.017 . . . . 0.0 109.716 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 16.5 tt0 -54.35 -44.66 72.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.751 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -50.81 50.06 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.017 -1.052 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.576 ' CG2' ' CG2' ' A' ' 48' ' ' ILE . 19.4 t -55.34 -21.48 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -74.99 -40.08 60.88 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.29 -56.27 9.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.267 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -55.3 -29.43 58.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 109.3 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.612 HD12 ' CE3' ' A' ' 61' ' ' TRP . 7.6 tp -64.33 -56.11 16.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -0.842 . . . . 0.0 109.732 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.51 8.15 69.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.488 ' HG2' ' N ' ' A' ' 60' ' ' ALA . 22.7 ttt180 -98.8 -84.59 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -1.17 . . . . 0.0 109.973 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.488 ' N ' ' HG2' ' A' ' 59' ' ' ARG . . . -96.03 -22.6 17.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.585 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.612 ' CE3' HD12 ' A' ' 57' ' ' LEU . 8.6 t90 -90.18 25.78 2.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.313 -0.867 . . . . 0.0 109.177 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.2 44.31 1.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.264 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 65' ' ' GLU . 3.9 t -98.93 9.4 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.415 -0.803 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.503 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 7.4 mm100 -39.9 -28.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.522 -0.736 . . . . 0.0 109.944 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 68' ' ' VAL . 16.1 tt0 -58.06 -55.26 37.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.136 -0.977 . . . . 0.0 109.404 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.433 ' HB2' HG12 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -72.32 -9.57 58.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 64' ' ' GLN . 11.8 tp -53.74 -16.35 1.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.432 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 65' ' ' GLU . 17.2 t -40.2 -42.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -0.954 . . . . 0.0 109.715 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.696 ' CA ' ' HG3' ' A' ' 10' ' ' GLN . 10.1 m-20 -81.52 -74.75 0.32 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.181 -0.949 . . . . 0.0 109.818 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 71' ' ' ILE . 1.3 t -43.56 -170.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 122.152 -0.343 . . . . 0.0 110.98 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.728 HG22 ' O ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER 161.46 -167.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.939 HG22 ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -175.39 -158.87 0.07 Allowed 'General case' 0 C--O 1.193 -1.903 0 O-C-N 119.348 -2.095 . . . . 0.0 108.143 179.371 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.747 HG22 ' H ' ' A' ' 74' ' ' GLY . 48.6 mm -168.39 -127.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.747 ' H ' HG22 ' A' ' 73' ' ' ILE . . . 161.84 -71.81 0.21 Allowed Glycine 0 N--CA 1.486 1.996 0 O-C-N 120.427 -1.421 . . . . 0.0 110.591 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.16 -37.93 1.59 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.813 ' C ' HD13 ' A' ' 86' ' ' LEU . 2.4 t-20 -176.48 -149.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.974 . . . . 0.0 109.205 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.779 ' O ' HG13 ' A' ' 77' ' ' VAL . 9.1 p -151.33 100.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.016 . . . . 0.0 109.415 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.475 ' OD2' ' HD3' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -114.47 150.58 34.57 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.942 -1.098 . . . . 0.0 110.325 -179.006 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.577 ' HB3' ' CD1' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -118.12 164.64 14.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.588 -0.695 . . . . 0.0 109.229 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.533 ' OD1' ' HB2' ' A' ' 47' ' ' GLU . 3.6 p-10 -114.42 -115.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.035 -1.04 . . . . 0.0 109.646 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -98.36 -41.12 7.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.828 -1.17 . . . . 0.0 109.753 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -130.91 -58.78 1.01 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.03 -1.044 . . . . 0.0 108.606 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 48' ' ' ILE . 2.1 mpp_? -57.2 -173.22 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.664 ' CE1' HG22 ' A' ' 77' ' ' VAL . 2.2 t80 173.41 120.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.051 -1.031 . . . . 0.0 111.816 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.088 HG12 ' CA ' ' A' ' 47' ' ' GLU . 8.1 p -160.39 -115.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.813 HD13 ' C ' ' A' ' 76' ' ' ASN . 22.0 tp -131.85 144.62 51.03 Favored 'General case' 0 C--N 1.282 -2.352 0 O-C-N 120.19 -1.569 . . . . 0.0 112.368 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.803 ' H ' HD12 ' A' ' 86' ' ' LEU . 16.8 mt-10 -120.72 -150.16 0.45 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.639 ' CG ' ' HA ' ' A' ' 3' ' ' SER . 7.0 t90 -64.19 -90.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.802 -1.186 . . . . 0.0 108.2 177.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.525 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 5.9 mptt 43.42 97.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.57 -0.706 . . . . 0.0 110.049 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 35.0 t30 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.378 179.698 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.485 ' HA ' HD11 ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.301 0.572 . . . . 0.0 109.489 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.62 -51.29 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.201 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.84 23.21 3.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 109.414 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -128.2 -167.03 1.7 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -0.98 . . . . 0.0 109.797 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.835 HG13 ' HA2' ' A' ' 75' ' ' GLY . 11.3 t -152.28 161.31 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.594 ' O ' ' N ' ' A' ' 74' ' ' GLY . 6.6 t80 -153.16 136.0 15.38 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.67 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -162.68 137.68 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.921 -1.112 . . . . 0.0 109.786 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.635 ' C ' HG22 ' A' ' 71' ' ' ILE . . . -126.6 173.89 9.11 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 69' ' ' ASP . 2.6 m-85 -168.56 155.56 7.48 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.496 -1.378 . . . . 0.0 109.366 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.633 ' NE2' ' O ' ' A' ' 11' ' ' ASP . 0.4 OUTLIER -120.91 93.82 4.15 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.633 ' O ' ' NE2' ' A' ' 10' ' ' GLN . 1.1 m-20 -74.38 -166.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.38 -0.825 . . . . 0.0 109.831 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.7 -114.59 0.12 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.09 -1.006 . . . . 0.0 108.911 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -119.08 -31.97 4.57 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.843 -1.161 . . . . 0.0 108.579 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -103.07 -34.87 8.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.473 -0.767 . . . . 0.0 109.331 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.53 82.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.556 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.463 HH11 ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -63.07 -36.22 82.86 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.315 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -37.65 83.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.075 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.86 -53.04 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 109.191 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.411 ' HA ' HD12 ' A' ' 22' ' ' ILE . 55.9 t -64.37 -23.65 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.409 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.35 -35.28 73.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 109.747 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -77.53 -33.08 54.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.773 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.411 HD12 ' HA ' ' A' ' 19' ' ' VAL . 8.3 mt -71.89 -37.62 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.181 -0.949 . . . . 0.0 109.058 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.3 mt -67.24 -53.02 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.894 . . . . 0.0 109.335 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -63.48 -29.25 70.55 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.358 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -47.13 -43.94 21.16 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -87.01 126.96 61.28 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.7 Cg_endo -84.02 49.34 2.78 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.817 1.43 . . . . 0.0 110.254 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.8 t-160 -154.76 -48.47 0.09 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.19 -0.944 . . . . 0.0 109.917 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -41.11 141.08 0.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.475 -0.766 . . . . 0.0 109.873 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.411 ' C ' ' CG2' ' A' ' 31' ' ' VAL . 2.6 t -98.0 162.32 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.523 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.411 ' CG2' ' C ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -155.11 156.85 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.036 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -170.09 83.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.568 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -119.41 167.42 11.94 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.176 -0.953 . . . . 0.0 109.644 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.582 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -164.26 -48.09 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.833 . . . . 0.0 109.132 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 2.0 Cg_endo -81.98 -167.02 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.752 1.396 . . . . 0.0 109.737 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.77 -5.1 41.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.248 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.522 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 1.9 mtm -97.04 151.42 19.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -111.09 161.08 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.141 -0.975 . . . . 0.0 109.328 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.51 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -149.7 155.46 40.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 109.792 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.648 HG22 ' H ' ' A' ' 41' ' ' GLU . 13.2 mt -156.25 175.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.821 . . . . 0.0 109.045 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.648 ' H ' HG22 ' A' ' 40' ' ' ILE . 11.2 tt0 178.76 144.42 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.009 . . . . 0.0 109.367 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.669 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . . . -129.19 -160.13 1.01 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.797 . . . . 0.0 109.642 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 17.0 pt-20 -164.01 69.23 0.19 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.452 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -159.46 -164.35 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 110.009 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' HA ' ' CG ' ' A' ' 87' ' ' GLU . 9.2 ptm180 -133.33 -166.42 1.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.506 -0.747 . . . . 0.0 109.014 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 87' ' ' GLU . 4.1 mt -163.42 156.04 18.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.036 -1.04 . . . . 0.0 110.193 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.743 ' HG3' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -146.32 139.74 25.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.81 ' N ' HD12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -148.2 158.41 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 109.933 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.517 ' HA ' ' CG ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -100.62 -151.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -4.08 23.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.387 -0.821 . . . . 0.0 109.661 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 13.4 pt-20 -71.77 -23.8 61.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.784 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.44 ' OG1' ' CG2' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -64.08 -49.11 73.55 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.983 -1.073 . . . . 0.0 109.56 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.2 t -51.52 -25.82 5.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.066 -1.021 . . . . 0.0 108.889 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 10.0 mt-10 -75.38 -39.89 58.62 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.278 -0.889 . . . . 0.0 109.429 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 15.3 mm-40 -65.52 -46.59 79.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.344 -0.848 . . . . 0.0 109.376 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -43.61 80.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.533 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.09 -54.93 41.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.9 . . . . 0.0 109.556 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.31 -2.1 58.56 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 12.9 ttt180 -119.17 10.12 11.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -1.195 . . . . 0.0 109.701 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.19 -27.4 68.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.12 -0.988 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -89.35 29.04 1.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 109.706 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -110.93 5.42 20.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.611 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.3 t -72.75 -49.44 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.593 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -49.9 -47.98 51.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -71.65 -25.1 61.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -81.37 -12.34 59.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.507 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.38 -22.16 26.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 10' ' ' GLN . 14.0 t -59.25 -33.91 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.523 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.633 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.6 86.84 3.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 109.185 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.564 ' O ' ' CB ' ' A' ' 71' ' ' ILE . 2.4 p -101.93 140.57 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.312 -0.867 . . . . 0.0 111.309 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.635 HG22 ' C ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER 167.69 -53.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.038 -1.039 . . . . 0.0 111.912 175.797 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 73' ' ' ILE . 1.7 m -165.98 171.54 12.46 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.057 -1.652 . . . . 0.0 112.761 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.625 ' H ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -163.67 165.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 174.94 51.23 0.05 OUTLIER Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.514 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.835 ' HA2' HG13 ' A' ' 5' ' ' VAL . . . -104.67 -100.32 2.62 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.738 ' O ' HD21 ' A' ' 86' ' ' LEU . 1.9 t30 -175.33 -174.0 0.69 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.4 -1.059 . . . . 0.0 108.931 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.775 HG13 ' O ' ' A' ' 77' ' ' VAL . 12.4 p 177.97 67.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 108.806 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.505 ' O ' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -98.95 141.58 31.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 0.0 110.394 -178.806 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -127.21 145.24 50.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.775 . . . . 0.0 108.932 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -107.24 -109.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.069 -1.02 . . . . 0.0 109.485 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -104.39 -77.14 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.817 -1.177 . . . . 0.0 109.242 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -109.94 -9.43 14.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.252 -0.905 . . . . 0.0 109.075 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.517 ' CG ' ' HA ' ' A' ' 49' ' ' ARG . 3.0 ttt180 -91.92 -160.62 0.75 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.374 -0.829 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 48' ' ' ILE . 2.1 t80 -169.38 148.89 3.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.072 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.743 HG23 ' HG3' ' A' ' 47' ' ' GLU . 2.5 p -133.73 179.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.053 -1.03 . . . . 0.0 109.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.738 HD21 ' O ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER 178.26 -169.34 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 46' ' ' LEU . 3.9 mt-10 -121.71 -164.81 1.18 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.941 -1.099 . . . . 0.0 109.796 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.669 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -42.49 154.1 0.07 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.504 ' O ' ' CE2' ' A' ' 88' ' ' TRP . 0.5 OUTLIER -107.41 148.77 28.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.381 -0.824 . . . . 0.0 109.385 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.8 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.507 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m 56.22 20.31 4.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.528 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.8 p -102.94 12.36 36.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.882 . . . . 0.0 109.677 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -122.48 -176.82 3.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.059 -1.025 . . . . 0.0 109.222 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.586 ' CG2' ' N ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -156.97 165.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.891 -1.131 . . . . 0.0 110.703 -179.157 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.586 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -135.41 147.53 49.04 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.935 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.566 ' C ' HD12 ' A' ' 7' ' ' ILE . 1.4 pp -158.21 139.45 4.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.881 ' HB3' ' OG1' ' A' ' 72' ' ' THR . . . -124.72 -179.16 4.4 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.108 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 1.012 ' CD2' HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -141.79 -178.7 5.79 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.195 177.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.774 ' N ' ' HA ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 177.97 97.93 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.305 -177.628 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.644 ' OD1' HG21 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -107.7 167.92 9.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.968 . . . . 0.0 109.856 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -124.57 -64.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.881 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -101.6 -32.64 10.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 109.57 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' HB2' ' OD2' ' A' ' 11' ' ' ASP . 25.9 m-80 -87.64 10.61 17.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.129 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.903 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -58.8 -16.6 17.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.215 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.523 ' NH1' ' HG2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -61.97 -62.13 2.0 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 109.214 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.432 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 49.3 m-85 -62.95 -33.37 75.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 0.0 108.872 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.936 ' O ' HD13 ' A' ' 22' ' ' ILE . 60.1 t -59.34 -32.97 49.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 15' ' ' ALA . 61.3 t -77.45 -25.5 15.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 6.9 tp10 -65.27 -53.94 36.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -67.65 -44.31 78.19 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.206 -0.934 . . . . 0.0 108.556 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.936 HD13 ' O ' ' A' ' 18' ' ' VAL . 1.5 mp -54.04 -31.03 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.537 ' O ' ' CD ' ' A' ' 27' ' ' PRO . 17.9 mt -70.38 -42.16 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 108.844 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.3 4.92 49.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.722 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -118.67 -11.88 9.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.301 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.576 ' ND2' HG11 ' A' ' 31' ' ' VAL . 3.4 m-20 -85.57 -65.88 0.2 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 110.377 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.537 ' CD ' ' O ' ' A' ' 23' ' ' ILE . 2.5 Cg_endo -41.0 -27.95 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.66 1.348 . . . . 0.0 110.051 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 26' ' ' ASN . 2.6 t-160 -98.64 -33.45 10.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.667 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 25' ' ' ASP . . . -102.33 176.89 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -0.99 . . . . 0.0 110.265 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 40' ' ' ILE . 1.9 t -101.2 162.88 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.034 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.6 HG22 ' N ' ' A' ' 32' ' ' GLN . 2.1 p -169.66 166.88 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 109.813 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.6 ' N ' HG22 ' A' ' 31' ' ' VAL . 2.5 pt20 -172.18 65.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 109.566 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.508 ' CB ' ' HA ' ' A' ' 38' ' ' ILE . 26.0 p80 -101.12 179.14 4.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.588 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -156.67 -62.62 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.589 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -67.84 -167.78 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.684 1.36 . . . . 0.0 109.911 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.19 -15.41 33.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 108.957 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.583 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 66.9 mtp -81.84 135.32 35.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.327 -0.858 . . . . 0.0 109.619 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.63 ' CG1' ' HB3' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -113.77 82.54 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.16 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.532 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.39 167.3 21.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 111.25 -178.389 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 30' ' ' VAL . 89.5 mt -149.99 155.25 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.408 ' N ' HG22 ' A' ' 40' ' ' ILE . 3.4 tt0 -131.15 147.14 52.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 109.662 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' A' ' 43' ' ' GLU . . . -143.88 -171.61 3.58 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.372 -0.83 . . . . 0.0 108.877 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 44.8 mt-10 -159.28 99.55 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.548 ' HB3' ' CB ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -162.2 -145.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.768 -1.208 . . . . 0.0 111.078 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -162.43 159.65 25.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -0.869 . . . . 0.0 109.502 -178.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.754 ' CD1' HD11 ' A' ' 86' ' ' LEU . 1.4 mt -126.18 -173.79 2.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.056 -1.027 . . . . 0.0 108.298 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 4.3 pt-20 -178.95 141.99 0.19 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.256 -0.902 . . . . 0.0 109.421 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.408 ' CG1' ' C ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -160.43 -161.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.15 -0.969 . . . . 0.0 109.585 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -100.21 -169.08 1.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.859 . . . . 0.0 109.152 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -88.5 -46.3 9.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.162 -0.961 . . . . 0.0 109.026 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 30.7 tt0 -49.49 -32.15 11.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.362 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 53' ' ' VAL . 1.3 m -70.88 -50.28 36.86 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.207 -0.933 . . . . 0.0 109.039 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.739 HG21 ' CD1' ' A' ' 84' ' ' PHE . 97.4 t -48.1 -27.64 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 21.7 tp10 -74.54 -44.41 51.21 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -54.23 -47.11 72.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.349 -0.844 . . . . 0.0 108.853 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 60' ' ' ALA . 7.8 t-20 -60.47 -36.96 79.52 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.8 tp -57.99 -55.75 30.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 109.364 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.6 -11.29 59.69 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -114.82 7.25 15.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -1.139 . . . . 0.0 109.625 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -70.01 -29.97 67.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.26 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -90.34 38.45 0.94 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.868 . . . . 0.0 109.384 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -103.07 -86.06 0.44 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.299 -0.876 . . . . 0.0 109.571 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' A' ' 66' ' ' MET . 1.3 t -97.92 0.99 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.599 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.486 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 1.2 mp0 -51.9 -27.57 13.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 109.574 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -64.18 -43.07 96.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.173 -0.954 . . . . 0.0 109.017 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.517 ' HB3' ' CD1' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -64.62 -9.96 23.19 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 3.3 tt -53.29 -18.05 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 109.833 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.8 t -82.28 -35.43 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.009 -1.057 . . . . 0.0 109.775 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 39.9 m-20 -98.93 -118.26 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.952 . . . . 0.0 111.383 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 1.012 HG22 ' CD2' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -49.71 -3.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.179 -2.634 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -176.586 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.64 HG23 ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -132.31 142.92 41.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 121.658 2.026 . . . . 0.0 112.5 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.881 ' OG1' ' HB3' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -155.52 149.07 25.08 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 1.4 pp -139.06 -174.66 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.094 -1.003 . . . . 0.0 109.61 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 167.48 44.28 0.03 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.594 ' O ' ' ND2' ' A' ' 76' ' ' ASN . . . -94.05 -104.92 1.82 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.594 ' ND2' ' O ' ' A' ' 75' ' ' GLY . 0.4 OUTLIER -176.58 166.72 2.69 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.476 -1.014 . . . . 0.0 109.577 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.2 p -133.41 92.34 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.709 ' OD1' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -104.69 137.33 42.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 109.97 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.98 133.84 55.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.865 . . . . 0.0 109.457 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.6 -96.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 109.501 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.86 -61.14 1.58 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.253 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -126.37 -39.0 2.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.4 -173.77 0.16 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.739 ' CD1' HG21 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -141.05 166.42 24.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.228 -0.92 . . . . 0.0 109.051 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.709 HG13 ' OD1' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -154.62 162.75 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.533 -179.725 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.754 HD11 ' CD1' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -172.75 -123.76 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 109.335 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 pt-20 -112.18 165.75 11.87 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.372 -0.83 . . . . 0.0 110.991 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.561 ' HA ' ' HG ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -104.59 134.34 47.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.047 -1.033 . . . . 0.0 109.469 177.307 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.33 103.89 9.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.311 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.1 t30 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.385 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 2' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 72.8 -160.69 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.788 ' C ' HD13 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -171.55 108.71 0.26 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.564 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.883 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -156.59 160.61 39.59 Favored 'General case' 0 C--N 1.31 -1.152 0 O-C-N 120.918 -1.114 . . . . 0.0 111.213 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.968 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 48.8 t -114.71 171.36 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.618 ' N ' HG12 ' A' ' 5' ' ' VAL . 50.3 t80 -147.73 138.59 23.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.743 -1.223 . . . . 0.0 109.259 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' A' ' 73' ' ' ILE . 2.8 pt -160.68 159.31 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 39' ' ' ARG . . . -165.83 164.63 18.65 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.339 -1.476 . . . . 0.0 110.591 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 1.185 ' CE2' HG22 ' A' ' 71' ' ' ILE . 5.3 m-85 -149.18 163.15 38.44 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.73 ' HB3' HG23 ' A' ' 70' ' ' VAL . 0.7 OUTLIER -125.76 81.65 2.0 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.807 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.508 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 14.9 p30 -106.41 167.13 10.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 0.0 110.37 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.32 5.86 40.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.529 -0.732 . . . . 0.0 109.505 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -79.66 103.93 9.9 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.111 -0.993 . . . . 0.0 108.972 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.8 t-20 -66.17 -8.82 26.47 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 108.715 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.89 -40.66 85.11 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.42 ' NH2' HD13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -65.36 -36.5 84.2 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -46.67 81.67 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.345 -0.847 . . . . 0.0 108.937 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.12 -57.41 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.228 -0.92 . . . . 0.0 108.594 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.59 -21.68 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.379 -0.826 . . . . 0.0 108.801 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.506 ' O ' HG22 ' A' ' 23' ' ' ILE . 6.8 tt0 -75.09 -37.6 61.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.517 -0.739 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.78 -28.02 63.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.056 -1.027 . . . . 0.0 109.231 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.413 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 32.1 mm -76.85 -41.13 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.231 -0.918 . . . . 0.0 109.086 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 24' ' ' GLN . 1.3 tt -60.45 -46.29 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 108.655 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.517 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -67.65 -32.15 72.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.413 ' HB2' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -49.18 -30.04 6.34 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.819 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -79.66 136.37 55.49 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -84.0 45.15 1.7 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.826 1.435 . . . . 0.0 110.108 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -149.6 -47.71 0.14 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.181 -0.949 . . . . 0.0 109.636 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.03 55.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.573 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.717 HG13 ' HG3' ' A' ' 41' ' ' GLU . 4.8 p -100.31 140.41 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.37 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.498 HG21 HG23 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -151.34 166.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 0.0 109.449 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -165.16 82.37 0.36 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.491 ' CE1' ' HG2' ' A' ' 20' ' ' GLU . 2.3 p-80 -117.36 142.61 46.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -0.896 . . . . 0.0 109.286 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.566 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -160.93 -58.58 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.183 -0.948 . . . . 0.0 109.54 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.9 Cg_endo -68.62 -155.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.715 1.376 . . . . 0.0 109.862 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.98 -4.03 58.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 109.425 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.505 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 2.9 ttm -89.57 168.54 12.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.656 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -138.48 115.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.642 ' C ' HD12 ' A' ' 40' ' ' ILE . 3.6 ptp180 -129.62 168.66 16.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.662 -1.274 . . . . 0.0 111.433 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.642 HD12 ' C ' ' A' ' 39' ' ' ARG . 2.7 mp -158.98 157.43 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.717 ' HG3' HG13 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -131.58 -177.4 4.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.944 -1.098 . . . . 0.0 109.71 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.968 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . . . -129.2 -149.02 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 109.113 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.663 ' H ' HD21 ' A' ' 46' ' ' LEU . 1.2 mm-40 -135.6 26.94 3.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.824 -1.173 . . . . 0.0 111.699 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.642 ' CG ' ' HB2' ' A' ' 88' ' ' TRP . 0.5 OUTLIER 83.07 -39.49 0.09 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.887 0.851 . . . . 0.0 111.629 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.696 ' O ' HD23 ' A' ' 46' ' ' LEU . 6.3 mtm180 -127.81 113.23 15.68 Favored 'General case' 0 C--N 1.263 -3.177 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.087 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.696 HD23 ' O ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -141.18 144.52 34.84 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.696 ' HA ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -154.54 139.65 17.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 109.598 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -142.96 143.74 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -0.815 . . . . 0.0 109.132 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 -101.25 -98.35 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.002 . . . . 0.0 110.288 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -15.27 4.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.68 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HB3' ' HB ' ' A' ' 48' ' ' ILE . 33.8 tp10 -49.43 -24.86 2.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.725 -1.234 . . . . 0.0 108.986 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.663 HG21 ' O ' ' A' ' 82' ' ' ASP . 1.6 m -66.4 -46.16 77.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.085 -1.009 . . . . 0.0 108.929 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 52' ' ' THR . 78.2 t -47.26 -30.27 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -70.43 -46.81 63.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.424 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 52' ' ' THR . 7.2 mt-10 -51.09 -63.62 1.07 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' ARG . 1.0 OUTLIER -44.05 -33.98 1.62 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.526 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.7 tp -51.06 -62.74 1.43 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.667 ' O ' ' CB ' ' A' ' 59' ' ' ARG . . . -52.79 -24.79 20.47 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.667 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 8.9 tpt180 110.59 39.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.869 1.267 . . . . 0.0 108.576 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 61.4 96.36 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 102.672 -3.085 . . . . 0.0 102.672 -176.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.594 ' CD1' HG23 ' A' ' 63' ' ' VAL . 29.3 t90 -18.41 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 123.219 1.485 . . . . 0.0 109.845 -174.121 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 60' ' ' ALA . 23.7 t70 -102.19 53.21 0.8 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.96 -177.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 63' ' ' VAL . 40.5 t -88.47 9.42 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.479 -0.763 . . . . 0.0 110.037 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 63' ' ' VAL . 61.3 mm-40 -39.88 -31.74 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 109.693 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -64.46 -53.42 48.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 108.889 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.04 -1.28 25.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.406 -0.809 . . . . 0.0 109.54 179.255 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 69' ' ' ASP . 12.0 tp -38.53 -23.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.657 -0.652 . . . . 0.0 111.367 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' MET . 2.4 m -39.0 -28.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.033 -1.042 . . . . 0.0 109.953 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 21.6 p30 -59.08 165.12 2.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.43 -0.794 . . . . 0.0 109.587 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.73 HG23 ' HB3' ' A' ' 10' ' ' GLN . 45.7 t -79.45 167.09 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.194 -0.941 . . . . 0.0 109.015 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 1.185 HG22 ' CE2' ' A' ' 9' ' ' PHE . 1.5 pp -132.53 148.76 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.086 -1.009 . . . . 0.0 110.204 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 1.041 ' O ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -151.89 140.46 20.7 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.215 -0.928 . . . . 0.0 109.406 178.835 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.041 HD13 ' O ' ' A' ' 72' ' ' THR . 5.4 mm -137.33 153.82 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.448 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -166.33 32.27 0.22 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.576 ' CA ' HG13 ' A' ' 5' ' ' VAL . . . -146.24 -95.31 0.17 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.573 ' C ' HD21 ' A' ' 86' ' ' LEU . 0.6 OUTLIER -172.8 -151.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -1.167 . . . . 0.0 109.519 179.703 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.731 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.6 p 179.18 89.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.369 -0.832 . . . . 0.0 109.273 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.483 ' OD2' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -110.78 129.93 55.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.114 -0.991 . . . . 0.0 109.811 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.68 146.71 50.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.498 -0.751 . . . . 0.0 109.14 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.64 -101.14 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.071 -1.018 . . . . 0.0 109.422 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.2 -53.95 2.57 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.966 -1.084 . . . . 0.0 109.322 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.663 ' O ' HG21 ' A' ' 52' ' ' THR . 0.5 OUTLIER -130.86 -43.55 1.09 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.513 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 82' ' ' ASP . 10.1 mpt_? -54.53 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.661 -0.649 . . . . 0.0 109.346 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.923 ' O ' HD12 ' A' ' 48' ' ' ILE . 14.5 t80 -161.17 143.12 12.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 109.027 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.696 HG23 ' HA ' ' A' ' 47' ' ' GLU . 9.3 p -150.73 144.27 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.987 -1.071 . . . . 0.0 110.606 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.69 HD12 HD12 ' A' ' 46' ' ' LEU . 2.7 tm? -143.72 133.99 24.49 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.614 ' O ' HG21 ' A' ' 5' ' ' VAL . 5.5 mp0 -125.2 -135.45 0.27 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.316 -0.865 . . . . 0.0 108.755 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.642 ' HB2' ' CG ' ' A' ' 44' ' ' LYS . 10.0 t90 -92.62 -95.6 0.14 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.181 -0.949 . . . . 0.0 109.4 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.5 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 0.1 OUTLIER 67.75 157.33 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.0 109.475 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 t30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.583 -179.967 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' HB3' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.264 0.554 . . . . 0.0 109.547 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 1' ' ' MET . 4.1 p 178.01 -31.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.592 ' HA ' ' CE3' ' A' ' 88' ' ' TRP . 49.0 m -77.65 152.28 33.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.402 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.866 ' O ' HD12 ' A' ' 4' ' ' LEU . 1.2 pp -148.35 152.1 36.47 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.384 -0.822 . . . . 0.0 109.884 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.821 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 3.7 t -113.63 176.62 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.608 -0.683 . . . . 0.0 109.197 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.625 ' H ' HG12 ' A' ' 5' ' ' VAL . 8.9 t80 -143.18 138.46 29.74 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.001 -1.062 . . . . 0.0 108.276 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 73' ' ' ILE . 3.6 pt -156.89 156.07 4.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 108.475 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' THR . . . -163.99 141.25 6.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.78 -1.2 . . . . 0.0 109.902 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.67 ' CD2' HD11 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -139.54 -167.47 2.27 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.079 -1.013 . . . . 0.0 109.02 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.665 ' HB2' HG12 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -156.27 93.51 1.42 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.5 OUTLIER -109.6 -170.97 1.75 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -71.72 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.034 . . . . 0.0 109.235 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -145.0 7.17 1.19 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.867 -1.146 . . . . 0.0 110.088 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -102.52 -57.13 2.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.045 -1.034 . . . . 0.0 109.494 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.2 92.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.816 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.512 ' NH1' ' HG3' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -66.46 -36.72 83.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.133 -0.979 . . . . 0.0 109.301 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 11.1 t80 -62.73 -44.13 97.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 0.0 109.148 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.14 -53.11 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.238 -0.913 . . . . 0.0 109.17 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.57 -24.01 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -0.934 . . . . 0.0 109.281 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -66.64 -48.87 68.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.289 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.63 91.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.371 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.81 -46.89 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.412 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.402 HG21 ' O ' ' A' ' 30' ' ' VAL . 29.1 mt -52.83 -52.45 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 108.813 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 25' ' ' ASP . 1.4 mp0 -58.68 -31.06 67.86 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.208 -0.932 . . . . 0.0 108.631 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 24' ' ' GLN . 1.1 t70 -46.15 -42.0 13.28 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.589 -1.264 . . . . 0.0 107.589 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -96.63 131.49 28.09 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.92 47.57 2.31 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.703 1.37 . . . . 0.0 110.085 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 29' ' ' ALA . 30.0 t-80 -154.52 -50.83 0.09 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.25 -0.906 . . . . 0.0 109.977 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -41.36 140.42 0.87 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.796 . . . . 0.0 109.991 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.708 HG22 ' H ' ' A' ' 31' ' ' VAL . 1.6 p -78.66 -169.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.317 -0.864 . . . . 0.0 108.715 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.708 ' H ' HG22 ' A' ' 30' ' ' VAL . 15.6 m -122.88 -155.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.996 -1.065 . . . . 0.0 109.477 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.559 ' HB3' ' CA ' ' A' ' 38' ' ' ILE . 2.3 mp0 -112.75 -151.74 0.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.073 -1.017 . . . . 0.0 109.604 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.34 -96.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.873 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.565 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -163.89 -69.55 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.009 -1.057 . . . . 0.0 109.569 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 34' ' ' HIS . 5.7 Cg_exo -49.27 -178.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.904 1.476 . . . . 0.0 110.47 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.451 ' HB1' ' CD ' ' A' ' 10' ' ' GLN . . . -43.09 -36.07 1.52 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.384 -0.823 . . . . 0.0 109.896 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.494 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 66.2 mtm -63.91 144.18 57.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.002 -1.061 . . . . 0.0 109.13 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.67 HD11 ' CD2' ' A' ' 9' ' ' PHE . 6.3 pt -146.28 109.3 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.554 ' N ' ' HB3' ' A' ' 32' ' ' GLN . 1.6 mtt-85 -90.74 174.45 7.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 0.0 109.523 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 41' ' ' GLU . 11.4 mt -161.98 166.96 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.449 -0.782 . . . . 0.0 109.391 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.615 ' HB2' HG11 ' A' ' 30' ' ' VAL . 5.7 tp10 -142.79 170.4 15.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 0.0 109.005 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.821 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . . . -140.84 -168.81 2.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.724 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.741 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 1.6 pm0 -143.37 85.16 1.84 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.511 -0.743 . . . . 0.0 109.758 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.581 ' CB ' ' HB2' ' A' ' 3' ' ' SER . 0.0 OUTLIER 83.4 -179.68 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -178.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.674 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 3.8 mmt180 179.5 -165.58 0.06 Allowed 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.435 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 4.8 mt 164.48 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.836 ' H ' HG23 ' A' ' 85' ' ' VAL . 2.0 mt-10 162.59 -167.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.828 -1.17 . . . . 0.0 109.394 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.825 HG23 ' N ' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -177.31 -151.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.972 . . . . 0.0 109.634 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.825 ' N ' HG23 ' A' ' 48' ' ' ILE . 11.0 ttp180 -91.73 -37.05 13.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.949 -1.095 . . . . 0.0 110.131 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.621 ' H ' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -59.7 -32.46 70.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.918 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 20.8 mm-40 -58.05 -27.64 63.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.134 -0.979 . . . . 0.0 109.665 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m -64.84 -41.39 95.76 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.003 -1.06 . . . . 0.0 109.434 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.6 t -53.52 -29.66 17.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -70.69 -40.5 72.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 17.8 mt-10 -57.49 -62.91 1.45 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.47 ' HA ' ' H ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -44.0 -36.75 2.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.98 . . . . 0.0 109.057 179.306 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 9.9 tp -57.65 -50.02 74.53 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -78.59 15.79 9.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 176.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.565 ' HB3' ' O ' ' A' ' 58' ' ' GLY . 2.8 ttt180 68.34 49.64 0.79 Allowed 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 121.415 0.626 . . . . 0.0 110.056 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 57.31 93.21 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TRP . . . . . 0.598 ' C ' ' O ' ' A' ' 60' ' ' ALA . 57.4 t90 -16.3 81.09 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.434 1.588 . . . . 0.0 109.319 -174.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 60' ' ' ALA . 20.8 t70 -102.44 66.82 0.99 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.138 -1.846 . . . . 0.0 110.012 -176.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 63' ' ' VAL . 19.5 t -89.56 6.63 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 109.558 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.946 ' O ' HD22 ' A' ' 67' ' ' LEU . 5.4 mp0 -42.58 -31.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 109.454 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.48 -49.66 65.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.119 -0.988 . . . . 0.0 109.236 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.5 ' O ' ' N ' ' A' ' 68' ' ' VAL . 1.4 mtt -72.95 -5.35 37.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.919 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.946 HD22 ' O ' ' A' ' 64' ' ' GLN . 1.5 pt? -39.21 -26.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.467 -0.771 . . . . 0.0 110.788 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 69' ' ' ASP . 5.8 p -40.52 -49.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.589 ' N ' HG13 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -72.64 146.17 46.78 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 10' ' ' GLN . 6.9 p -76.15 173.79 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.841 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ILE . . . . . 0.64 ' H ' HG22 ' A' ' 70' ' ' VAL . 9.1 mt -153.17 157.0 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.228 -0.92 . . . . 0.0 109.835 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -149.56 152.07 34.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.491 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.697 HD13 ' C ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -137.47 159.31 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -159.81 66.73 0.27 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.441 -1.362 . . . . 0.0 110.794 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.505 ' C ' ' O ' ' A' ' 88' ' ' TRP . . . -127.94 -105.89 1.31 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.609 ' C ' HD21 ' A' ' 86' ' ' LEU . 2.9 t-20 -165.12 -144.57 0.07 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -1.188 . . . . 0.0 108.435 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.4 p -170.28 98.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.881 -1.137 . . . . 0.0 110.587 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -114.38 127.46 55.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.439 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -128.05 149.99 50.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 109.61 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -109.82 -103.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 109.364 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -104.23 -54.14 2.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.951 -1.093 . . . . 0.0 108.909 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ARG . 79.8 m-20 -130.67 -39.75 1.25 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -51.65 -175.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.602 0.715 . . . . 0.0 109.728 179.457 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -160.23 111.07 1.88 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.836 HG23 ' H ' ' A' ' 47' ' ' GLU . 4.0 p -124.37 143.6 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.061 -1.024 . . . . 0.0 109.251 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.803 ' C ' HD13 ' A' ' 86' ' ' LEU . 2.2 tm? -151.22 129.45 11.95 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.885 -1.526 . . . . 0.0 110.571 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.665 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -118.18 -178.9 3.62 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.24 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.647 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 5.6 t90 -43.1 -88.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.457 -1.297 . . . . 0.0 108.244 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.558 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 1.3 tttt -167.11 36.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.022 -1.049 . . . . 0.0 109.523 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.7 t30 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.415 179.879 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.513 ' O ' ' N ' ' A' ' 44' ' ' LYS . 20.0 m . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.69 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -130.05 155.65 45.8 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.218 -0.926 . . . . 0.0 110.336 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.13 HG11 HD21 ' A' ' 46' ' ' LEU . 1.1 m -116.66 -150.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.566 -0.709 . . . . 0.0 109.361 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.959 ' OH ' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER 172.78 139.82 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.106 -0.996 . . . . 0.0 109.625 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.817 HG22 ' HA ' ' A' ' 73' ' ' ILE . 46.4 pt -136.61 139.41 45.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.612 ' HB2' ' HD2' ' A' ' 39' ' ' ARG . . . -134.2 164.78 26.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.551 -1.343 . . . . 0.0 110.65 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 1.065 ' CZ ' HD13 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -158.78 151.55 22.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.526 ' HG2' ' CB ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -131.81 92.97 3.22 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.05 -1.031 . . . . 0.0 108.51 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -87.04 -132.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.405 -0.809 . . . . 0.0 109.762 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.451 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 5.0 t-20 -86.42 -111.88 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.837 -1.164 . . . . 0.0 109.385 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -132.63 -24.52 1.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.927 -1.108 . . . . 0.0 109.775 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.416 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.6 t-20 -102.96 -54.35 2.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.025 -1.047 . . . . 0.0 109.817 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ASN . . . -44.27 -31.17 0.94 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.809 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 13' ' ' ASP . 55.9 mtm180 -64.79 -63.58 1.08 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.613 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 1.1 m-85 -47.5 -36.57 10.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -0.958 . . . . 0.0 109.455 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 14' ' ' ASN . 41.2 t -54.67 -58.64 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.93 . . . . 0.0 109.031 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.3 t -56.73 -22.78 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.207 -0.933 . . . . 0.0 108.865 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 23' ' ' ILE . 13.3 tt0 -69.46 -38.36 77.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.437 -0.789 . . . . 0.0 109.217 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.36 68.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.246 -0.909 . . . . 0.0 108.891 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.43 ' HA ' HD13 ' A' ' 22' ' ' ILE . 24.3 mm -70.31 -55.58 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 20' ' ' GLU . 1.0 OUTLIER -58.98 -35.54 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.055 -1.028 . . . . 0.0 109.668 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -69.63 -35.97 75.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.108 -0.995 . . . . 0.0 108.693 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 24' ' ' GLN . 0.3 OUTLIER -46.18 -42.8 14.56 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -79.8 136.54 54.81 Favored Pre-proline 0 N--CA 1.486 1.356 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -84.28 46.23 1.91 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.795 1.418 . . . . 0.0 109.979 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -149.04 -39.57 0.15 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.18 -0.95 . . . . 0.0 109.629 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 23' ' ' ILE . . . -44.81 140.18 2.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 109.746 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.663 HG12 ' H ' ' A' ' 31' ' ' VAL . 2.6 t -101.22 177.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.663 ' H ' HG12 ' A' ' 30' ' ' VAL . 2.0 t -141.45 154.58 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.23 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -140.29 -71.73 0.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.636 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -95.27 176.66 6.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.969 . . . . 0.0 109.595 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.565 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -152.13 -64.55 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.285 -0.885 . . . . 0.0 109.538 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 4.2 Cg_exo -61.17 -75.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.636 1.335 . . . . 0.0 110.417 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 35' ' ' PRO . . . -46.52 -93.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.526 ' CB ' ' HG2' ' A' ' 10' ' ' GLN . 2.0 ptm -115.46 -167.23 1.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.687 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 0.9 OUTLIER -128.43 101.96 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.356 -0.84 . . . . 0.0 109.114 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.612 ' HD2' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -87.31 169.26 12.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.746 -179.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.563 HG22 ' N ' ' A' ' 41' ' ' GLU . 45.3 mt -142.69 164.92 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.725 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -143.85 147.27 33.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.209 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.019 ' CB ' HG22 ' A' ' 5' ' ' VAL . . . -127.51 -171.81 2.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.69 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 8.3 mt-10 -140.11 64.91 1.43 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.878 -1.139 . . . . 0.0 110.372 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 8.5 tttt 175.25 -140.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.952 -1.093 . . . . 0.0 110.263 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.982 ' C ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -126.51 166.69 16.79 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.301 -0.874 . . . . 0.0 110.182 -178.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.13 HD21 HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -129.03 157.72 40.93 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HG2' HG23 ' A' ' 85' ' ' VAL . 8.2 mt-10 -150.96 140.01 21.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.077 -1.014 . . . . 0.0 109.99 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.658 HG22 ' OG1' ' A' ' 52' ' ' THR . 1.3 mp -138.94 150.44 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 0.0 109.159 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -97.3 176.42 5.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.122 -0.986 . . . . 0.0 109.969 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -67.08 -24.39 65.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 109.332 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 34.9 mm-40 -49.53 -40.89 39.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.028 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.658 ' OG1' HG22 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -65.56 -46.44 79.46 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.162 -0.961 . . . . 0.0 108.755 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.6 t -56.08 -22.98 14.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -75.58 -38.21 59.29 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -66.69 -53.02 38.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 108.956 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -56.12 -33.39 65.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.288 -0.883 . . . . 0.0 109.139 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.18 -55.83 29.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.246 -0.909 . . . . 0.0 109.095 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.32 -7.49 63.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.44 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -117.01 10.22 13.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -1.108 . . . . 0.0 109.402 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -69.3 -6.89 32.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.707 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -91.42 19.75 5.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.021 . . . . 0.0 109.336 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.435 ' OD1' ' HB3' ' A' ' 65' ' ' GLU . 26.8 t70 -111.84 10.2 20.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.541 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 63' ' ' VAL . 3.1 t -49.54 -46.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 109.871 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -51.61 -45.87 63.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 109.406 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HB3' ' OD1' ' A' ' 62' ' ' ASP . 2.7 tt0 -68.29 -27.86 66.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.195 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 69' ' ' ASP . 1.1 mtm -74.78 -17.88 60.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.301 -0.874 . . . . 0.0 109.224 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -69.83 -57.49 5.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.557 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.9 t -46.96 -64.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.524 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 2.0 p30 -82.87 154.79 24.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 71' ' ' ILE . 21.1 t -99.53 165.75 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.168 -0.958 . . . . 0.0 109.568 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.065 HD13 ' CZ ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -146.11 151.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 0.0 109.648 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.959 HG21 ' OH ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -165.4 151.86 10.01 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.817 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -154.61 152.0 10.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.898 -1.126 . . . . 0.0 111.185 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.661 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 46.84 -85.12 0.01 OUTLIER Glycine 0 C--N 1.299 -1.492 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.926 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 73' ' ' ILE . . . 171.37 -47.81 0.19 Allowed Glycine 0 C--N 1.284 -2.329 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.538 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 16.2 t30 -120.34 -141.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.973 -1.31 . . . . 0.0 108.959 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.85 HG23 ' CE1' ' A' ' 84' ' ' PHE . 3.0 p 178.94 98.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.988 -1.07 . . . . 0.0 110.151 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.42 129.9 46.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 108.865 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -125.6 139.98 53.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.58 -96.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -104.04 -60.97 1.5 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.042 -1.036 . . . . 0.0 109.373 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -127.88 -30.8 2.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.341 -0.849 . . . . 0.0 109.01 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.496 ' CG ' ' N ' ' A' ' 84' ' ' PHE . 34.4 ttp180 -68.59 168.21 13.48 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.359 -0.838 . . . . 0.0 109.146 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.85 ' CE1' HG23 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -141.84 127.11 18.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 108.907 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.531 HG23 ' HG2' ' A' ' 47' ' ' GLU . 3.7 p -138.64 150.72 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.22 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.811 HD22 ' N ' ' A' ' 87' ' ' GLU . 1.7 tm? -157.19 135.75 11.42 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.811 ' N ' HD22 ' A' ' 86' ' ' LEU . 2.0 mp0 . . . . . 0 C--N 1.303 -1.445 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.672 ' C ' HD13 ' A' ' 4' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.916 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.17 154.92 42.32 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.032 -1.043 . . . . 0.0 110.47 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.023 HG22 ' HB3' ' A' ' 42' ' ' ALA . 3.4 m -115.1 -171.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.458 0.647 . . . . 0.0 109.313 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.567 ' O ' ' N ' ' A' ' 74' ' ' GLY . 4.9 t80 -159.08 137.98 11.11 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.553 HG22 ' HA ' ' A' ' 73' ' ' ILE . 3.2 pt -158.11 142.14 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.694 ' HB3' ' OG1' ' A' ' 72' ' ' THR . . . -146.89 150.41 35.18 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.776 -1.203 . . . . 0.0 110.109 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 1.102 ' CZ ' HG23 ' A' ' 71' ' ' ILE . 8.8 m-85 -134.57 172.27 13.16 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.632 ' HB3' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -147.33 80.99 1.52 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.258 178.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.546 ' CA ' ' HB3' ' A' ' 69' ' ' ASP . 5.5 t0 -106.75 -178.91 3.79 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.1 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.157 -0.964 . . . . 0.0 109.049 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.56 14.12 0.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.034 -1.041 . . . . 0.0 109.938 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -102.46 -56.5 2.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.317 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.41 -54.51 39.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.756 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -51.12 -39.2 55.68 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 109.611 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' N ' ' HG3' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -59.44 -47.5 85.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.229 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.479 HG12 HD11 ' A' ' 22' ' ' ILE . 73.1 t -53.81 -53.84 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.287 -0.883 . . . . 0.0 109.241 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.972 ' HA ' HD12 ' A' ' 22' ' ' ILE . 53.3 t -62.37 -21.82 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.216 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -43.84 73.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.777 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.11 67.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.0 109.324 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.972 HD12 ' HA ' ' A' ' 19' ' ' VAL . 14.8 mt -67.14 -42.26 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.276 -0.89 . . . . 0.0 109.172 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.789 HG23 ' CB ' ' A' ' 29' ' ' ALA . 41.2 mt -60.87 -54.63 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.33 -0.856 . . . . 0.0 109.298 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 25' ' ' ASP . 18.6 mt-30 -57.79 -31.33 66.45 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.157 -0.964 . . . . 0.0 108.56 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 24' ' ' GLN . 9.0 t70 -46.12 -47.51 17.38 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -84.58 135.27 40.97 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -83.65 45.19 1.75 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.761 1.4 . . . . 0.0 110.155 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.6 t60 -151.7 -49.06 0.11 Allowed 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.165 -0.959 . . . . 0.0 109.759 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.789 ' CB ' HG23 ' A' ' 23' ' ' ILE . . . -41.85 141.43 0.83 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.4 -0.813 . . . . 0.0 109.704 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -100.85 -169.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.185 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.592 HG22 ' N ' ' A' ' 32' ' ' GLN . 2.0 p -169.01 166.46 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 0.0 109.536 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.592 ' N ' HG22 ' A' ' 31' ' ' VAL . 2.8 mm-40 -144.84 77.24 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.513 ' CD2' ' O ' ' A' ' 33' ' ' HIS . 0.3 OUTLIER -48.49 103.36 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 109.547 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.586 ' CD2' ' HD2' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -104.84 -178.56 0.63 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.586 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 3.8 Cg_exo -67.6 -74.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.939 1.494 . . . . 0.0 110.116 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.39 3.39 11.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.758 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.3 mtt -112.28 157.54 20.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.128 -0.982 . . . . 0.0 109.388 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.515 ' CG1' ' O ' ' A' ' 9' ' ' PHE . 12.1 pt -134.51 92.02 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.651 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.645 ' C ' HD12 ' A' ' 40' ' ' ILE . 2.1 ttp180 -85.55 162.23 18.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 110.086 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.645 HD12 ' C ' ' A' ' 39' ' ' ARG . 4.1 mp -150.97 162.01 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 0.0 109.499 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.516 ' N ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -161.96 157.1 23.22 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.027 -1.046 . . . . 0.0 110.251 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.023 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -129.34 177.75 6.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.388 -0.82 . . . . 0.0 109.068 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 2.8 pt-20 -158.74 68.74 0.46 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.915 -1.116 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.4 OUTLIER 169.82 -152.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.816 -1.178 . . . . 0.0 110.82 178.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 1.045 ' C ' HD23 ' A' ' 46' ' ' LEU . 20.1 mtp180 -125.43 135.14 52.05 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.045 HD23 ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -127.32 162.53 26.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.45 -0.781 . . . . 0.0 109.168 -178.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.948 ' CB ' HG23 ' A' ' 85' ' ' VAL . 1.2 pt-20 -176.19 158.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.984 -1.073 . . . . 0.0 110.668 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.526 ' CG2' ' CB ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -152.27 155.84 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.627 ' HA ' ' CB ' ' A' ' 83' ' ' ARG . 30.0 ttp180 -100.12 -112.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 110.112 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -61.63 -5.29 1.78 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.982 -1.074 . . . . 0.0 110.519 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.526 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 1.0 OUTLIER -54.61 -14.7 1.41 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.708 -1.245 . . . . 0.0 109.363 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 1.9 m -58.26 -39.33 78.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.69 -1.256 . . . . 0.0 109.47 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.91 -32.45 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 1.3 tt0 -67.63 -40.56 84.63 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 60' ' ' ALA . 1.1 tt0 -49.85 -63.29 1.16 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.536 ' HA ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -48.55 -31.44 6.53 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.634 -0.666 . . . . 0.0 109.387 179.006 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.516 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.5 tp -52.27 -59.03 4.88 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.68 ' O ' ' CB ' ' A' ' 59' ' ' ARG . . . -53.63 -24.52 25.19 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 106.861 -2.496 . . . . 0.0 106.861 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.68 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 1.6 ttm-85 110.68 35.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.786 1.234 . . . . 0.0 108.557 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 62.92 96.42 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.772 ' CZ2' HG21 ' A' ' 63' ' ' VAL . 24.6 t-105 -20.11 82.74 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 123.26 1.505 . . . . 0.0 109.35 -174.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 60' ' ' ALA . 19.0 t70 -109.2 71.1 0.76 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.415 -1.721 . . . . 0.0 109.738 -176.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.772 HG21 ' CZ2' ' A' ' 61' ' ' TRP . 2.1 t -86.91 6.51 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.865 . . . . 0.0 109.799 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.887 ' O ' HD23 ' A' ' 67' ' ' LEU . 1.3 mp0 -41.63 -34.01 0.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.614 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.54 -50.93 67.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.003 -1.061 . . . . 0.0 108.979 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.575 ' HB2' HG12 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -75.68 -2.64 30.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.46 -0.775 . . . . 0.0 110.02 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 64' ' ' GLN . 3.7 pp -38.5 -26.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.503 -0.748 . . . . 0.0 110.961 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.608 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.4 m -39.89 -45.42 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.151 -0.968 . . . . 0.0 110.156 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.546 ' HB3' ' CA ' ' A' ' 11' ' ' ASP . 15.8 p30 -65.29 149.45 49.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.67 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.632 HG23 ' HB3' ' A' ' 10' ' ' GLN . 21.8 t -62.53 169.77 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.102 HG23 ' CZ ' ' A' ' 9' ' ' PHE . 11.4 mt -143.56 157.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.056 -1.028 . . . . 0.0 110.643 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.694 ' OG1' ' HB3' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -159.31 142.38 14.34 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.553 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -143.78 163.33 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.084 -1.01 . . . . 0.0 110.194 -179.087 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -174.25 71.95 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 136.02 108.13 0.91 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 1.008 ' HA ' HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -157.78 139.42 13.86 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.183 -1.187 . . . . 0.0 110.908 -178.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 85' ' ' VAL . 1.8 t -152.37 30.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.634 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 5.2 p-10 -47.84 -38.95 17.12 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.898 0.856 . . . . 0.0 111.233 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.407 ' N ' ' CG ' ' A' ' 78' ' ' ASP . 1.5 mm-40 -110.79 103.06 11.54 Favored 'General case' 0 C--N 1.266 -3.023 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.93 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.557 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 58.1 t0 -115.2 -68.46 0.92 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.035 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 24.0 m-20 -108.21 -96.6 0.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -0.93 . . . . 0.0 109.365 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -131.03 0.22 4.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.036 -1.04 . . . . 0.0 109.221 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.627 ' CB ' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -102.6 -107.09 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.796 . . . . 0.0 109.42 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 78' ' ' ASP . 12.9 t80 -174.74 118.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.831 -1.168 . . . . 0.0 108.718 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.948 HG23 ' CB ' ' A' ' 47' ' ' GLU . 10.7 p -131.83 174.92 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.867 -1.146 . . . . 0.0 110.588 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.008 HD23 ' HA ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER -177.84 130.56 0.15 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.992 ' N ' HD22 ' A' ' 86' ' ' LEU . 2.2 mt-10 . . . . . 0 C--N 1.302 -1.463 0 O-C-N 120.902 -1.124 . . . . 0.0 111.624 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 44' ' ' LYS . 15.8 m . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.072 0.463 . . . . 0.0 109.867 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -122.44 168.41 12.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.049 -1.032 . . . . 0.0 109.707 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.772 HG22 ' HB3' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -132.85 -178.35 2.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.346 -0.846 . . . . 0.0 109.954 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 74' ' ' GLY . 1.3 t80 -149.53 142.37 24.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 6' ' ' TYR . 1.8 pp -160.84 158.51 2.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.555 ' N ' ' HB ' ' A' ' 72' ' ' THR . . . -159.35 145.69 16.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.658 -1.276 . . . . 0.0 109.691 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 1.005 ' CE2' HD11 ' A' ' 38' ' ' ILE . 2.6 p90 -145.26 -171.2 3.61 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 109.539 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.684 ' HB3' HG23 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -148.97 98.98 2.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -0.76 . . . . 0.0 109.108 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.445 ' OD1' ' OD2' ' A' ' 69' ' ' ASP . 35.4 t70 -108.57 136.76 47.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.629 -0.67 . . . . 0.0 109.525 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -71.67 -31.49 66.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 109.561 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.43 ' CB ' ' OD2' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -57.52 106.02 0.3 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.087 -1.008 . . . . 0.0 108.575 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.61 -11.43 7.21 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.82 -31.53 49.58 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.034 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.459 HH11 ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -67.29 -45.45 76.52 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.486 -0.759 . . . . 0.0 109.067 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.4 -44.53 72.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.206 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -54.95 -60.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.237 -0.915 . . . . 0.0 108.828 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.683 ' HA ' HD12 ' A' ' 22' ' ' ILE . 85.1 t -52.95 -23.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 108.864 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -54.39 19.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.191 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.89 -35.45 61.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.271 -0.893 . . . . 0.0 109.304 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 19' ' ' VAL . 57.8 mt -64.52 -45.34 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 109.191 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.512 HG23 ' CB ' ' A' ' 29' ' ' ALA . 95.9 mt -51.43 -48.06 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.879 . . . . 0.0 109.14 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.2 72.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.21 -0.931 . . . . 0.0 108.573 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.12 -32.69 16.56 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -80.07 137.59 53.26 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -84.47 44.9 1.59 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.818 1.431 . . . . 0.0 109.822 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -151.06 -53.97 0.14 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.305 -0.872 . . . . 0.0 109.201 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.512 ' CB ' HG23 ' A' ' 23' ' ' ILE . . . -63.49 139.59 58.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.356 -0.84 . . . . 0.0 109.075 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.546 ' CG1' ' HG3' ' A' ' 41' ' ' GLU . 11.7 p -101.21 158.95 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.193 -0.942 . . . . 0.0 109.609 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.444 ' N ' HG22 ' A' ' 30' ' ' VAL . 1.9 t -138.78 148.7 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.408 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -144.29 43.73 1.42 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.225 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 32' ' ' GLN . 12.5 p80 -44.32 140.31 2.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.892 . . . . 0.0 109.35 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.492 ' CG ' ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -103.73 178.26 1.22 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.504 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.492 ' HD2' ' CG ' ' A' ' 34' ' ' HIS . 2.7 Cg_endo -76.53 -28.01 7.13 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.066 1.561 . . . . 0.0 110.331 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.89 -30.62 3.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.592 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.518 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -117.16 -168.99 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.569 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.005 HD11 ' CE2' ' A' ' 9' ' ' PHE . 11.3 pt -140.03 115.65 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.346 -0.847 . . . . 0.0 108.831 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.773 ' O ' HD13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -111.89 142.76 43.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.447 -178.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.773 HD13 ' O ' ' A' ' 39' ' ' ARG . 28.0 mm -145.91 152.42 14.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.583 -0.698 . . . . 0.0 109.213 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.546 ' HG3' ' CG1' ' A' ' 30' ' ' VAL . 2.9 pt-20 -129.29 176.59 7.82 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.113 -0.992 . . . . 0.0 108.893 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.772 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -132.66 -179.43 5.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.079 -1.013 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 17.9 mt-10 -140.48 58.87 1.56 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.373 -0.83 . . . . 0.0 109.261 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.457 ' N ' ' O ' ' A' ' 3' ' ' SER . 1.6 mmtp -153.0 -166.28 2.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.908 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.56 ' HA ' ' CG ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -141.26 -171.2 3.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.798 HD12 ' O ' ' A' ' 87' ' ' GLU . 15.2 mt -159.03 157.33 30.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 110.741 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.88 ' HA ' HG23 ' A' ' 85' ' ' VAL . 1.4 tt0 -160.94 139.75 10.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.179 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.793 HG22 ' CG ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -154.69 141.63 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.128 -0.983 . . . . 0.0 109.912 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.601 ' HA ' ' CG ' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -101.58 -101.38 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.811 179.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -6.38 27.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.018 -1.052 . . . . 0.0 109.294 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.793 ' CG ' HG22 ' A' ' 48' ' ' ILE . 3.2 mt-10 -56.41 -16.12 5.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.422 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -59.14 -42.48 90.76 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.87 -1.144 . . . . 0.0 109.259 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 52' ' ' THR . 59.0 t -48.38 -33.48 4.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.979 -1.076 . . . . 0.0 108.158 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -68.39 -44.93 74.03 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -45.08 46.42 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -53.86 -44.13 70.12 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.674 ' C ' HD13 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -51.44 -72.52 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 57' ' ' LEU . . . -39.32 -28.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.506 ' CB ' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -53.07 -58.97 5.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -1.201 . . . . 0.0 109.008 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 59' ' ' ARG . . . -42.85 -32.92 0.68 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -90.86 50.21 1.77 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.56 78.7 2.57 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.942 0.877 . . . . 0.0 109.396 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.505 HG12 ' HB2' ' A' ' 66' ' ' MET . 8.2 t -72.58 7.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.918 -0.489 . . . . 0.0 110.622 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 63' ' ' VAL . 2.7 mp0 -39.52 -27.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.141 -0.974 . . . . 0.0 109.91 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.657 ' O ' HG23 ' A' ' 68' ' ' VAL . 11.7 mt-10 -57.48 -56.23 24.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.008 . . . . 0.0 108.902 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.505 ' HB2' HG12 ' A' ' 63' ' ' VAL . 1.6 mmm -67.39 -8.34 32.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 0.0 109.403 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.87 HD21 HG21 ' A' ' 71' ' ' ILE . 5.9 tp -76.6 7.85 4.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.443 -0.786 . . . . 0.0 110.433 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 65' ' ' GLU . 58.2 t -40.41 -25.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.995 -1.066 . . . . 0.0 110.489 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' LEU . 7.2 m-20 -58.18 143.55 43.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.007 -1.058 . . . . 0.0 109.019 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.694 ' C ' HD13 ' A' ' 71' ' ' ILE . 57.3 t -43.82 159.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.144 -0.972 . . . . 0.0 109.126 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.87 HG21 HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -141.54 141.56 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.579 -0.7 . . . . 0.0 109.787 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.555 ' HB ' ' N ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -154.73 147.63 24.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.564 179.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.511 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -133.17 174.8 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.344 -0.847 . . . . 0.0 109.443 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 174.94 64.44 0.05 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.18 -95.3 0.49 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.26 153.58 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 0.0 109.473 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.54 102.8 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.127 -0.983 . . . . 0.0 109.869 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.619 ' OD1' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -107.7 112.95 25.9 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.006 178.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.58 131.46 54.83 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.473 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -104.04 -107.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -108.41 -56.34 2.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.93 -1.106 . . . . 0.0 109.495 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -127.28 -33.7 2.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.35 -0.844 . . . . 0.0 108.96 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.601 ' CG ' ' HA ' ' A' ' 49' ' ' ARG . 1.7 mpt_? -66.48 -178.06 0.64 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.548 -0.72 . . . . 0.0 109.397 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.478 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.3 t80 -161.5 130.16 4.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 109.661 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.88 HG23 ' HA ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -132.64 157.31 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.989 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.641 ' CD1' ' CB ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -165.49 -150.41 0.13 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.798 ' O ' HD12 ' A' ' 46' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.29 -1.986 0 O-C-N 121.092 -1.005 . . . . 0.0 109.373 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m . . . . . 0 N--CA 1.49 1.564 0 CA-C-O 121.15 0.5 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 4' ' ' LEU . 0.7 OUTLIER -122.33 161.56 23.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.222 -0.924 . . . . 0.0 109.212 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.019 HG22 ' HB3' ' A' ' 42' ' ' ALA . 3.1 m -125.52 -171.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.271 -0.893 . . . . 0.0 110.272 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.586 ' O ' ' N ' ' A' ' 74' ' ' GLY . 10.5 t80 -163.43 137.75 6.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.536 -0.727 . . . . 0.0 109.134 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.583 HG22 ' HA ' ' A' ' 73' ' ' ILE . 7.7 pt -148.76 139.67 17.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.965 ' HA ' ' CB ' ' A' ' 39' ' ' ARG . . . -144.36 137.52 27.18 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 117.752 -1.579 . . . . 0.0 111.98 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD2' ' HG2' ' A' ' 39' ' ' ARG . 2.0 p90 -128.8 178.15 6.56 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.084 -1.046 . . . . 0.0 109.106 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.844 ' N ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -127.03 94.04 3.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 5.1 p-10 -108.12 143.16 37.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 110.214 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -78.48 -5.06 51.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.446 -0.784 . . . . 0.0 109.157 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' O ' ' OD2' ' A' ' 11' ' ' ASP . 32.9 t0 -80.78 103.46 10.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.24 -0.913 . . . . 0.0 108.819 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.29 -9.16 21.91 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.32 -0.862 . . . . 0.0 108.895 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.06 -39.27 71.78 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.24 -0.913 . . . . 0.0 108.931 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.43 -44.95 80.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.429 -0.794 . . . . 0.0 109.009 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CE2' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -55.11 -45.55 75.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.0 108.999 179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.18 -61.07 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -0.878 . . . . 0.0 108.81 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -53.05 -23.26 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.274 -0.892 . . . . 0.0 108.613 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -54.95 17.83 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.6 -37.41 17.99 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 25' ' ' ASP . 36.8 mt -61.26 -45.09 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.718 HG23 ' HB1' ' A' ' 29' ' ' ALA . 22.4 mm -50.45 -57.04 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 109.024 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -59.5 -28.52 67.12 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.195 -0.94 . . . . 0.0 108.489 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -50.4 -39.44 47.06 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -79.69 141.77 56.34 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -84.48 44.84 1.58 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.777 1.409 . . . . 0.0 109.904 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -150.65 -48.28 0.12 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.718 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -71.1 139.26 50.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.385 -0.822 . . . . 0.0 109.657 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 t -101.98 152.04 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 109.502 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -129.07 169.14 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.21 -0.932 . . . . 0.0 109.367 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -147.73 111.46 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.406 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -82.14 127.77 33.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -123.93 148.2 56.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.29 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.661 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 2.2 Cg_endo -87.23 43.77 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.895 1.471 . . . . 0.0 110.206 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 35' ' ' PRO . . . 166.43 -29.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.957 ' C ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -104.8 171.6 7.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.579 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.957 HD13 ' C ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -156.04 124.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.448 -0.783 . . . . 0.0 109.199 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.965 ' CB ' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER 171.59 -151.88 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.993 -1.067 . . . . 0.0 110.949 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.775 HG22 ' H ' ' A' ' 41' ' ' GLU . 2.5 mt -160.79 -170.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.587 -1.321 . . . . 0.0 110.306 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.775 ' H ' HG22 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -134.83 -173.35 3.28 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 1.019 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -138.74 -171.34 3.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.973 -1.08 . . . . 0.0 110.007 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 18.6 mt-10 -141.36 33.01 1.68 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.404 -0.81 . . . . 0.0 109.741 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.3 tttp -168.34 -144.65 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.891 -1.131 . . . . 0.0 110.332 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.565 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.1 OUTLIER -145.3 -154.09 0.52 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.716 HD13 HD21 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -155.5 148.32 24.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.059 -1.026 . . . . 0.0 110.061 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.492 ' HA ' HG23 ' A' ' 85' ' ' VAL . 4.3 tm-20 -137.81 139.56 40.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.064 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.536 ' CD1' HG21 ' A' ' 52' ' ' THR . 0.1 OUTLIER -159.4 154.79 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.11 -0.994 . . . . 0.0 109.967 -179.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.459 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -82.82 -166.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.382 -0.823 . . . . 0.0 110.092 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.52 ' HG3' ' NH1' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -73.38 -27.01 61.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.928 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -49.19 -30.42 6.87 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.027 -1.046 . . . . 0.0 108.921 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.598 ' HB ' ' CD2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -65.74 -45.28 83.22 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.894 -1.129 . . . . 0.0 108.478 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.941 HG22 ' CD1' ' A' ' 84' ' ' PHE . 40.6 t -47.88 -29.56 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 3.3 tt0 -71.85 -45.09 62.57 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -55.97 -51.7 66.77 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.397 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.67 -38.64 72.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 109.643 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.21 -52.3 65.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.208 -0.932 . . . . 0.0 109.244 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.12 -14.55 61.64 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -112.52 20.87 16.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -1.082 . . . . 0.0 109.713 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.58 -7.43 43.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.665 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.612 ' CD1' ' O ' ' A' ' 61' ' ' TRP . 65.3 t-105 -92.31 22.89 4.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.932 . . . . 0.0 109.481 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -110.79 5.95 21.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.022 -1.049 . . . . 0.0 109.988 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.01 -33.84 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 109.644 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -53.48 -37.15 62.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.227 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.77 -31.52 68.34 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.348 -0.845 . . . . 0.0 109.236 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mtm -67.78 -12.84 61.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 tt -68.61 -50.57 50.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.095 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.86 -43.57 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 10' ' ' GLN . 1.4 p-10 -94.14 162.64 13.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.148 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.844 HG12 ' N ' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -81.5 175.39 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.207 -0.933 . . . . 0.0 109.124 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.403 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -147.35 137.5 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.309 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -144.3 154.86 43.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.583 ' HA ' HG22 ' A' ' 7' ' ' ILE . 1.9 pp -145.27 174.68 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.774 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -177.76 58.17 0.09 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 87' ' ' GLU . . . 120.12 61.42 0.25 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.574 ' CB ' ' HB3' ' A' ' 87' ' ' GLU . 2.3 p-10 -175.85 138.11 0.36 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.418 -1.048 . . . . 0.0 108.642 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.6 p 177.19 79.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 O-C-N 121.291 -0.88 . . . . 0.0 109.32 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.591 ' HB3' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -49.06 -15.86 0.12 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.754 -0.591 . . . . 0.0 111.679 -178.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -111.66 100.82 9.27 Favored 'General case' 0 C--N 1.281 -2.401 0 O-C-N 121.153 -0.967 . . . . 0.0 109.21 179.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.8 -79.97 0.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.787 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.59 -90.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.922 . . . . 0.0 109.925 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -118.67 -29.5 5.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.824 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -88.84 -158.19 0.48 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 109.016 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.941 ' CD1' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -126.84 120.5 29.4 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.094 -1.004 . . . . 0.0 109.633 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.601 ' O ' ' O ' ' A' ' 77' ' ' VAL . 2.5 p -144.7 140.05 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.18 -0.95 . . . . 0.0 109.545 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.729 HD12 ' H ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -151.53 -155.39 0.62 Allowed 'General case' 0 C--N 1.284 -2.252 0 O-C-N 120.885 -1.134 . . . . 0.0 108.124 177.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.999 ' CD ' HG21 ' A' ' 5' ' ' VAL . 0.6 OUTLIER . . . . . 0 C--N 1.283 -2.318 0 CA-C-O 122.115 0.959 . . . . 0.0 110.725 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 44' ' ' LYS . 20.8 p . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -143.22 164.86 29.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.965 -1.084 . . . . 0.0 110.485 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.524 ' HB ' ' HA3' ' A' ' 75' ' ' GLY . 10.5 m -130.79 167.37 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.515 0.674 . . . . 0.0 109.858 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.568 ' O ' ' N ' ' A' ' 74' ' ' GLY . 0.8 OUTLIER -145.06 135.78 24.5 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.53 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 1.9 pt -160.5 137.77 2.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.877 -1.139 . . . . 0.0 110.368 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.706 ' HB3' HG22 ' A' ' 71' ' ' ILE . . . -120.79 167.72 12.2 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CD1' ' O ' ' A' ' 8' ' ' ALA . 12.0 m-85 -163.18 155.13 17.87 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.536 -1.353 . . . . 0.0 109.793 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.53 ' H ' ' N ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -121.05 94.86 4.48 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.033 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB3' ' OD1' ' A' ' 69' ' ' ASP . 1.4 p30 -108.83 137.53 46.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.585 -0.697 . . . . 0.0 109.749 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -13.76 59.48 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.245 -0.91 . . . . 0.0 109.174 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.8 105.83 4.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 17' ' ' TYR . 18.1 t30 -60.71 -12.83 11.65 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.28 -42.03 66.15 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.256 -0.903 . . . . 0.0 108.784 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -38.78 74.34 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.442 ' HB3' ' OD1' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -58.64 -43.16 89.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.477 -0.764 . . . . 0.0 108.966 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.49 -52.87 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 108.81 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 23' ' ' ILE . 48.1 t -62.39 -24.06 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.375 -0.828 . . . . 0.0 109.025 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.572 ' HA ' HD12 ' A' ' 23' ' ' ILE . 1.7 tt0 -76.08 -27.14 57.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.267 -0.896 . . . . 0.0 109.049 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.39 -44.48 64.88 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -63.82 -46.94 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 20' ' ' GLU . 60.1 mt -54.25 -49.1 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.423 ' OE1' ' CG ' ' A' ' 20' ' ' GLU . 17.9 mt-30 -61.7 -32.64 72.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.146 -0.972 . . . . 0.0 108.457 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -47.06 -36.82 8.54 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -79.84 133.69 58.12 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.36 46.24 1.91 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.805 1.424 . . . . 0.0 109.98 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -149.92 -45.44 0.13 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.126 -0.984 . . . . 0.0 109.713 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -59.92 144.21 49.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.613 ' C ' HG22 ' A' ' 31' ' ' VAL . 5.7 t -101.11 139.67 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.521 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.613 HG22 ' C ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -168.88 166.54 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 109.14 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 33' ' ' HIS . 2.5 mm-40 -149.43 -94.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.338 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.765 ' CE1' HG22 ' A' ' 38' ' ' ILE . 4.9 t60 55.72 110.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 109.88 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.559 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -154.16 -62.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.616 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.3 Cg_endo -67.21 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.652 1.343 . . . . 0.0 109.772 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.64 -53.75 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.399 -0.813 . . . . 0.0 109.243 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.486 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -72.08 157.33 37.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 109.153 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.765 HG22 ' CE1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -122.83 165.22 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.017 -1.052 . . . . 0.0 109.34 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.494 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -132.21 156.87 45.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.966 . . . . 0.0 109.986 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.555 HG22 ' H ' ' A' ' 41' ' ' GLU . 8.7 mt -152.83 172.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.401 -0.812 . . . . 0.0 109.053 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.555 ' H ' HG22 ' A' ' 40' ' ' ILE . 5.9 tt0 171.36 145.21 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.522 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -144.12 -162.8 1.54 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.085 -1.01 . . . . 0.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -140.67 82.92 1.87 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.456 ' O ' ' O ' ' A' ' 3' ' ' SER . 31.2 mmtt -129.64 -165.13 1.48 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.048 -1.032 . . . . 0.0 110.856 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.546 ' CA ' ' HG3' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -165.24 165.34 19.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.645 HD13 ' H ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -164.55 150.61 10.56 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.897 -1.127 . . . . 0.0 110.478 178.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.645 ' H ' HD13 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -142.99 139.67 30.72 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.037 HG21 HG21 ' A' ' 52' ' ' THR . 2.3 pt -139.71 163.64 24.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.064 -1.022 . . . . 0.0 110.305 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.504 ' HA ' ' HG3' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -95.46 -147.43 0.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.476 -0.765 . . . . 0.0 109.336 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.454 ' NH1' ' CG ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -87.67 -40.59 14.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.081 -1.012 . . . . 0.0 109.726 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 69.1 tt0 -54.67 -31.21 57.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 109.06 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 1.037 HG21 HG21 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -61.92 -40.16 94.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.036 -1.04 . . . . 0.0 108.536 179.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.579 HG22 ' CD2' ' A' ' 84' ' ' PHE . 21.2 t -46.25 -32.93 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 3.8 tt0 -71.24 -46.01 61.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 52' ' ' THR . 40.0 mm-40 -52.82 -55.12 25.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.364 -0.835 . . . . 0.0 109.529 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -55.51 -34.92 65.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.257 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.8 tp -56.43 -54.8 41.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.149 -0.969 . . . . 0.0 109.284 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.65 -9.64 65.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.44 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -112.75 5.61 17.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -1.076 . . . . 0.0 109.396 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -79.29 -19.15 51.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -89.89 23.64 2.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.196 -0.94 . . . . 0.0 109.286 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.64 39.48 2.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.401 -0.812 . . . . 0.0 109.017 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' A' ' 66' ' ' MET . 2.1 t -91.95 -3.94 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.708 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.433 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 13.1 mp0 -50.2 -25.24 3.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 0.0 109.465 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -66.31 -44.53 83.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.147 -0.971 . . . . 0.0 109.426 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.45 ' CE ' HD11 ' A' ' 73' ' ' ILE . 5.1 mtp -59.27 -16.11 19.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 0.0 109.523 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 11.2 tp -78.1 -52.25 9.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.703 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 68' ' ' VAL . 2.0 t -66.56 -55.19 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.626 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -98.76 85.22 3.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.648 ' O ' HG12 ' A' ' 71' ' ' ILE . 7.1 p -103.29 141.77 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.247 -0.908 . . . . 0.0 112.513 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.706 HG22 ' HB3' ' A' ' 8' ' ' ALA . 2.1 mm 178.41 -85.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.699 HG22 ' H ' ' A' ' 73' ' ' ILE . 2.2 m -133.44 176.33 8.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.921 -1.112 . . . . 0.0 111.621 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.699 ' H ' HG22 ' A' ' 72' ' ' THR . 0.6 OUTLIER -160.87 162.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -179.65 34.99 0.07 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.524 ' HA3' ' HB ' ' A' ' 5' ' ' VAL . . . -162.58 85.31 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -129.2 -135.33 0.22 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.586 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 85' ' ' VAL . 7.1 p -118.22 126.6 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -0.999 . . . . 0.0 109.724 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.486 ' O ' HG12 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -105.98 148.0 28.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.513 -0.742 . . . . 0.0 109.943 -179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -103.3 133.52 48.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 108.961 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -106.15 -93.94 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 110.102 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -105.39 -75.72 0.62 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.899 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.53 -31.41 4.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 108.761 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.504 ' HG3' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -81.04 -171.74 3.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.699 ' CE1' HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -134.87 158.96 42.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.09 -1.006 . . . . 0.0 109.269 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 77' ' ' VAL . 2.4 p -143.7 169.56 10.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.242 -0.911 . . . . 0.0 109.438 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 77' ' ' VAL . 1.3 pp -176.84 -167.39 0.18 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.546 ' HG3' ' CA ' ' A' ' 45' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.298 -1.652 0 O-C-N 120.894 -1.129 . . . . 0.0 110.645 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 4' ' ' LEU . 0.4 OUTLIER -137.02 156.43 48.44 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.087 -1.008 . . . . 0.0 110.512 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.131 HG11 HD21 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -113.73 -176.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.956 ' CE2' HG21 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -147.05 139.15 24.52 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.991 ' HB ' HG22 ' A' ' 72' ' ' THR . 1.3 pt -143.63 135.32 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.296 -0.878 . . . . 0.0 108.801 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.652 ' HB2' ' HE1' ' A' ' 6' ' ' TYR . . . -145.3 147.1 31.97 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.384 -1.326 . . . . 0.0 110.522 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.607 ' CE2' HG13 ' A' ' 38' ' ' ILE . 16.7 p90 -135.96 175.98 9.1 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.677 ' HB2' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -141.08 80.14 1.73 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.095 -1.003 . . . . 0.0 108.748 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.443 ' CB ' ' NH1' ' A' ' 16' ' ' ARG . 4.0 t70 -110.18 178.84 4.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.336 -0.853 . . . . 0.0 110.0 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -121.91 16.26 10.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 109.397 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -85.96 103.89 15.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.214 -0.929 . . . . 0.0 108.985 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -67.23 -7.76 26.43 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.251 -0.906 . . . . 0.0 108.873 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.77 -56.01 9.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.32 -0.863 . . . . 0.0 109.016 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HG2' ' N ' ' A' ' 17' ' ' TYR . 6.2 ptm180 -59.37 -28.71 67.12 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.46 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 26.4 t80 -60.3 -49.94 75.59 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.523 ' O ' HD12 ' A' ' 22' ' ' ILE . 70.4 t -54.38 -56.08 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.663 ' HA ' HD13 ' A' ' 22' ' ' ILE . 95.6 t -49.59 -30.93 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.29 -46.17 77.9 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.99 -41.08 46.19 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.302 -0.874 . . . . 0.0 108.667 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.727 ' H ' HD12 ' A' ' 22' ' ' ILE . 4.3 mp -65.55 -43.05 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.469 -0.769 . . . . 0.0 108.976 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.411 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 7.0 mt -52.89 -43.98 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 108.844 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.906 ' HG2' HG23 ' A' ' 31' ' ' VAL . 1.9 mt-30 -67.26 -32.08 72.85 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -24.88 6.54 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -83.05 135.37 44.95 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -84.6 47.12 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.761 1.4 . . . . 0.0 109.843 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -146.87 -40.07 0.2 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.338 -0.851 . . . . 0.0 109.084 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.411 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . . . -73.91 139.9 45.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.442 -0.786 . . . . 0.0 109.538 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.674 HG21 ' HB3' ' A' ' 41' ' ' GLU . 16.0 t -71.24 -120.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.181 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.906 HG23 ' HG2' ' A' ' 24' ' ' GLN . 1.1 p -174.23 -165.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.729 -1.232 . . . . 0.0 109.935 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.711 ' H ' HG22 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -114.19 -167.73 1.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.551 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -89.45 -99.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 109.928 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.569 ' HB3' ' HD3' ' A' ' 35' ' ' PRO . 46.7 t-80 -166.17 -58.69 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 110.587 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 34' ' ' HIS . 3.5 Cg_exo -49.53 -179.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 117.442 -1.239 . . . . 0.0 110.822 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 38' ' ' ILE . . . -52.21 -22.57 4.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.005 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.524 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 3.1 mmt -65.37 156.4 32.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.926 -1.109 . . . . 0.0 109.242 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.607 HG13 ' CE2' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -127.82 129.17 69.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.291 -0.881 . . . . 0.0 108.63 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.74 ' C ' HD12 ' A' ' 40' ' ' ILE . 2.2 ttt180 -126.52 164.62 20.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.06 -1.025 . . . . 0.0 110.053 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 7' ' ' ILE . 2.7 mp -156.51 169.22 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.37 -0.831 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.674 ' HB3' HG21 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -155.91 152.79 28.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.682 -1.261 . . . . 0.0 110.26 -179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.839 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -129.93 -177.26 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 91.0 mt-10 -140.04 74.97 1.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.126 -0.984 . . . . 0.0 110.186 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 175.11 -141.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.972 -1.08 . . . . 0.0 110.208 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.957 ' C ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -126.1 167.83 14.83 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.228 -0.92 . . . . 0.0 109.931 -179.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 1.131 HD21 HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -130.88 152.91 49.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.384 -0.823 . . . . 0.0 109.665 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.35 154.7 46.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.2 mt -150.55 141.02 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.141 -0.975 . . . . 0.0 109.71 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.46 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.6 ptt180 -100.92 -171.93 2.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 109.567 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.53 ' NH1' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -75.76 -32.85 60.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.184 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 4.4 mt-10 -50.37 -41.59 52.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.865 . . . . 0.0 109.297 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -69.26 -47.67 64.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 108.88 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.6 -26.73 2.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 1.4 tt0 -74.84 -43.59 53.74 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -55.73 -50.32 70.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 108.731 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -59.79 -33.46 71.74 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.372 -0.83 . . . . 0.0 109.016 179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.5 tp -57.73 -51.76 68.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 108.905 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.05 -14.82 66.48 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -113.02 15.23 19.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.964 . . . . 0.0 109.306 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -67.18 -19.42 65.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -0.838 . . . . 0.0 109.426 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -89.42 35.59 0.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.309 -0.869 . . . . 0.0 109.381 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 65' ' ' GLU . 34.9 t70 -104.97 5.87 33.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.476 ' H ' HG23 ' A' ' 63' ' ' VAL . 2.8 t -52.21 -40.65 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.932 . . . . 0.0 109.539 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -52.46 -40.93 62.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.143 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 0.4 OUTLIER -73.03 -28.39 62.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.049 179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -12.03 61.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.278 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 67' ' ' LEU . 1.5 mm? -74.47 -56.97 4.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.297 -0.877 . . . . 0.0 109.945 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.53 ' CG1' ' OD2' ' A' ' 69' ' ' ASP . 2.3 p -90.52 -46.47 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.119 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -103.02 146.69 27.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.983 -1.073 . . . . 0.0 109.967 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.742 HG12 ' H ' ' A' ' 71' ' ' ILE . 7.0 t -100.56 -176.07 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.797 ' O ' HG23 ' A' ' 72' ' ' THR . 0.6 OUTLIER -136.02 -37.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.276 -1.515 . . . . 0.0 112.165 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.991 HG22 ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER 170.75 -148.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.682 -1.261 . . . . 0.0 108.7 -178.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.956 HG21 ' CE2' ' A' ' 6' ' ' TYR . 1.4 tp 176.95 -129.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.648 ' H ' HG23 ' A' ' 73' ' ' ILE . . . 167.98 -108.27 0.3 Allowed Glycine 0 N--CA 1.485 1.965 0 O-C-N 120.04 -1.662 . . . . 0.0 109.945 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.53 -65.62 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.639 ' H ' HD21 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -124.42 -147.21 0.37 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -1.179 . . . . 0.0 108.662 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.2 p 178.9 93.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.091 -1.006 . . . . 0.0 109.994 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.6 134.88 49.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.148 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -118.43 156.31 29.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 109.493 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -109.82 -94.93 0.41 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.556 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -106.03 -70.76 0.77 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.178 -0.951 . . . . 0.0 109.281 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.1 -6.37 7.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.313 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -90.94 -169.68 2.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -0.86 . . . . 0.0 109.406 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -155.51 122.07 5.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.941 . . . . 0.0 109.369 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.85 139.2 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.17 -0.956 . . . . 0.0 110.003 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.976 HD22 ' N ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -149.38 136.76 20.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.976 ' N ' HD22 ' A' ' 86' ' ' LEU . 2.4 mp0 . . . . . 0 C--N 1.302 -1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.699 -179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 1.0 OUTLIER -126.98 158.14 37.68 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.994 -1.066 . . . . 0.0 110.283 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -119.49 170.96 8.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.543 0.687 . . . . 0.0 110.232 -178.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 74' ' ' GLY . 10.2 t80 -140.49 141.33 35.39 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.867 HD11 HD12 ' A' ' 40' ' ' ILE . 1.5 pp -159.18 152.84 5.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.671 ' HB1' ' O ' ' A' ' 38' ' ' ILE . . . -146.37 -173.4 4.18 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.599 -1.24 . . . . 0.0 110.59 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 1.095 ' CD2' HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.84 171.23 14.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 122.633 1.206 . . . . 0.0 111.866 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.716 ' C ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER 176.35 105.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.32 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.623 ' N ' HG23 ' A' ' 70' ' ' VAL . 3.3 t0 -109.87 -156.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.641 0.734 . . . . 0.0 110.078 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -128.45 -63.43 0.99 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -118.59 -15.06 9.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.441 -0.787 . . . . 0.0 108.904 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.459 ' HB3' ' OD2' ' A' ' 11' ' ' ASP . 0.6 OUTLIER -82.51 7.59 14.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.399 -0.813 . . . . 0.0 109.017 179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 18' ' ' VAL . . . -42.4 -32.92 0.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.401 -0.812 . . . . 0.0 109.166 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -51.43 -56.74 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 109.012 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -61.74 -32.1 72.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.229 -0.92 . . . . 0.0 109.281 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 15' ' ' ALA . 55.8 t -57.01 -41.43 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.831 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.71 -30.96 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.63 -49.85 73.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.501 -0.749 . . . . 0.0 109.45 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -62.91 -40.17 96.78 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.119 -0.988 . . . . 0.0 108.97 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.004 HD11 HG13 ' A' ' 38' ' ' ILE . 5.6 mm -50.1 -42.92 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.026 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.487 ' O ' ' CD ' ' A' ' 27' ' ' PRO . 40.1 mm -69.29 -33.56 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.15 -0.969 . . . . 0.0 109.024 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -90.88 4.94 50.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.438 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.872 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -117.18 -11.64 10.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.875 ' OD1' HG13 ' A' ' 31' ' ' VAL . 1.1 m-80 -87.91 -68.79 0.12 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.519 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 26' ' ' ASN . 3.6 Cg_exo -41.28 -28.08 0.46 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.69 1.363 . . . . 0.0 110.195 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -97.78 -39.03 9.24 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.322 -0.861 . . . . 0.0 109.199 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' A' ' 25' ' ' ASP . . . -102.94 -158.08 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.125 -0.985 . . . . 0.0 109.685 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.519 ' O ' HG22 ' A' ' 31' ' ' VAL . 3.2 t -96.3 -127.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.875 HG13 ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -161.72 141.76 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.648 -1.283 . . . . 0.0 109.726 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -174.21 95.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 109.46 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.535 ' CE1' ' HB ' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -115.05 157.17 23.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.501 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.559 ' CD2' ' HD2' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -117.45 -167.22 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.523 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.559 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 2.3 Cg_endo -90.56 15.19 1.88 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.96 1.505 . . . . 0.0 110.338 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.68 -76.39 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.195 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -84.21 167.34 16.77 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.004 HG13 HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.95 163.44 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.843 -1.161 . . . . 0.0 108.922 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.554 ' N ' HD13 ' A' ' 38' ' ' ILE . 8.9 mtp180 -139.48 162.47 34.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.879 -1.138 . . . . 0.0 109.5 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.867 HD12 HD11 ' A' ' 7' ' ' ILE . 33.0 mt -158.64 164.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 110.003 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.567 ' N ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -159.17 166.67 30.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.381 -0.825 . . . . 0.0 109.006 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.515 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -159.83 -165.23 1.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.937 -1.102 . . . . 0.0 110.545 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -139.2 97.28 3.26 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 3' ' ' SER . 30.8 mttm -142.43 -164.54 1.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.972 -1.08 . . . . 0.0 110.925 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.509 ' HA ' ' HG3' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -167.79 171.32 10.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 109.154 -179.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.964 HD12 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -160.82 142.19 11.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.026 -1.046 . . . . 0.0 109.723 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.817 ' C ' HD12 ' A' ' 48' ' ' ILE . 1.1 tt0 -138.86 138.81 37.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.996 . . . . 0.0 109.434 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 46' ' ' LEU . 4.1 mp -151.2 162.8 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.257 -0.902 . . . . 0.0 110.294 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.524 ' N ' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -98.36 -153.42 0.43 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.425 ' CG ' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -69.98 -12.68 61.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.598 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 3.4 tt0 -64.84 -9.8 23.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.193 -0.942 . . . . 0.0 109.603 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.743 HG21 ' OD2' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -59.99 -40.34 88.83 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.866 -1.146 . . . . 0.0 109.02 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 52' ' ' THR . 94.5 t -46.37 -34.24 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -70.27 -45.75 65.76 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 52' ' ' THR . 3.0 mm-40 -47.7 -46.1 29.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -38.75 88.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.357 -0.84 . . . . 0.0 108.812 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.2 tp -55.17 -55.22 33.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.364 -0.835 . . . . 0.0 109.15 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.41 -9.4 68.37 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -90.95 -9.53 45.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -1.123 . . . . 0.0 109.517 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.72 -25.35 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.453 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -88.29 40.26 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.389 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -111.28 74.63 0.88 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.397 -0.814 . . . . 0.0 109.137 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.16 2.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -0.86 . . . . 0.0 109.994 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.546 ' O ' HD11 ' A' ' 71' ' ' ILE . 1.3 mp0 -49.01 -22.63 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.055 -1.028 . . . . 0.0 109.315 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 1.016 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.0 pt-20 -56.4 -48.67 76.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -17.08 64.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.194 -0.941 . . . . 0.0 109.423 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.714 HD23 HG12 ' A' ' 71' ' ' ILE . 4.9 tp -98.67 11.98 36.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 109.399 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.016 HG23 ' O ' ' A' ' 65' ' ' GLU . 40.5 t -39.34 -24.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.414 -0.804 . . . . 0.0 110.867 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 71' ' ' ILE . 67.4 m-20 -58.2 -100.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.713 -1.242 . . . . 0.0 109.807 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.095 HG22 ' CD2' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -42.08 -13.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.175 -2.819 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.461 -178.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.714 HG12 HD23 ' A' ' 67' ' ' LEU . 1.7 pt -123.42 131.91 72.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 120.453 1.478 . . . . 0.0 110.253 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.659 ' OG1' ' HB3' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -130.74 150.02 52.12 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -133.47 174.53 13.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.229 -0.919 . . . . 0.0 110.403 -178.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 178.89 38.74 0.07 OUTLIER Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 5' ' ' VAL . . . -152.37 82.94 0.17 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' H ' ' A' ' 87' ' ' GLU . 27.6 p-10 -176.03 138.47 0.35 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.674 ' O ' ' O ' ' A' ' 85' ' ' VAL . 13.8 p -171.34 52.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.101 -0.999 . . . . 0.0 109.228 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.995 ' CG ' HD23 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -49.92 -9.54 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -110.52 94.83 5.21 Favored 'General case' 0 C--N 1.28 -2.422 0 O-C-N 120.6 -1.313 . . . . 0.0 109.729 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.685 ' HB2' HG12 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -107.11 -82.11 0.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 108.951 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.01 -82.72 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 108.996 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -128.18 -30.88 2.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.364 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -80.11 -157.88 0.16 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.575 ' CD2' ' HB ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -126.1 112.9 16.38 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.749 -1.22 . . . . 0.0 108.752 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.685 HG12 ' HB2' ' A' ' 80' ' ' ASP . 4.1 p -129.51 138.78 53.41 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.655 0 C-N-CA 118.922 -1.111 . . . . 0.0 109.763 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.995 HD23 ' CG ' ' A' ' 78' ' ' ASP . 0.9 OUTLIER -143.0 -176.27 4.84 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 120.837 -1.164 . . . . 0.0 108.309 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.588 ' C ' ' HB2' ' A' ' 46' ' ' LEU . 1.9 tt0 . . . . . 0 C--N 1.286 -2.185 0 CA-C-O 121.947 0.88 . . . . 0.0 110.61 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 44' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -142.26 160.93 39.27 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.759 -1.213 . . . . 0.0 112.235 -178.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.922 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 1.2 t -113.52 -176.65 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.734 ' CE2' HG21 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -159.19 144.77 16.16 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.939 ' HB ' HG22 ' A' ' 72' ' ' THR . 4.5 pt -160.31 137.11 2.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 120.529 -1.357 . . . . 0.0 107.919 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.728 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -132.36 146.41 51.95 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.186 -1.806 . . . . 0.0 109.606 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 1.007 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 14.0 p90 -140.9 170.34 15.93 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.488 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.696 ' HG3' ' CA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -119.61 143.33 47.73 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.052 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 2.7 p30 -108.73 154.07 22.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.745 -1.222 . . . . 0.0 109.957 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -89.63 -37.97 14.26 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.377 -0.827 . . . . 0.0 109.424 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 12' ' ' ASN . 16.6 t0 168.84 -34.88 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -102.97 -30.31 10.87 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 11' ' ' ASP . . . -52.65 -20.37 3.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.0 109.141 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -64.98 -56.14 14.91 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.832 . . . . 0.0 109.132 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.73 -39.32 73.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.238 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.1 t -56.49 -49.04 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 108.605 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 1.007 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 60.9 t -67.45 -19.13 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.454 -0.779 . . . . 0.0 109.137 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.509 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 45.6 tt0 -76.28 -36.7 58.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.385 -0.822 . . . . 0.0 109.784 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.61 -36.23 65.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.8 mt -71.67 -48.91 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.642 HD12 ' N ' ' A' ' 24' ' ' GLN . 2.2 pp -57.81 -38.96 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.217 -0.927 . . . . 0.0 108.934 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.642 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -62.89 -43.05 99.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.343 -0.848 . . . . 0.0 109.035 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 24' ' ' GLN . 3.0 t0 -44.43 -36.3 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.56 88.15 23.39 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 2.4 Cg_endo -65.89 81.31 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 124.31 1.69 . . . . 0.0 110.308 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 5.5 t-80 179.33 -43.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -40.86 140.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.725 -0.61 . . . . 0.0 110.002 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.604 HG22 ' N ' ' A' ' 31' ' ' VAL . 3.7 p -97.42 165.77 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 0.0 109.441 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.604 ' N ' HG22 ' A' ' 30' ' ' VAL . 1.4 p -155.49 163.44 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.521 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -174.55 141.78 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 0.0 109.849 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.931 ' HB3' HG22 ' A' ' 38' ' ' ILE . 1.3 p-80 -143.66 160.34 40.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.27 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.579 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -157.62 -61.57 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.106 -0.996 . . . . 0.0 109.881 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.5 Cg_endo -66.92 -54.27 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.725 1.382 . . . . 0.0 110.002 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -177.63 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.315 -0.866 . . . . 0.0 108.971 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 1.2 ptm -69.02 158.62 34.42 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.931 HG22 ' HB3' ' A' ' 33' ' ' HIS . 0.1 OUTLIER -110.31 120.59 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.891 -1.13 . . . . 0.0 109.857 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.535 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -81.85 177.78 8.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.34 -0.85 . . . . 0.0 110.219 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.698 HD12 HG13 ' A' ' 7' ' ' ILE . 3.1 mt -152.72 -174.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.273 -0.892 . . . . 0.0 109.673 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.67 ' H ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -171.09 158.55 5.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.795 -1.191 . . . . 0.0 111.04 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.922 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . . . -129.84 -175.31 3.56 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 10.2 pt-20 -151.25 70.67 0.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.147 -0.97 . . . . 0.0 110.033 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 173.4 -143.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.856 -1.152 . . . . 0.0 109.321 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.966 ' O ' HD23 ' A' ' 46' ' ' LEU . 4.9 mpt_? -126.01 154.99 42.15 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.04 -1.037 . . . . 0.0 109.375 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.966 HD23 ' O ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -144.92 135.76 24.68 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.173 -0.955 . . . . 0.0 109.833 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 1.088 ' CA ' HG12 ' A' ' 85' ' ' VAL . 2.3 pm0 -151.05 135.55 17.03 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.781 ' CD1' HG11 ' A' ' 85' ' ' VAL . 2.5 mt -137.8 152.4 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 0.0 109.117 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.527 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -50.49 147.58 4.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 108.949 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.453 ' CG ' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -89.27 -60.55 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.017 . . . . 0.0 109.716 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 16.5 tt0 -54.35 -44.66 72.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.751 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -50.81 50.06 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.017 -1.052 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.576 ' CG2' ' CG2' ' A' ' 48' ' ' ILE . 19.4 t -55.34 -21.48 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -74.99 -40.08 60.88 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.29 -56.27 9.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.267 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -55.3 -29.43 58.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 109.3 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.612 HD12 ' CE3' ' A' ' 61' ' ' TRP . 7.6 tp -64.33 -56.11 16.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -0.842 . . . . 0.0 109.732 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.51 8.15 69.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.488 ' HG2' ' N ' ' A' ' 60' ' ' ALA . 22.7 ttt180 -98.8 -84.59 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -1.17 . . . . 0.0 109.973 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.488 ' N ' ' HG2' ' A' ' 59' ' ' ARG . . . -96.03 -22.6 17.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.585 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.612 ' CE3' HD12 ' A' ' 57' ' ' LEU . 8.6 t90 -90.18 25.78 2.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.313 -0.867 . . . . 0.0 109.177 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.2 44.31 1.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.264 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 65' ' ' GLU . 3.9 t -98.93 9.4 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.415 -0.803 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.503 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 16.7 mm-40 -39.9 -28.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.522 -0.736 . . . . 0.0 109.944 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 68' ' ' VAL . 16.1 tt0 -58.06 -55.26 37.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.136 -0.977 . . . . 0.0 109.404 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.433 ' HB2' HG12 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -72.32 -9.57 58.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 64' ' ' GLN . 11.8 tp -53.74 -16.35 1.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.432 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 65' ' ' GLU . 17.2 t -40.2 -42.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -0.954 . . . . 0.0 109.715 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.696 ' CA ' ' HG3' ' A' ' 10' ' ' GLN . 10.1 m-20 -81.52 -74.75 0.32 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.181 -0.949 . . . . 0.0 109.818 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 71' ' ' ILE . 1.3 t -43.56 -170.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 122.152 -0.343 . . . . 0.0 110.98 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.728 HG22 ' O ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER 161.46 -167.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.939 HG22 ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -175.39 -158.87 0.07 Allowed 'General case' 0 C--O 1.193 -1.903 0 O-C-N 119.348 -2.095 . . . . 0.0 108.143 179.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.747 HG22 ' H ' ' A' ' 74' ' ' GLY . 48.6 mm -168.39 -127.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.747 ' H ' HG22 ' A' ' 73' ' ' ILE . . . 161.84 -71.81 0.21 Allowed Glycine 0 N--CA 1.486 1.996 0 O-C-N 120.427 -1.421 . . . . 0.0 110.591 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.16 -37.93 1.59 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.813 ' C ' HD13 ' A' ' 86' ' ' LEU . 2.4 t-20 -176.48 -149.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.974 . . . . 0.0 109.205 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.779 ' O ' HG13 ' A' ' 77' ' ' VAL . 9.1 p -151.33 100.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.016 . . . . 0.0 109.415 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.459 ' HB2' ' CD ' ' A' ' 87' ' ' GLU . 0.2 OUTLIER -114.47 150.58 34.57 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.942 -1.098 . . . . 0.0 110.325 -179.006 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.577 ' HB3' ' CD1' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -118.12 164.64 14.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.588 -0.695 . . . . 0.0 109.229 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . 0.533 ' OD1' ' HB2' ' A' ' 47' ' ' GLU . 3.6 p-10 -114.42 -115.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.035 -1.04 . . . . 0.0 109.646 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -98.36 -41.12 7.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.828 -1.17 . . . . 0.0 109.753 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -130.91 -58.78 1.01 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.03 -1.044 . . . . 0.0 108.606 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 48' ' ' ILE . 2.1 mpp_? -57.2 -173.22 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.664 ' CE1' HG22 ' A' ' 77' ' ' VAL . 2.2 t80 173.41 120.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.051 -1.031 . . . . 0.0 111.816 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.088 HG12 ' CA ' ' A' ' 47' ' ' GLU . 8.1 p -160.39 -115.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.813 HD13 ' C ' ' A' ' 76' ' ' ASN . 22.0 tp -131.85 144.62 51.03 Favored 'General case' 0 C--N 1.282 -2.352 0 O-C-N 120.19 -1.569 . . . . 0.0 112.368 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.803 ' H ' HD12 ' A' ' 86' ' ' LEU . 16.8 mt-10 . . . . . 0 C--N 1.301 -1.538 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.446 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -128.2 -167.03 1.7 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -0.98 . . . . 0.0 109.797 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.835 HG13 ' HA2' ' A' ' 75' ' ' GLY . 11.3 t -152.28 161.31 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.594 ' O ' ' N ' ' A' ' 74' ' ' GLY . 6.6 t80 -153.16 136.0 15.38 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.67 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -162.68 137.68 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.921 -1.112 . . . . 0.0 109.786 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.635 ' C ' HG22 ' A' ' 71' ' ' ILE . . . -126.6 173.89 9.11 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 69' ' ' ASP . 2.6 m-85 -168.56 155.56 7.48 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.496 -1.378 . . . . 0.0 109.366 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.524 ' HA ' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -120.91 93.82 4.15 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.483 ' HB2' HD11 ' A' ' 38' ' ' ILE . 1.1 m-20 -74.38 -166.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.38 -0.825 . . . . 0.0 109.831 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.7 -114.59 0.12 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.09 -1.006 . . . . 0.0 108.911 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -119.08 -31.97 4.57 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.843 -1.161 . . . . 0.0 108.579 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -103.07 -34.87 8.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.473 -0.767 . . . . 0.0 109.331 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.53 82.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.556 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.463 HH11 ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -63.07 -36.22 82.86 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.315 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -37.65 83.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.075 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.86 -53.04 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 109.191 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.411 ' HA ' HD12 ' A' ' 22' ' ' ILE . 55.9 t -64.37 -23.65 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.409 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.35 -35.28 73.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 109.747 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -77.53 -33.08 54.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.773 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.507 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 8.3 mt -71.89 -37.62 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.181 -0.949 . . . . 0.0 109.058 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.3 mt -67.24 -53.02 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.894 . . . . 0.0 109.335 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -63.48 -29.25 70.55 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -47.13 -43.94 21.16 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 22' ' ' ILE . 2.9 m-80 -87.01 126.96 61.28 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.7 Cg_endo -84.02 49.34 2.78 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.817 1.43 . . . . 0.0 110.254 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.8 t-160 -154.76 -48.47 0.09 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.19 -0.944 . . . . 0.0 109.917 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -41.11 141.08 0.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.475 -0.766 . . . . 0.0 109.873 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.411 ' C ' ' CG2' ' A' ' 31' ' ' VAL . 2.6 t -98.0 162.32 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.523 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.411 ' CG2' ' C ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -155.11 156.85 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.036 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -170.09 83.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.568 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -119.41 167.42 11.94 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.176 -0.953 . . . . 0.0 109.644 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.582 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -164.26 -48.09 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.833 . . . . 0.0 109.132 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 2.0 Cg_endo -81.98 -167.02 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.752 1.396 . . . . 0.0 109.737 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.77 -5.1 41.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.248 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.522 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 1.9 mtm -97.04 151.42 19.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -111.09 161.08 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.141 -0.975 . . . . 0.0 109.328 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.51 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -149.7 155.46 40.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 109.792 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.648 HG22 ' H ' ' A' ' 41' ' ' GLU . 13.2 mt -156.25 175.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.821 . . . . 0.0 109.045 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.648 ' H ' HG22 ' A' ' 40' ' ' ILE . 11.2 tt0 178.76 144.42 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.009 . . . . 0.0 109.367 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.45 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . . . -129.19 -160.13 1.01 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.797 . . . . 0.0 109.642 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 17.0 pt-20 -164.01 69.23 0.19 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.452 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -159.46 -164.35 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 110.009 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.494 ' HA ' ' CG ' ' A' ' 87' ' ' GLU . 9.2 ptm180 -133.33 -166.42 1.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.506 -0.747 . . . . 0.0 109.014 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 87' ' ' GLU . 4.1 mt -163.42 156.04 18.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.036 -1.04 . . . . 0.0 110.193 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.743 ' HG3' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -146.32 139.74 25.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.81 ' N ' HD12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -148.2 158.41 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 109.933 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.517 ' HA ' ' CG ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -100.62 -151.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -4.08 23.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.387 -0.821 . . . . 0.0 109.661 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 13.4 pt-20 -71.77 -23.8 61.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.784 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.44 ' OG1' ' CG2' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -64.08 -49.11 73.55 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.983 -1.073 . . . . 0.0 109.56 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.2 t -51.52 -25.82 5.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.066 -1.021 . . . . 0.0 108.889 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 10.0 mt-10 -75.38 -39.89 58.62 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.278 -0.889 . . . . 0.0 109.429 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 15.3 mm-40 -65.52 -46.59 79.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.344 -0.848 . . . . 0.0 109.376 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -43.61 80.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.533 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.09 -54.93 41.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.9 . . . . 0.0 109.556 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.31 -2.1 58.56 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 12.9 ttt180 -119.17 10.12 11.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -1.195 . . . . 0.0 109.701 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.19 -27.4 68.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.12 -0.988 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -89.35 29.04 1.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 109.706 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -110.93 5.42 20.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.611 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.3 t -72.75 -49.44 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.593 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -49.9 -47.98 51.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -71.65 -25.1 61.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -81.37 -12.34 59.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.507 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.38 -22.16 26.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 10' ' ' GLN . 14.0 t -59.25 -33.91 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.523 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.633 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.6 86.84 3.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 109.185 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.564 ' O ' ' CB ' ' A' ' 71' ' ' ILE . 2.4 p -101.93 140.57 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.312 -0.867 . . . . 0.0 111.309 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.635 HG22 ' C ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER 167.69 -53.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.038 -1.039 . . . . 0.0 111.912 175.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 73' ' ' ILE . 1.7 m -165.98 171.54 12.46 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.057 -1.652 . . . . 0.0 112.761 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.625 ' H ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -163.67 165.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 174.94 51.23 0.05 OUTLIER Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.514 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.835 ' HA2' HG13 ' A' ' 5' ' ' VAL . . . -104.67 -100.32 2.62 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.738 ' O ' HD21 ' A' ' 86' ' ' LEU . 1.9 t30 -175.33 -174.0 0.69 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.4 -1.059 . . . . 0.0 108.931 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.775 HG13 ' O ' ' A' ' 77' ' ' VAL . 12.4 p 177.97 67.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 108.806 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.505 ' O ' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -98.95 141.58 31.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 0.0 110.394 -178.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -127.21 145.24 50.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.775 . . . . 0.0 108.932 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -107.24 -109.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.069 -1.02 . . . . 0.0 109.485 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -104.39 -77.14 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.817 -1.177 . . . . 0.0 109.242 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -109.94 -9.43 14.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.252 -0.905 . . . . 0.0 109.075 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.517 ' CG ' ' HA ' ' A' ' 49' ' ' ARG . 3.0 ttt180 -91.92 -160.62 0.75 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.374 -0.829 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 48' ' ' ILE . 2.1 t80 -169.38 148.89 3.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.072 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.743 HG23 ' HG3' ' A' ' 47' ' ' GLU . 2.5 p -133.73 179.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.053 -1.03 . . . . 0.0 109.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.738 HD21 ' O ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER 178.26 -169.34 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 46' ' ' LEU . 3.9 mt-10 . . . . . 0 C--N 1.302 -1.488 0 O-C-N 120.941 -1.099 . . . . 0.0 109.796 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.8 p . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -122.48 -176.82 3.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.059 -1.025 . . . . 0.0 109.222 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.586 ' CG2' ' N ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -156.97 165.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.891 -1.131 . . . . 0.0 110.703 -179.157 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.586 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -135.41 147.53 49.04 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.935 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.566 ' C ' HD12 ' A' ' 7' ' ' ILE . 1.4 pp -158.21 139.45 4.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.881 ' HB3' ' OG1' ' A' ' 72' ' ' THR . . . -124.72 -179.16 4.4 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.108 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 1.012 ' CD2' HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -141.79 -178.7 5.79 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.195 177.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.774 ' N ' ' HA ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 177.97 97.93 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.305 -177.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.644 ' OD1' HG21 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -107.7 167.92 9.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.968 . . . . 0.0 109.856 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -124.57 -64.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.881 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -101.6 -32.64 10.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 109.57 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.403 ' HB2' ' OD2' ' A' ' 11' ' ' ASP . 25.9 m-80 -87.64 10.61 17.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.129 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.903 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -58.8 -16.6 17.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.215 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.523 ' NH1' ' HG2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -61.97 -62.13 2.0 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 109.214 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.432 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 49.3 m-85 -62.95 -33.37 75.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 0.0 108.872 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.936 ' O ' HD13 ' A' ' 22' ' ' ILE . 60.1 t -59.34 -32.97 49.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 15' ' ' ALA . 61.3 t -77.45 -25.5 15.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 6.9 tp10 -65.27 -53.94 36.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -67.65 -44.31 78.19 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.206 -0.934 . . . . 0.0 108.556 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.936 HD13 ' O ' ' A' ' 18' ' ' VAL . 1.5 mp -54.04 -31.03 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.537 ' O ' ' CD ' ' A' ' 27' ' ' PRO . 17.9 mt -70.38 -42.16 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 108.844 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.3 4.92 49.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.722 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -118.67 -11.88 9.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.301 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.551 ' ND2' HG23 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -85.57 -65.88 0.2 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 110.377 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.537 ' CD ' ' O ' ' A' ' 23' ' ' ILE . 2.5 Cg_endo -41.0 -27.95 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.66 1.348 . . . . 0.0 110.051 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 26' ' ' ASN . 2.6 t-160 -98.64 -33.45 10.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.667 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 25' ' ' ASP . . . -102.33 176.89 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -0.99 . . . . 0.0 110.265 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 40' ' ' ILE . 1.9 t -101.2 162.88 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.034 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.6 HG22 ' N ' ' A' ' 32' ' ' GLN . 2.1 p -169.66 166.88 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 109.813 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.6 ' N ' HG22 ' A' ' 31' ' ' VAL . 2.5 pt20 -172.18 65.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 109.566 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.508 ' CB ' ' HA ' ' A' ' 38' ' ' ILE . 26.0 p80 -101.12 179.14 4.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.588 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -156.67 -62.62 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.589 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -67.84 -167.78 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.684 1.36 . . . . 0.0 109.911 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.19 -15.41 33.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 108.957 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.583 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 66.9 mtp -81.84 135.32 35.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.327 -0.858 . . . . 0.0 109.619 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.63 ' CG1' ' HB3' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -113.77 82.54 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.16 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.532 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.39 167.3 21.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 111.25 -178.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 30' ' ' VAL . 89.5 mt -149.99 155.25 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.408 ' N ' HG22 ' A' ' 40' ' ' ILE . 3.4 tt0 -131.15 147.14 52.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 109.662 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' A' ' 43' ' ' GLU . . . -143.88 -171.61 3.58 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.372 -0.83 . . . . 0.0 108.877 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 44.8 mt-10 -159.28 99.55 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -162.2 -145.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.768 -1.208 . . . . 0.0 111.078 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -162.43 159.65 25.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -0.869 . . . . 0.0 109.502 -178.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.754 ' CD1' HD11 ' A' ' 86' ' ' LEU . 1.4 mt -126.18 -173.79 2.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.056 -1.027 . . . . 0.0 108.298 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 4.3 pt-20 -178.95 141.99 0.19 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.256 -0.902 . . . . 0.0 109.421 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.408 ' CG1' ' C ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -160.43 -161.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.15 -0.969 . . . . 0.0 109.585 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -100.21 -169.08 1.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.859 . . . . 0.0 109.152 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -88.5 -46.3 9.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.162 -0.961 . . . . 0.0 109.026 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 30.7 tt0 -49.49 -32.15 11.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.362 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 53' ' ' VAL . 1.3 m -70.88 -50.28 36.86 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.207 -0.933 . . . . 0.0 109.039 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.739 HG21 ' CD1' ' A' ' 84' ' ' PHE . 97.4 t -48.1 -27.64 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 21.7 tp10 -74.54 -44.41 51.21 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -54.23 -47.11 72.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.349 -0.844 . . . . 0.0 108.853 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -60.47 -36.96 79.52 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.8 tp -57.99 -55.75 30.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 109.364 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.6 -11.29 59.69 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -114.82 7.25 15.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -1.139 . . . . 0.0 109.625 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -70.01 -29.97 67.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.26 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -90.34 38.45 0.94 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.868 . . . . 0.0 109.384 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -103.07 -86.06 0.44 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.299 -0.876 . . . . 0.0 109.571 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' A' ' 66' ' ' MET . 1.3 t -97.92 0.99 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.599 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.486 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 1.2 mp0 -51.9 -27.57 13.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 109.574 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -64.18 -43.07 96.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.173 -0.954 . . . . 0.0 109.017 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.517 ' HB3' ' CD1' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -64.62 -9.96 23.19 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 3.3 tt -53.29 -18.05 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 109.833 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.8 t -82.28 -35.43 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.009 -1.057 . . . . 0.0 109.775 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 39.9 m-20 -98.93 -118.26 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.952 . . . . 0.0 111.383 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 1.012 HG22 ' CD2' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -49.71 -3.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.179 -2.634 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -176.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.64 HG23 ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -132.31 142.92 41.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 121.658 2.026 . . . . 0.0 112.5 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.881 ' OG1' ' HB3' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -155.52 149.07 25.08 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 1.4 pp -139.06 -174.66 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.094 -1.003 . . . . 0.0 109.61 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 167.48 44.28 0.03 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' A' ' 5' ' ' VAL . . . -94.05 -104.92 1.82 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 75' ' ' GLY . 0.7 OUTLIER -176.58 166.72 2.69 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.476 -1.014 . . . . 0.0 109.577 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.2 p -133.41 92.34 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.709 ' OD1' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -104.69 137.33 42.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 109.97 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.98 133.84 55.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.865 . . . . 0.0 109.457 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.6 -96.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 109.501 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.86 -61.14 1.58 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.253 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -126.37 -39.0 2.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.4 -173.77 0.16 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.739 ' CD1' HG21 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -141.05 166.42 24.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.228 -0.92 . . . . 0.0 109.051 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.709 HG13 ' OD1' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -154.62 162.75 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.533 -179.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.754 HD11 ' CD1' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -172.75 -123.76 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 109.335 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 pt-20 . . . . . 0 C--N 1.297 -1.695 0 O-C-N 121.372 -0.83 . . . . 0.0 110.991 -179.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.788 ' C ' HD13 ' A' ' 4' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.883 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -156.59 160.61 39.59 Favored 'General case' 0 C--N 1.31 -1.152 0 O-C-N 120.918 -1.114 . . . . 0.0 111.213 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.968 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 48.8 t -114.71 171.36 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.618 ' N ' HG12 ' A' ' 5' ' ' VAL . 50.3 t80 -147.73 138.59 23.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.743 -1.223 . . . . 0.0 109.259 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' A' ' 73' ' ' ILE . 2.8 pt -160.68 159.31 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 39' ' ' ARG . . . -165.83 164.63 18.65 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.339 -1.476 . . . . 0.0 110.591 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 1.185 ' CE2' HG22 ' A' ' 71' ' ' ILE . 5.3 m-85 -149.18 163.15 38.44 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.73 ' HB3' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -125.76 81.65 2.0 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.508 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 14.9 p30 -106.41 167.13 10.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 0.0 110.37 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.32 5.86 40.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.529 -0.732 . . . . 0.0 109.505 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -79.66 103.93 9.9 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.111 -0.993 . . . . 0.0 108.972 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.8 t-20 -66.17 -8.82 26.47 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 108.715 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.89 -40.66 85.11 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.42 ' NH2' HD13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -65.36 -36.5 84.2 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -46.67 81.67 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.345 -0.847 . . . . 0.0 108.937 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.12 -57.41 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.228 -0.92 . . . . 0.0 108.594 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.59 -21.68 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.379 -0.826 . . . . 0.0 108.801 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.543 ' OE2' ' CD2' ' A' ' 33' ' ' HIS . 6.8 tt0 -75.09 -37.6 61.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.517 -0.739 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.78 -28.02 63.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.056 -1.027 . . . . 0.0 109.231 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.413 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 32.1 mm -76.85 -41.13 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.231 -0.918 . . . . 0.0 109.086 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 24' ' ' GLN . 1.3 tt -60.45 -46.29 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 108.655 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.517 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -67.65 -32.15 72.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.413 ' HB2' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -49.18 -30.04 6.34 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.515 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -79.66 136.37 55.49 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -84.0 45.15 1.7 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.826 1.435 . . . . 0.0 110.108 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -149.6 -47.71 0.14 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.181 -0.949 . . . . 0.0 109.636 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.03 55.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.573 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.717 HG13 ' HG3' ' A' ' 41' ' ' GLU . 4.8 p -100.31 140.41 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.37 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.498 HG21 HG23 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -151.34 166.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 0.0 109.449 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -165.16 82.37 0.36 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.543 ' CD2' ' OE2' ' A' ' 20' ' ' GLU . 2.2 p80 -117.36 142.61 46.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -0.896 . . . . 0.0 109.286 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.566 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -160.93 -58.58 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.183 -0.948 . . . . 0.0 109.54 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.9 Cg_endo -68.62 -155.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.715 1.376 . . . . 0.0 109.862 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.98 -4.03 58.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 109.425 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.505 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 2.9 ttm -89.57 168.54 12.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.656 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -138.48 115.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.642 ' C ' HD12 ' A' ' 40' ' ' ILE . 3.6 ptp180 -129.62 168.66 16.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.662 -1.274 . . . . 0.0 111.433 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.642 HD12 ' C ' ' A' ' 39' ' ' ARG . 2.7 mp -158.98 157.43 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.717 ' HG3' HG13 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -131.58 -177.4 4.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.944 -1.098 . . . . 0.0 109.71 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.968 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . . . -129.2 -149.02 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 109.113 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.663 ' H ' HD21 ' A' ' 46' ' ' LEU . 1.2 mm-40 -135.6 26.94 3.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.824 -1.173 . . . . 0.0 111.699 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.612 ' HB3' ' O ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER 83.07 -39.49 0.09 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.887 0.851 . . . . 0.0 111.629 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.696 ' O ' HD23 ' A' ' 46' ' ' LEU . 6.3 mtm180 -127.81 113.23 15.68 Favored 'General case' 0 C--N 1.263 -3.177 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.087 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.696 HD23 ' O ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -141.18 144.52 34.84 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.696 ' HA ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -154.54 139.65 17.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 109.598 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -142.96 143.74 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -0.815 . . . . 0.0 109.132 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 -101.25 -98.35 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.002 . . . . 0.0 110.288 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -15.27 4.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.68 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HB3' ' HB ' ' A' ' 48' ' ' ILE . 33.8 tp10 -49.43 -24.86 2.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.725 -1.234 . . . . 0.0 108.986 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.663 HG21 ' O ' ' A' ' 82' ' ' ASP . 1.6 m -66.4 -46.16 77.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.085 -1.009 . . . . 0.0 108.929 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 52' ' ' THR . 78.2 t -47.26 -30.27 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -70.43 -46.81 63.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 52' ' ' THR . 7.2 mt-10 -51.09 -63.62 1.07 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' ARG . 1.0 OUTLIER -44.05 -33.98 1.62 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.526 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.7 tp -51.06 -62.74 1.43 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.667 ' O ' ' CB ' ' A' ' 59' ' ' ARG . . . -52.79 -24.79 20.47 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.667 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 8.9 tpt180 110.59 39.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.869 1.267 . . . . 0.0 108.576 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 61.4 96.36 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 102.672 -3.085 . . . . 0.0 102.672 -176.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.594 ' CD1' HG23 ' A' ' 63' ' ' VAL . 29.3 t90 -18.41 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 123.219 1.485 . . . . 0.0 109.845 -174.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 60' ' ' ALA . 23.7 t70 -102.19 53.21 0.8 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.96 -177.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 63' ' ' VAL . 40.5 t -88.47 9.42 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.479 -0.763 . . . . 0.0 110.037 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 63' ' ' VAL . 61.3 mm-40 -39.88 -31.74 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 109.693 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -64.46 -53.42 48.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 108.889 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.04 -1.28 25.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.406 -0.809 . . . . 0.0 109.54 179.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 69' ' ' ASP . 12.0 tp -38.53 -23.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.657 -0.652 . . . . 0.0 111.367 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' MET . 2.4 m -39.0 -28.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.033 -1.042 . . . . 0.0 109.953 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 21.6 p30 -59.08 165.12 2.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.43 -0.794 . . . . 0.0 109.587 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.73 HG23 ' HB3' ' A' ' 10' ' ' GLN . 45.7 t -79.45 167.09 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.194 -0.941 . . . . 0.0 109.015 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 1.185 HG22 ' CE2' ' A' ' 9' ' ' PHE . 1.5 pp -132.53 148.76 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.086 -1.009 . . . . 0.0 110.204 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 1.041 ' O ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -151.89 140.46 20.7 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.215 -0.928 . . . . 0.0 109.406 178.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.041 HD13 ' O ' ' A' ' 72' ' ' THR . 5.4 mm -137.33 153.82 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.448 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -166.33 32.27 0.22 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.576 ' CA ' HG13 ' A' ' 5' ' ' VAL . . . -146.24 -95.31 0.17 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.573 ' C ' HD21 ' A' ' 86' ' ' LEU . 5.4 t30 -172.8 -151.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -1.167 . . . . 0.0 109.519 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.731 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.6 p 179.18 89.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.369 -0.832 . . . . 0.0 109.273 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.483 ' OD2' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -110.78 129.93 55.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.114 -0.991 . . . . 0.0 109.811 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.68 146.71 50.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.498 -0.751 . . . . 0.0 109.14 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.64 -101.14 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.071 -1.018 . . . . 0.0 109.422 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.2 -53.95 2.57 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.966 -1.084 . . . . 0.0 109.322 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.663 ' O ' HG21 ' A' ' 52' ' ' THR . 0.5 OUTLIER -130.86 -43.55 1.09 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 82' ' ' ASP . 10.1 mpt_? -54.53 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.661 -0.649 . . . . 0.0 109.346 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.923 ' O ' HD12 ' A' ' 48' ' ' ILE . 14.5 t80 -161.17 143.12 12.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 109.027 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.696 HG23 ' HA ' ' A' ' 47' ' ' GLU . 9.3 p -150.73 144.27 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.987 -1.071 . . . . 0.0 110.606 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.69 HD12 HD12 ' A' ' 46' ' ' LEU . 2.7 tm? -143.72 133.99 24.49 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.614 ' O ' HG21 ' A' ' 5' ' ' VAL . 5.5 mp0 . . . . . 0 C--N 1.306 -1.295 0 O-C-N 121.316 -0.865 . . . . 0.0 108.755 178.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.581 ' HB2' ' CB ' ' A' ' 44' ' ' LYS . 49.0 m . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.866 ' O ' HD12 ' A' ' 4' ' ' LEU . 1.2 pp -148.35 152.1 36.47 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.384 -0.822 . . . . 0.0 109.884 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.821 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 3.7 t -113.63 176.62 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.608 -0.683 . . . . 0.0 109.197 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.625 ' H ' HG12 ' A' ' 5' ' ' VAL . 8.9 t80 -143.18 138.46 29.74 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.001 -1.062 . . . . 0.0 108.276 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 73' ' ' ILE . 3.6 pt -156.89 156.07 4.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 108.475 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' THR . . . -163.99 141.25 6.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.78 -1.2 . . . . 0.0 109.902 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.67 ' CD2' HD11 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -139.54 -167.47 2.27 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.079 -1.013 . . . . 0.0 109.02 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.665 ' HB2' HG12 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -156.27 93.51 1.42 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.5 OUTLIER -109.6 -170.97 1.75 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -71.72 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.034 . . . . 0.0 109.235 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -145.0 7.17 1.19 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.867 -1.146 . . . . 0.0 110.088 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -102.52 -57.13 2.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.045 -1.034 . . . . 0.0 109.494 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.2 92.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.816 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.512 ' NH1' ' HG3' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -66.46 -36.72 83.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.133 -0.979 . . . . 0.0 109.301 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 11.1 t80 -62.73 -44.13 97.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 0.0 109.148 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.14 -53.11 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.238 -0.913 . . . . 0.0 109.17 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.57 -24.01 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -0.934 . . . . 0.0 109.281 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -66.64 -48.87 68.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.289 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.63 91.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.371 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.81 -46.89 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.412 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.402 HG21 ' O ' ' A' ' 30' ' ' VAL . 29.1 mt -52.83 -52.45 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 108.813 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 25' ' ' ASP . 1.4 mp0 -58.68 -31.06 67.86 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.208 -0.932 . . . . 0.0 108.631 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 24' ' ' GLN . 1.1 t70 -46.15 -42.0 13.28 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.589 -1.264 . . . . 0.0 107.589 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -96.63 131.49 28.09 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.92 47.57 2.31 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.703 1.37 . . . . 0.0 110.085 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 29' ' ' ALA . 30.0 t-80 -154.52 -50.83 0.09 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.25 -0.906 . . . . 0.0 109.977 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -41.36 140.42 0.87 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.796 . . . . 0.0 109.991 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.708 HG22 ' H ' ' A' ' 31' ' ' VAL . 1.6 p -78.66 -169.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.317 -0.864 . . . . 0.0 108.715 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.708 ' H ' HG22 ' A' ' 30' ' ' VAL . 15.6 m -122.88 -155.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.996 -1.065 . . . . 0.0 109.477 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.559 ' HB3' ' CA ' ' A' ' 38' ' ' ILE . 2.3 mp0 -112.75 -151.74 0.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.073 -1.017 . . . . 0.0 109.604 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.34 -96.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.873 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.565 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -163.89 -69.55 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.009 -1.057 . . . . 0.0 109.569 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 34' ' ' HIS . 5.7 Cg_exo -49.27 -178.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.904 1.476 . . . . 0.0 110.47 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HB1' ' NE2' ' A' ' 10' ' ' GLN . . . -43.09 -36.07 1.52 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.384 -0.823 . . . . 0.0 109.896 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.494 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 66.2 mtm -63.91 144.18 57.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.002 -1.061 . . . . 0.0 109.13 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.67 HD11 ' CD2' ' A' ' 9' ' ' PHE . 6.3 pt -146.28 109.3 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.554 ' N ' ' HB3' ' A' ' 32' ' ' GLN . 1.6 mtt-85 -90.74 174.45 7.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 0.0 109.523 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 41' ' ' GLU . 11.4 mt -161.98 166.96 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.449 -0.782 . . . . 0.0 109.391 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.615 ' HB2' HG11 ' A' ' 30' ' ' VAL . 5.7 tp10 -142.79 170.4 15.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 0.0 109.005 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.821 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . . . -140.84 -168.81 2.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.724 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.741 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 1.6 pm0 -143.37 85.16 1.84 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.511 -0.743 . . . . 0.0 109.758 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.581 ' CB ' ' HB2' ' A' ' 3' ' ' SER . 0.0 OUTLIER 83.4 -179.68 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -178.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.674 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 3.8 mmt180 179.5 -165.58 0.06 Allowed 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.435 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 4.8 mt 164.48 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.836 ' H ' HG23 ' A' ' 85' ' ' VAL . 2.0 mt-10 162.59 -167.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.828 -1.17 . . . . 0.0 109.394 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.825 HG23 ' N ' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -177.31 -151.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.972 . . . . 0.0 109.634 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.825 ' N ' HG23 ' A' ' 48' ' ' ILE . 11.0 ttp180 -91.73 -37.05 13.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.949 -1.095 . . . . 0.0 110.131 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.621 ' H ' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -59.7 -32.46 70.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.918 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 20.8 mm-40 -58.05 -27.64 63.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.134 -0.979 . . . . 0.0 109.665 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m -64.84 -41.39 95.76 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.003 -1.06 . . . . 0.0 109.434 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.6 t -53.52 -29.66 17.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -70.69 -40.5 72.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 17.8 mt-10 -57.49 -62.91 1.45 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.47 ' HA ' ' H ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -44.0 -36.75 2.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.98 . . . . 0.0 109.057 179.306 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 9.9 tp -57.65 -50.02 74.53 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -78.59 15.79 9.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 176.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.565 ' HB3' ' O ' ' A' ' 58' ' ' GLY . 2.8 ttt180 68.34 49.64 0.79 Allowed 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 121.415 0.626 . . . . 0.0 110.056 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 57.31 93.21 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TRP . . . . . 0.598 ' C ' ' O ' ' A' ' 60' ' ' ALA . 57.4 t90 -16.3 81.09 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.434 1.588 . . . . 0.0 109.319 -174.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 60' ' ' ALA . 20.8 t70 -102.44 66.82 0.99 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.138 -1.846 . . . . 0.0 110.012 -176.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 63' ' ' VAL . 19.5 t -89.56 6.63 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 109.558 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.946 ' O ' HD22 ' A' ' 67' ' ' LEU . 5.4 mp0 -42.58 -31.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 109.454 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.48 -49.66 65.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.119 -0.988 . . . . 0.0 109.236 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.5 ' O ' ' N ' ' A' ' 68' ' ' VAL . 1.4 mtt -72.95 -5.35 37.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.919 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.946 HD22 ' O ' ' A' ' 64' ' ' GLN . 1.5 pt? -39.21 -26.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.467 -0.771 . . . . 0.0 110.788 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 69' ' ' ASP . 5.8 p -40.52 -49.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.589 ' N ' HG13 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -72.64 146.17 46.78 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 10' ' ' GLN . 6.9 p -76.15 173.79 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.841 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ILE . . . . . 0.64 ' H ' HG22 ' A' ' 70' ' ' VAL . 9.1 mt -153.17 157.0 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.228 -0.92 . . . . 0.0 109.835 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -149.56 152.07 34.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.491 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.697 HD13 ' C ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -137.47 159.31 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -159.81 66.73 0.27 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.441 -1.362 . . . . 0.0 110.794 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.94 -105.89 1.31 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 178.434 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.609 ' C ' HD21 ' A' ' 86' ' ' LEU . 2.9 t-20 -165.12 -144.57 0.07 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -1.188 . . . . 0.0 108.435 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.4 p -170.28 98.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.881 -1.137 . . . . 0.0 110.587 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -114.38 127.46 55.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.439 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -128.05 149.99 50.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 109.61 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -109.82 -103.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 109.364 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -104.23 -54.14 2.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.951 -1.093 . . . . 0.0 108.909 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ARG . 79.8 m-20 -130.67 -39.75 1.25 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -51.65 -175.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.602 0.715 . . . . 0.0 109.728 179.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -160.23 111.07 1.88 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.836 HG23 ' H ' ' A' ' 47' ' ' GLU . 4.0 p -124.37 143.6 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.061 -1.024 . . . . 0.0 109.251 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.803 ' C ' HD13 ' A' ' 86' ' ' LEU . 2.2 tm? -151.22 129.45 11.95 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.885 -1.526 . . . . 0.0 110.571 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.665 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.306 -1.31 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.487 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -162.22 -54.21 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.315 -0.866 . . . . 0.0 109.271 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.577 ' HA ' ' CE3' ' A' ' 88' ' ' TRP . 20.0 m -44.35 110.15 0.2 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.287 -0.883 . . . . 0.0 109.554 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.69 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -130.05 155.65 45.8 Favored 'General case' 0 N--CA 1.486 1.325 0 O-C-N 121.218 -0.926 . . . . 0.0 110.336 -179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.13 HG11 HD21 ' A' ' 46' ' ' LEU . 1.1 m -116.66 -150.16 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 O-C-N 121.566 -0.709 . . . . 0.0 109.361 -179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.959 ' OH ' HG21 ' A' ' 72' ' ' THR . 0.0 OUTLIER 172.78 139.82 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.106 -0.996 . . . . 0.0 109.625 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.817 HG22 ' HA ' ' A' ' 73' ' ' ILE . 46.4 pt -136.61 139.41 45.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.612 ' HB2' ' HD2' ' A' ' 39' ' ' ARG . . . -134.2 164.78 26.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.551 -1.343 . . . . 0.0 110.65 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 1.065 ' CZ ' HD13 ' A' ' 71' ' ' ILE . 0.5 OUTLIER -158.78 151.55 22.08 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.526 ' HG2' ' CB ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -131.81 92.97 3.22 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.05 -1.031 . . . . 0.0 108.51 179.102 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -87.04 -132.27 0.06 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.405 -0.809 . . . . 0.0 109.762 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.451 ' O ' ' HD3' ' A' ' 16' ' ' ARG . 5.0 t-20 -86.42 -111.88 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.837 -1.164 . . . . 0.0 109.385 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -132.63 -24.52 1.98 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.927 -1.108 . . . . 0.0 109.775 -179.864 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.416 ' O ' HG23 ' A' ' 18' ' ' VAL . 1.6 t-20 -102.96 -54.35 2.64 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.025 -1.047 . . . . 0.0 109.817 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.402 ' C ' ' O ' ' A' ' 14' ' ' ASN . . . -44.27 -31.17 0.94 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.257 -0.902 . . . . 0.0 109.809 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 13' ' ' ASP . 55.9 mtm180 -64.79 -63.58 1.08 Allowed 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.327 -0.858 . . . . 0.0 109.613 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 1.1 m-85 -47.5 -36.57 10.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.168 -0.958 . . . . 0.0 109.455 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.416 HG23 ' O ' ' A' ' 14' ' ' ASN . 41.2 t -54.67 -58.64 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.211 -0.93 . . . . 0.0 109.031 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.3 t -56.73 -22.78 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.207 -0.933 . . . . 0.0 108.865 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.488 ' O ' HG13 ' A' ' 23' ' ' ILE . 13.3 tt0 -69.46 -38.36 77.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.437 -0.789 . . . . 0.0 109.217 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.93 -30.36 68.81 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.246 -0.909 . . . . 0.0 108.891 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.43 ' HA ' HD13 ' A' ' 22' ' ' ILE . 24.3 mm -70.31 -55.58 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.369 -0.832 . . . . 0.0 109.791 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 20' ' ' GLU . 1.0 OUTLIER -58.98 -35.54 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.055 -1.028 . . . . 0.0 109.668 -179.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.431 ' O ' ' C ' ' A' ' 25' ' ' ASP . 0.6 OUTLIER -69.63 -35.97 75.71 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.108 -0.995 . . . . 0.0 108.693 179.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.431 ' C ' ' O ' ' A' ' 24' ' ' GLN . 0.3 OUTLIER -46.18 -42.8 14.56 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 179.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -79.8 136.54 54.81 Favored Pre-proline 0 N--CA 1.486 1.356 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -84.28 46.23 1.91 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.795 1.418 . . . . 0.0 109.979 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 5.4 t-160 -149.04 -39.57 0.15 Allowed 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.18 -0.95 . . . . 0.0 109.629 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.456 ' HB1' ' HB ' ' A' ' 23' ' ' ILE . . . -44.81 140.18 2.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 109.746 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.663 HG12 ' H ' ' A' ' 31' ' ' VAL . 2.6 t -101.22 177.11 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.244 -0.91 . . . . 0.0 109.646 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.663 ' H ' HG12 ' A' ' 30' ' ' VAL . 2.0 t -141.45 154.58 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 0.0 109.23 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -140.29 -71.73 0.37 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.188 -0.945 . . . . 0.0 109.636 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 37' ' ' MET . 0.2 OUTLIER -95.27 176.66 6.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.149 -0.969 . . . . 0.0 109.595 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.565 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -152.13 -64.55 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.285 -0.885 . . . . 0.0 109.538 -179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 4.2 Cg_exo -61.17 -75.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.636 1.335 . . . . 0.0 110.417 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.416 ' O ' ' O ' ' A' ' 35' ' ' PRO . . . -46.52 -93.12 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.153 -0.967 . . . . 0.0 109.937 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.526 ' CB ' ' HG2' ' A' ' 10' ' ' GLN . 2.0 ptm -115.46 -167.23 1.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.183 -0.948 . . . . 0.0 109.687 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 38' ' ' ILE . 0.9 OUTLIER -128.43 101.96 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.356 -0.84 . . . . 0.0 109.114 179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.612 ' HD2' ' HB2' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -87.31 169.26 12.45 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.172 -0.955 . . . . 0.0 109.746 -179.265 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.563 HG22 ' N ' ' A' ' 41' ' ' GLU . 45.3 mt -142.69 164.92 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.207 -0.933 . . . . 0.0 109.725 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.6 ' HA ' ' HA ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -143.85 147.27 33.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.0 110.209 -179.506 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.019 ' CB ' HG22 ' A' ' 5' ' ' VAL . . . -127.51 -171.81 2.52 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.69 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 8.3 mt-10 -140.11 64.91 1.43 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.878 -1.139 . . . . 0.0 110.372 -178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 43' ' ' GLU . 8.5 tttt 175.25 -140.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.952 -1.093 . . . . 0.0 110.263 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.982 ' C ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -126.51 166.69 16.79 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.301 -0.874 . . . . 0.0 110.182 -178.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.13 HD21 HG11 ' A' ' 5' ' ' VAL . 0.2 OUTLIER -129.03 157.72 40.93 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 -179.553 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.531 ' HG2' HG23 ' A' ' 85' ' ' VAL . 8.2 mt-10 -150.96 140.01 21.07 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.077 -1.014 . . . . 0.0 109.99 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.658 HG22 ' OG1' ' A' ' 52' ' ' THR . 1.3 mp -138.94 150.44 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.381 -0.824 . . . . 0.0 109.159 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 7.8 mmt180 -97.3 176.42 5.91 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.122 -0.986 . . . . 0.0 109.969 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -67.08 -24.39 65.95 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.864 . . . . 0.0 109.332 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.498 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 34.9 mm-40 -49.53 -40.89 39.63 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.226 -0.921 . . . . 0.0 109.028 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.658 ' OG1' HG22 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -65.56 -46.44 79.46 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.162 -0.961 . . . . 0.0 108.755 179.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.6 t -56.08 -22.98 14.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.498 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.7 OUTLIER -75.58 -38.21 59.29 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.8 tt0 -66.69 -53.02 38.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.218 -0.926 . . . . 0.0 108.956 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -56.12 -33.39 65.09 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.288 -0.883 . . . . 0.0 109.139 179.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -58.18 -55.83 29.92 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.246 -0.909 . . . . 0.0 109.095 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.32 -7.49 63.84 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.344 -1.502 . . . . 0.0 109.344 179.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.44 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -117.01 10.22 13.91 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -1.108 . . . . 0.0 109.402 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.522 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -69.3 -6.89 32.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.707 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 8.6 t90 -91.42 19.75 5.84 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.067 -1.021 . . . . 0.0 109.336 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.435 ' OD1' ' HB3' ' A' ' 65' ' ' GLU . 26.8 t70 -111.84 10.2 20.74 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.49 -0.756 . . . . 0.0 109.541 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.414 HG23 ' H ' ' A' ' 63' ' ' VAL . 3.1 t -49.54 -46.17 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.182 -0.949 . . . . 0.0 109.871 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -51.61 -45.87 63.37 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.167 -0.958 . . . . 0.0 109.406 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.435 ' HB3' ' OD1' ' A' ' 62' ' ' ASP . 2.7 tt0 -68.29 -27.86 66.67 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.257 -0.902 . . . . 0.0 109.195 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.457 ' O ' ' O ' ' A' ' 69' ' ' ASP . 1.1 mtm -74.78 -17.88 60.56 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.301 -0.874 . . . . 0.0 109.224 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.505 HD22 ' HA ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -69.83 -57.49 5.01 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.32 -0.863 . . . . 0.0 109.557 179.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 62.9 t -46.96 -64.91 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 109.524 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.513 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 2.0 p30 -82.87 154.79 24.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.161 -0.962 . . . . 0.0 109.407 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.522 HG12 ' N ' ' A' ' 71' ' ' ILE . 21.1 t -99.53 165.75 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.168 -0.958 . . . . 0.0 109.568 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.065 HD13 ' CZ ' ' A' ' 9' ' ' PHE . 0.3 OUTLIER -146.11 151.78 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.945 . . . . 0.0 109.648 -179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.959 HG21 ' OH ' ' A' ' 6' ' ' TYR . 0.3 OUTLIER -165.4 151.86 10.01 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.264 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.817 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.0 OUTLIER -154.61 152.0 10.06 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 120.898 -1.126 . . . . 0.0 111.185 -179.113 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.661 ' HA2' ' HB ' ' A' ' 5' ' ' VAL . . . 46.84 -85.12 0.01 OUTLIER Glycine 0 C--N 1.299 -1.492 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.926 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 73' ' ' ILE . . . 171.37 -47.81 0.19 Allowed Glycine 0 C--N 1.284 -2.329 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.538 ' O ' ' HG ' ' A' ' 86' ' ' LEU . 16.2 t30 -120.34 -141.7 0.34 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.973 -1.31 . . . . 0.0 108.959 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.85 HG23 ' CE1' ' A' ' 84' ' ' PHE . 3.0 p 178.94 98.48 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 120.988 -1.07 . . . . 0.0 110.151 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -100.42 129.9 46.45 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 108.865 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -125.6 139.98 53.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -97.58 -96.37 0.21 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.242 -0.911 . . . . 0.0 109.659 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -104.04 -60.97 1.5 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.042 -1.036 . . . . 0.0 109.373 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -127.88 -30.8 2.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.341 -0.849 . . . . 0.0 109.01 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.496 ' CG ' ' N ' ' A' ' 84' ' ' PHE . 34.4 ttp180 -68.59 168.21 13.48 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.359 -0.838 . . . . 0.0 109.146 179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.85 ' CE1' HG23 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -141.84 127.11 18.63 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.306 -0.871 . . . . 0.0 108.907 -179.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.531 HG23 ' HG2' ' A' ' 47' ' ' GLU . 3.7 p -138.64 150.72 23.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.22 -0.925 . . . . 0.0 110.22 -179.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.811 HD22 ' N ' ' A' ' 87' ' ' GLU . 1.7 tm? -157.19 135.75 11.42 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.811 ' N ' HD22 ' A' ' 86' ' ' LEU . 2.0 mp0 -121.47 -151.84 0.49 Allowed 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.608 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 2.4 t90 -50.77 -78.37 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.508 ' HB3' ' HB2' ' A' ' 76' ' ' ASN . 11.8 mmtt 58.93 112.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.305 -0.872 . . . . 0.0 109.589 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.403 ' OD1' ' C ' ' A' ' 90' ' ' ASN . 8.8 t-20 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 118.016 -0.992 . . . . 0.0 109.474 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 3' ' ' SER . 54.0 m -137.08 -80.01 0.38 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.245 -0.909 . . . . 0.0 109.353 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.672 ' C ' HD13 ' A' ' 4' ' ' LEU . 0.8 OUTLIER 72.05 93.19 0.08 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.206 -0.934 . . . . 0.0 109.7 179.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.916 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -146.17 154.92 42.32 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 121.032 -1.043 . . . . 0.0 110.47 179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.023 HG22 ' HB3' ' A' ' 42' ' ' ALA . 3.4 m -115.1 -171.69 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.458 0.647 . . . . 0.0 109.313 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.567 ' O ' ' N ' ' A' ' 74' ' ' GLY . 4.9 t80 -159.08 137.98 11.11 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.553 HG22 ' HA ' ' A' ' 73' ' ' ILE . 3.2 pt -158.11 142.14 6.99 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.694 ' HB3' ' OG1' ' A' ' 72' ' ' THR . . . -146.89 150.41 35.18 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.776 -1.203 . . . . 0.0 110.109 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 1.102 ' CZ ' HG23 ' A' ' 71' ' ' ILE . 8.8 m-85 -134.57 172.27 13.16 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.632 ' HB3' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -147.33 80.99 1.52 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.244 -0.91 . . . . 0.0 109.258 178.886 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.546 ' CA ' ' HB3' ' A' ' 69' ' ' ASP . 5.5 t0 -106.75 -178.91 3.79 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -65.1 -97.09 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.157 -0.964 . . . . 0.0 109.049 179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.56 14.12 0.56 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.034 -1.041 . . . . 0.0 109.938 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -102.46 -56.5 2.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.136 -0.978 . . . . 0.0 109.317 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.41 -54.51 39.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.327 -0.858 . . . . 0.0 109.756 -179.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.45 ' HG3' ' N ' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -51.12 -39.2 55.68 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.318 -0.864 . . . . 0.0 109.611 -179.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' N ' ' HG3' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -59.44 -47.5 85.23 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.197 -0.94 . . . . 0.0 109.229 179.685 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.479 HG12 HD11 ' A' ' 22' ' ' ILE . 73.1 t -53.81 -53.84 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.287 -0.883 . . . . 0.0 109.241 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.972 ' HA ' HD12 ' A' ' 22' ' ' ILE . 53.3 t -62.37 -21.82 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.909 . . . . 0.0 109.216 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -69.04 -43.84 73.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.36 -0.838 . . . . 0.0 109.777 -179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.79 -32.11 67.29 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.086 -1.009 . . . . 0.0 109.324 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.972 HD12 ' HA ' ' A' ' 19' ' ' VAL . 14.8 mt -67.14 -42.26 87.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.276 -0.89 . . . . 0.0 109.172 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.789 HG23 ' CB ' ' A' ' 29' ' ' ALA . 41.2 mt -60.87 -54.63 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.33 -0.856 . . . . 0.0 109.298 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.422 ' O ' ' C ' ' A' ' 25' ' ' ASP . 18.6 mt-30 -57.79 -31.33 66.45 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.157 -0.964 . . . . 0.0 108.56 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 24' ' ' GLN . 9.0 t70 -46.12 -47.51 17.38 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -84.58 135.27 40.97 Favored Pre-proline 0 C--N 1.305 -1.359 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -83.65 45.19 1.75 Allowed 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.761 1.4 . . . . 0.0 110.155 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.6 t60 -151.7 -49.06 0.11 Allowed 'General case' 0 N--CA 1.485 1.295 0 O-C-N 121.165 -0.959 . . . . 0.0 109.759 -179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.789 ' CB ' HG23 ' A' ' 23' ' ' ILE . . . -41.85 141.43 0.83 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.4 -0.813 . . . . 0.0 109.704 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 31' ' ' VAL . 0.6 OUTLIER -100.85 -169.17 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.246 -0.909 . . . . 0.0 109.185 -179.984 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.592 HG22 ' N ' ' A' ' 32' ' ' GLN . 2.0 p -169.01 166.46 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.297 -0.877 . . . . 0.0 109.536 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.592 ' N ' HG22 ' A' ' 31' ' ' VAL . 2.8 mm-40 -144.84 77.24 1.52 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.453 -0.779 . . . . 0.0 109.311 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.513 ' CD2' ' O ' ' A' ' 33' ' ' HIS . 0.3 OUTLIER -48.49 103.36 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.229 -0.919 . . . . 0.0 109.547 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.586 ' CD2' ' HD2' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -104.84 -178.56 0.63 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.37 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.586 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 3.8 Cg_exo -67.6 -74.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.939 1.494 . . . . 0.0 110.116 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -119.39 3.39 11.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.239 -0.913 . . . . 0.0 109.758 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.3 mtt -112.28 157.54 20.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.128 -0.982 . . . . 0.0 109.388 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.515 ' CG1' ' O ' ' A' ' 9' ' ' PHE . 12.1 pt -134.51 92.02 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.651 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.645 ' C ' HD12 ' A' ' 40' ' ' ILE . 2.1 ttp180 -85.55 162.23 18.98 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.161 -0.962 . . . . 0.0 110.086 -179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.645 HD12 ' C ' ' A' ' 39' ' ' ARG . 4.1 mp -150.97 162.01 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.374 -0.829 . . . . 0.0 109.499 179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.516 ' N ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -161.96 157.1 23.22 Favored 'General case' 0 N--CA 1.483 1.197 0 O-C-N 121.027 -1.046 . . . . 0.0 110.251 -179.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.023 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -129.34 177.75 6.95 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.388 -0.82 . . . . 0.0 109.068 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.626 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 2.8 pt-20 -158.74 68.74 0.46 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.915 -1.116 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.53 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.4 OUTLIER 169.82 -152.11 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.816 -1.178 . . . . 0.0 110.82 178.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 1.045 ' C ' HD23 ' A' ' 46' ' ' LEU . 20.1 mtp180 -125.43 135.14 52.05 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.045 HD23 ' C ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -127.32 162.53 26.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.45 -0.781 . . . . 0.0 109.168 -178.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.948 ' CB ' HG23 ' A' ' 85' ' ' VAL . 1.2 pt-20 -176.19 158.78 1.98 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.984 -1.073 . . . . 0.0 110.668 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.526 ' CG2' ' CB ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -152.27 155.84 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.484 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.627 ' HA ' ' CB ' ' A' ' 83' ' ' ARG . 30.0 ttp180 -100.12 -112.14 0.19 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.178 -0.951 . . . . 0.0 110.112 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.41 ' HD2' ' N ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -61.63 -5.29 1.78 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.982 -1.074 . . . . 0.0 110.519 179.961 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.526 ' CB ' ' CG2' ' A' ' 48' ' ' ILE . 1.0 OUTLIER -54.61 -14.7 1.41 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.708 -1.245 . . . . 0.0 109.363 179.526 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 55' ' ' GLU . 1.9 m -58.26 -39.33 78.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.69 -1.256 . . . . 0.0 109.47 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -52.91 -32.45 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 179.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 1.3 tt0 -67.63 -40.56 84.63 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 60' ' ' ALA . 1.1 tt0 -49.85 -63.29 1.16 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 178.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.536 ' HA ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -48.55 -31.44 6.53 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.634 -0.666 . . . . 0.0 109.387 179.006 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.516 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.5 tp -52.27 -59.03 4.88 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.68 ' O ' ' CB ' ' A' ' 59' ' ' ARG . . . -53.63 -24.52 25.19 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 106.861 -2.496 . . . . 0.0 106.861 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.68 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 1.6 ttm-85 110.68 35.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 124.786 1.234 . . . . 0.0 108.557 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.689 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 62.92 96.42 0.04 OUTLIER 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 102.586 -3.116 . . . . 0.0 102.586 -176.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.772 ' CZ2' HG21 ' A' ' 63' ' ' VAL . 24.6 t-105 -20.11 82.74 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 123.26 1.505 . . . . 0.0 109.35 -174.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.689 ' N ' ' O ' ' A' ' 60' ' ' ALA . 19.0 t70 -109.2 71.1 0.76 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.415 -1.721 . . . . 0.0 109.738 -176.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.772 HG21 ' CZ2' ' A' ' 61' ' ' TRP . 2.1 t -86.91 6.51 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.315 -0.865 . . . . 0.0 109.799 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.887 ' O ' HD23 ' A' ' 67' ' ' LEU . 1.3 mp0 -41.63 -34.01 0.54 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.386 -0.821 . . . . 0.0 109.614 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -63.54 -50.93 67.58 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.003 -1.061 . . . . 0.0 108.979 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.575 ' HB2' HG12 ' A' ' 63' ' ' VAL . 0.8 OUTLIER -75.68 -2.64 30.45 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.46 -0.775 . . . . 0.0 110.02 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 64' ' ' GLN . 3.7 pp -38.5 -26.07 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.503 -0.748 . . . . 0.0 110.961 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.608 ' N ' HD12 ' A' ' 67' ' ' LEU . 9.4 m -39.89 -45.42 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.151 -0.968 . . . . 0.0 110.156 -179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.546 ' HB3' ' CA ' ' A' ' 11' ' ' ASP . 15.8 p30 -65.29 149.45 49.94 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.266 -0.896 . . . . 0.0 109.67 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.632 HG23 ' HB3' ' A' ' 10' ' ' GLN . 21.8 t -62.53 169.77 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.102 HG23 ' CZ ' ' A' ' 9' ' ' PHE . 11.4 mt -143.56 157.39 16.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.056 -1.028 . . . . 0.0 110.643 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.694 ' OG1' ' HB3' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -159.31 142.38 14.34 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.291 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.553 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.1 OUTLIER -143.78 163.33 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.084 -1.01 . . . . 0.0 110.194 -179.087 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.567 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -174.25 71.95 0.09 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.403 ' CA ' ' HA ' ' A' ' 89' ' ' LYS . . . 136.02 108.13 0.91 Allowed Glycine 0 N--CA 1.486 2.001 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -179.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 1.008 ' HA ' HD23 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -157.78 139.42 13.86 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.183 -1.187 . . . . 0.0 110.908 -178.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 85' ' ' VAL . 1.8 t -152.37 30.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.634 ' HA ' ' O ' ' A' ' 85' ' ' VAL . 5.2 p-10 -47.84 -38.95 17.12 Favored 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 121.898 0.856 . . . . 0.0 111.233 -177.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.407 ' N ' ' CG ' ' A' ' 78' ' ' ASP . 1.5 mm-40 -110.79 103.06 11.54 Favored 'General case' 0 C--N 1.266 -3.023 0 C-N-CA 119.352 -0.939 . . . . 0.0 110.93 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.557 ' HB2' ' CG1' ' A' ' 85' ' ' VAL . 58.1 t0 -115.2 -68.46 0.92 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.035 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.403 ' HB2' ' HD3' ' A' ' 83' ' ' ARG . 24.0 m-20 -108.21 -96.6 0.38 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.212 -0.93 . . . . 0.0 109.365 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -131.03 0.22 4.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.036 -1.04 . . . . 0.0 109.221 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.627 ' CB ' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -102.6 -107.09 0.26 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.796 . . . . 0.0 109.42 -179.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 78' ' ' ASP . 12.9 t80 -174.74 118.28 0.2 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.831 -1.168 . . . . 0.0 108.718 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.948 HG23 ' CB ' ' A' ' 47' ' ' GLU . 10.7 p -131.83 174.92 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 120.867 -1.146 . . . . 0.0 110.588 -178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.008 HD23 ' HA ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER -177.84 130.56 0.15 Allowed 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 179.355 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.992 ' N ' HD22 ' A' ' 86' ' ' LEU . 2.2 mt-10 -128.23 -151.56 0.48 Allowed 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.902 -1.124 . . . . 0.0 111.624 -178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.851 ' C ' HG12 ' A' ' 5' ' ' VAL . 1.4 p-90 -54.52 -157.55 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.858 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.453 ' O ' ' O ' ' A' ' 88' ' ' TRP . 0.1 OUTLIER -59.26 -155.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.088 -1.008 . . . . 0.0 109.086 179.462 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 52.2 t30 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 117.999 -1.0 . . . . 0.0 109.467 179.847 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.193 0.521 . . . . 0.0 109.7 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -127.04 64.18 1.31 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.125 -0.984 . . . . 0.0 109.329 179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 44' ' ' LYS . 15.8 m -130.55 33.88 4.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.245 -0.909 . . . . 0.0 109.867 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -122.44 168.41 12.14 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.049 -1.032 . . . . 0.0 109.707 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.772 HG22 ' HB3' ' A' ' 42' ' ' ALA . 1.0 OUTLIER -132.85 -178.35 2.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.346 -0.846 . . . . 0.0 109.954 -179.26 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.585 ' O ' ' N ' ' A' ' 74' ' ' GLY . 1.3 t80 -149.53 142.37 24.7 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 6' ' ' TYR . 1.8 pp -160.84 158.51 2.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.555 ' N ' ' HB ' ' A' ' 72' ' ' THR . . . -159.35 145.69 16.48 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.658 -1.276 . . . . 0.0 109.691 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 1.005 ' CE2' HD11 ' A' ' 38' ' ' ILE . 2.6 p90 -145.26 -171.2 3.61 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.108 -0.995 . . . . 0.0 109.539 -179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.684 ' HB3' HG23 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -148.97 98.98 2.92 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.484 -0.76 . . . . 0.0 109.108 179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.445 ' OD1' ' OD2' ' A' ' 69' ' ' ASP . 35.4 t70 -108.57 136.76 47.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.629 -0.67 . . . . 0.0 109.525 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -71.67 -31.49 66.86 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.163 -0.961 . . . . 0.0 109.561 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.43 ' CB ' ' OD2' ' A' ' 11' ' ' ASP . 1.0 OUTLIER -57.52 106.02 0.3 Allowed 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.087 -1.008 . . . . 0.0 108.575 179.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -60.61 -11.43 7.21 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.82 -31.53 49.58 Favored 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 119.522 -0.871 . . . . 0.0 109.034 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.459 HH11 ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -67.29 -45.45 76.52 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.486 -0.759 . . . . 0.0 109.067 179.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -54.4 -44.53 72.41 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.206 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 38.2 t -54.95 -60.58 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.237 -0.915 . . . . 0.0 108.828 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.683 ' HA ' HD12 ' A' ' 22' ' ' ILE . 85.1 t -52.95 -23.44 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.257 -0.902 . . . . 0.0 108.864 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -54.39 19.98 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.393 -0.817 . . . . 0.0 109.191 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.89 -35.45 61.62 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.271 -0.893 . . . . 0.0 109.304 179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.683 HD12 ' HA ' ' A' ' 19' ' ' VAL . 57.8 mt -64.52 -45.34 95.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.183 -0.948 . . . . 0.0 109.191 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.512 HG23 ' CB ' ' A' ' 29' ' ' ALA . 95.9 mt -51.43 -48.06 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.293 -0.879 . . . . 0.0 109.14 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -31.2 72.29 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.21 -0.931 . . . . 0.0 108.573 179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 1.4 t0 -50.12 -32.69 16.56 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -80.07 137.59 53.26 Favored Pre-proline 0 N--CA 1.486 1.334 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -84.47 44.9 1.59 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.818 1.431 . . . . 0.0 109.822 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.5 t-160 -151.06 -53.97 0.14 Allowed 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.305 -0.872 . . . . 0.0 109.201 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.512 ' CB ' HG23 ' A' ' 23' ' ' ILE . . . -63.49 139.59 58.78 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.356 -0.84 . . . . 0.0 109.075 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.546 ' CG1' ' HG3' ' A' ' 41' ' ' GLU . 11.7 p -101.21 158.95 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.193 -0.942 . . . . 0.0 109.609 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.444 ' N ' HG22 ' A' ' 30' ' ' VAL . 1.9 t -138.78 148.7 24.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.408 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.415 ' O ' ' C ' ' A' ' 33' ' ' HIS . 0.6 OUTLIER -144.29 43.73 1.42 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.225 179.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.415 ' C ' ' O ' ' A' ' 32' ' ' GLN . 12.5 p80 -44.32 140.31 2.29 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.272 -0.892 . . . . 0.0 109.35 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.492 ' CG ' ' HD2' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -103.73 178.26 1.22 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.181 -0.949 . . . . 0.0 109.504 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.492 ' HD2' ' CG ' ' A' ' 34' ' ' HIS . 2.7 Cg_endo -76.53 -28.01 7.13 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.066 1.561 . . . . 0.0 110.331 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.89 -30.62 3.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.149 -0.969 . . . . 0.0 109.592 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.518 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 0.1 OUTLIER -117.16 -168.99 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.907 . . . . 0.0 109.569 179.967 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.005 HD11 ' CE2' ' A' ' 9' ' ' PHE . 11.3 pt -140.03 115.65 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.346 -0.847 . . . . 0.0 108.831 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.773 ' O ' HD13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -111.89 142.76 43.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.182 -0.949 . . . . 0.0 110.447 -178.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.773 HD13 ' O ' ' A' ' 39' ' ' ARG . 28.0 mm -145.91 152.42 14.03 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.583 -0.698 . . . . 0.0 109.213 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.546 ' HG3' ' CG1' ' A' ' 30' ' ' VAL . 2.9 pt-20 -129.29 176.59 7.82 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.113 -0.992 . . . . 0.0 108.893 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.772 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -132.66 -179.43 5.46 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.079 -1.013 . . . . 0.0 109.66 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 17.9 mt-10 -140.48 58.87 1.56 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.373 -0.83 . . . . 0.0 109.261 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.499 ' CB ' ' HB2' ' A' ' 88' ' ' TRP . 1.6 mmtp -153.0 -166.28 2.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.212 -0.93 . . . . 0.0 109.908 -179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.56 ' HA ' ' CG ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -141.26 -171.2 3.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.348 -0.845 . . . . 0.0 109.641 -179.526 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.798 HD12 ' O ' ' A' ' 87' ' ' GLU . 15.2 mt -159.03 157.33 30.96 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.241 -0.912 . . . . 0.0 110.741 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.88 ' HA ' HG23 ' A' ' 85' ' ' VAL . 1.4 tt0 -160.94 139.75 10.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.477 -0.764 . . . . 0.0 109.179 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.793 HG22 ' CG ' ' A' ' 51' ' ' GLU . 0.0 OUTLIER -154.69 141.63 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.128 -0.983 . . . . 0.0 109.912 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.601 ' HA ' ' CG ' ' A' ' 83' ' ' ARG . 0.1 OUTLIER -101.58 -101.38 0.26 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.147 -0.971 . . . . 0.0 109.811 179.465 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -69.02 -6.38 27.64 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.018 -1.052 . . . . 0.0 109.294 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.793 ' CG ' HG22 ' A' ' 48' ' ' ILE . 3.2 mt-10 -56.41 -16.12 5.23 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.26 -0.9 . . . . 0.0 109.422 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 53' ' ' VAL . 0.2 OUTLIER -59.14 -42.48 90.76 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 120.87 -1.144 . . . . 0.0 109.259 -179.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.408 ' C ' ' O ' ' A' ' 52' ' ' THR . 59.0 t -48.38 -33.48 4.52 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 120.979 -1.076 . . . . 0.0 108.158 179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.499 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -68.39 -44.93 74.03 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 178.873 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.48 -45.08 46.42 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 178.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -53.86 -44.13 70.12 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.674 ' C ' HD13 ' A' ' 57' ' ' LEU . 0.9 OUTLIER -51.44 -72.52 0.05 OUTLIER 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 178.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 57' ' ' LEU . . . -39.32 -28.31 0.1 OUTLIER Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.705 -1.358 . . . . 0.0 109.705 179.701 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.506 ' CB ' ' O ' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -53.07 -58.97 5.21 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -1.201 . . . . 0.0 109.008 179.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 59' ' ' ARG . . . -42.85 -32.92 0.68 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -90.86 50.21 1.77 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 178.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -75.56 78.7 2.57 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.942 0.877 . . . . 0.0 109.396 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.505 HG12 ' HB2' ' A' ' 66' ' ' MET . 8.2 t -72.58 7.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 O-C-N 121.918 -0.489 . . . . 0.0 110.622 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.464 ' C ' ' O ' ' A' ' 63' ' ' VAL . 2.7 mp0 -39.52 -27.83 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.141 -0.974 . . . . 0.0 109.91 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.657 ' O ' HG23 ' A' ' 68' ' ' VAL . 11.7 mt-10 -57.48 -56.23 24.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.088 -1.008 . . . . 0.0 108.902 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.505 ' HB2' HG12 ' A' ' 63' ' ' VAL . 1.6 mmm -67.39 -8.34 32.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.37 -0.831 . . . . 0.0 109.403 179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.87 HD21 HG21 ' A' ' 71' ' ' ILE . 5.9 tp -76.6 7.85 4.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.443 -0.786 . . . . 0.0 110.433 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 65' ' ' GLU . 58.2 t -40.41 -25.29 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.995 -1.066 . . . . 0.0 110.489 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 67' ' ' LEU . 7.2 m-20 -58.18 143.55 43.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.007 -1.058 . . . . 0.0 109.019 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.694 ' C ' HD13 ' A' ' 71' ' ' ILE . 57.3 t -43.82 159.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.144 -0.972 . . . . 0.0 109.126 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.87 HG21 HD21 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -141.54 141.56 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.579 -0.7 . . . . 0.0 109.787 -179.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.555 ' HB ' ' N ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -154.73 147.63 24.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 109.564 179.178 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.511 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.7 OUTLIER -133.17 174.8 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.344 -0.847 . . . . 0.0 109.443 -179.446 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 174.94 64.44 0.05 OUTLIER Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 -179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -135.18 -95.3 0.49 Allowed Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.169 -1.572 . . . . 0.0 109.169 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -176.26 153.58 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -1.122 . . . . 0.0 109.473 179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -141.54 102.8 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.127 -0.983 . . . . 0.0 109.869 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.619 ' OD1' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -107.7 112.95 25.9 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.933 -1.107 . . . . 0.0 109.006 178.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -108.58 131.46 54.83 Favored 'General case' 0 C--N 1.286 -2.191 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.473 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -104.04 -107.46 0.28 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.146 -0.971 . . . . 0.0 109.635 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -108.41 -56.34 2.27 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.93 -1.106 . . . . 0.0 109.495 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -127.28 -33.7 2.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.35 -0.844 . . . . 0.0 108.96 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.601 ' CG ' ' HA ' ' A' ' 49' ' ' ARG . 1.7 mpt_? -66.48 -178.06 0.64 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.548 -0.72 . . . . 0.0 109.397 179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.478 ' O ' HG13 ' A' ' 48' ' ' ILE . 28.3 t80 -161.5 130.16 4.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.131 -0.98 . . . . 0.0 109.661 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.88 HG23 ' HA ' ' A' ' 47' ' ' GLU . 0.9 OUTLIER -132.64 157.31 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.116 -0.99 . . . . 0.0 109.989 179.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.641 ' CD1' ' CB ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -165.49 -150.41 0.13 Allowed 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 178.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.798 ' O ' HD12 ' A' ' 46' ' ' LEU . 0.2 OUTLIER -121.42 -171.06 2.14 Favored 'General case' 0 C--N 1.29 -1.986 0 O-C-N 121.092 -1.005 . . . . 0.0 109.373 -179.763 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.77 ' O ' HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -78.39 118.66 20.78 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.239 -0.913 . . . . 0.0 109.466 179.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.82 -53.26 0.87 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.845 . . . . 0.0 109.448 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.558 -179.935 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 13.4 t -74.81 136.48 41.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.145 -0.972 . . . . 0.0 109.246 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 16.0 m -133.12 90.31 2.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.208 -0.933 . . . . 0.0 109.843 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.622 ' O ' HD12 ' A' ' 4' ' ' LEU . 0.7 OUTLIER -122.33 161.56 23.17 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.222 -0.924 . . . . 0.0 109.212 179.515 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.019 HG22 ' HB3' ' A' ' 42' ' ' ALA . 3.1 m -125.52 -171.51 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.397 0 O-C-N 121.271 -0.893 . . . . 0.0 110.272 -178.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.586 ' O ' ' N ' ' A' ' 74' ' ' GLY . 10.5 t80 -163.43 137.75 6.04 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.536 -0.727 . . . . 0.0 109.134 178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.583 HG22 ' HA ' ' A' ' 73' ' ' ILE . 7.7 pt -148.76 139.67 17.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.965 ' HA ' ' CB ' ' A' ' 39' ' ' ARG . . . -144.36 137.52 27.18 Favored 'General case' 0 C--N 1.304 -1.376 0 C-N-CA 117.752 -1.579 . . . . 0.0 111.98 -178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.634 ' CD2' ' HG2' ' A' ' 39' ' ' ARG . 2.0 p90 -128.8 178.15 6.56 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 119.084 -1.046 . . . . 0.0 109.106 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.844 ' N ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -127.03 94.04 3.92 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 179.331 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.504 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 5.1 p-10 -108.12 143.16 37.27 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.426 -0.796 . . . . 0.0 110.214 -179.198 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -78.48 -5.06 51.46 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.446 -0.784 . . . . 0.0 109.157 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' O ' ' OD2' ' A' ' 11' ' ' ASP . 32.9 t0 -80.78 103.46 10.64 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.24 -0.913 . . . . 0.0 108.819 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -65.29 -9.16 21.91 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.32 -0.862 . . . . 0.0 108.895 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.06 -39.27 71.78 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 121.24 -0.913 . . . . 0.0 108.931 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 mmp_? -56.43 -44.95 80.89 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.429 -0.794 . . . . 0.0 109.009 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.5 ' CE2' HG22 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -55.11 -45.55 75.5 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.0 108.999 179.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 55.7 t -54.18 -61.07 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.295 -0.878 . . . . 0.0 108.81 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.3 t -53.05 -23.26 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.274 -0.892 . . . . 0.0 108.613 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.63 -54.95 17.83 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.6 -37.41 17.99 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.444 ' O ' ' CB ' ' A' ' 25' ' ' ASP . 36.8 mt -61.26 -45.09 99.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 179.218 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.718 HG23 ' HB1' ' A' ' 29' ' ' ALA . 22.4 mm -50.45 -57.04 2.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.359 -0.838 . . . . 0.0 109.024 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -59.5 -28.52 67.12 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.195 -0.94 . . . . 0.0 108.489 179.326 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.444 ' CB ' ' O ' ' A' ' 22' ' ' ILE . 0.8 OUTLIER -50.4 -39.44 47.06 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 13.5 m-80 -79.69 141.77 56.34 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -84.48 44.84 1.58 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.777 1.409 . . . . 0.0 109.904 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -150.65 -48.28 0.12 Allowed 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.718 ' HB1' HG23 ' A' ' 23' ' ' ILE . . . -71.1 139.26 50.28 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.385 -0.822 . . . . 0.0 109.657 -179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.6 t -101.98 152.04 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.203 -0.936 . . . . 0.0 109.502 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.477 HG21 ' HB2' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -129.07 169.14 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.21 -0.932 . . . . 0.0 109.367 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -147.73 111.46 5.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.155 -0.966 . . . . 0.0 109.406 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -82.14 127.77 33.47 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.225 -0.922 . . . . 0.0 109.679 -179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.4 m170 -123.93 148.2 56.22 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.218 -0.926 . . . . 0.0 109.29 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.661 ' O ' ' HB2' ' A' ' 36' ' ' ALA . 2.2 Cg_endo -87.23 43.77 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.895 1.471 . . . . 0.0 110.206 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 35' ' ' PRO . . . 166.43 -29.76 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.195 -0.941 . . . . 0.0 109.655 179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.957 ' C ' HD13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -104.8 171.6 7.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.18 -0.95 . . . . 0.0 109.579 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.957 HD13 ' C ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -156.04 124.54 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.448 -0.783 . . . . 0.0 109.199 -179.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.965 ' CB ' ' HA ' ' A' ' 8' ' ' ALA . 0.1 OUTLIER 171.59 -151.88 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.993 -1.067 . . . . 0.0 110.949 179.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.775 HG22 ' H ' ' A' ' 41' ' ' GLU . 2.5 mt -160.79 -170.62 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.587 -1.321 . . . . 0.0 110.306 -178.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.775 ' H ' HG22 ' A' ' 40' ' ' ILE . 0.6 OUTLIER -134.83 -173.35 3.28 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.491 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 1.019 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -138.74 -171.34 3.05 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.973 -1.08 . . . . 0.0 110.007 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 18.6 mt-10 -141.36 33.01 1.68 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.404 -0.81 . . . . 0.0 109.741 -179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.567 ' HB3' ' HB2' ' A' ' 88' ' ' TRP . 1.3 tttp -168.34 -144.65 0.05 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.891 -1.131 . . . . 0.0 110.332 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.585 ' O ' ' CA ' ' A' ' 88' ' ' TRP . 0.1 OUTLIER -145.3 -154.09 0.52 Allowed 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.116 -0.99 . . . . 0.0 110.404 -179.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.716 HD13 HD21 ' A' ' 86' ' ' LEU . 0.7 OUTLIER -155.5 148.32 24.3 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.059 -1.026 . . . . 0.0 110.061 -179.606 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.492 ' HA ' HG23 ' A' ' 85' ' ' VAL . 4.3 tm-20 -137.81 139.56 40.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.203 -0.936 . . . . 0.0 109.064 178.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.536 ' CD1' HG21 ' A' ' 52' ' ' THR . 0.1 OUTLIER -159.4 154.79 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.11 -0.994 . . . . 0.0 109.967 -179.534 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.459 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -82.82 -166.08 1.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.382 -0.823 . . . . 0.0 110.092 -179.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.52 ' HG3' ' NH1' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -73.38 -27.01 61.24 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.433 -0.792 . . . . 0.0 109.928 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.492 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 0.8 OUTLIER -49.19 -30.42 6.87 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.027 -1.046 . . . . 0.0 108.921 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.598 ' HB ' ' CD2' ' A' ' 84' ' ' PHE . 0.2 OUTLIER -65.74 -45.28 83.22 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.894 -1.129 . . . . 0.0 108.478 179.23 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.941 HG22 ' CD1' ' A' ' 84' ' ' PHE . 40.6 t -47.88 -29.56 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 179.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 3.3 tt0 -71.85 -45.09 62.57 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 108.185 -1.042 . . . . 0.0 108.185 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 55.9 tt0 -55.97 -51.7 66.77 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 119.64 -0.824 . . . . 0.0 109.397 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.67 -38.64 72.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.148 -0.97 . . . . 0.0 109.643 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.21 -52.3 65.88 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.208 -0.932 . . . . 0.0 109.244 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -66.12 -14.55 61.64 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.6 ttt180 -112.52 20.87 16.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -1.082 . . . . 0.0 109.713 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -70.58 -7.43 43.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 109.665 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.612 ' CD1' ' O ' ' A' ' 61' ' ' TRP . 65.3 t-105 -92.31 22.89 4.19 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.21 -0.932 . . . . 0.0 109.481 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -110.79 5.95 21.07 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.022 -1.049 . . . . 0.0 109.988 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 2.1 t -89.01 -33.84 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.092 -1.005 . . . . 0.0 109.644 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 35.1 mm-40 -53.48 -37.15 62.41 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.181 -0.949 . . . . 0.0 109.227 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -70.77 -31.52 68.34 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.348 -0.845 . . . . 0.0 109.236 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mtm -67.78 -12.84 61.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.313 -0.867 . . . . 0.0 109.354 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.1 tt -68.61 -50.57 50.47 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.264 -0.897 . . . . 0.0 110.095 -179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 57.5 t -55.86 -43.57 74.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.185 -0.947 . . . . 0.0 110.196 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.542 ' CB ' ' O ' ' A' ' 10' ' ' GLN . 1.4 p-10 -94.14 162.64 13.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.097 -1.002 . . . . 0.0 110.148 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.844 HG12 ' N ' ' A' ' 10' ' ' GLN . 0.3 OUTLIER -81.5 175.39 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.207 -0.933 . . . . 0.0 109.124 179.728 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.403 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -147.35 137.5 17.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 0.0 110.309 -179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.55 ' N ' ' O ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER -144.3 154.86 43.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.081 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.583 ' HA ' HG22 ' A' ' 7' ' ' ILE . 1.9 pp -145.27 174.68 2.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.165 -0.96 . . . . 0.0 109.774 -178.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -177.76 58.17 0.09 OUTLIER Glycine 0 N--CA 1.489 2.172 0 N-CA-C 108.882 -1.687 . . . . 0.0 108.882 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 87' ' ' GLU . . . 120.12 61.42 0.25 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -179.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.574 ' CB ' ' HB3' ' A' ' 87' ' ' GLU . 2.3 p-10 -175.85 138.11 0.36 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.418 -1.048 . . . . 0.0 108.642 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.625 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.6 p 177.19 79.66 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.794 0 O-C-N 121.291 -0.88 . . . . 0.0 109.32 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.591 ' HB3' ' CE2' ' A' ' 84' ' ' PHE . 0.5 OUTLIER -49.06 -15.86 0.12 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.754 -0.591 . . . . 0.0 111.679 -178.709 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.435 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -111.66 100.82 9.27 Favored 'General case' 0 C--N 1.281 -2.401 0 O-C-N 121.153 -0.967 . . . . 0.0 109.21 179.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.8 -79.97 0.59 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.787 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -103.59 -90.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.224 -0.922 . . . . 0.0 109.925 -179.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -118.67 -29.5 5.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.19 -0.944 . . . . 0.0 109.824 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 1.3 ttt180 -88.84 -158.19 0.48 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.154 -0.966 . . . . 0.0 109.016 179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.941 ' CD1' HG22 ' A' ' 53' ' ' VAL . 0.1 OUTLIER -126.84 120.5 29.4 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.094 -1.004 . . . . 0.0 109.633 -179.977 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.601 ' O ' ' O ' ' A' ' 77' ' ' VAL . 2.5 p -144.7 140.05 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.18 -0.95 . . . . 0.0 109.545 179.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.729 HD12 ' H ' ' A' ' 87' ' ' GLU . 0.5 OUTLIER -151.53 -155.39 0.62 Allowed 'General case' 0 C--N 1.284 -2.252 0 O-C-N 120.885 -1.134 . . . . 0.0 108.124 177.754 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.999 ' CD ' HG21 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -89.14 173.4 8.45 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-O 122.115 0.959 . . . . 0.0 110.725 -179.943 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.591 ' HA ' ' HG ' ' A' ' 46' ' ' LEU . 4.8 t90 -77.9 122.07 24.99 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.255 -0.978 . . . . 0.0 109.784 177.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -156.78 19.94 0.32 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.318 -0.864 . . . . 0.0 109.557 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.925 -1.035 . . . . 0.0 109.503 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m -172.28 59.25 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.305 -0.872 . . . . 0.0 109.231 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 44' ' ' LYS . 20.8 p -123.41 9.33 9.09 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.358 -0.839 . . . . 0.0 109.798 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.2 OUTLIER -143.22 164.86 29.02 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.965 -1.084 . . . . 0.0 110.485 -179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.524 ' HB ' ' HA3' ' A' ' 75' ' ' GLY . 10.5 m -130.79 167.37 26.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-O 121.515 0.674 . . . . 0.0 109.858 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.568 ' O ' ' N ' ' A' ' 74' ' ' GLY . 0.8 OUTLIER -145.06 135.78 24.5 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 178.026 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.53 ' N ' ' CD1' ' A' ' 6' ' ' TYR . 1.9 pt -160.5 137.77 2.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 120.877 -1.139 . . . . 0.0 110.368 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.706 ' HB3' HG22 ' A' ' 71' ' ' ILE . . . -120.79 167.72 12.2 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 106.243 -1.762 . . . . 0.0 106.243 176.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.632 ' CD1' ' O ' ' A' ' 8' ' ' ALA . 12.0 m-85 -163.18 155.13 17.87 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 120.536 -1.353 . . . . 0.0 109.793 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.53 ' H ' ' N ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -121.05 94.86 4.48 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.033 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.494 ' HB3' ' OD1' ' A' ' 69' ' ' ASP . 1.4 p30 -108.83 137.53 46.61 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.585 -0.697 . . . . 0.0 109.749 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.23 -13.76 59.48 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.245 -0.91 . . . . 0.0 109.174 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.8 105.83 4.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 17' ' ' TYR . 18.1 t30 -60.71 -12.83 11.65 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 179.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.28 -42.03 66.15 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.256 -0.903 . . . . 0.0 108.784 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.25 -38.78 74.34 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.442 ' HB3' ' OD1' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -58.64 -43.16 89.68 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.477 -0.764 . . . . 0.0 108.966 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.2 t -54.49 -52.87 36.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.25 -0.906 . . . . 0.0 108.81 179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 23' ' ' ILE . 48.1 t -62.39 -24.06 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.375 -0.828 . . . . 0.0 109.025 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.572 ' HA ' HD12 ' A' ' 23' ' ' ILE . 1.7 tt0 -76.08 -27.14 57.08 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.267 -0.896 . . . . 0.0 109.049 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.39 -44.48 64.88 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.7 mt -63.82 -46.94 92.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 20' ' ' GLU . 60.1 mt -54.25 -49.1 65.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.37 -0.831 . . . . 0.0 109.328 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.423 ' OE1' ' CG ' ' A' ' 20' ' ' GLU . 17.9 mt-30 -61.7 -32.64 72.86 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.146 -0.972 . . . . 0.0 108.457 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 24' ' ' GLN . 1.0 OUTLIER -47.06 -36.82 8.54 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -79.84 133.69 58.12 Favored Pre-proline 0 C--N 1.305 -1.346 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -84.36 46.24 1.91 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.805 1.424 . . . . 0.0 109.98 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.1 t-160 -149.92 -45.44 0.13 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.126 -0.984 . . . . 0.0 109.713 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.452 ' HB1' ' CG2' ' A' ' 23' ' ' ILE . . . -59.92 144.21 49.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.255 -0.903 . . . . 0.0 109.566 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.613 ' C ' HG22 ' A' ' 31' ' ' VAL . 5.7 t -101.11 139.67 21.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.521 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.613 HG22 ' C ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -168.88 166.54 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.275 -0.891 . . . . 0.0 109.14 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.478 ' O ' ' O ' ' A' ' 33' ' ' HIS . 2.5 mm-40 -149.43 -94.15 0.07 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.27 -0.894 . . . . 0.0 109.338 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.765 ' CE1' HG22 ' A' ' 38' ' ' ILE . 4.9 t60 55.72 110.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.144 -0.973 . . . . 0.0 109.88 179.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.559 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.0 OUTLIER -154.16 -62.47 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 109.616 179.591 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.559 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.3 Cg_endo -67.21 -78.93 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 O-C-N 123.652 1.343 . . . . 0.0 109.772 179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -141.64 -53.75 0.45 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.399 -0.813 . . . . 0.0 109.243 179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.486 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -72.08 157.33 37.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.0 109.153 179.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.765 HG22 ' CE1' ' A' ' 33' ' ' HIS . 0.0 OUTLIER -122.83 165.22 19.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.017 -1.052 . . . . 0.0 109.34 179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.494 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -132.21 156.87 45.68 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.155 -0.966 . . . . 0.0 109.986 -179.436 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.555 HG22 ' H ' ' A' ' 41' ' ' GLU . 8.7 mt -152.83 172.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.401 -0.812 . . . . 0.0 109.053 179.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.555 ' H ' HG22 ' A' ' 40' ' ' ILE . 5.9 tt0 171.36 145.21 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.522 ' N ' ' HG2' ' A' ' 41' ' ' GLU . . . -144.12 -162.8 1.54 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.085 -1.01 . . . . 0.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.7 OUTLIER -140.67 82.92 1.87 Allowed 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' ' CB ' ' A' ' 88' ' ' TRP . 31.2 mmtt -129.64 -165.13 1.48 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.048 -1.032 . . . . 0.0 110.856 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.546 ' CA ' ' HG3' ' A' ' 87' ' ' GLU . 0.9 OUTLIER -165.24 165.34 19.68 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 108.96 -0.755 . . . . 0.0 108.96 -179.175 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.645 HD13 ' H ' ' A' ' 47' ' ' GLU . 0.2 OUTLIER -164.55 150.61 10.56 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.897 -1.127 . . . . 0.0 110.478 178.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.645 ' H ' HD13 ' A' ' 46' ' ' LEU . 0.6 OUTLIER -142.99 139.67 30.72 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 179.137 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.037 HG21 HG21 ' A' ' 52' ' ' THR . 2.3 pt -139.71 163.64 24.78 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.064 -1.022 . . . . 0.0 110.305 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.504 ' HA ' ' HG3' ' A' ' 83' ' ' ARG . 0.2 OUTLIER -95.46 -147.43 0.28 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.476 -0.765 . . . . 0.0 109.336 179.812 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.454 ' NH1' ' CG ' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -87.67 -40.59 14.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.081 -1.012 . . . . 0.0 109.726 -179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 69.1 tt0 -54.67 -31.21 57.34 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.109 -0.994 . . . . 0.0 109.06 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 1.037 HG21 HG21 ' A' ' 48' ' ' ILE . 0.6 OUTLIER -61.92 -40.16 94.53 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.036 -1.04 . . . . 0.0 108.536 179.409 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.579 HG22 ' CD2' ' A' ' 84' ' ' PHE . 21.2 t -46.25 -32.93 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.487 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 3.8 tt0 -71.24 -46.01 61.98 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.426 ' N ' ' O ' ' A' ' 52' ' ' THR . 40.0 mm-40 -52.82 -55.12 25.32 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.364 -0.835 . . . . 0.0 109.529 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.1 OUTLIER -55.51 -34.92 65.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.076 -1.015 . . . . 0.0 109.257 179.844 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.487 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.8 tp -56.43 -54.8 41.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.149 -0.969 . . . . 0.0 109.284 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.65 -9.64 65.71 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.44 ' CG ' ' NH1' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -112.75 5.61 17.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.371 -1.076 . . . . 0.0 109.396 179.909 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.524 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -79.29 -19.15 51.17 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.209 -0.932 . . . . 0.0 109.381 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.1 t90 -89.89 23.64 2.68 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.196 -0.94 . . . . 0.0 109.286 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -110.64 39.48 2.21 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.401 -0.812 . . . . 0.0 109.017 179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.424 HG12 ' HB2' ' A' ' 66' ' ' MET . 2.1 t -91.95 -3.94 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 0.0 109.708 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.433 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 13.1 mp0 -50.2 -25.24 3.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.074 -1.016 . . . . 0.0 109.465 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 81.7 mm-40 -66.31 -44.53 83.18 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.147 -0.971 . . . . 0.0 109.426 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.45 ' CE ' HD11 ' A' ' 73' ' ' ILE . 5.1 mtp -59.27 -16.11 19.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.285 -0.885 . . . . 0.0 109.523 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 11.2 tp -78.1 -52.25 9.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.236 -0.915 . . . . 0.0 109.703 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.448 HG23 ' H ' ' A' ' 68' ' ' VAL . 2.0 t -66.56 -55.19 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.261 -0.899 . . . . 0.0 109.805 -179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.626 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -98.76 85.22 3.27 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 -179.683 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.648 ' O ' HG12 ' A' ' 71' ' ' ILE . 7.1 p -103.29 141.77 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.247 -0.908 . . . . 0.0 112.513 -179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.706 HG22 ' HB3' ' A' ' 8' ' ' ALA . 2.1 mm 178.41 -85.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.513 2.679 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.699 HG22 ' H ' ' A' ' 73' ' ' ILE . 2.2 m -133.44 176.33 8.63 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 120.921 -1.112 . . . . 0.0 111.621 -178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.699 ' H ' HG22 ' A' ' 72' ' ' THR . 0.6 OUTLIER -160.87 162.41 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 179.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.568 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -179.65 34.99 0.07 OUTLIER Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.524 ' HA3' ' HB ' ' A' ' 5' ' ' VAL . . . -162.58 85.31 0.11 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.952 -1.659 . . . . 0.0 108.952 179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 62.1 m-20 -129.2 -135.33 0.22 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.586 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.868 HG23 ' O ' ' A' ' 85' ' ' VAL . 7.1 p -118.22 126.6 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.101 -0.999 . . . . 0.0 109.724 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.486 ' O ' HG12 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -105.98 148.0 28.19 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.513 -0.742 . . . . 0.0 109.943 -179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -103.3 133.52 48.23 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.323 -0.861 . . . . 0.0 108.961 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -106.15 -93.94 0.37 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.0 110.102 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -105.39 -75.72 0.62 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.149 -0.969 . . . . 0.0 109.899 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -121.53 -31.41 4.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.241 -0.912 . . . . 0.0 108.761 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.504 ' HG3' ' HA ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -81.04 -171.74 3.37 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.679 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.699 ' CE1' HG22 ' A' ' 77' ' ' VAL . 0.2 OUTLIER -134.87 158.96 42.88 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.09 -1.006 . . . . 0.0 109.269 179.926 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.868 ' O ' HG23 ' A' ' 77' ' ' VAL . 2.4 p -143.7 169.56 10.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.242 -0.911 . . . . 0.0 109.438 179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.577 ' HB3' ' HA ' ' A' ' 77' ' ' VAL . 1.3 pp -176.84 -167.39 0.18 Allowed 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.546 ' HG3' ' CA ' ' A' ' 45' ' ' ARG . 0.3 OUTLIER -119.91 173.07 7.28 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.894 -1.129 . . . . 0.0 110.645 179.87 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.54 ' CB ' ' HB3' ' A' ' 44' ' ' LYS . 1.5 t90 -70.65 128.47 36.18 Favored 'General case' 0 C--N 1.296 -1.76 0 C-N-CA 119.769 -0.772 . . . . 0.0 109.666 -178.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.4 mttm -107.37 159.49 16.34 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.176 -0.953 . . . . 0.0 109.669 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.1 t30 . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.392 -179.987 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.5 p -90.7 -35.38 14.95 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 109.377 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.609 ' HA ' ' CE3' ' A' ' 88' ' ' TRP . 0.1 OUTLIER -173.85 93.29 0.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.424 -0.798 . . . . 0.0 108.962 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.694 ' O ' HD12 ' A' ' 4' ' ' LEU . 0.4 OUTLIER -137.02 156.43 48.44 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.087 -1.008 . . . . 0.0 110.512 -179.386 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.131 HG11 HD21 ' A' ' 46' ' ' LEU . 0.9 OUTLIER -113.73 -176.05 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 -179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.956 ' CE2' HG21 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -147.05 139.15 24.52 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 179.089 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.991 ' HB ' HG22 ' A' ' 72' ' ' THR . 1.3 pt -143.63 135.32 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.296 -0.878 . . . . 0.0 108.801 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.652 ' HB2' ' HE1' ' A' ' 6' ' ' TYR . . . -145.3 147.1 31.97 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.384 -1.326 . . . . 0.0 110.522 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.607 ' CE2' HG13 ' A' ' 38' ' ' ILE . 16.7 p90 -135.96 175.98 9.1 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.677 ' HB2' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -141.08 80.14 1.73 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.095 -1.003 . . . . 0.0 108.748 179.809 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.443 ' CB ' ' NH1' ' A' ' 16' ' ' ARG . 4.0 t70 -110.18 178.84 4.27 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.336 -0.853 . . . . 0.0 110.0 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -121.91 16.26 10.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.919 . . . . 0.0 109.397 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -85.96 103.89 15.09 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.214 -0.929 . . . . 0.0 108.985 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -67.23 -7.76 26.43 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.251 -0.906 . . . . 0.0 108.873 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -68.77 -56.01 9.43 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.32 -0.863 . . . . 0.0 109.016 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.46 ' HG2' ' N ' ' A' ' 17' ' ' TYR . 6.2 ptm180 -59.37 -28.71 67.12 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.46 ' N ' ' HG2' ' A' ' 16' ' ' ARG . 26.4 t80 -60.3 -49.94 75.59 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.523 ' O ' HD12 ' A' ' 22' ' ' ILE . 70.4 t -54.38 -56.08 11.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.663 ' HA ' HD13 ' A' ' 22' ' ' ILE . 95.6 t -49.59 -30.93 5.6 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.179 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -66.29 -46.17 77.9 Favored 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.99 -41.08 46.19 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.302 -0.874 . . . . 0.0 108.667 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.727 ' H ' HD12 ' A' ' 22' ' ' ILE . 4.3 mp -65.55 -43.05 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.469 -0.769 . . . . 0.0 108.976 179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.411 ' CG2' ' CB ' ' A' ' 29' ' ' ALA . 7.0 mt -52.89 -43.98 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.165 -0.959 . . . . 0.0 108.844 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.906 ' HG2' HG23 ' A' ' 31' ' ' VAL . 1.9 mt-30 -67.26 -32.08 72.85 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 179.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -51.78 -24.88 6.54 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.551 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.3 OUTLIER -83.05 135.37 44.95 Favored Pre-proline 0 N--CA 1.486 1.346 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.193 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -84.6 47.12 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.761 1.4 . . . . 0.0 109.843 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 2.3 t-160 -146.87 -40.07 0.2 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.338 -0.851 . . . . 0.0 109.084 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.411 ' CB ' ' CG2' ' A' ' 23' ' ' ILE . . . -73.91 139.9 45.27 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.442 -0.786 . . . . 0.0 109.538 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.674 HG21 ' HB3' ' A' ' 41' ' ' GLU . 16.0 t -71.24 -120.6 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.181 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.906 HG23 ' HG2' ' A' ' 24' ' ' GLN . 1.1 p -174.23 -165.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.729 -1.232 . . . . 0.0 109.935 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.711 ' H ' HG22 ' A' ' 31' ' ' VAL . 0.9 OUTLIER -114.19 -167.73 1.26 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 109.551 -179.803 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -89.45 -99.87 0.1 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 109.928 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.569 ' HB3' ' HD3' ' A' ' 35' ' ' PRO . 46.7 t-80 -166.17 -58.69 0.01 OUTLIER Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 120.909 -1.119 . . . . 0.0 110.587 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.569 ' HD3' ' HB3' ' A' ' 34' ' ' HIS . 3.5 Cg_exo -49.53 -179.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 117.442 -1.239 . . . . 0.0 110.822 -179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.436 ' O ' ' CD1' ' A' ' 38' ' ' ILE . . . -52.21 -22.57 4.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.354 -0.841 . . . . 0.0 110.005 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.524 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 3.1 mmt -65.37 156.4 32.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.926 -1.109 . . . . 0.0 109.242 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.607 HG13 ' CE2' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -127.82 129.17 69.87 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.291 -0.881 . . . . 0.0 108.63 -179.536 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.74 ' C ' HD12 ' A' ' 40' ' ' ILE . 2.2 ttt180 -126.52 164.62 20.77 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.06 -1.025 . . . . 0.0 110.053 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.742 HG21 HD11 ' A' ' 7' ' ' ILE . 2.7 mp -156.51 169.22 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.37 -0.831 . . . . 0.0 109.303 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.674 ' HB3' HG21 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -155.91 152.79 28.7 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.682 -1.261 . . . . 0.0 110.26 -179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.839 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -129.93 -177.26 4.22 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.639 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 91.0 mt-10 -140.04 74.97 1.49 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.126 -0.984 . . . . 0.0 110.186 -179.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 175.11 -141.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.972 -1.08 . . . . 0.0 110.208 179.762 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.957 ' C ' HD23 ' A' ' 46' ' ' LEU . 0.0 OUTLIER -126.1 167.83 14.83 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.228 -0.92 . . . . 0.0 109.931 -179.093 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 1.131 HD21 HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -130.88 152.91 49.7 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.384 -0.823 . . . . 0.0 109.665 -179.217 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.35 154.7 46.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.225 -0.922 . . . . 0.0 109.406 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 1.2 mt -150.55 141.02 16.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.141 -0.975 . . . . 0.0 109.71 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.46 ' HD2' ' HG3' ' A' ' 51' ' ' GLU . 2.6 ptt180 -100.92 -171.93 2.09 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 0.0 109.567 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.53 ' NH1' ' HG2' ' A' ' 50' ' ' ARG . 0.0 OUTLIER -75.76 -32.85 60.13 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.236 -0.915 . . . . 0.0 109.184 179.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.488 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 4.4 mt-10 -50.37 -41.59 52.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.315 -0.865 . . . . 0.0 109.297 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.1 m -69.26 -47.67 64.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.188 -0.945 . . . . 0.0 108.88 179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.0 t -49.6 -26.73 2.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 1.4 tt0 -74.84 -43.59 53.74 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -55.73 -50.32 70.68 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.218 -0.926 . . . . 0.0 108.731 179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.521 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.3 OUTLIER -59.79 -33.46 71.74 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.372 -0.83 . . . . 0.0 109.016 179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.477 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.5 tp -57.73 -51.76 68.22 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 108.905 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.05 -14.82 66.48 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 108.552 -1.819 . . . . 0.0 108.552 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.1 tmm_? -113.02 15.23 19.66 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.964 . . . . 0.0 109.306 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.521 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -67.18 -19.42 65.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.359 -0.838 . . . . 0.0 109.426 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -89.42 35.59 0.82 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.309 -0.869 . . . . 0.0 109.381 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.476 ' OD1' ' HB2' ' A' ' 65' ' ' GLU . 34.9 t70 -104.97 5.87 33.05 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.326 -0.859 . . . . 0.0 109.465 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.476 ' H ' HG23 ' A' ' 63' ' ' VAL . 2.8 t -52.21 -40.65 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.932 . . . . 0.0 109.539 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.5 mp0 -52.46 -40.93 62.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.202 -0.936 . . . . 0.0 109.143 179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.476 ' HB2' ' OD1' ' A' ' 62' ' ' ASP . 0.4 OUTLIER -73.03 -28.39 62.31 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.252 -0.905 . . . . 0.0 109.049 179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.16 -12.03 61.0 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.278 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 67' ' ' LEU . 1.5 mm? -74.47 -56.97 4.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.297 -0.877 . . . . 0.0 109.945 -179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.53 ' CG1' ' OD2' ' A' ' 69' ' ' ASP . 2.3 p -90.52 -46.47 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.133 -0.979 . . . . 0.0 110.119 -179.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.586 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 0.0 OUTLIER -103.02 146.69 27.97 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.983 -1.073 . . . . 0.0 109.967 -179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.742 HG12 ' H ' ' A' ' 71' ' ' ILE . 7.0 t -100.56 -176.07 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.797 ' O ' HG23 ' A' ' 72' ' ' THR . 0.6 OUTLIER -136.02 -37.39 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 120.276 -1.515 . . . . 0.0 112.165 -178.607 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.991 HG22 ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER 170.75 -148.64 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.682 -1.261 . . . . 0.0 108.7 -178.503 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.956 HG21 ' CE2' ' A' ' 6' ' ' TYR . 1.4 tp 176.95 -129.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.648 ' H ' HG23 ' A' ' 73' ' ' ILE . . . 167.98 -108.27 0.3 Allowed Glycine 0 N--CA 1.485 1.965 0 O-C-N 120.04 -1.662 . . . . 0.0 109.945 179.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -160.53 -65.62 0.01 OUTLIER Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.639 ' H ' HD21 ' A' ' 86' ' ' LEU . 0.2 OUTLIER -124.42 -147.21 0.37 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.195 -1.179 . . . . 0.0 108.662 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.683 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.2 p 178.9 93.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.091 -1.006 . . . . 0.0 109.994 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.6 134.88 49.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.917 . . . . 0.0 109.148 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -118.43 156.31 29.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 109.493 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -109.82 -94.93 0.41 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.232 -0.918 . . . . 0.0 109.556 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -106.03 -70.76 0.77 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.178 -0.951 . . . . 0.0 109.281 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.1 -6.37 7.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.329 -0.857 . . . . 0.0 109.313 179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.412 ' HG3' ' HA ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -90.94 -169.68 2.44 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.323 -0.86 . . . . 0.0 109.406 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.627 ' CZ ' ' CG2' ' A' ' 77' ' ' VAL . 0.1 OUTLIER -155.51 122.07 5.28 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.195 -0.941 . . . . 0.0 109.369 179.965 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.3 p -132.85 139.2 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.17 -0.956 . . . . 0.0 110.003 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.976 HD22 ' N ' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -149.38 136.76 20.05 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.976 ' N ' HD22 ' A' ' 86' ' ' LEU . 2.4 mp0 -121.14 -148.39 0.41 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.49 -0.756 . . . . 0.0 109.699 -179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.609 ' CE3' ' HA ' ' A' ' 3' ' ' SER . 2.7 t90 -47.09 -91.1 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.58 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -141.77 -37.87 0.4 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.162 -0.961 . . . . 0.0 109.831 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.448 ' N ' ' CD ' ' A' ' 89' ' ' LYS . 22.5 t30 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.446 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.2 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 44.82 48.94 9.09 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.194 -0.941 . . . . 0.0 109.28 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -120.84 -2.36 9.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.318 -0.864 . . . . 0.0 109.691 -179.775 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 1.0 OUTLIER -126.98 158.14 37.68 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 120.994 -1.066 . . . . 0.0 110.283 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.515 HG22 ' HB3' ' A' ' 42' ' ' ALA . 0.7 OUTLIER -119.49 170.96 8.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 CA-C-O 121.543 0.687 . . . . 0.0 110.232 -178.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.593 ' O ' ' N ' ' A' ' 74' ' ' GLY . 10.2 t80 -140.49 141.33 35.39 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.867 HD11 HD12 ' A' ' 40' ' ' ILE . 1.5 pp -159.18 152.84 5.74 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.671 ' HB1' ' O ' ' A' ' 38' ' ' ILE . . . -146.37 -173.4 4.18 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 118.599 -1.24 . . . . 0.0 110.59 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 1.095 ' CD2' HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -140.84 171.23 14.37 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 122.633 1.206 . . . . 0.0 111.866 179.205 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.716 ' C ' HG23 ' A' ' 70' ' ' VAL . 0.5 OUTLIER 176.35 105.87 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 114.626 -1.17 . . . . 0.0 110.32 -179.517 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.623 ' N ' HG23 ' A' ' 70' ' ' VAL . 3.3 t0 -109.87 -156.3 0.58 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-O 121.641 0.734 . . . . 0.0 110.078 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -128.45 -63.43 0.99 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -118.59 -15.06 9.59 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.441 -0.787 . . . . 0.0 108.904 179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.459 ' HB3' ' OD2' ' A' ' 11' ' ' ASP . 0.6 OUTLIER -82.51 7.59 14.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.399 -0.813 . . . . 0.0 109.017 179.361 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 18' ' ' VAL . . . -42.4 -32.92 0.58 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.401 -0.812 . . . . 0.0 109.166 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 21.7 ttm180 -51.43 -56.74 11.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.337 -0.852 . . . . 0.0 109.012 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -61.74 -32.1 72.32 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.229 -0.92 . . . . 0.0 109.281 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 15' ' ' ALA . 55.8 t -57.01 -41.43 77.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.11 -0.994 . . . . 0.0 108.831 179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 98.2 t -69.71 -30.96 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -62.63 -49.85 73.55 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.501 -0.749 . . . . 0.0 109.45 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -62.91 -40.17 96.78 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.119 -0.988 . . . . 0.0 108.97 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.004 HD11 HG13 ' A' ' 38' ' ' ILE . 5.6 mm -50.1 -42.92 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.026 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.487 ' O ' ' CD ' ' A' ' 27' ' ' PRO . 40.1 mm -69.29 -33.56 58.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.15 -0.969 . . . . 0.0 109.024 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -90.88 4.94 50.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.372 -0.83 . . . . 0.0 109.438 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.872 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.2 OUTLIER -117.18 -11.64 10.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 -179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.875 ' OD1' HG13 ' A' ' 31' ' ' VAL . 1.1 m-80 -87.91 -68.79 0.12 Allowed Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.519 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.571 ' HD3' ' HB2' ' A' ' 26' ' ' ASN . 3.6 Cg_exo -41.28 -28.08 0.46 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 123.69 1.363 . . . . 0.0 110.195 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.443 ' N ' ' O ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -97.78 -39.03 9.24 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.322 -0.861 . . . . 0.0 109.199 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.872 ' HB3' ' O ' ' A' ' 25' ' ' ASP . . . -102.94 -158.08 0.65 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.125 -0.985 . . . . 0.0 109.685 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.519 ' O ' HG22 ' A' ' 31' ' ' VAL . 3.2 t -96.3 -127.27 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.875 HG13 ' OD1' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -161.72 141.76 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.648 -1.283 . . . . 0.0 109.726 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -174.21 95.24 0.09 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.38 -0.825 . . . . 0.0 109.46 179.731 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.535 ' CE1' ' HB ' ' A' ' 38' ' ' ILE . 0.2 OUTLIER -115.05 157.17 23.87 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.196 -0.94 . . . . 0.0 109.501 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.559 ' CD2' ' HD2' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -117.45 -167.22 0.1 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.183 -0.948 . . . . 0.0 109.523 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.559 ' HD2' ' CD2' ' A' ' 34' ' ' HIS . 2.3 Cg_endo -90.56 15.19 1.88 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.96 1.505 . . . . 0.0 110.338 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -158.68 -76.39 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.185 -0.947 . . . . 0.0 109.195 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.421 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -84.21 167.34 16.77 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.004 HG13 HD11 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.95 163.44 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.843 -1.161 . . . . 0.0 108.922 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.554 ' N ' HD13 ' A' ' 38' ' ' ILE . 8.9 mtp180 -139.48 162.47 34.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.879 -1.138 . . . . 0.0 109.5 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.867 HD12 HD11 ' A' ' 7' ' ' ILE . 33.0 mt -158.64 164.58 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.071 -1.018 . . . . 0.0 110.003 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.567 ' N ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -159.17 166.67 30.95 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.381 -0.825 . . . . 0.0 109.006 179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.515 ' HB3' HG22 ' A' ' 5' ' ' VAL . . . -159.83 -165.23 1.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.937 -1.102 . . . . 0.0 110.545 -179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.728 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 0.0 OUTLIER -139.2 97.28 3.26 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -179.81 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.547 ' CD ' ' HB3' ' A' ' 88' ' ' TRP . 30.8 mttm -142.43 -164.54 1.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.972 -1.08 . . . . 0.0 110.925 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.509 ' HA ' ' HG3' ' A' ' 87' ' ' GLU . 0.7 OUTLIER -167.79 171.32 10.08 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.569 -0.707 . . . . 0.0 109.154 -179.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.964 HD12 HD11 ' A' ' 48' ' ' ILE . 0.2 OUTLIER -160.82 142.19 11.97 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.026 -1.046 . . . . 0.0 109.723 179.608 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.817 ' C ' HD12 ' A' ' 48' ' ' ILE . 1.1 tt0 -138.86 138.81 37.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.107 -0.996 . . . . 0.0 109.434 179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 46' ' ' LEU . 4.1 mp -151.2 162.8 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.257 -0.902 . . . . 0.0 110.294 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.524 ' N ' HG22 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -98.36 -153.42 0.43 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 109.447 179.51 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.425 ' CG ' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -69.98 -12.68 61.79 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.279 -0.888 . . . . 0.0 109.598 -179.936 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.481 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 3.4 tt0 -64.84 -9.8 23.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.193 -0.942 . . . . 0.0 109.603 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.743 HG21 ' OD2' ' A' ' 78' ' ' ASP . 0.2 OUTLIER -59.99 -40.34 88.83 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 120.866 -1.146 . . . . 0.0 109.02 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.432 ' C ' ' O ' ' A' ' 52' ' ' THR . 94.5 t -46.37 -34.24 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -70.27 -45.75 65.76 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 178.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' A' ' 52' ' ' THR . 3.0 mm-40 -47.7 -46.1 29.13 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -61.32 -38.75 88.0 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.357 -0.84 . . . . 0.0 108.812 179.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.454 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 7.2 tp -55.17 -55.22 33.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.364 -0.835 . . . . 0.0 109.15 179.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.41 -9.4 68.37 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.453 ' HD2' ' OD1' ' A' ' 90' ' ' ASN . 1.1 ttp180 -90.95 -9.53 45.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -1.123 . . . . 0.0 109.517 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -45.72 -25.35 0.48 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.3 -0.875 . . . . 0.0 109.453 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 9.8 t90 -88.29 40.26 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.389 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -111.28 74.63 0.88 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.397 -0.814 . . . . 0.0 109.137 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 3.1 t -74.16 2.04 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.324 -0.86 . . . . 0.0 109.994 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.546 ' O ' HD11 ' A' ' 71' ' ' ILE . 1.3 mp0 -49.01 -22.63 0.91 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.055 -1.028 . . . . 0.0 109.315 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 1.016 ' O ' HG23 ' A' ' 68' ' ' VAL . 7.0 pt-20 -56.4 -48.67 76.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.229 -0.92 . . . . 0.0 109.579 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.46 -17.08 64.11 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.194 -0.941 . . . . 0.0 109.423 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.714 HD23 HG12 ' A' ' 71' ' ' ILE . 4.9 tp -98.67 11.98 36.82 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 0.0 109.399 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.016 HG23 ' O ' ' A' ' 65' ' ' GLU . 40.5 t -39.34 -24.3 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.414 -0.804 . . . . 0.0 110.867 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 71' ' ' ILE . 67.4 m-20 -58.2 -100.91 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.713 -1.242 . . . . 0.0 109.807 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.095 HG22 ' CD2' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -42.08 -13.62 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.175 -2.819 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.461 -178.166 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.714 HG12 HD23 ' A' ' 67' ' ' LEU . 1.7 pt -123.42 131.91 72.3 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.116 0 CA-C-N 120.453 1.478 . . . . 0.0 110.253 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.659 ' OG1' ' HB3' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -130.74 150.02 52.12 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 7' ' ' ILE . 0.8 OUTLIER -133.47 174.53 13.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.229 -0.919 . . . . 0.0 110.403 -178.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.593 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 178.89 38.74 0.07 OUTLIER Glycine 0 N--CA 1.486 2.027 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.494 ' HA3' ' HB ' ' A' ' 5' ' ' VAL . . . -152.37 82.94 0.17 Allowed Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.295 -1.922 . . . . 0.0 108.295 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.449 ' HA ' ' H ' ' A' ' 87' ' ' GLU . 27.6 p-10 -176.03 138.47 0.35 Allowed 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.674 ' O ' ' O ' ' A' ' 85' ' ' VAL . 13.8 p -171.34 52.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.296 -1.754 0 O-C-N 121.101 -0.999 . . . . 0.0 109.228 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.995 ' CG ' HD23 ' A' ' 86' ' ' LEU . 0.5 OUTLIER -49.92 -9.54 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 112.821 0.674 . . . . 0.0 112.821 -178.265 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.4 ' N ' ' O ' ' A' ' 77' ' ' VAL . 0.0 OUTLIER -110.52 94.83 5.21 Favored 'General case' 0 C--N 1.28 -2.422 0 O-C-N 120.6 -1.313 . . . . 0.0 109.729 179.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.685 ' HB2' HG12 ' A' ' 85' ' ' VAL . 0.3 OUTLIER -107.11 -82.11 0.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.332 -0.855 . . . . 0.0 108.951 179.673 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -104.01 -82.72 0.5 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.348 -0.845 . . . . 0.0 108.996 179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -128.18 -30.88 2.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.291 -0.881 . . . . 0.0 109.364 179.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 4.6 mpt_? -80.11 -157.88 0.16 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.575 ' CD2' ' HB ' ' A' ' 52' ' ' THR . 0.2 OUTLIER -126.1 112.9 16.38 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 120.749 -1.22 . . . . 0.0 108.752 179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.685 HG12 ' HB2' ' A' ' 80' ' ' ASP . 4.1 p -129.51 138.78 53.41 Favored 'Isoleucine or valine' 0 C--O 1.198 -1.655 0 C-N-CA 118.922 -1.111 . . . . 0.0 109.763 -179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.995 HD23 ' CG ' ' A' ' 78' ' ' ASP . 0.9 OUTLIER -143.0 -176.27 4.84 Favored 'General case' 0 C--N 1.288 -2.099 0 O-C-N 120.837 -1.164 . . . . 0.0 108.309 178.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.588 ' C ' ' HB2' ' A' ' 46' ' ' LEU . 1.9 tt0 -101.1 171.8 7.4 Favored 'General case' 0 C--N 1.286 -2.185 0 CA-C-O 121.947 0.88 . . . . 0.0 110.61 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.547 ' HB3' ' CD ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -73.07 81.21 1.24 Allowed 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.786 -178.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER 175.2 139.82 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.321 -0.862 . . . . 0.0 109.312 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.453 ' OD1' ' HD2' ' A' ' 59' ' ' ARG . 15.2 t30 . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.114 -0.991 . . . . 0.0 109.584 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.411 ' O ' ' HB2' ' A' ' 2' ' ' SER . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.411 ' HB2' ' O ' ' A' ' 1' ' ' MET . 9.0 t -179.57 122.27 0.07 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.269 -0.894 . . . . 0.0 109.363 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.639 ' HA ' ' CG ' ' A' ' 88' ' ' TRP . 1.0 OUTLIER 67.66 101.01 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -0.914 . . . . 0.0 109.271 -179.746 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.7 OUTLIER -142.26 160.93 39.27 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.759 -1.213 . . . . 0.0 112.235 -178.837 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.922 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 1.2 t -113.52 -176.65 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.734 ' CE2' HG21 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -159.19 144.77 16.16 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.474 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.939 ' HB ' HG22 ' A' ' 72' ' ' THR . 4.5 pt -160.31 137.11 2.1 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.866 0 O-C-N 120.529 -1.357 . . . . 0.0 107.919 179.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.728 ' O ' HG22 ' A' ' 71' ' ' ILE . . . -132.36 146.41 51.95 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 117.186 -1.806 . . . . 0.0 109.606 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 1.007 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 14.0 p90 -140.9 170.34 15.93 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.044 -0.662 . . . . 0.0 109.488 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.696 ' HG3' ' CA ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -119.61 143.33 47.73 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.687 -1.205 . . . . 0.0 109.052 178.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.569 ' HB2' ' HB3' ' A' ' 15' ' ' ALA . 2.7 p30 -108.73 154.07 22.57 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.745 -1.222 . . . . 0.0 109.957 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.493 ' O ' ' HB2' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -89.63 -37.97 14.26 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.377 -0.827 . . . . 0.0 109.424 179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.493 ' HB2' ' O ' ' A' ' 12' ' ' ASN . 16.6 t0 168.84 -34.88 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.9 m-20 -102.97 -30.31 10.87 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 11' ' ' ASP . . . -52.65 -20.37 3.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.401 -0.812 . . . . 0.0 109.141 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 14.3 mtm180 -64.98 -56.14 14.91 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.368 -0.832 . . . . 0.0 109.132 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -56.73 -39.32 73.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.282 -0.886 . . . . 0.0 109.238 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.1 t -56.49 -49.04 79.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.209 -0.932 . . . . 0.0 108.605 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 1.007 HG21 ' CZ ' ' A' ' 9' ' ' PHE . 60.9 t -67.45 -19.13 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.454 -0.779 . . . . 0.0 109.137 179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.509 ' HA ' ' CG1' ' A' ' 23' ' ' ILE . 45.6 tt0 -76.28 -36.7 58.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.385 -0.822 . . . . 0.0 109.784 -179.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -73.61 -36.23 65.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.0 109.307 179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 19.8 mt -71.67 -48.91 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.246 -0.909 . . . . 0.0 109.198 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.642 HD12 ' N ' ' A' ' 24' ' ' GLN . 2.2 pp -57.81 -38.96 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.217 -0.927 . . . . 0.0 108.934 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.642 ' N ' HD12 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -62.89 -43.05 99.84 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.343 -0.848 . . . . 0.0 109.035 179.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.445 ' C ' ' O ' ' A' ' 24' ' ' GLN . 3.0 t0 -44.43 -36.3 2.82 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -116.56 88.15 23.39 Favored Pre-proline 0 C--N 1.303 -1.454 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 178.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 28' ' ' HIS . 2.4 Cg_endo -65.89 81.31 0.26 Allowed 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 124.31 1.69 . . . . 0.0 110.308 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.456 ' HB2' ' O ' ' A' ' 27' ' ' PRO . 5.5 t-80 179.33 -43.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -40.86 140.67 0.69 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.725 -0.61 . . . . 0.0 110.002 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.604 HG22 ' N ' ' A' ' 31' ' ' VAL . 3.7 p -97.42 165.77 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.375 -0.828 . . . . 0.0 109.441 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.604 ' N ' HG22 ' A' ' 30' ' ' VAL . 1.4 p -155.49 163.44 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.521 ' N ' ' CG2' ' A' ' 31' ' ' VAL . 0.9 OUTLIER -174.55 141.78 0.69 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 0.0 109.849 179.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.931 ' HB3' HG22 ' A' ' 38' ' ' ILE . 1.3 p-80 -143.66 160.34 40.85 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.314 -0.866 . . . . 0.0 109.27 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.579 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -157.62 -61.57 0.02 OUTLIER Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 121.106 -0.996 . . . . 0.0 109.881 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.5 Cg_endo -66.92 -54.27 0.43 Allowed 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.725 1.382 . . . . 0.0 110.002 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -177.63 -56.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.315 -0.866 . . . . 0.0 108.971 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 9' ' ' PHE . 1.2 ptm -69.02 158.62 34.42 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.931 HG22 ' HB3' ' A' ' 33' ' ' HIS . 0.1 OUTLIER -110.31 120.59 61.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 120.891 -1.13 . . . . 0.0 109.857 -179.712 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.535 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -81.85 177.78 8.68 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.34 -0.85 . . . . 0.0 110.219 -179.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.698 HD12 HG13 ' A' ' 7' ' ' ILE . 3.1 mt -152.72 -174.72 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.273 -0.892 . . . . 0.0 109.673 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.67 ' H ' HG22 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -171.09 158.55 5.62 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.795 -1.191 . . . . 0.0 111.04 -179.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.922 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . . . -129.84 -175.31 3.56 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.631 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 10.2 pt-20 -151.25 70.67 0.98 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.147 -0.97 . . . . 0.0 110.033 -179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 3' ' ' SER . 0.0 OUTLIER 173.4 -143.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.856 -1.152 . . . . 0.0 109.321 -179.705 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.966 ' O ' HD23 ' A' ' 46' ' ' LEU . 4.9 mpt_? -126.01 154.99 42.15 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.04 -1.037 . . . . 0.0 109.375 -179.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.966 HD23 ' O ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -144.92 135.76 24.68 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.173 -0.955 . . . . 0.0 109.833 -179.4 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 1.088 ' CA ' HG12 ' A' ' 85' ' ' VAL . 2.3 pm0 -151.05 135.55 17.03 Favored 'General case' 0 N--CA 1.499 1.993 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.781 ' CD1' HG11 ' A' ' 85' ' ' VAL . 2.5 mt -137.8 152.4 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.035 -1.041 . . . . 0.0 109.117 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.527 ' O ' ' CG2' ' A' ' 53' ' ' VAL . 0.0 OUTLIER -50.49 147.58 4.42 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.151 -0.968 . . . . 0.0 108.949 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.453 ' CG ' HH11 ' A' ' 50' ' ' ARG . 0.0 OUTLIER -89.27 -60.55 1.92 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.072 -1.017 . . . . 0.0 109.716 -179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 16.5 tt0 -54.35 -44.66 72.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.751 -179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -50.81 50.06 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.017 -1.052 . . . . 0.0 109.445 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.576 ' CG2' ' CG2' ' A' ' 48' ' ' ILE . 19.4 t -55.34 -21.48 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -74.99 -40.08 60.88 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.263 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -68.29 -56.27 9.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.415 -0.803 . . . . 0.0 109.267 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 59' ' ' ARG . 0.1 OUTLIER -55.3 -29.43 58.21 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.245 -0.909 . . . . 0.0 109.3 179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.612 HD12 ' CE3' ' A' ' 61' ' ' TRP . 7.6 tp -64.33 -56.11 16.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.353 -0.842 . . . . 0.0 109.732 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.51 8.15 69.78 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.488 ' HG2' ' N ' ' A' ' 60' ' ' ALA . 22.7 ttt180 -98.8 -84.59 0.4 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.211 -1.17 . . . . 0.0 109.973 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.488 ' N ' ' HG2' ' A' ' 59' ' ' ARG . . . -96.03 -22.6 17.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.585 -179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.612 ' CE3' HD12 ' A' ' 57' ' ' LEU . 8.6 t90 -90.18 25.78 2.08 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.313 -0.867 . . . . 0.0 109.177 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -86.2 44.31 1.13 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.308 -0.87 . . . . 0.0 109.264 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.461 ' O ' ' N ' ' A' ' 65' ' ' GLU . 3.9 t -98.93 9.4 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.415 -0.803 . . . . 0.0 109.66 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.503 ' HA ' ' HB2' ' A' ' 67' ' ' LEU . 16.7 mm-40 -39.9 -28.72 0.05 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.522 -0.736 . . . . 0.0 109.944 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.546 ' O ' HG23 ' A' ' 68' ' ' VAL . 16.1 tt0 -58.06 -55.26 37.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.136 -0.977 . . . . 0.0 109.404 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.433 ' HB2' HG12 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -72.32 -9.57 58.66 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.248 -0.908 . . . . 0.0 109.423 179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.503 ' HB2' ' HA ' ' A' ' 64' ' ' GLN . 11.8 tp -53.74 -16.35 1.66 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.306 -0.871 . . . . 0.0 110.432 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 65' ' ' GLU . 17.2 t -40.2 -42.86 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.174 -0.954 . . . . 0.0 109.715 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.696 ' CA ' ' HG3' ' A' ' 10' ' ' GLN . 10.1 m-20 -81.52 -74.75 0.32 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.181 -0.949 . . . . 0.0 109.818 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.678 HG12 ' H ' ' A' ' 71' ' ' ILE . 1.3 t -43.56 -170.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 O-C-N 122.152 -0.343 . . . . 0.0 110.98 -178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.728 HG22 ' O ' ' A' ' 8' ' ' ALA . 0.4 OUTLIER 161.46 -167.13 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 N-CA-C 104.276 -2.49 . . . . 0.0 104.276 -179.11 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.939 HG22 ' HB ' ' A' ' 7' ' ' ILE . 0.0 OUTLIER -175.39 -158.87 0.07 Allowed 'General case' 0 C--O 1.193 -1.903 0 O-C-N 119.348 -2.095 . . . . 0.0 108.143 179.371 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.747 HG22 ' H ' ' A' ' 74' ' ' GLY . 48.6 mm -168.39 -127.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 178.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.747 ' H ' HG22 ' A' ' 73' ' ' ILE . . . 161.84 -71.81 0.21 Allowed Glycine 0 N--CA 1.486 1.996 0 O-C-N 120.427 -1.421 . . . . 0.0 110.591 177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 141.16 -37.93 1.59 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.162 -1.975 . . . . 0.0 108.162 -178.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.813 ' C ' HD13 ' A' ' 86' ' ' LEU . 2.4 t-20 -176.48 -149.5 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.544 -0.974 . . . . 0.0 109.205 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.779 ' O ' HG13 ' A' ' 77' ' ' VAL . 9.1 p -151.33 100.93 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.075 -1.016 . . . . 0.0 109.415 179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.475 ' OD2' ' HD3' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -114.47 150.58 34.57 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.942 -1.098 . . . . 0.0 110.325 -179.006 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.577 ' HB3' ' CD1' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -118.12 164.64 14.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.588 -0.695 . . . . 0.0 109.229 179.462 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.533 ' OD1' ' HB2' ' A' ' 47' ' ' GLU . 3.6 p-10 -114.42 -115.49 0.33 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.035 -1.04 . . . . 0.0 109.646 179.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -98.36 -41.12 7.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.828 -1.17 . . . . 0.0 109.753 -179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -130.91 -58.78 1.01 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.03 -1.044 . . . . 0.0 108.606 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.504 ' HG2' ' HA ' ' A' ' 48' ' ' ILE . 2.1 mpp_? -57.2 -173.22 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.664 ' CE1' HG22 ' A' ' 77' ' ' VAL . 2.2 t80 173.41 120.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.051 -1.031 . . . . 0.0 111.816 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.088 HG12 ' CA ' ' A' ' 47' ' ' GLU . 8.1 p -160.39 -115.41 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 175.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.813 HD13 ' C ' ' A' ' 76' ' ' ASN . 22.0 tp -131.85 144.62 51.03 Favored 'General case' 0 C--N 1.282 -2.352 0 O-C-N 120.19 -1.569 . . . . 0.0 112.368 -178.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.803 ' H ' HD12 ' A' ' 86' ' ' LEU . 16.8 mt-10 -120.72 -150.16 0.45 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.655 -1.609 . . . . 0.0 106.655 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.639 ' CG ' ' HA ' ' A' ' 3' ' ' SER . 7.0 t90 -64.19 -90.77 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 120.802 -1.186 . . . . 0.0 108.2 177.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.525 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 5.9 mptt 43.42 97.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.57 -0.706 . . . . 0.0 110.049 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.378 179.698 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.485 ' HA ' HD11 ' A' ' 4' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.301 0.572 . . . . 0.0 109.489 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.62 -51.29 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 109.201 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -136.84 23.21 3.09 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.281 -0.887 . . . . 0.0 109.414 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.4 OUTLIER -128.2 -167.03 1.7 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.133 -0.98 . . . . 0.0 109.797 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.835 HG13 ' HA2' ' A' ' 75' ' ' GLY . 11.3 t -152.28 161.31 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 110.177 -179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.594 ' O ' ' N ' ' A' ' 74' ' ' GLY . 6.6 t80 -153.16 136.0 15.38 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 177.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.67 ' N ' HD13 ' A' ' 7' ' ' ILE . 0.2 OUTLIER -162.68 137.68 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.921 -1.112 . . . . 0.0 109.786 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.635 ' C ' HG22 ' A' ' 71' ' ' ILE . . . -126.6 173.89 9.11 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 106.361 -1.718 . . . . 0.0 106.361 177.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.633 ' CD1' ' O ' ' A' ' 69' ' ' ASP . 2.6 m-85 -168.56 155.56 7.48 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.496 -1.378 . . . . 0.0 109.366 -178.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.524 ' HA ' HG13 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -120.91 93.82 4.15 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 179.09 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.483 ' HB2' HD11 ' A' ' 38' ' ' ILE . 1.1 m-20 -74.38 -166.66 0.45 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.38 -0.825 . . . . 0.0 109.831 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -95.7 -114.59 0.12 Allowed 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.09 -1.006 . . . . 0.0 108.911 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -119.08 -31.97 4.57 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.843 -1.161 . . . . 0.0 108.579 179.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -103.07 -34.87 8.73 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.473 -0.767 . . . . 0.0 109.331 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.53 82.41 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.324 -0.86 . . . . 0.0 109.556 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.463 HH11 ' CG ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -63.07 -36.22 82.86 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.396 -0.815 . . . . 0.0 109.315 179.863 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.38 -37.65 83.48 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -0.895 . . . . 0.0 109.075 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 71.5 t -59.86 -53.04 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.381 -0.824 . . . . 0.0 109.191 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.411 ' HA ' HD12 ' A' ' 22' ' ' ILE . 55.9 t -64.37 -23.65 33.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.409 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.35 -35.28 73.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.309 -0.87 . . . . 0.0 109.747 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.43 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -77.53 -33.08 54.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.175 -0.953 . . . . 0.0 109.773 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.507 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 8.3 mt -71.89 -37.62 62.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.181 -0.949 . . . . 0.0 109.058 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 51.3 mt -67.24 -53.02 36.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.894 . . . . 0.0 109.335 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.404 ' O ' ' C ' ' A' ' 25' ' ' ASP . 0.5 OUTLIER -63.48 -29.25 70.55 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.173 -1.047 . . . . 0.0 108.173 179.358 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 27' ' ' PRO . 0.9 OUTLIER -47.13 -43.94 21.16 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 178.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 22' ' ' ILE . 2.9 m-80 -87.01 126.96 61.28 Favored Pre-proline 0 C--N 1.307 -1.276 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 25' ' ' ASP . 2.7 Cg_endo -84.02 49.34 2.78 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.817 1.43 . . . . 0.0 110.254 -179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.419 ' O ' ' C ' ' A' ' 29' ' ' ALA . 2.8 t-160 -154.76 -48.47 0.09 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.19 -0.944 . . . . 0.0 109.917 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.419 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -41.11 141.08 0.69 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.475 -0.766 . . . . 0.0 109.873 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.411 ' C ' ' CG2' ' A' ' 31' ' ' VAL . 2.6 t -98.0 162.32 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.523 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.411 ' CG2' ' C ' ' A' ' 30' ' ' VAL . 0.2 OUTLIER -155.11 156.85 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.318 -0.864 . . . . 0.0 109.036 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -170.09 83.79 0.11 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.14 -0.975 . . . . 0.0 109.568 -179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 6.8 p-80 -119.41 167.42 11.94 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.176 -0.953 . . . . 0.0 109.644 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.582 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -164.26 -48.09 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.366 -0.833 . . . . 0.0 109.132 179.607 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 2.0 Cg_endo -81.98 -167.02 0.44 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.752 1.396 . . . . 0.0 109.737 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -74.77 -5.1 41.53 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.21 -0.931 . . . . 0.0 109.248 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.522 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 1.9 mtm -97.04 151.42 19.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.311 -0.868 . . . . 0.0 109.383 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.524 HG13 ' HA ' ' A' ' 10' ' ' GLN . 1.0 OUTLIER -111.09 161.08 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.141 -0.975 . . . . 0.0 109.328 179.834 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.51 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -149.7 155.46 40.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.168 -0.957 . . . . 0.0 109.792 -179.224 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.648 HG22 ' H ' ' A' ' 41' ' ' GLU . 13.2 mt -156.25 175.81 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.386 -0.821 . . . . 0.0 109.045 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.648 ' H ' HG22 ' A' ' 40' ' ' ILE . 11.2 tt0 178.76 144.42 0.13 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.085 -1.009 . . . . 0.0 109.367 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.669 ' HB2' ' CE2' ' A' ' 88' ' ' TRP . . . -129.19 -160.13 1.01 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.797 . . . . 0.0 109.642 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 17.0 pt-20 -164.01 69.23 0.19 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.375 -0.828 . . . . 0.0 109.452 -179.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -159.46 -164.35 1.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 0.0 110.009 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.494 ' HA ' ' CG ' ' A' ' 87' ' ' GLU . 9.2 ptm180 -133.33 -166.42 1.77 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.506 -0.747 . . . . 0.0 109.014 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 87' ' ' GLU . 4.1 mt -163.42 156.04 18.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.036 -1.04 . . . . 0.0 110.193 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.743 ' HG3' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -146.32 139.74 25.92 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.617 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.81 ' N ' HD12 ' A' ' 48' ' ' ILE . 0.3 OUTLIER -148.2 158.41 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.099 -1.001 . . . . 0.0 109.933 -179.597 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.517 ' HA ' ' CG ' ' A' ' 83' ' ' ARG . 0.0 OUTLIER -100.62 -151.16 0.4 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.651 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -71.24 -4.08 23.81 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.387 -0.821 . . . . 0.0 109.661 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.482 ' O ' ' HB2' ' A' ' 54' ' ' GLU . 13.4 pt-20 -71.77 -23.8 61.65 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.176 -0.953 . . . . 0.0 109.784 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.44 ' OG1' ' CG2' ' A' ' 48' ' ' ILE . 0.2 OUTLIER -64.08 -49.11 73.55 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.983 -1.073 . . . . 0.0 109.56 -179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 73.2 t -51.52 -25.82 5.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.066 -1.021 . . . . 0.0 108.889 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 51' ' ' GLU . 10.0 mt-10 -75.38 -39.89 58.62 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.278 -0.889 . . . . 0.0 109.429 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.477 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 15.3 mm-40 -65.52 -46.59 79.06 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.344 -0.848 . . . . 0.0 109.376 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -43.61 80.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.258 -0.901 . . . . 0.0 109.533 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.4 tp -57.09 -54.93 41.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.259 -0.9 . . . . 0.0 109.556 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -73.31 -2.1 58.56 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 55' ' ' GLU . 12.9 ttt180 -119.17 10.12 11.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.169 -1.195 . . . . 0.0 109.701 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -61.19 -27.4 68.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.12 -0.988 . . . . 0.0 109.51 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -89.35 29.04 1.15 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.282 -0.887 . . . . 0.0 109.706 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.467 ' HB2' ' HG2' ' A' ' 59' ' ' ARG . 0.7 OUTLIER -110.93 5.42 20.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.222 -0.924 . . . . 0.0 109.611 179.92 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 13.3 t -72.75 -49.44 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.26 -0.9 . . . . 0.0 109.593 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 82.5 mm-40 -49.9 -47.98 51.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.284 -0.885 . . . . 0.0 109.39 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -71.65 -25.1 61.99 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.448 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -81.37 -12.34 59.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.24 -0.912 . . . . 0.0 109.507 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.2 tp -86.38 -22.16 26.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.258 -0.901 . . . . 0.0 109.443 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 10' ' ' GLN . 14.0 t -59.25 -33.91 52.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.256 -0.902 . . . . 0.0 109.523 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.633 ' O ' ' CD1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -99.6 86.84 3.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 109.185 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.564 ' O ' ' CB ' ' A' ' 71' ' ' ILE . 2.4 p -101.93 140.57 20.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 O-C-N 121.312 -0.867 . . . . 0.0 111.309 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.635 HG22 ' C ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER 167.69 -53.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.038 -1.039 . . . . 0.0 111.912 175.797 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 73' ' ' ILE . 1.7 m -165.98 171.54 12.46 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 120.057 -1.652 . . . . 0.0 112.761 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.625 ' H ' HG22 ' A' ' 72' ' ' THR . 0.2 OUTLIER -163.67 165.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 179.426 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 174.94 51.23 0.05 OUTLIER Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.514 -179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.835 ' HA2' HG13 ' A' ' 5' ' ' VAL . . . -104.67 -100.32 2.62 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 108.755 -1.738 . . . . 0.0 108.755 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.738 ' O ' HD21 ' A' ' 86' ' ' LEU . 1.9 t30 -175.33 -174.0 0.69 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.4 -1.059 . . . . 0.0 108.931 179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.775 HG13 ' O ' ' A' ' 77' ' ' VAL . 12.4 p 177.97 67.64 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 108.806 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.505 ' O ' HG12 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -98.95 141.58 31.53 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.086 -1.009 . . . . 0.0 110.394 -178.806 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -127.21 145.24 50.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.461 -0.775 . . . . 0.0 108.932 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -107.24 -109.67 0.31 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.069 -1.02 . . . . 0.0 109.485 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -104.39 -77.14 0.58 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.817 -1.177 . . . . 0.0 109.242 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.8 p-10 -109.94 -9.43 14.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.252 -0.905 . . . . 0.0 109.075 179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.517 ' CG ' ' HA ' ' A' ' 49' ' ' ARG . 3.0 ttt180 -91.92 -160.62 0.75 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.374 -0.829 . . . . 0.0 109.344 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.465 ' O ' ' O ' ' A' ' 48' ' ' ILE . 2.1 t80 -169.38 148.89 3.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.072 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.743 HG23 ' HG3' ' A' ' 47' ' ' GLU . 2.5 p -133.73 179.36 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.053 -1.03 . . . . 0.0 109.871 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.738 HD21 ' O ' ' A' ' 76' ' ' ASN . 0.2 OUTLIER 178.26 -169.34 0.09 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.826 ' O ' HD12 ' A' ' 46' ' ' LEU . 3.9 mt-10 -121.71 -164.81 1.18 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.941 -1.099 . . . . 0.0 109.796 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.669 ' CE2' ' HB2' ' A' ' 42' ' ' ALA . 0.0 OUTLIER -42.49 154.1 0.07 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.284 -0.885 . . . . 0.0 109.302 -179.731 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.504 ' O ' ' CE2' ' A' ' 88' ' ' TRP . 0.5 OUTLIER -107.41 148.77 28.68 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.381 -0.824 . . . . 0.0 109.385 -179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 15.8 t30 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.507 179.991 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.0 m 56.22 20.31 4.45 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 0.0 109.528 -179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.479 ' O ' ' O ' ' A' ' 44' ' ' LYS . 5.8 p -102.94 12.36 36.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.288 -0.882 . . . . 0.0 109.677 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 43' ' ' GLU . 0.5 OUTLIER -122.48 -176.82 3.47 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.059 -1.025 . . . . 0.0 109.222 179.394 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.586 ' CG2' ' N ' ' A' ' 6' ' ' TYR . 0.2 OUTLIER -156.97 165.62 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.891 -1.131 . . . . 0.0 110.703 -179.157 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.586 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -135.41 147.53 49.04 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.072 -1.051 . . . . 0.0 108.935 177.733 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.566 ' C ' HD12 ' A' ' 7' ' ' ILE . 1.4 pp -158.21 139.45 4.84 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.881 ' HB3' ' OG1' ' A' ' 72' ' ' THR . . . -124.72 -179.16 4.4 Favored 'General case' 0 C--N 1.295 -1.765 0 C-N-CA 118.782 -1.167 . . . . 0.0 110.108 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 1.012 ' CD2' HG22 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -141.79 -178.7 5.79 Favored 'General case' 0 C--N 1.295 -1.787 0 C-N-CA 118.94 -1.104 . . . . 0.0 110.195 177.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.774 ' N ' ' HA ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER 177.97 97.93 0.02 OUTLIER 'General case' 0 C--N 1.29 -1.998 0 C-N-CA 119.265 -0.974 . . . . 0.0 111.305 -177.628 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.644 ' OD1' HG21 ' A' ' 70' ' ' VAL . 0.4 OUTLIER -107.7 167.92 9.63 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.152 -0.968 . . . . 0.0 109.856 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -124.57 -64.63 1.1 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.323 -0.861 . . . . 0.0 109.881 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -101.6 -32.64 10.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.224 -0.923 . . . . 0.0 109.57 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.403 ' HB2' ' OD2' ' A' ' 11' ' ' ASP . 25.9 m-80 -87.64 10.61 17.47 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.304 -0.872 . . . . 0.0 109.129 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.903 ' O ' HG23 ' A' ' 19' ' ' VAL . . . -58.8 -16.6 17.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.313 -0.867 . . . . 0.0 109.215 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.523 ' NH1' ' HG2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -61.97 -62.13 2.0 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.355 -0.841 . . . . 0.0 109.214 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.432 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 49.3 m-85 -62.95 -33.37 75.22 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.252 -0.905 . . . . 0.0 108.872 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.936 ' O ' HD13 ' A' ' 22' ' ' ILE . 60.1 t -59.34 -32.97 49.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.903 HG23 ' O ' ' A' ' 15' ' ' ALA . 61.3 t -77.45 -25.5 15.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.432 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 6.9 tp10 -65.27 -53.94 36.62 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 25' ' ' ASP . . . -67.65 -44.31 78.19 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.206 -0.934 . . . . 0.0 108.556 179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.936 HD13 ' O ' ' A' ' 18' ' ' VAL . 1.5 mp -54.04 -31.03 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.537 ' O ' ' CD ' ' A' ' 27' ' ' PRO . 17.9 mt -70.38 -42.16 78.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.312 -0.868 . . . . 0.0 108.844 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.3 4.92 49.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.14 -0.975 . . . . 0.0 109.532 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.722 ' O ' ' HB3' ' A' ' 29' ' ' ALA . 0.8 OUTLIER -118.67 -11.88 9.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.301 179.539 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.551 ' ND2' HG23 ' A' ' 22' ' ' ILE . 1.0 OUTLIER -85.57 -65.88 0.2 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.389 -0.819 . . . . 0.0 110.377 -179.461 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.537 ' CD ' ' O ' ' A' ' 23' ' ' ILE . 2.5 Cg_endo -41.0 -27.95 0.35 Allowed 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.66 1.348 . . . . 0.0 110.051 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 26' ' ' ASN . 2.6 t-160 -98.64 -33.45 10.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.391 -0.818 . . . . 0.0 109.667 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.722 ' HB3' ' O ' ' A' ' 25' ' ' ASP . . . -102.33 176.89 5.03 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -0.99 . . . . 0.0 110.265 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 40' ' ' ILE . 1.9 t -101.2 162.88 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.867 . . . . 0.0 109.034 179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.6 HG22 ' N ' ' A' ' 32' ' ' GLN . 2.1 p -169.66 166.88 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.046 -1.034 . . . . 0.0 109.813 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.6 ' N ' HG22 ' A' ' 31' ' ' VAL . 2.5 pt20 -172.18 65.38 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.418 -0.801 . . . . 0.0 109.566 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.508 ' CB ' ' HA ' ' A' ' 38' ' ' ILE . 26.0 p80 -101.12 179.14 4.46 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.198 -0.939 . . . . 0.0 109.813 -179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.588 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.1 OUTLIER -156.67 -62.62 0.02 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.27 -0.894 . . . . 0.0 109.589 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.0 OUTLIER -67.84 -167.78 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.684 1.36 . . . . 0.0 109.911 179.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.19 -15.41 33.85 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.234 -0.916 . . . . 0.0 108.957 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.583 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 66.9 mtp -81.84 135.32 35.45 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.327 -0.858 . . . . 0.0 109.619 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.63 ' CG1' ' HB3' ' A' ' 9' ' ' PHE . 0.5 OUTLIER -113.77 82.54 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 0.0 109.16 -179.785 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.532 ' HA ' ' CB ' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -78.39 167.3 21.53 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.241 -0.912 . . . . 0.0 111.25 -178.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.461 HG23 ' O ' ' A' ' 30' ' ' VAL . 89.5 mt -149.99 155.25 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.408 ' N ' HG22 ' A' ' 40' ' ' ILE . 3.4 tt0 -131.15 147.14 52.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.08 -1.013 . . . . 0.0 109.662 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.521 ' O ' ' CG ' ' A' ' 43' ' ' GLU . . . -143.88 -171.61 3.58 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.372 -0.83 . . . . 0.0 108.877 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.66 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 44.8 mt-10 -159.28 99.55 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.26 -0.9 . . . . 0.0 109.513 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.548 ' HB3' ' CB ' ' A' ' 88' ' ' TRP . 0.0 OUTLIER -162.2 -145.25 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.768 -1.208 . . . . 0.0 111.078 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.672 ' HA ' ' HA ' ' A' ' 87' ' ' GLU . 0.0 OUTLIER -162.43 159.65 25.38 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.31 -0.869 . . . . 0.0 109.502 -178.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.754 ' CD1' HD11 ' A' ' 86' ' ' LEU . 1.4 mt -126.18 -173.79 2.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.056 -1.027 . . . . 0.0 108.298 178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.49 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 4.3 pt-20 -178.95 141.99 0.19 Allowed 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.256 -0.902 . . . . 0.0 109.421 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.408 ' CG1' ' C ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -160.43 -161.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.15 -0.969 . . . . 0.0 109.585 179.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.457 ' CG ' ' NH1' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -100.21 -169.08 1.68 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.325 -0.859 . . . . 0.0 109.152 179.75 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.0 ttp180 -88.5 -46.3 9.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.162 -0.961 . . . . 0.0 109.026 179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.462 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 30.7 tt0 -49.49 -32.15 11.54 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.321 -0.862 . . . . 0.0 109.362 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 53' ' ' VAL . 1.3 m -70.88 -50.28 36.86 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.207 -0.933 . . . . 0.0 109.039 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.739 HG21 ' CD1' ' A' ' 84' ' ' PHE . 97.4 t -48.1 -27.64 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.462 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 21.7 tp10 -74.54 -44.41 51.21 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.104 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -54.23 -47.11 72.56 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.349 -0.844 . . . . 0.0 108.853 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 60' ' ' ALA . 0.2 OUTLIER -60.47 -36.96 79.52 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.437 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.8 tp -57.99 -55.75 30.95 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.385 -0.822 . . . . 0.0 109.364 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -67.6 -11.29 59.69 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 15.1 ttt180 -114.82 7.25 15.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.263 -1.139 . . . . 0.0 109.625 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 56' ' ' ASN . . . -70.01 -29.97 67.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.231 -0.918 . . . . 0.0 109.26 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -90.34 38.45 0.94 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.31 -0.868 . . . . 0.0 109.384 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t0 -103.07 -86.06 0.44 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.299 -0.876 . . . . 0.0 109.571 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.515 HG12 ' HB2' ' A' ' 66' ' ' MET . 1.3 t -97.92 0.99 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.599 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.486 ' O ' ' HB3' ' A' ' 67' ' ' LEU . 1.2 mp0 -51.9 -27.57 13.38 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.201 -0.937 . . . . 0.0 109.574 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -64.18 -43.07 96.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.173 -0.954 . . . . 0.0 109.017 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.517 ' HB3' ' CD1' ' A' ' 71' ' ' ILE . 0.0 OUTLIER -64.62 -9.96 23.19 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.431 -0.793 . . . . 0.0 109.438 179.776 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 3.3 tt -53.29 -18.05 2.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 0.0 109.833 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 47.8 t -82.28 -35.43 12.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.009 -1.057 . . . . 0.0 109.775 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 39.9 m-20 -98.93 -118.26 0.14 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.952 . . . . 0.0 111.383 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 1.012 HG22 ' CD2' ' A' ' 9' ' ' PHE . 0.4 OUTLIER -49.71 -3.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.179 -2.634 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 -176.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.64 HG23 ' CE1' ' A' ' 9' ' ' PHE . 0.0 OUTLIER -132.31 142.92 41.43 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.052 0 CA-C-N 121.658 2.026 . . . . 0.0 112.5 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.881 ' OG1' ' HB3' ' A' ' 8' ' ' ALA . 0.0 OUTLIER -155.52 149.07 25.08 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 7' ' ' ILE . 1.4 pp -139.06 -174.66 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.094 -1.003 . . . . 0.0 109.61 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . 167.48 44.28 0.03 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.55 ' HA2' ' HA ' ' A' ' 5' ' ' VAL . . . -94.05 -104.92 1.82 Allowed Glycine 0 N--CA 1.484 1.862 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.454 ' OD1' ' O ' ' A' ' 75' ' ' GLY . 0.7 OUTLIER -176.58 166.72 2.69 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.476 -1.014 . . . . 0.0 109.577 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.2 p -133.41 92.34 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.709 ' OD1' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -104.69 137.33 42.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.121 -0.987 . . . . 0.0 109.97 -179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -119.98 133.84 55.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.315 -0.865 . . . . 0.0 109.457 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -90.6 -96.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.155 -0.966 . . . . 0.0 109.501 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.86 -61.14 1.58 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.152 -0.967 . . . . 0.0 109.253 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -126.37 -39.0 2.07 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -65.4 -173.77 0.16 Allowed 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 109.044 -0.724 . . . . 0.0 109.044 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.739 ' CD1' HG21 ' A' ' 53' ' ' VAL . 0.6 OUTLIER -141.05 166.42 24.84 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.228 -0.92 . . . . 0.0 109.051 179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.709 HG13 ' OD1' ' A' ' 78' ' ' ASP . 0.4 OUTLIER -154.62 162.75 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.214 -0.929 . . . . 0.0 109.533 -179.725 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.754 HD11 ' CD1' ' A' ' 46' ' ' LEU . 0.4 OUTLIER -172.75 -123.76 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.43 -0.794 . . . . 0.0 109.335 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.672 ' HA ' ' HA ' ' A' ' 45' ' ' ARG . 2.0 pt-20 -112.18 165.75 11.87 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.372 -0.83 . . . . 0.0 110.991 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.561 ' HA ' ' HG ' ' A' ' 46' ' ' LEU . 0.2 OUTLIER -104.59 134.34 47.93 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.047 -1.033 . . . . 0.0 109.469 177.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.33 103.89 9.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -0.909 . . . . 0.0 109.311 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.1 t30 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.385 -179.998 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' ' CB ' ' A' ' 2' ' ' SER . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 1' ' ' MET . 0.1 OUTLIER 72.8 -160.69 0.1 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.262 -0.899 . . . . 0.0 109.636 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.788 ' C ' HD13 ' A' ' 4' ' ' LEU . 0.3 OUTLIER -171.55 108.71 0.26 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.564 -179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.883 ' N ' HD13 ' A' ' 4' ' ' LEU . 0.0 OUTLIER -156.59 160.61 39.59 Favored 'General case' 0 C--N 1.31 -1.152 0 O-C-N 120.918 -1.114 . . . . 0.0 111.213 179.582 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.968 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 48.8 t -114.71 171.36 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.618 ' N ' HG12 ' A' ' 5' ' ' VAL . 50.3 t80 -147.73 138.59 23.34 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.743 -1.223 . . . . 0.0 109.259 179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.533 HG22 ' HA ' ' A' ' 73' ' ' ILE . 2.8 pt -160.68 159.31 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.64 ' HB2' ' HB2' ' A' ' 39' ' ' ARG . . . -165.83 164.63 18.65 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.339 -1.476 . . . . 0.0 110.591 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 1.185 ' CE2' HG22 ' A' ' 71' ' ' ILE . 5.3 m-85 -149.18 163.15 38.44 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 -179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.73 ' HB3' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -125.76 81.65 2.0 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 178.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.508 ' HA ' ' HB3' ' A' ' 69' ' ' ASP . 14.9 p30 -106.41 167.13 10.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.425 -0.797 . . . . 0.0 110.37 -179.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -102.32 5.86 40.12 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.529 -0.732 . . . . 0.0 109.505 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -79.66 103.93 9.9 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.111 -0.993 . . . . 0.0 108.972 179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.462 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 9.8 t-20 -66.17 -8.82 26.47 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.198 -0.939 . . . . 0.0 108.715 179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.89 -40.66 85.11 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.42 ' NH2' HD13 ' A' ' 40' ' ' ILE . 0.1 OUTLIER -65.36 -36.5 84.2 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 179.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -56.87 -46.67 81.67 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.345 -0.847 . . . . 0.0 108.937 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 39.1 t -56.12 -57.41 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.228 -0.92 . . . . 0.0 108.594 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 21.5 t -55.59 -21.68 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.379 -0.826 . . . . 0.0 108.801 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.543 ' OE2' ' CD2' ' A' ' 33' ' ' HIS . 6.8 tt0 -75.09 -37.6 61.48 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.517 -0.739 . . . . 0.0 109.446 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.78 -28.02 63.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.056 -1.027 . . . . 0.0 109.231 179.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.413 ' HA ' ' HB2' ' A' ' 25' ' ' ASP . 32.1 mm -76.85 -41.13 32.33 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.231 -0.918 . . . . 0.0 109.086 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.517 ' CG2' ' N ' ' A' ' 24' ' ' GLN . 1.3 tt -60.45 -46.29 95.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.129 -0.982 . . . . 0.0 108.655 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.517 ' N ' ' CG2' ' A' ' 23' ' ' ILE . 0.2 OUTLIER -67.65 -32.15 72.63 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.413 ' HB2' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -49.18 -30.04 6.34 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 178.819 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.515 ' ND2' ' N ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER -79.66 136.37 55.49 Favored Pre-proline 0 N--CA 1.487 1.379 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -84.0 45.15 1.7 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.826 1.435 . . . . 0.0 110.108 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 -149.6 -47.71 0.14 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.181 -0.949 . . . . 0.0 109.636 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.32 142.03 55.35 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.573 -179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.717 HG13 ' HG3' ' A' ' 41' ' ' GLU . 4.8 p -100.31 140.41 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.171 -0.956 . . . . 0.0 109.37 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.498 HG21 HG23 ' A' ' 23' ' ' ILE . 0.4 OUTLIER -151.34 166.11 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.24 -0.913 . . . . 0.0 109.449 -179.797 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -165.16 82.37 0.36 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.219 -0.926 . . . . 0.0 109.627 179.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.543 ' CD2' ' OE2' ' A' ' 20' ' ' GLU . 2.2 p80 -117.36 142.61 46.89 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.266 -0.896 . . . . 0.0 109.286 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.566 ' CB ' ' HD3' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -160.93 -58.58 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.183 -0.948 . . . . 0.0 109.54 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 34' ' ' HIS . 1.9 Cg_endo -68.62 -155.93 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.612 0 O-C-N 123.715 1.376 . . . . 0.0 109.862 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -83.98 -4.03 58.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.203 -0.936 . . . . 0.0 109.425 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.505 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 2.9 ttm -89.57 168.54 12.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.184 -0.948 . . . . 0.0 109.656 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.54 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 0.1 OUTLIER -138.48 115.7 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.642 ' C ' HD12 ' A' ' 40' ' ' ILE . 3.6 ptp180 -129.62 168.66 16.11 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.662 -1.274 . . . . 0.0 111.433 -178.086 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.642 HD12 ' C ' ' A' ' 39' ' ' ARG . 2.7 mp -158.98 157.43 3.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.717 ' HG3' HG13 ' A' ' 30' ' ' VAL . 1.0 OUTLIER -131.58 -177.4 4.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.944 -1.098 . . . . 0.0 109.71 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.968 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . . . -129.2 -149.02 0.39 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.15 -0.969 . . . . 0.0 109.113 179.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.663 ' H ' HD21 ' A' ' 46' ' ' LEU . 1.2 mm-40 -135.6 26.94 3.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.824 -1.173 . . . . 0.0 111.699 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.642 ' CG ' ' HB2' ' A' ' 88' ' ' TRP . 0.5 OUTLIER 83.07 -39.49 0.09 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 121.887 0.851 . . . . 0.0 111.629 178.269 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.696 ' O ' HD23 ' A' ' 46' ' ' LEU . 6.3 mtm180 -127.81 113.23 15.68 Favored 'General case' 0 C--N 1.263 -3.177 0 C-N-CA 118.717 -1.193 . . . . 0.0 110.087 -178.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.696 HD23 ' O ' ' A' ' 45' ' ' ARG . 0.1 OUTLIER -141.18 144.52 34.84 Favored 'General case' 0 C--N 1.303 -1.455 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 -178.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.696 ' HA ' HG23 ' A' ' 85' ' ' VAL . 0.2 OUTLIER -154.54 139.65 17.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 109.598 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -142.96 143.74 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.397 -0.815 . . . . 0.0 109.132 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . . . . . . . . . 3.6 ptt180 -101.25 -98.35 0.26 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.096 -1.002 . . . . 0.0 110.288 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -56.87 -15.27 4.48 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.25 -0.906 . . . . 0.0 110.68 -179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.517 ' HB3' ' HB ' ' A' ' 48' ' ' ILE . 33.8 tp10 -49.43 -24.86 2.19 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.725 -1.234 . . . . 0.0 108.986 -179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.663 HG21 ' O ' ' A' ' 82' ' ' ASP . 1.6 m -66.4 -46.16 77.54 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.085 -1.009 . . . . 0.0 108.929 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.418 ' C ' ' O ' ' A' ' 52' ' ' THR . 78.2 t -47.26 -30.27 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.526 ' O ' ' HB3' ' A' ' 57' ' ' LEU . 0.7 OUTLIER -70.43 -46.81 63.17 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 107.381 -1.34 . . . . 0.0 107.381 178.424 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.428 ' N ' ' O ' ' A' ' 52' ' ' THR . 7.2 mt-10 -51.09 -63.62 1.07 Allowed 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 178.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 59' ' ' ARG . 1.0 OUTLIER -44.05 -33.98 1.62 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.526 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 8.7 tp -51.06 -62.74 1.43 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 178.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.667 ' O ' ' CB ' ' A' ' 59' ' ' ARG . . . -52.79 -24.79 20.47 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 106.968 -2.453 . . . . 0.0 106.968 177.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.667 ' CB ' ' O ' ' A' ' 58' ' ' GLY . 8.9 tpt180 110.59 39.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.869 1.267 . . . . 0.0 108.576 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.669 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 61.4 96.36 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 102.672 -3.085 . . . . 0.0 102.672 -176.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.594 ' CD1' HG23 ' A' ' 63' ' ' VAL . 29.3 t90 -18.41 81.89 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 CA-C-O 123.219 1.485 . . . . 0.0 109.845 -174.121 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.669 ' N ' ' O ' ' A' ' 60' ' ' ALA . 23.7 t70 -102.19 53.21 0.8 Allowed 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 113.461 -1.7 . . . . 0.0 108.96 -177.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.628 HG12 ' O ' ' A' ' 63' ' ' VAL . 40.5 t -88.47 9.42 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.479 -0.763 . . . . 0.0 110.037 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.459 ' C ' ' O ' ' A' ' 63' ' ' VAL . 61.3 mm-40 -39.88 -31.74 0.13 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.553 -0.717 . . . . 0.0 109.693 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.41 ' N ' ' O ' ' A' ' 63' ' ' VAL . 0.9 OUTLIER -64.46 -53.42 48.59 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.166 -0.959 . . . . 0.0 108.889 179.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.523 ' O ' ' N ' ' A' ' 68' ' ' VAL . 0.0 OUTLIER -76.04 -1.28 25.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.406 -0.809 . . . . 0.0 109.54 179.255 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.503 ' O ' ' N ' ' A' ' 69' ' ' ASP . 12.0 tp -38.53 -23.95 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.657 -0.652 . . . . 0.0 111.367 -179.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.523 ' N ' ' O ' ' A' ' 66' ' ' MET . 2.4 m -39.0 -28.76 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 121.033 -1.042 . . . . 0.0 109.953 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.549 ' HA ' ' O ' ' A' ' 10' ' ' GLN . 21.6 p30 -59.08 165.12 2.65 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.43 -0.794 . . . . 0.0 109.587 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.73 HG23 ' HB3' ' A' ' 10' ' ' GLN . 45.7 t -79.45 167.09 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.194 -0.941 . . . . 0.0 109.015 179.389 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 1.185 HG22 ' CE2' ' A' ' 9' ' ' PHE . 1.5 pp -132.53 148.76 31.74 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 O-C-N 121.086 -1.009 . . . . 0.0 110.204 -179.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 1.041 ' O ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -151.89 140.46 20.7 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.215 -0.928 . . . . 0.0 109.406 178.835 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.041 HD13 ' O ' ' A' ' 72' ' ' THR . 5.4 mm -137.33 153.82 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.448 -179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.611 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -166.33 32.27 0.22 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.576 ' CA ' HG13 ' A' ' 5' ' ' VAL . . . -146.24 -95.31 0.17 Allowed Glycine 0 N--CA 1.487 2.05 0 N-CA-C 108.46 -1.856 . . . . 0.0 108.46 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.573 ' C ' HD21 ' A' ' 86' ' ' LEU . 5.4 t30 -172.8 -151.3 0.06 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.216 -1.167 . . . . 0.0 109.519 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.731 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.6 p 179.18 89.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.369 -0.832 . . . . 0.0 109.273 179.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.483 ' OD2' HG13 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -110.78 129.93 55.71 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.114 -0.991 . . . . 0.0 109.811 -179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -127.68 146.71 50.47 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.498 -0.751 . . . . 0.0 109.14 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.64 -101.14 0.35 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.071 -1.018 . . . . 0.0 109.422 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -108.2 -53.95 2.57 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.966 -1.084 . . . . 0.0 109.322 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.663 ' O ' HG21 ' A' ' 52' ' ' THR . 0.5 OUTLIER -130.86 -43.55 1.09 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.414 ' O ' ' O ' ' A' ' 82' ' ' ASP . 10.1 mpt_? -54.53 -171.67 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.661 -0.649 . . . . 0.0 109.346 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.923 ' O ' HD12 ' A' ' 48' ' ' ILE . 14.5 t80 -161.17 143.12 12.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.302 -0.874 . . . . 0.0 109.027 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.696 HG23 ' HA ' ' A' ' 47' ' ' GLU . 9.3 p -150.73 144.27 16.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.987 -1.071 . . . . 0.0 110.606 -179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.69 HD12 HD12 ' A' ' 46' ' ' LEU . 2.7 tm? -143.72 133.99 24.49 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 108.247 -1.019 . . . . 0.0 108.247 179.258 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.614 ' O ' HG21 ' A' ' 5' ' ' VAL . 5.5 mp0 -125.2 -135.45 0.27 Allowed 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.316 -0.865 . . . . 0.0 108.755 178.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.642 ' HB2' ' CG ' ' A' ' 44' ' ' LYS . 10.0 t90 -92.62 -95.6 0.14 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.181 -0.949 . . . . 0.0 109.4 179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.545 ' HD3' ' ND2' ' A' ' 76' ' ' ASN . 0.1 OUTLIER 67.75 157.33 0.13 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.0 109.475 -179.683 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 t30 . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.583 -179.967 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.45 ' O ' ' HB3' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.264 0.554 . . . . 0.0 109.547 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.45 ' HB3' ' O ' ' A' ' 1' ' ' MET . 4.1 p 178.01 -31.76 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.215 -0.928 . . . . 0.0 109.536 179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.592 ' HA ' ' CE3' ' A' ' 88' ' ' TRP . 49.0 m -77.65 152.28 33.9 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 0.0 109.402 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.866 ' O ' HD12 ' A' ' 4' ' ' LEU . 1.2 pp -148.35 152.1 36.47 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 121.384 -0.822 . . . . 0.0 109.884 179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.821 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 3.7 t -113.63 176.62 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.608 -0.683 . . . . 0.0 109.197 -179.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.625 ' H ' HG12 ' A' ' 5' ' ' VAL . 8.9 t80 -143.18 138.46 29.74 Favored 'General case' 0 C--N 1.295 -1.769 0 O-C-N 121.001 -1.062 . . . . 0.0 108.276 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.562 HG22 ' HA ' ' A' ' 73' ' ' ILE . 3.6 pt -156.89 156.07 4.73 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 O-C-N 121.13 -0.981 . . . . 0.0 108.475 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' THR . . . -163.99 141.25 6.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.78 -1.2 . . . . 0.0 109.902 179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.67 ' CD2' HD11 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -139.54 -167.47 2.27 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.079 -1.013 . . . . 0.0 109.02 -179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.665 ' HB2' HG12 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -156.27 93.51 1.42 Allowed 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 11' ' ' ASP . 0.5 OUTLIER -109.6 -170.97 1.75 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -71.72 -104.34 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.045 -1.034 . . . . 0.0 109.235 179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -145.0 7.17 1.19 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.867 -1.146 . . . . 0.0 110.088 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -102.52 -57.13 2.11 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.045 -1.034 . . . . 0.0 109.494 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.2 92.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.326 -0.859 . . . . 0.0 109.816 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.512 ' NH1' ' HG3' ' A' ' 16' ' ' ARG . 0.1 OUTLIER -66.46 -36.72 83.47 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.133 -0.979 . . . . 0.0 109.301 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.473 ' O ' ' HB3' ' A' ' 20' ' ' GLU . 11.1 t80 -62.73 -44.13 97.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.32 -0.863 . . . . 0.0 109.148 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.8 t -57.14 -53.11 47.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.238 -0.913 . . . . 0.0 109.17 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 49.0 t -62.57 -24.01 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.205 -0.934 . . . . 0.0 109.281 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -66.64 -48.87 68.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.289 179.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.27 -38.63 91.91 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.205 -0.934 . . . . 0.0 109.371 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 95.9 mt -60.81 -46.89 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.254 -0.904 . . . . 0.0 109.412 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.402 HG21 ' O ' ' A' ' 30' ' ' VAL . 29.1 mt -52.83 -52.45 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 0.0 108.813 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.418 ' O ' ' C ' ' A' ' 25' ' ' ASP . 1.4 mp0 -58.68 -31.06 67.86 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.208 -0.932 . . . . 0.0 108.631 179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 24' ' ' GLN . 1.1 t70 -46.15 -42.0 13.28 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.589 -1.264 . . . . 0.0 107.589 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -96.63 131.49 28.09 Favored Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 178.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -83.92 47.57 2.31 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.703 1.37 . . . . 0.0 110.085 -179.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 29' ' ' ALA . 30.0 t-80 -154.52 -50.83 0.09 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.25 -0.906 . . . . 0.0 109.977 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 28' ' ' HIS . . . -41.36 140.42 0.87 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.796 . . . . 0.0 109.991 -179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.708 HG22 ' H ' ' A' ' 31' ' ' VAL . 1.6 p -78.66 -169.28 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.317 -0.864 . . . . 0.0 108.715 179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.708 ' H ' HG22 ' A' ' 30' ' ' VAL . 15.6 m -122.88 -155.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 120.996 -1.065 . . . . 0.0 109.477 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.559 ' HB3' ' CA ' ' A' ' 38' ' ' ILE . 2.3 mp0 -112.75 -151.74 0.49 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.073 -1.017 . . . . 0.0 109.604 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -99.34 -96.21 0.24 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.873 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.565 ' CB ' ' CD ' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -163.89 -69.55 0.01 OUTLIER Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 121.009 -1.057 . . . . 0.0 109.569 -179.645 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 34' ' ' HIS . 5.7 Cg_exo -49.27 -178.96 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.534 0 O-C-N 123.904 1.476 . . . . 0.0 110.47 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.481 ' HB1' ' NE2' ' A' ' 10' ' ' GLN . . . -43.09 -36.07 1.52 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.384 -0.823 . . . . 0.0 109.896 -179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.494 ' HA ' ' HG2' ' A' ' 10' ' ' GLN . 66.2 mtm -63.91 144.18 57.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.002 -1.061 . . . . 0.0 109.13 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.67 HD11 ' CD2' ' A' ' 9' ' ' PHE . 6.3 pt -146.28 109.3 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.251 -0.906 . . . . 0.0 109.524 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.554 ' N ' ' HB3' ' A' ' 32' ' ' GLN . 1.6 mtt-85 -90.74 174.45 7.47 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 0.0 109.523 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.611 HG22 ' N ' ' A' ' 41' ' ' GLU . 11.4 mt -161.98 166.96 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.449 -0.782 . . . . 0.0 109.391 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.615 ' HB2' HG11 ' A' ' 30' ' ' VAL . 5.7 tp10 -142.79 170.4 15.76 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.2 -0.938 . . . . 0.0 109.005 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.821 ' HB3' ' HB ' ' A' ' 5' ' ' VAL . . . -140.84 -168.81 2.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.26 -0.9 . . . . 0.0 109.724 179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.741 ' HA ' ' HA ' ' A' ' 4' ' ' LEU . 1.6 pm0 -143.37 85.16 1.84 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.511 -0.743 . . . . 0.0 109.758 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.581 ' CB ' ' HB2' ' A' ' 3' ' ' SER . 0.0 OUTLIER 83.4 -179.68 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 107.611 -1.255 . . . . 0.0 107.611 -178.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.674 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 3.8 mmt180 179.5 -165.58 0.06 Allowed 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 118.998 -1.081 . . . . 0.0 109.435 178.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.674 ' HG ' ' O ' ' A' ' 45' ' ' ARG . 4.8 mt 164.48 -158.28 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 177.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.836 ' H ' HG23 ' A' ' 85' ' ' VAL . 2.0 mt-10 162.59 -167.22 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.828 -1.17 . . . . 0.0 109.394 178.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.825 HG23 ' N ' ' A' ' 49' ' ' ARG . 0.8 OUTLIER -177.31 -151.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.146 -0.972 . . . . 0.0 109.634 179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.825 ' N ' HG23 ' A' ' 48' ' ' ILE . 11.0 ttp180 -91.73 -37.05 13.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.949 -1.095 . . . . 0.0 110.131 -179.094 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.621 ' H ' HG23 ' A' ' 48' ' ' ILE . 0.0 OUTLIER -59.7 -32.46 70.54 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.879 . . . . 0.0 109.918 -179.555 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 54' ' ' GLU . 20.8 mm-40 -58.05 -27.64 63.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.134 -0.979 . . . . 0.0 109.665 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 4.1 m -64.84 -41.39 95.76 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.003 -1.06 . . . . 0.0 109.434 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.6 t -53.52 -29.66 17.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.494 ' HB3' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -70.69 -40.5 72.85 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HB3' ' HA ' ' A' ' 60' ' ' ALA . 17.8 mt-10 -57.49 -62.91 1.45 Allowed 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.47 ' HA ' ' H ' ' A' ' 60' ' ' ALA . 0.7 OUTLIER -44.0 -36.75 2.62 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.131 -0.98 . . . . 0.0 109.057 179.306 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 54' ' ' GLU . 9.9 tp -57.65 -50.02 74.53 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 177.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.565 ' O ' ' HB3' ' A' ' 59' ' ' ARG . . . -78.59 15.79 9.07 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 107.845 -2.102 . . . . 0.0 107.845 176.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.565 ' HB3' ' O ' ' A' ' 58' ' ' GLY . 2.8 ttt180 68.34 49.64 0.79 Allowed 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 121.415 0.626 . . . . 0.0 110.056 179.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.659 ' O ' ' N ' ' A' ' 62' ' ' ASP . . . 57.31 93.21 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 104.015 -2.587 . . . . 0.0 104.015 -177.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TRP . . . . . 0.598 ' C ' ' O ' ' A' ' 60' ' ' ALA . 57.4 t90 -16.3 81.09 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.567 0 CA-C-O 123.434 1.588 . . . . 0.0 109.319 -174.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 60' ' ' ALA . 20.8 t70 -102.44 66.82 0.99 Allowed 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 113.138 -1.846 . . . . 0.0 110.012 -176.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.514 HG12 ' O ' ' A' ' 63' ' ' VAL . 19.5 t -89.56 6.63 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.293 -0.88 . . . . 0.0 109.558 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.946 ' O ' HD22 ' A' ' 67' ' ' LEU . 5.4 mp0 -42.58 -31.66 0.47 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.346 -0.847 . . . . 0.0 109.454 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -66.48 -49.66 65.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.119 -0.988 . . . . 0.0 109.236 179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.5 ' O ' ' N ' ' A' ' 68' ' ' VAL . 1.4 mtt -72.95 -5.35 37.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.919 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.946 HD22 ' O ' ' A' ' 64' ' ' GLN . 1.5 pt? -39.21 -26.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.467 -0.771 . . . . 0.0 110.788 -179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.589 HG13 ' N ' ' A' ' 69' ' ' ASP . 5.8 p -40.52 -49.08 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.217 -0.927 . . . . 0.0 109.599 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.589 ' N ' HG13 ' A' ' 68' ' ' VAL . 0.6 OUTLIER -72.64 146.17 46.78 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.665 HG12 ' HB2' ' A' ' 10' ' ' GLN . 6.9 p -76.15 173.79 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 C-N-CA 118.832 -1.147 . . . . 0.0 108.841 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ILE . . . . . 0.64 ' H ' HG22 ' A' ' 70' ' ' VAL . 9.1 mt -153.17 157.0 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.228 -0.92 . . . . 0.0 109.835 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.553 ' N ' ' O ' ' A' ' 8' ' ' ALA . 1.0 OUTLIER -149.56 152.07 34.89 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.274 -0.891 . . . . 0.0 109.491 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.697 HD13 ' C ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -137.47 159.31 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 -179.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 6' ' ' TYR . . . -159.81 66.73 0.27 Allowed Glycine 0 N--CA 1.49 2.291 0 C-N-CA 119.441 -1.362 . . . . 0.0 110.794 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.505 ' C ' ' O ' ' A' ' 88' ' ' TRP . . . -127.94 -105.89 1.31 Allowed Glycine 0 N--CA 1.484 1.866 0 N-CA-C 108.004 -2.038 . . . . 0.0 108.004 178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.609 ' C ' HD21 ' A' ' 86' ' ' LEU . 2.9 t-20 -165.12 -144.57 0.07 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.18 -1.188 . . . . 0.0 108.435 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.649 HG13 ' O ' ' A' ' 77' ' ' VAL . 7.4 p -170.28 98.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 120.881 -1.137 . . . . 0.0 110.587 178.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.495 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 0.0 OUTLIER -114.38 127.46 55.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.438 -0.789 . . . . 0.0 109.439 179.404 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -128.05 149.99 50.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 109.61 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -109.82 -103.65 0.38 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.211 -0.93 . . . . 0.0 109.364 179.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -104.23 -54.14 2.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.951 -1.093 . . . . 0.0 108.909 179.628 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 83' ' ' ARG . 79.8 m-20 -130.67 -39.75 1.25 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.554 ' CG ' ' HB2' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -51.65 -175.86 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 121.602 0.715 . . . . 0.0 109.728 179.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 48' ' ' ILE . 0.3 OUTLIER -160.23 111.07 1.88 Allowed 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.603 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.836 HG23 ' H ' ' A' ' 47' ' ' GLU . 4.0 p -124.37 143.6 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.061 -1.024 . . . . 0.0 109.251 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.803 ' C ' HD13 ' A' ' 86' ' ' LEU . 2.2 tm? -151.22 129.45 11.95 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 117.885 -1.526 . . . . 0.0 110.571 179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.665 ' HB3' ' O ' ' A' ' 45' ' ' ARG . 0.0 OUTLIER -118.18 -178.9 3.62 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.647 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 5.6 t90 -43.1 -88.79 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 118.457 -1.297 . . . . 0.0 108.244 177.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.558 ' N ' ' CG ' ' A' ' 88' ' ' TRP . 1.3 tttt -167.11 36.38 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.022 -1.049 . . . . 0.0 109.523 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.7 t30 . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 118.054 -0.974 . . . . 0.0 109.415 179.879 . . . . . . . . 0 0 . 1 stop_ save_